(+)-catechin multiple interactions ISO Bcl2 (Mus musculus) 6480464 Quercetin affects the reaction [Catechin affects the expression of BCL2 mRNA] CTD PMID:26363153 (+)-catechin decreases expression ISO BCL2 (Homo sapiens) 6480464 Catechin results in decreased expression of BCL2 mRNA and Catechin results in decreased expression of BCL2 protein CTD PMID:23706674 (+)-catechin multiple interactions EXP 6480464 Catechin analog inhibits the reaction [Benzo(a)pyrene results in decreased expression of BCL2 mRNA] more ... CTD PMID:18611398 and PMID:34027802 (+)-catechin multiple interactions ISO BCL2 (Homo sapiens) 6480464 Catechin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein] CTD PMID:19557821 (+)-catechin affects expression ISO Bcl2 (Mus musculus) 6480464 Catechin affects the expression of BCL2 mRNA CTD PMID:26363153 (+)-epicatechin-3-O-gallate multiple interactions ISO Bcl2 (Mus musculus) 6480464 epicatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of BCL2 mRNA] CTD PMID:18656336 (+)-pilocarpine decreases expression EXP 6480464 Pilocarpine results in decreased expression of BCL2 protein CTD PMID:19429016 (+)-sesamin multiple interactions ISO Bcl2 (Mus musculus) 6480464 sesamin inhibits the reaction [nickel sulfate results in decreased expression of BCL2 protein] CTD PMID:23317420 (+)-sesamin multiple interactions EXP 6480464 sesamin affects the reaction [Glucose affects the expression of BCL2 protein] CTD PMID:22524206 (+)-taxifolin multiple interactions EXP 6480464 Fluvastatin promotes the reaction [taxifolin inhibits the reaction [bisphenol A results in decreased expression of BCL2 protein]] more ... CTD PMID:32525071 and PMID:35465754 (+)-Tetrandrine decreases expression ISO BCL2 (Homo sapiens) 6480464 tetrandrine results in decreased expression of BCL2 mRNA and tetrandrine results in decreased expression of BCL2 protein CTD PMID:18495333 more ... (+)-Tetrandrine increases expression ISO BCL2 (Homo sapiens) 6480464 tetrandrine results in increased expression of BCL2 protein CTD PMID:31255635 (+)-Tetrandrine multiple interactions ISO BCL2 (Homo sapiens) 6480464 CYP3A5 protein promotes the reaction [tetrandrine results in decreased expression of BCL2 protein] CTD PMID:26302866 (+)-Tetrandrine affects response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein affects the susceptibility to tetrandrine CTD PMID:18495333 (-)-alpha-phellandrene increases phosphorylation ISO BCL2 (Homo sapiens) 6480464 alpha phellandrene results in increased phosphorylation of BCL2 protein CTD PMID:25649747 (-)-anisomycin multiple interactions EXP 6480464 [Colistin co-treated with Anisomycin] results in increased phosphorylation of BCL2 protein CTD PMID:28842171 (-)-citrinin decreases expression ISO Bcl2 (Mus musculus) 6480464 Citrinin results in decreased expression of BCL2 protein CTD PMID:21622943 (-)-citrinin affects expression ISO Bcl2 (Mus musculus) 6480464 Citrinin affects the expression of BCL2 protein CTD PMID:22771370 (-)-epigallocatechin 3-gallate multiple interactions ISO Bcl2 (Mus musculus) 6480464 epigallocatechin gallate affects the reaction [mono-(2-ethylhexyl)phthalate affects the expression of BCL2 protein] more ... CTD PMID:18656336 more ... (-)-epigallocatechin 3-gallate decreases expression ISO Bcl2 (Mus musculus) 6480464 epigallocatechin gallate results in decreased expression of BCL2 protein CTD PMID:34600025 (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 [epigallocatechin gallate co-treated with coenzyme Q10] inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] and epigallocatechin gallate inhibits the reaction [Acrylamide results in decreased expression of BCL2 protein] CTD PMID:28056603 and PMID:33393703 (-)-epigallocatechin 3-gallate affects expression EXP 6480464 epigallocatechin gallate affects the expression of BCL2 protein CTD PMID:22000973 (-)-epigallocatechin 3-gallate decreases expression ISO BCL2 (Homo sapiens) 6480464 epigallocatechin gallate analog results in decreased expression of BCL2 protein and epigallocatechin gallate results in decreased expression of BCL2 protein CTD PMID:15657356 more ... (-)-epigallocatechin 3-gallate affects expression ISO BCL2 (Homo sapiens) 6480464 epigallocatechin gallate affects the expression of BCL2 protein CTD PMID:15975156 (-)-epigallocatechin 3-gallate multiple interactions ISO BCL2 (Homo sapiens) 6480464 [arsenic trioxide co-treated with epigallocatechin gallate] results in decreased expression of BCL2 protein more ... CTD PMID:12672908 more ... (-)-gambogic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Verapamil co-treated with gambogic acid] results in decreased expression of BCL2 protein and Fluorouracil promotes the reaction [gambogic acid results in decreased expression of BCL2 mRNA] CTD PMID:19084572 and PMID:24373880 (-)-gambogic acid affects expression ISO BCL2 (Homo sapiens) 6480464 gambogic acid affects the expression of BCL2 protein CTD PMID:19433130 (-)-gambogic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 gambogic acid results in decreased expression of BCL2 mRNA CTD PMID:15968715 more ... (-)-noscapine decreases expression ISO BCL2 (Homo sapiens) 6480464 Noscapine results in decreased expression of BCL2 protein CTD PMID:20674069 (-)-noscapine multiple interactions ISO BCL2 (Homo sapiens) 6480464 Noscapine promotes the reaction [Cisplatin results in decreased expression of BCL2 protein] CTD PMID:20674069 (-)-selegiline multiple interactions ISO Bcl2 (Mus musculus) 6480464 Selegiline inhibits the reaction [linsidomine results in decreased expression of BCL2 protein] CTD PMID:12880480 (20S)-ginsenoside Rg3 multiple interactions ISO BCL2 (Homo sapiens) 6480464 ginsenoside Rg3 inhibits the reaction [cagA protein and Helicobacter pylori results in increased expression of BCL2 protein] CTD PMID:26427350 (20S)-ginsenoside Rh2 decreases expression ISO BCL2 (Homo sapiens) 6480464 ginsenoside Rh2 results in decreased expression of BCL2 protein CTD PMID:26482938 and PMID:32762018 (6aR,11aS,11bR)-10-acetyl-11-hydroxy-7,7-dimethyl-2,6,6a,7,11a,11b-hexahydro-9H-pyrrolo[1',2':2,3]isoindolo[4,5,6-cd]indol-9-one decreases expression ISO Bcl2 (Mus musculus) 6480464 cyclopiazonic acid results in decreased expression of BCL2 mRNA CTD PMID:33400354 (E)-roxithromycin decreases expression ISO BCL2 (Homo sapiens) 6480464 Roxithromycin results in decreased expression of BCL2 protein CTD PMID:12921874 (E)-thiamethoxam decreases expression ISO Bcl2 (Mus musculus) 6480464 Thiamethoxam results in decreased expression of BCL2 protein CTD PMID:33533595 (E,E)-germacrone multiple interactions ISO BCL2 (Homo sapiens) 6480464 [germacrone results in increased susceptibility to Doxorubicin] which results in decreased expression of BCL2 CTD PMID:29655913 (R)-adrenaline increases expression ISO Bcl2 (Mus musculus) 6480464 Epinephrine results in increased expression of BCL2 protein CTD PMID:36423730 (R)-adrenaline increases expression ISO BCL2 (Homo sapiens) 6480464 Epinephrine results in increased expression of BCL2 protein CTD PMID:36423730 (R)-carnitine multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carnitine results in increased phosphorylation of BCL2 protein] more ... CTD PMID:23213347 more ... (R)-carnitine increases phosphorylation EXP 6480464 Carnitine results in increased phosphorylation of BCL2 protein CTD PMID:29186614 (R)-lipoic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 Thioctic Acid inhibits the reaction [Zinc deficiency results in decreased expression of BCL2 protein] more ... CTD PMID:16990509 more ... (R)-lipoic acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 Thioctic Acid inhibits the reaction [Dietary Fats results in decreased expression of BCL2 mRNA] CTD PMID:27260466 (R)-lipoic acid multiple interactions EXP 6480464 Thioctic Acid inhibits the reaction [[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of BCL2 mRNA] more ... CTD PMID:23830814 more ... (R)-lipoic acid decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to Thioctic Acid CTD PMID:16990509 (R)-noradrenaline multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Norepinephrine results in decreased expression of BCL2 protein] and N-(1-methyl-5-indolyl)-N'-(3-methyl-5-isothiazolyl)urea inhibits the reaction [Norepinephrine results in decreased expression of BCL2 protein] CTD PMID:17041759 and PMID:20374255 (R)-noradrenaline decreases expression EXP 6480464 Norepinephrine results in decreased expression of BCL2 protein CTD PMID:14732211 more ... (R)-salsolinol decreases expression EXP 6480464 salsolinol results in decreased expression of BCL2 protein CTD PMID:23261589 (R,R,R)-alpha-tocopherol multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with Ascorbic Acid] inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 mRNA] more ... CTD PMID:16005924 more ... (R,R,R)-alpha-tocopherol decreases expression ISO BCL2 (Homo sapiens) 6480464 alpha-Tocopherol analog results in decreased expression of BCL2 mRNA and alpha-Tocopherol analog results in decreased expression of BCL2 protein CTD PMID:20686688 (R,R,R)-alpha-tocopherol multiple interactions ISO BCL2 (Homo sapiens) 6480464 alpha-Tocopherol affects the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein] more ... CTD PMID:11805214 more ... (R,S)-Scoulerine decreases expression ISO BCL2 (Homo sapiens) 6480464 discretamine results in decreased expression of BCL2 protein CTD PMID:32590070 (S)-(-)-perillyl alcohol multiple interactions ISO Bcl2 (Mus musculus) 6480464 perillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BCL2 protein] CTD PMID:19161993 (S)-amphetamine decreases expression ISO BCL2 (Homo sapiens) 6480464 Dextroamphetamine results in decreased expression of BCL2 mRNA CTD PMID:23820845 (S)-amphetamine multiple interactions ISO BCL2 (Homo sapiens) 6480464 [N-Methyl-3 and 4-methylenedioxyamphetamine co-treated with Methamphetamine co-treated with 4-methylthioamphetamine co-treated with Dextroamphetamine] results in decreased expression of BCL2 mRNA CTD PMID:23820845 (S)-colchicine multiple interactions EXP 6480464 Colchicine inhibits the reaction [Ethanol results in increased expression of BCL2 mRNA] CTD PMID:22446813 (S)-colchicine multiple interactions ISO BCL2 (Homo sapiens) 6480464 dihydroactinidiolide inhibits the reaction [Colchicine results in decreased expression of BCL2 protein] CTD PMID:33617922 (S)-colchicine decreases expression ISO BCL2 (Homo sapiens) 6480464 Colchicine results in decreased expression of BCL2 protein CTD PMID:22342440 more ... (S)-naringenin decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to naringenin CTD PMID:19124070 (S)-naringenin decreases expression ISO BCL2 (Homo sapiens) 6480464 naringenin results in decreased expression of BCL2 mRNA CTD PMID:30153467 and PMID:36235125 (S)-naringenin multiple interactions EXP 6480464 naringenin inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA] and naringenin inhibits the reaction [Glucose results in decreased expression of BCL2 protein] CTD PMID:23192364 (S)-naringenin multiple interactions ISO BCL2 (Homo sapiens) 6480464 [naringenin co-treated with bisphenol A] results in increased expression of BCL2 mRNA more ... CTD PMID:19124070 more ... (S)-nicotine multiple interactions ISO BCL2 (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [Nicotine results in decreased expression of BCL2 protein] more ... CTD PMID:12421819 more ... (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of BCL2 protein CTD PMID:34153408 (S)-nicotine multiple interactions EXP 6480464 Folic Acid inhibits the reaction [Nicotine results in decreased expression of BCL2 protein] CTD PMID:29972271 (S)-nicotine increases expression ISO Bcl2 (Mus musculus) 6480464 Nicotine results in increased expression of BCL2 protein CTD PMID:31783125 (S)-nicotine multiple interactions ISO Bcl2 (Mus musculus) 6480464 royal jelly inhibits the reaction [Nicotine results in decreased expression of BCL2 mRNA] CTD PMID:30896085 (S)-nicotine decreases expression ISO BCL2 (Homo sapiens) 6480464 Nicotine results in decreased expression of BCL2 protein CTD PMID:33010382 (S)-nicotine increases expression ISO BCL2 (Homo sapiens) 6480464 Nicotine results in increased expression of BCL2 mRNA more ... CTD PMID:18448488 more ... (S)-nicotine decreases expression ISO Bcl2 (Mus musculus) 6480464 Nicotine results in decreased expression of BCL2 mRNA CTD PMID:15831280 and PMID:30896085 (S)-nicotine increases phosphorylation ISO BCL2 (Homo sapiens) 6480464 Nicotine results in increased phosphorylation of BCL2 protein CTD PMID:12421819 (S)-nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of BCL2 mRNA and Nicotine results in decreased expression of BCL2 protein CTD PMID:20339300 and PMID:29972271 (S)-ropivacaine decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to Ropivacaine CTD PMID:15538973 (S)-ropivacaine decreases expression ISO BCL2 (Homo sapiens) 6480464 Ropivacaine results in decreased expression of BCL2 protein CTD PMID:36193553 (S)-ropivacaine decreases expression EXP 6480464 Ropivacaine results in decreased expression of BCL2 mRNA and Ropivacaine results in decreased expression of BCL2 protein CTD PMID:34091999 (S)-ropivacaine multiple interactions EXP 6480464 pifithrin inhibits the reaction [Ropivacaine results in decreased expression of BCL2 mRNA] and pifithrin inhibits the reaction [Ropivacaine results in decreased expression of BCL2 protein] CTD PMID:34091999 (S)-ropivacaine multiple interactions ISO BCL2 (Homo sapiens) 6480464 BCL2 protein inhibits the reaction [Ropivacaine results in increased cleavage of CASP3 protein] and BCL2 protein inhibits the reaction [Ropivacaine results in increased cleavage of PARP1 protein] CTD PMID:15538973 (Z)-ligustilide decreases expression ISO BCL2 (Homo sapiens) 6480464 ligustilide results in decreased expression of BCL2 mRNA and ligustilide results in decreased expression of BCL2 protein CTD PMID:31765699 1'-acetoxychavicol acetate multiple interactions ISO BCL2 (Homo sapiens) 6480464 1'-acetoxychavicol acetate inhibits the reaction [TNF protein results in increased expression of BCL2 protein] CTD PMID:15905586 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane increases expression ISO Bcl2 (Mus musculus) 6480464 2 more ... CTD PMID:15525693 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO BCL2 (Homo sapiens) 6480464 o more ... CTD PMID:10545406 and PMID:22609851 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression ISO BCL2 (Homo sapiens) 6480464 o and p'-DDT results in decreased expression of BCL2 protein CTD PMID:35122929 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane multiple interactions ISO BCL2 (Homo sapiens) 6480464 fulvestrant inhibits the reaction [o and p'-DDT results in increased expression of BCL2 protein] CTD PMID:10545406 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP 6480464 o and p'-DDT results in increased expression of BCL2 mRNA CTD PMID:22937105 1,2-dichloroethane decreases expression ISO Bcl2 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of BCL2 mRNA and ethylene dichloride results in decreased expression of BCL2 protein CTD PMID:28973639 and PMID:34560092 1,2-dichloroethane decreases expression ISO BCL2 (Homo sapiens) 6480464 ethylene dichloride results in decreased expression of BCL2 mRNA and ethylene dichloride results in decreased expression of BCL2 protein CTD PMID:34560092 1,2-dichloroethane multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Antagomirs results in decreased expression of MIR182 mRNA] inhibits the reaction [ethylene dichloride results in decreased expression of BCL2 mRNA] and [Antagomirs results in decreased expression of MIR182 mRNA] inhibits the reaction [ethylene dichloride results in decreased expression of BCL2 protein] CTD PMID:34560092 1,2-dichloroethane increases expression ISO Bcl2 (Mus musculus) 6480464 ethylene dichloride results in increased expression of BCL2 mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1 more ... CTD PMID:15309441 more ... 1,2-dimethylhydrazine affects expression ISO Bcl2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine affects the expression of BCL2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression EXP 6480464 1 and 2-Dimethylhydrazine results in decreased expression of BCL2 protein CTD PMID:31925992 1,2-dimethylhydrazine increases expression EXP 6480464 1 more ... CTD PMID:15309441 more ... 1,3-dichloropropan-2-ol multiple interactions ISO Bcl2 (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [1 and 3-dichloro-2-propanol results in decreased expression of BCL2 protein] CTD PMID:29248572 1,3-dichloropropan-2-ol decreases expression ISO Bcl2 (Mus musculus) 6480464 1 and 3-dichloro-2-propanol results in decreased expression of BCL2 protein CTD PMID:29248572 1,3-dinitrobenzene increases expression EXP 6480464 3-dinitrobenzene results in increased expression of BCL2 mRNA CTD PMID:16025311 1,3-dinitrobenzene decreases expression ISO Bcl2 (Mus musculus) 6480464 3-dinitrobenzene results in decreased expression of BCL2 mRNA and 3-dinitrobenzene results in decreased expression of BCL2 protein CTD PMID:19477251 1,3-thiazolidine-2,4-dione decreases expression ISO BCL2 (Homo sapiens) 6480464 2 and 4-thiazolidinedione results in decreased expression of BCL2 protein CTD PMID:15916743 1,4-benzoquinone decreases expression ISO BCL2 (Homo sapiens) 6480464 quinone results in decreased expression of BCL2 protein CTD PMID:20499891 1,4-benzoquinone multiple interactions ISO BCL2 (Homo sapiens) 6480464 [HIF1A protein co-treated with quinone] results in increased expression of BCL2 protein CTD PMID:30448556 1,4-dithiothreitol multiple interactions ISO BCL2 (Homo sapiens) 6480464 Dithiothreitol inhibits the reaction [arsenic trioxide results in increased expression of BCL2 protein] CTD PMID:18022205 1,4-naphthoquinone multiple interactions ISO BCL2 (Homo sapiens) 6480464 FR 180204 promotes the reaction [1 more ... CTD PMID:30871965 1,4-naphthoquinone decreases expression ISO BCL2 (Homo sapiens) 6480464 1 and 4-naphthoquinone analog results in decreased expression of BCL2 protein CTD PMID:30871965 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine multiple interactions EXP 6480464 Trimetazidine inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 mRNA] CTD PMID:25937560 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine multiple interactions ISO Bcl2 (Mus musculus) 6480464 Trimetazidine inhibits the reaction [Folic Acid results in decreased expression of BCL2 protein] CTD PMID:35191561 1-chloro-2,4-dinitrobenzene multiple interactions ISO Bcl2 (Mus musculus) 6480464 NFE2L2 protein promotes the reaction [Dinitrochlorobenzene results in increased expression of BCL2 mRNA] CTD PMID:28219650 1-chloro-2,4-dinitrobenzene affects expression ISO Bcl2 (Mus musculus) 6480464 Dinitrochlorobenzene affects the expression of BCL2 mRNA CTD PMID:28219650 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions ISO Bcl2 (Mus musculus) 6480464 2 more ... CTD PMID:23911879 more ... 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine decreases expression ISO Bcl2 (Mus musculus) 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:23911879 more ... 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of BCL2 mRNA CTD PMID:12883083 1-naphthyl isothiocyanate increases expression ISO Bcl2 (Mus musculus) 6480464 1-Naphthylisothiocyanate results in increased expression of BCL2 mRNA CTD PMID:36460194 1-naphthyl isothiocyanate multiple interactions ISO Bcl2 (Mus musculus) 6480464 3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1 more ... CTD PMID:36460194 1-octadec-9-enoylglycero-3-phosphate increases expression ISO Bcl2 (Mus musculus) 6480464 lysophosphatidic acid analog results in increased expression of BCL2 protein and lysophosphatidic acid results in increased expression of BCL2 protein CTD PMID:23251428 10-Hydroxycamptothecin affects response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein affects the susceptibility to 10-hydroxycamptothecin CTD PMID:16603448 11-deoxycorticosterone multiple interactions EXP 6480464 [Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of BCL2 protein more ... CTD PMID:22431579 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of BCL2 protein CTD PMID:12857939 17alpha-ethynylestradiol multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Streptozocin co-treated with Ethinyl Estradiol] results in increased expression of BCL2 mRNA and Ethinyl Estradiol promotes the reaction [Streptozocin results in decreased expression of BCL2 protein] CTD PMID:24781736 17beta-estradiol decreases expression ISO Bcl2 (Mus musculus) 6480464 Estradiol results in decreased expression of BCL2 mRNA CTD PMID:25210133 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of BCL2 protein CTD PMID:16951259 17beta-estradiol multiple interactions ISO Bcl2 (Mus musculus) 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Estradiol] results in decreased expression of BCL2 mRNA and Estradiol inhibits the reaction [manganese chloride results in decreased expression of BCL2 protein] CTD PMID:24412242 and PMID:29183790 17beta-estradiol increases expression ISO Bcl2 (Mus musculus) 6480464 Estradiol results in increased expression of BCL2 mRNA CTD PMID:17578864 17beta-estradiol increases expression ISO BCL2 (Homo sapiens) 6480464 Estradiol results in increased expression of BCL2 mRNA and Estradiol results in increased expression of BCL2 protein CTD PMID:10455518 more ... 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of BCL2 protein more ... CTD PMID:14659978 more ... 17beta-estradiol decreases expression ISO BCL2 (Homo sapiens) 6480464 Estradiol analog results in decreased expression of BCL2 mRNA more ... CTD PMID:20945400 and PMID:36460128 17beta-estradiol multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Estradiol results in increased activity of ESR1 protein] which results in increased expression of BCL2 mRNA more ... CTD PMID:10545406 more ... 17beta-estradiol affects expression ISO BCL2 (Homo sapiens) 6480464 Estradiol affects the expression of BCL2 mRNA CTD PMID:11896290 and PMID:22082530 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of BCL2 mRNA] and Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of BCL2 protein] CTD PMID:24316378 17beta-estradiol 3-benzoate increases expression EXP 6480464 estradiol 3-benzoate results in increased expression of BCL2 mRNA and estradiol 3-benzoate results in increased expression of BCL2 protein CTD PMID:24316378 17beta-hydroxy-5alpha-androstan-3-one multiple interactions EXP 6480464 Dihydrotestosterone inhibits the reaction [Dehydroepiandrosterone results in increased expression of BCL2 protein] CTD PMID:16407456 17beta-hydroxy-5alpha-androstan-3-one multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Dihydrotestosterone co-treated with Curcumin co-treated with Quercetin] results in increased expression of BCL2 protein CTD PMID:27132804 1H-pyrazole decreases expression ISO Bcl2 (Mus musculus) 6480464 pyrazole results in decreased expression of BCL2 mRNA CTD PMID:33737021 2''-galloylhyperin multiple interactions ISO BCL2 (Homo sapiens) 6480464 2''-galloylhyperin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] CTD PMID:28213291 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression ISO Bcl2 (Mus musculus) 6480464 2 more ... CTD PMID:21291966 2,2',4,4',5,5'-hexachlorobiphenyl affects cleavage ISO Bcl2 (Mus musculus) 6480464 2 more ... CTD PMID:25659934 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression ISO BCL2 (Homo sapiens) 6480464 2 more ... CTD PMID:20638727 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Bcl2 (Mus musculus) 6480464 [2 more ... CTD PMID:21291966 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO Bcl2 (Mus musculus) 6480464 2 more ... CTD PMID:25639565 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO BCL2 (Homo sapiens) 6480464 2 more ... CTD PMID:25697951 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO BCL2 (Homo sapiens) 6480464 ERN1 protein affects the reaction [2 more ... CTD PMID:22543052 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO BCL2 (Homo sapiens) 6480464 2 more ... CTD PMID:22543052 and PMID:31675489 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO Bcl2 (Mus musculus) 6480464 epoxomicin inhibits the reaction [troxerutin inhibits the reaction [2 more ... CTD PMID:25639565 2,2,2-tetramine decreases expression ISO BCL2 (Homo sapiens) 6480464 Trientine results in decreased expression of BCL2 protein CTD PMID:11369509 2,2,2-tetramine increases expression ISO BCL2 (Homo sapiens) 6480464 Trientine results in increased expression of BCL2 protein CTD PMID:14513838 2,2,2-tetramine multiple interactions ISO BCL2 (Homo sapiens) 6480464 Copper Sulfate inhibits the reaction [Trientine results in increased expression of BCL2 protein] CTD PMID:14513838 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO BCL2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of BCL2 protein CTD PMID:9677421 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Bcl2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of BCL2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Bcl2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of BCL2 mRNA CTD PMID:19770486 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of BCL2 mRNA and Tetrachlorodibenzodioxin results in decreased expression of BCL2 protein CTD PMID:15965093 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of BCL2 mRNA and Tetrachlorodibenzodioxin results in increased expression of BCL2 protein CTD PMID:15965093 and PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO BCL2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of BCL2 mRNA CTD PMID:20044593 2,3-bis(4-hydroxyphenyl)propionitrile multiple interactions ISO Bcl2 (Mus musculus) 6480464 2 and 3-bis(4-hydroxyphenyl)-propionitrile promotes the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of BCL2 protein] CTD PMID:24216299 2,3-bis(4-hydroxyphenyl)propionitrile multiple interactions ISO BCL2 (Homo sapiens) 6480464 ESR1 protein affects the reaction [2 more ... CTD PMID:19264808 2,3-bis(4-hydroxyphenyl)propionitrile increases expression ISO BCL2 (Homo sapiens) 6480464 2 more ... CTD PMID:19264808 2,4,6-trinitrobenzenesulfonic acid multiple interactions EXP 6480464 dapagliflozin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of BCL2 protein] more ... CTD PMID:15502641 more ... 2,4,6-trinitrobenzenesulfonic acid decreases abundance EXP 152995414 2 more ... RGD 2,4,6-trinitrobenzenesulfonic acid increases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in increased expression of BCL2 mRNA and Trinitrobenzenesulfonic Acid results in increased expression of BCL2 protein CTD PMID:24637189 2,4,6-trinitrobenzenesulfonic acid decreases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of BCL2 mRNA and Trinitrobenzenesulfonic Acid results in decreased expression of BCL2 protein CTD PMID:15502641 more ... 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:22024335 2,5-hexanedione increases expression EXP 6480464 2 and 5-hexanedione results in increased expression of BCL2 protein CTD PMID:17492505 2,5-hexanedione decreases expression EXP 6480464 2 and 5-hexanedione results in decreased expression of BCL2 mRNA CTD PMID:22337490 2,5-hexanedione decreases expression ISO BCL2 (Homo sapiens) 6480464 2 more ... CTD PMID:21901545 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Temozolomide co-treated with Verapamil] results in decreased expression of BCL2 mRNA more ... CTD PMID:24373880 and PMID:30003979 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile decreases expression ISO BCL2 (Homo sapiens) 6480464 Verapamil results in decreased expression of BCL2 mRNA and Verapamil results in decreased expression of BCL2 protein CTD PMID:30003979 2-(tert-butylimino)-5-phenyl-3-(propan-2-yl)-1,3,5-thiadiazinan-4-one decreases expression ISO BCL2 (Homo sapiens) 6480464 buprofezin results in decreased expression of BCL2 mRNA and buprofezin results in decreased expression of BCL2 protein CTD PMID:36287832 2-acetamidofluorene multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2 protein and IFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2 protein] CTD PMID:11915028 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of BCL2 mRNA CTD PMID:19167416 and PMID:22213190 2-acetamidophenol decreases expression ISO BCL2 (Homo sapiens) 6480464 2-hydroxyacetanilide results in decreased expression of BCL2 mRNA and 2-hydroxyacetanilide results in decreased expression of BCL2 protein CTD PMID:31207345 2-amino-2-deoxy-D-galactopyranose multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of BCL2 protein more ... CTD PMID:20558151 and PMID:20850421 2-amino-2-deoxy-D-galactopyranose multiple interactions EXP 6480464 glycine propionyl carnitine inhibits the reaction [Galactosamine results in decreased expression of BCL2 mRNA] and mangiferin inhibits the reaction [Galactosamine results in decreased expression of BCL2 protein] CTD PMID:22118634 and PMID:24565947 2-amino-2-deoxy-D-galactopyranose decreases expression EXP 6480464 Galactosamine results in decreased expression of BCL2 mRNA and Galactosamine results in decreased expression of BCL2 protein CTD PMID:22118634 and PMID:24565947 2-aminoethoxydiphenylborane multiple interactions EXP 6480464 2-aminoethoxydiphenylborane inhibits the reaction [cadmium acetate results in decreased expression of BCL2 protein] CTD PMID:29883672 2-chloroethanol multiple interactions EXP 6480464 allyl sulfide inhibits the reaction [Ethylene Chlorohydrin results in decreased expression of BCL2 protein] CTD PMID:31585129 2-chloroethanol decreases expression EXP 6480464 Ethylene Chlorohydrin results in decreased expression of BCL2 protein CTD PMID:31585129 2-deoxy-D-glucose multiple interactions ISO BCL2 (Homo sapiens) 6480464 Deoxyglucose affects the reaction [demycarosyl-3D-digitoxosylmithramycin SK affects the expression of BCL2 mRNA] CTD PMID:26079942 2-Hydroxy-6-(8,11,14-pentadecatrienyl)benzoic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 anacardic acid inhibits the reaction [TNF protein results in increased expression of BCL2 protein] CTD PMID:18349320 2-hydroxypropanoic acid increases expression ISO BCL2 (Homo sapiens) 6480464 Lactic Acid results in increased expression of BCL2 mRNA CTD PMID:30851411 2-methoxy-17beta-estradiol multiple interactions EXP 6480464 2-Methoxyestradiol inhibits the reaction [testosterone enanthate results in increased expression of BCL2 mRNA] CTD PMID:30154949 2-methoxy-17beta-estradiol increases phosphorylation ISO Bcl2 (Mus musculus) 6480464 2-Methoxyestradiol results in increased phosphorylation of BCL2 protein CTD PMID:36414027 2-methoxy-17beta-estradiol decreases expression ISO Bcl2 (Mus musculus) 6480464 2-Methoxyestradiol results in decreased expression of BCL2 protein CTD PMID:36414027 2-methoxy-17beta-estradiol decreases expression ISO BCL2 (Homo sapiens) 6480464 2-Methoxyestradiol results in decreased expression of BCL2 protein CTD PMID:17418156 2-methyl-6-(phenylethynyl)pyridine multiple interactions ISO Bcl2 (Mus musculus) 6480464 [6-methyl-2-(phenylethynyl)pyridine co-treated with Oxidopamine] results in decreased expression of BCL2 protein CTD PMID:33571554 2-methyl-6-(phenylethynyl)pyridine multiple interactions EXP 6480464 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Cocaine results in increased phosphorylation of BCL2 protein] CTD PMID:19879923 2-tert-butylhydroquinone increases expression ISO Bcl2 (Mus musculus) 6480464 2-tert-butylhydroquinone results in increased expression of BCL2 mRNA and 2-tert-butylhydroquinone results in increased expression of BCL2 protein CTD PMID:22275372 2-tert-butylhydroquinone multiple interactions EXP 6480464 2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in decreased expression of BCL2 mRNA] more ... CTD PMID:28583816 more ... 2-tert-butylhydroquinone multiple interactions ISO BCL2 (Homo sapiens) 6480464 2-tert-butylhydroquinone inhibits the reaction [Atorvastatin results in decreased expression of BCL2 protein] and 2-tert-butylhydroquinone inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein] CTD PMID:26878773 and PMID:31423616 2-tert-butylhydroquinone increases expression ISO BCL2 (Homo sapiens) 6480464 2-tert-butylhydroquinone results in increased expression of BCL2 protein CTD PMID:22275372 2-tert-butylhydroquinone multiple interactions ISO Bcl2 (Mus musculus) 6480464 2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to BCL2 promoter] more ... CTD PMID:22275372 2-trans,6-trans,10-trans-geranylgeranyl diphosphate multiple interactions ISO BCL2 (Homo sapiens) 6480464 geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of BCL2 mRNA] CTD PMID:18031796 20-hydroxyecdysone affects expression ISO BCL2 (Homo sapiens) 6480464 Ecdysterone affects the expression of BCL2 protein CTD PMID:33878320 20-hydroxypregn-4-en-3-one multiple interactions ISO BCL2 (Homo sapiens) 6480464 3-hydroxypregn-4-en-20-one inhibits the reaction [5-alpha-Dihydroprogesterone results in increased expression of BCL2 mRNA] CTD PMID:19931389 20-hydroxypregn-4-en-3-one decreases expression ISO BCL2 (Homo sapiens) 6480464 3-hydroxypregn-4-en-20-one results in decreased expression of BCL2 mRNA CTD PMID:19931389 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine multiple interactions EXP 6480464 [Puromycin Aminonucleoside co-treated with Melatonin] results in increased expression of BCL2 protein CTD PMID:14993511 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine increases expression EXP 6480464 Puromycin Aminonucleoside results in increased expression of BCL2 protein CTD PMID:15113391 and PMID:16152783 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO BCL2 (Homo sapiens) 6480464 3 more ... CTD PMID:20840854 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO Bcl2 (Mus musculus) 6480464 3 more ... CTD PMID:31563530 3,3',5'-triiodo-L-thyronine multiple interactions EXP 6480464 alpha-Tocopherol inhibits the reaction [Triiodothyronine and Reverse results in increased activity of BCL2 protein] CTD PMID:16135673 3,3',5'-triiodo-L-thyronine increases activity EXP 6480464 Triiodothyronine and Reverse results in increased activity of BCL2 protein CTD PMID:16135673 3,3',5'-triiodothyronine increases activity EXP 6480464 Triiodothyronine and Reverse results in increased activity of BCL2 protein CTD PMID:16135673 3,3',5'-triiodothyronine multiple interactions EXP 6480464 alpha-Tocopherol inhibits the reaction [Triiodothyronine and Reverse results in increased activity of BCL2 protein] CTD PMID:16135673 3,3',5,5'-tetrabromobisphenol A decreases expression ISO Bcl2 (Mus musculus) 6480464 tetrabromobisphenol A results in decreased expression of BCL2 mRNA and tetrabromobisphenol A results in decreased expression of BCL2 protein CTD PMID:22677475 and PMID:27592553 3,3',5,5'-tetrabromobisphenol A increases expression ISO Bcl2 (Mus musculus) 6480464 tetrabromobisphenol A results in increased expression of BCL2 mRNA CTD PMID:35950316 3,3',5,5'-tetrabromobisphenol A decreases expression ISO BCL2 (Homo sapiens) 6480464 tetrabromobisphenol A results in decreased expression of BCL2 mRNA and tetrabromobisphenol A results in decreased expression of BCL2 protein CTD PMID:30951941 3,3',5-triiodo-L-thyronine multiple interactions ISO BCL2 (Homo sapiens) 6480464 Triiodothyronine promotes the reaction [tamibarotene results in decreased expression of BCL2 mRNA] CTD PMID:11201846 3,3',5-triiodo-L-thyronine increases expression EXP 6480464 Triiodothyronine results in increased expression of BCL2 protein CTD PMID:16021636 3,3',5-triiodo-L-thyronine increases expression ISO BCL2 (Homo sapiens) 6480464 Triiodothyronine results in increased expression of BCL2 protein CTD PMID:16021636 3,3'-Dichlorobenzidine affects expression ISO BCL2 (Homo sapiens) 6480464 3 and 3'-Dichlorobenzidine affects the expression of BCL2 protein CTD PMID:24604609 3,3'-diindolylmethane decreases expression ISO BCL2 (Homo sapiens) 6480464 3 more ... CTD PMID:16051428 more ... 3,3'-diindolylmethane decreases expression ISO Bcl2 (Mus musculus) 6480464 3 and 3'-diindolylmethane analog results in decreased expression of BCL2 mRNA CTD PMID:26593444 3,3'-diindolylmethane multiple interactions ISO BCL2 (Homo sapiens) 6480464 3 and 3'-diindolylmethane promotes the reaction [Paclitaxel results in decreased expression of BCL2 protein] CTD PMID:16580691 3,4,8-Trimethyl-1H,2H,3H-imidazo[4,5-F]quinoxalin-2-imine increases expression ISO BCL2 (Homo sapiens) 6480464 3 more ... CTD PMID:23810796 3,4-dihydroxybenzoic acid multiple interactions EXP 6480464 protocatechuic acid inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 mRNA] more ... CTD PMID:18082360 more ... 3,4-dihydroxybenzoic acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 protocatechuic acid inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA] and protocatechuic acid inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein] CTD PMID:33497687 3,4-methylenedioxymethamphetamine increases expression ISO Bcl2 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of BCL2 mRNA CTD PMID:20188158 3,4-methylenedioxymethamphetamine decreases expression ISO BCL2 (Homo sapiens) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of BCL2 mRNA CTD PMID:23820845 3,4-methylenedioxymethamphetamine multiple interactions ISO BCL2 (Homo sapiens) 6480464 [N-Methyl-3 and 4-methylenedioxyamphetamine co-treated with Methamphetamine co-treated with 4-methylthioamphetamine co-treated with Dextroamphetamine] results in decreased expression of BCL2 mRNA CTD PMID:23820845 3,7-dihydropurine-6-thione decreases expression ISO Bcl2 (Mus musculus) 6480464 Mercaptopurine results in decreased expression of BCL2 protein CTD PMID:9058596 3,7-dihydropurine-6-thione multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Doxorubicin co-treated with Dexamethasone co-treated with Vincristine co-treated with Cytarabine co-treated with Mercaptopurine co-treated with Methotrexate co-treated with Cyclophosphamide co-treated with Enzymes and Coenzymes] results in increased expression of BCL2 protein CTD PMID:21182165 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 MK-886 inhibits the reaction [Nicotine results in increased expression of BCL2 protein] CTD PMID:20061081 3-chloropropane-1,2-diol decreases expression ISO BCL2 (Homo sapiens) 6480464 alpha-Chlorohydrin results in decreased expression of BCL2 mRNA and alpha-Chlorohydrin results in decreased expression of BCL2 protein CTD PMID:27732882 and PMID:28070108 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of BCL2 mRNA and alpha-Chlorohydrin results in decreased expression of BCL2 protein CTD PMID:30107153 more ... 3-chloropropane-1,2-diol multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in decreased expression of BCL2 protein] and Apigenin inhibits the reaction [alpha-Chlorohydrin results in decreased expression of BCL2 mRNA] CTD PMID:30107153 and PMID:33651226 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO BCL2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of BCL2 mRNA CTD PMID:28628672 3-methyladenine multiple interactions ISO BCL2 (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [alisol A 24-acetate results in decreased expression of BCL2 protein] more ... CTD PMID:23912912 more ... 3-methyladenine multiple interactions ISO Bcl2 (Mus musculus) 6480464 3-methyladenine inhibits the reaction [Alpha-Amanitin results in decreased expression of BCL2 protein] CTD PMID:35175747 3-methyladenine multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [citreoviridin results in decreased expression of BCL2 protein] CTD PMID:31419397 3-methylcholanthrene increases expression EXP 6480464 Methylcholanthrene results in increased expression of BCL2 mRNA CTD PMID:23273579 3-methylcholanthrene decreases expression ISO Bcl2 (Mus musculus) 6480464 Methylcholanthrene results in decreased expression of BCL2 mRNA CTD PMID:35487396 3-methylthiopropanal affects response to substance ISO Bcl2 (Mus musculus) 6480464 BCL2 protein affects the susceptibility to methional CTD PMID:8611183 3-nitropropanoic acid multiple interactions EXP 6480464 [Tacrolimus co-treated with 3-nitropropionic acid] affects the localization of BCL2 protein more ... CTD PMID:15571979 more ... 3-nitropropanoic acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 3-nitropropionic acid inhibits the reaction [ginsenoside Re inhibits the reaction [3-Pyridinecarboxylic acid more ... CTD PMID:37308051 3-nitropropanoic acid decreases expression EXP 6480464 3-nitropropionic acid results in decreased expression of BCL2 mRNA CTD PMID:21945202 3-phenylprop-2-enal decreases expression ISO BCL2 (Homo sapiens) 6480464 cinnamaldehyde analog results in decreased expression of BCL2 protein and cinnamaldehyde results in decreased expression of BCL2 protein CTD PMID:15566391 more ... 3-phenylprop-2-enal multiple interactions EXP 6480464 cinnamaldehyde inhibits the reaction [Testosterone results in increased expression of BCL2 mRNA] CTD PMID:32628957 3-phenylprop-2-enal multiple interactions ISO BCL2 (Homo sapiens) 6480464 Vitamin E inhibits the reaction [cinnamaldehyde results in decreased expression of BCL2 protein] CTD PMID:15566391 4'-epidoxorubicin increases expression ISO BCL2 (Homo sapiens) 6480464 Epirubicin analog results in increased expression of BCL2 mRNA and Epirubicin results in increased expression of BCL2 mRNA CTD PMID:14503796 more ... 4'-epidoxorubicin multiple interactions ISO Bcl2 (Mus musculus) 6480464 paeonol inhibits the reaction [Epirubicin results in decreased expression of BCL2 protein] CTD PMID:26646421 and PMID:29505745 4'-epidoxorubicin decreases expression ISO Bcl2 (Mus musculus) 6480464 Epirubicin results in decreased expression of BCL2 protein CTD PMID:26646421 and PMID:29505745 4'-epidoxorubicin multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Epirubicin analog co-treated with chrysophsin analog] results in increased expression of BCL2 mRNA and [Epirubicin co-treated with chrysophsin] results in increased expression of BCL2 mRNA CTD PMID:26335193 4,4'-sulfonyldiphenol multiple interactions ISO BCL2 (Homo sapiens) 6480464 6 more ... CTD PMID:28628672 and PMID:33749030 4,4'-sulfonyldiphenol decreases expression EXP 6480464 bisphenol S results in decreased expression of BCL2 mRNA CTD PMID:37357847 4,4'-sulfonyldiphenol increases expression EXP 6480464 bisphenol S results in increased expression of BCL2 mRNA and bisphenol S results in increased expression of BCL2 protein CTD PMID:37357847 4,4'-sulfonyldiphenol affects methylation ISO Bcl2 (Mus musculus) 6480464 bisphenol S affects the methylation of BCL2 gene CTD PMID:31683443 4,4'-sulfonyldiphenol decreases expression ISO BCL2 (Homo sapiens) 6480464 bisphenol S results in decreased expression of BCL2 protein CTD PMID:33749030 4,4'-sulfonyldiphenol decreases methylation ISO BCL2 (Homo sapiens) 6480464 bisphenol S results in decreased methylation of BCL2 gene CTD PMID:31601247 4,4'-sulfonyldiphenol increases methylation ISO Bcl2 (Mus musculus) 6480464 bisphenol S results in increased methylation of BCL2 exon CTD PMID:33297965 4,5,6,7-TETRABROMOBENZOTRIAZOLE multiple interactions ISO BCL2 (Homo sapiens) 6480464 [4 more ... CTD PMID:16489027 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression ISO BCL2 (Homo sapiens) 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BCL2 mRNA and 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BCL2 protein CTD PMID:16582591 more ... 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions ISO BCL2 (Homo sapiens) 6480464 Bungarotoxins inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BCL2 mRNA] more ... CTD PMID:16835749 and PMID:18508827 4-amino-1,8-naphthalimide multiple interactions ISO BCL2 (Homo sapiens) 6480464 4-amino-1 and 8-naphthalimide inhibits the reaction [arsenic trioxide results in increased expression of BCL2 protein] CTD PMID:25972196 4-hydroxy-TEMPO affects expression ISO Bcl2 (Mus musculus) 6480464 tempol affects the expression of BCL2 protein CTD PMID:24550650 4-hydroxyphenyl retinamide decreases expression ISO Bcl2 (Mus musculus) 6480464 Fenretinide results in decreased expression of BCL2 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide decreases expression ISO BCL2 (Homo sapiens) 6480464 Fenretinide results in decreased expression of BCL2 mRNA and Fenretinide results in decreased expression of BCL2 protein CTD PMID:16187019 more ... 4-hydroxyphenyl retinamide multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Fenretinide co-treated with Carmustine] results in decreased expression of BCL2 protein and Fenretinide inhibits the reaction [TNF protein results in increased expression of BCL2 protein] CTD PMID:16187019 and PMID:16230421 4-hydroxyphenyl retinamide affects response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein affects the susceptibility to Fenretinide CTD PMID:7811993 4-methyl-3-[[1-oxo-2-(propylamino)propyl]amino]-2-thiophenecarboxylic acid methyl ester multiple interactions ISO Bcl2 (Mus musculus) 6480464 Carticaine inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein] CTD PMID:32687258 4-nitroaniline multiple interactions ISO BCL2 (Homo sapiens) 6480464 BCL2 protein inhibits the reaction [resveratrol promotes the reaction [[CASP3 protein results in increased cleavage of aspartyl-glutamyl-valyl-aspartyl-p-nitroanilide] which results in increased chemical synthesis of 4-nitroaniline]] CTD PMID:11577002 4-nitrophenol decreases expression ISO Bcl2 (Mus musculus) 6480464 4-nitrophenol results in decreased expression of BCL2 mRNA CTD PMID:34673133 4-nonylphenol increases expression ISO BCL2 (Homo sapiens) 6480464 4-nonylphenol results in increased expression of BCL2 mRNA CTD PMID:15461258 4-nonylphenol multiple interactions EXP 6480464 [bisphenol A co-treated with 4-nonylphenol] results in decreased expression of BCL2 mRNA CTD PMID:30228064 4-nonylphenol decreases expression EXP 6480464 4-nonylphenol results in decreased expression of BCL2 mRNA and 4-nonylphenol results in decreased expression of BCL2 protein CTD PMID:26804764 more ... 4-octylphenol decreases expression ISO Bcl2 (Mus musculus) 6480464 4-octylphenol results in decreased expression of BCL2 mRNA CTD PMID:31345089 4-phenylbutyric acid multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in decreased expression of BCL2 protein] and 4-phenylbutyric acid inhibits the reaction [Methamphetamine results in decreased expression of BCL2 protein] CTD PMID:33651226 and PMID:34214594 4-phenylbutyric acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 4-phenylbutyric acid inhibits the reaction [Silver Compounds results in decreased expression of BCL2 protein] more ... CTD PMID:27816613 and PMID:29306025 4-phenylbutyric acid increases expression EXP 6480464 4-phenylbutyric acid results in increased expression of BCL2 protein CTD PMID:33651226 4-vinylcyclohexene dioxide decreases expression ISO BCL2 (Homo sapiens) 6480464 4-vinyl-1-cyclohexene dioxide results in decreased expression of BCL2 protein CTD PMID:37182589 5-aminolevulinic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 Aminolevulinic Acid analog results in decreased expression of BCL2 mRNA CTD PMID:20676910 5-aza-2'-deoxycytidine increases expression ISO BCL2 (Homo sapiens) 6480464 Decitabine results in increased expression of BCL2 mRNA CTD PMID:21515334 5-aza-2'-deoxycytidine increases expression ISO Bcl2 (Mus musculus) 6480464 Decitabine results in increased expression of BCL2 mRNA CTD PMID:27915011 5-aza-2'-deoxycytidine multiple interactions EXP 6480464 [Paraquat co-treated with Decitabine] results in decreased expression of BCL2 protein and Decitabine inhibits the reaction [Benzene results in decreased expression of BCL2 mRNA] CTD PMID:21143203 and PMID:22796470 5-aza-2'-deoxycytidine multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Decitabine co-treated with epigallocatechin gallate] affects the expression of BCL2 mRNA more ... CTD PMID:18250043 more ... 5-aza-2'-deoxycytidine decreases expression ISO BCL2 (Homo sapiens) 6480464 Decitabine results in decreased expression of BCL2 mRNA and Decitabine results in decreased expression of BCL2 protein CTD PMID:18636160 and PMID:22082530 5-azacytidine multiple interactions ISO Bcl2 (Mus musculus) 6480464 Bleomycin inhibits the reaction [Azacitidine results in decreased expression of BCL2 mRNA] and Bleomycin inhibits the reaction [Azacitidine results in decreased expression of BCL2 protein] CTD PMID:32278510 5-azacytidine decreases expression ISO Bcl2 (Mus musculus) 6480464 Azacitidine results in decreased expression of BCL2 mRNA and Azacitidine results in decreased expression of BCL2 protein CTD PMID:32278510 5-fluorouracil multiple interactions ISO BCL2 (Homo sapiens) 6480464 [[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Fluorouracil] which results in increased expression of BCL2 mRNA more ... CTD PMID:15754201 more ... 5-fluorouracil multiple interactions EXP 6480464 Fluorouracil inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 mRNA] and Fluorouracil inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein] CTD PMID:31129132 5-fluorouracil affects expression ISO BCL2 (Homo sapiens) 6480464 Fluorouracil affects the expression of BCL2 protein CTD PMID:23941782 5-fluorouracil affects response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein affects the susceptibility to Fluorouracil CTD PMID:15177426 more ... 5-fluorouracil decreases expression ISO Bcl2 (Mus musculus) 6480464 Fluorouracil results in decreased expression of BCL2 protein CTD PMID:18567086 more ... 5-fluorouracil increases expression EXP 6480464 Fluorouracil results in increased expression of BCL2 mRNA and Fluorouracil results in increased expression of BCL2 protein CTD PMID:16888818 and PMID:38078205 5-fluorouracil multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Fluorouracil co-treated with casticin] results in decreased expression of BCL2 protein more ... CTD PMID:18567086 more ... 5-fluorouracil increases phosphorylation ISO BCL2 (Homo sapiens) 6480464 Fluorouracil results in increased phosphorylation of BCL2 protein CTD PMID:7654318 5-fluorouracil increases expression ISO BCL2 (Homo sapiens) 6480464 Fluorouracil results in increased expression of BCL2 mRNA CTD PMID:14503796 5-fluorouracil decreases expression ISO BCL2 (Homo sapiens) 6480464 Fluorouracil results in decreased expression of BCL2 more ... CTD PMID:15754201 more ... 5-fluorouracil decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to Fluorouracil CTD PMID:17439414 5-Hydroxycapric acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 5-hydroxydecanoic acid inhibits the reaction [baicalein inhibits the reaction [Bleomycin results in decreased expression of BCL2 protein]] and 5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Bleomycin results in decreased expression of BCL2 protein]] CTD PMID:37783230 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole multiple interactions ISO BCL2 (Homo sapiens) 6480464 Omeprazole inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] CTD PMID:30452898 5alpha-pregnane-3,20-dione increases expression ISO BCL2 (Homo sapiens) 6480464 5-alpha-Dihydroprogesterone results in increased expression of BCL2 mRNA CTD PMID:19931389 5alpha-pregnane-3,20-dione multiple interactions ISO BCL2 (Homo sapiens) 6480464 3-hydroxypregn-4-en-20-one inhibits the reaction [5-alpha-Dihydroprogesterone results in increased expression of BCL2 mRNA] CTD PMID:19931389 6-anilino-5,8-quinolinedione decreases expression ISO BCL2 (Homo sapiens) 6480464 6-anilino-5 and 8-quinolinedione results in decreased expression of BCL2 protein CTD PMID:18544562 6-anilino-5,8-quinolinedione multiple interactions ISO BCL2 (Homo sapiens) 6480464 6-anilino-5 and 8-quinolinedione inhibits the reaction [sodium bichromate results in increased ubiquitination of BCL2 protein] CTD PMID:18544562 6-bromoindirubin-3'-oxime multiple interactions ISO Bcl2 (Mus musculus) 6480464 [trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of BCL2 protein CTD PMID:37116855 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions EXP 6480464 6-chloro-2 more ... CTD PMID:29653943 more ... 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions ISO BCL2 (Homo sapiens) 6480464 6-chloro-2 more ... CTD PMID:37436358 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide decreases expression EXP 6480464 6-chloro-2 more ... CTD PMID:29653943 and PMID:35307491 6-oxocampestanol decreases expression ISO BCL2 (Homo sapiens) 6480464 6-oxocampestanol results in decreased expression of BCL2 protein CTD PMID:32001316 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of BCL2 protein CTD PMID:35101570 6-propyl-2-thiouracil multiple interactions EXP 6480464 Thyroxine inhibits the reaction [Propylthiouracil results in increased expression of BCL2 protein] and xiaoluowan inhibits the reaction [Propylthiouracil results in increased expression of BCL2 protein] CTD PMID:35101570 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of BCL2 mRNA CTD PMID:30047161 6alpha-methylprednisolone multiple interactions EXP 6480464 Methylprednisolone inhibits the reaction [Hydrogen Peroxide affects the expression of BCL2 mRNA] and Methylprednisolone inhibits the reaction [Hydrogen Peroxide affects the expression of BCL2 protein] CTD PMID:17570061 7,12-dimethyltetraphene multiple interactions ISO Bcl2 (Mus musculus) 6480464 [9 more ... CTD PMID:20103723 more ... 7,12-dimethyltetraphene multiple interactions EXP 6480464 [Ruthenium binds to Phloretin] inhibits the reaction [9 more ... CTD PMID:21088903 more ... 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:21088903 more ... 7,12-dimethyltetraphene increases expression ISO Bcl2 (Mus musculus) 6480464 9 more ... CTD PMID:20103723 more ... 7,8-dihydroxycoumarin multiple interactions ISO BCL2 (Homo sapiens) 6480464 alpha-cyano-(3 more ... CTD PMID:30738023 and PMID:37209277 7,8-dihydroxycoumarin multiple interactions ISO Bcl2 (Mus musculus) 6480464 daphnetin inhibits the reaction [Dextran Sulfate results in decreased expression of BCL2 protein] CTD PMID:37209277 7-ketocholesterol multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [7-ketocholesterol results in decreased expression of BCL2 protein] more ... CTD PMID:25845326 7-ketocholesterol decreases expression EXP 6480464 7-ketocholesterol results in decreased expression of BCL2 protein CTD PMID:25845326 8-Br-cAMP decreases expression ISO BCL2 (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of BCL2 CTD PMID:11802967 8-OH-DPAT decreases expression ISO Bcl2 (Mus musculus) 6480464 8-Hydroxy-2-(di-n-propylamino)tetralin results in decreased expression of BCL2 protein CTD PMID:30366073 8-OH-DPAT multiple interactions ISO Bcl2 (Mus musculus) 6480464 acetovanillone inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in decreased expression of BCL2 protein] more ... CTD PMID:30366073 9,10-anthraquinone decreases expression ISO BCL2 (Homo sapiens) 6480464 9 more ... CTD PMID:26915975 9,10-phenanthroquinone decreases expression ISO BCL2 (Homo sapiens) 6480464 9 and 10-phenanthrenequinone results in decreased expression of BCL2 protein CTD PMID:29108775 9,11,13-octadecatrienoic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 eleostearic acid results in decreased expression of BCL2 protein CTD PMID:15961301 9-cis-retinoic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 Alitretinoin results in decreased expression of BCL2 and Alitretinoin results in decreased expression of BCL2 protein CTD PMID:12189556 more ... 9-cis-retinoic acid decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to Alitretinoin CTD PMID:12189556 9-Methoxycamptothecin increases expression ISO BCL2 (Homo sapiens) 6480464 9-methoxycamptothecin results in increased expression of BCL2 mRNA CTD PMID:23369935 [6]-Shogaol decreases expression ISO BCL2 (Homo sapiens) 6480464 shogaol results in decreased expression of BCL2 protein CTD PMID:18384088 abamectin decreases expression EXP 6480464 abamectin results in decreased expression of BCL2 mRNA and abamectin results in decreased expression of BCL2 protein CTD PMID:34748272 abamectin multiple interactions EXP 6480464 Hesperidin inhibits the reaction [abamectin results in decreased expression of BCL2 mRNA] and Hesperidin inhibits the reaction [abamectin results in decreased expression of BCL2 protein] CTD PMID:34748272 ABT-737 multiple interactions ISO Bcl2 (Mus musculus) 6480464 ABT-737 inhibits the reaction [BCL2 protein results in decreased susceptibility to Valproic Acid] and ABT-737 inhibits the reaction [BCL2 protein results in decreased susceptibility to Vorinostat] CTD PMID:19060243 ABT-737 multiple interactions ISO BCL2 (Homo sapiens) 6480464 [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased phosphorylation of BCL2 protein] which results in increased susceptibility to ABT-737 more ... CTD PMID:17097560 more ... ABT-737 decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein modified form results in decreased susceptibility to ABT-737 CTD PMID:17097560 acadesine multiple interactions ISO BCL2 (Homo sapiens) 6480464 acadesine promotes the reaction [Artesunate results in decreased expression of BCL2 protein] CTD PMID:33002460 acadesine multiple interactions EXP 6480464 acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein] CTD PMID:26989860 acetaldehyde decreases expression ISO BCL2 (Homo sapiens) 6480464 Acetaldehyde results in decreased expression of BCL2 mRNA and Acetaldehyde results in decreased expression of BCL2 protein CTD PMID:16814256 and PMID:35158046 acetaldehyde multiple interactions ISO BCL2 (Homo sapiens) 6480464 ADIPOQ protein inhibits the reaction [Acetaldehyde results in decreased expression of BCL2 mRNA] more ... CTD PMID:16814256 and PMID:35158046 acetamide increases expression EXP 6480464 acetamide results in increased expression of BCL2 mRNA CTD PMID:31881176 acetamiprid increases expression ISO Bcl2 (Mus musculus) 6480464 acetamiprid results in increased expression of BCL2 protein CTD PMID:36457797 acetic acid decreases expression EXP 6480464 Acetic Acid results in decreased expression of BCL2 mRNA and Acetic Acid results in decreased expression of BCL2 protein CTD PMID:29518435 and PMID:30594690 acetic acid multiple interactions EXP 6480464 Mesalamine inhibits the reaction [Acetic Acid results in decreased expression of BCL2 mRNA] more ... CTD PMID:29518435 and PMID:30594690 acetylsalicylic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 Aspirin inhibits the reaction [Methotrexate results in decreased expression of BCL2 protein] more ... CTD PMID:16199534 and PMID:23799623 acetylsalicylic acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 Aspirin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BCL2 protein] more ... CTD PMID:25449198 and PMID:37179038 acetylsalicylic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 Aspirin results in decreased expression of BCL2 mRNA and Aspirin results in decreased expression of BCL2 protein CTD PMID:12490308 more ... acetylsalicylic acid multiple interactions EXP 6480464 Aspirin inhibits the reaction [Azoxymethane results in increased expression of BCL2 mRNA] CTD PMID:20043115 acetylsalicylic acid decreases expression ISO Bcl2 (Mus musculus) 6480464 Aspirin results in decreased expression of BCL2 protein CTD PMID:20886344 acetylsalicylic acid increases expression ISO BCL2 (Homo sapiens) 6480464 Aspirin results in increased expression of BCL2 mRNA and Aspirin results in increased expression of BCL2 protein CTD PMID:17342322 and PMID:18636671 acifluorfen decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to acifluorfen CTD PMID:15475374 aconitine decreases expression EXP 6480464 Aconitine results in decreased expression of BCL2 protein CTD PMID:24840785 and PMID:31975431 acrolein decreases expression ISO Bcl2 (Mus musculus) 6480464 Acrolein results in decreased expression of BCL2 protein CTD PMID:24376112 acrolein decreases expression ISO BCL2 (Homo sapiens) 6480464 Acrolein results in decreased expression of BCL2 protein CTD PMID:34958888 acrolein decreases expression EXP 6480464 Acrolein results in decreased expression of BCL2 mRNA and Acrolein results in decreased expression of BCL2 protein CTD PMID:29414845 acrolein multiple interactions EXP 6480464 3 more ... CTD PMID:29414845 acrolein multiple interactions ISO Bcl2 (Mus musculus) 6480464 capsazepine inhibits the reaction [Acrolein results in decreased expression of BCL2 protein] and Glutathione inhibits the reaction [Acrolein results in decreased expression of BCL2 protein] CTD PMID:24376112 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of BCL2 mRNA and Acrylamide results in decreased expression of BCL2 protein CTD PMID:27920337 more ... acrylamide multiple interactions ISO Bcl2 (Mus musculus) 6480464 TFEB protein inhibits the reaction [Acrylamide results in decreased expression of BCL2 protein] CTD PMID:37172712 acrylamide multiple interactions EXP 6480464 epigallocatechin gallate inhibits the reaction [Acrylamide results in decreased expression of BCL2 protein] and Taurine inhibits the reaction [Acrylamide results in decreased expression of BCL2 protein] CTD PMID:28056603 and PMID:29607694 acrylamide decreases expression ISO Bcl2 (Mus musculus) 6480464 Acrylamide results in decreased expression of BCL2 mRNA and Acrylamide results in decreased expression of BCL2 protein CTD PMID:28067054 more ... acrylamide decreases expression ISO BCL2 (Homo sapiens) 6480464 Acrylamide results in decreased expression of BCL2 mRNA CTD PMID:32763439 acrylonitrile decreases expression ISO BCL2 (Homo sapiens) 6480464 Acrylonitrile results in decreased expression of BCL2 protein CTD PMID:16173056 acrylonitrile decreases expression ISO Bcl2 (Mus musculus) 6480464 Acrylonitrile results in decreased expression of BCL2 mRNA and Acrylonitrile results in decreased expression of BCL2 protein CTD PMID:35429547 actinomycin D multiple interactions ISO BCL2 (Homo sapiens) 6480464 BCL2 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein] more ... CTD PMID:11726273 more ... actinomycin D decreases expression ISO BCL2 (Homo sapiens) 6480464 Dactinomycin results in decreased expression of BCL2 mRNA and Dactinomycin results in decreased expression of BCL2 protein CTD PMID:12927789 and PMID:17581298 Adenosine, cyclic 3',5'-[hydrogen [p(s)]-phosphorothioate] multiple interactions ISO BCL2 (Homo sapiens) 6480464 adenosine-3' and 5'-cyclic phosphorothioate inhibits the reaction [Bucladesine inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]] CTD PMID:16822680 afimoxifene decreases expression ISO BCL2 (Homo sapiens) 6480464 afimoxifene results in decreased expression of BCL2 mRNA CTD PMID:19698761 afimoxifene multiple interactions ISO BCL2 (Homo sapiens) 6480464 [annonacin co-treated with afimoxifene] results in decreased expression of BCL2 protein CTD PMID:21840388 aflatoxin B1 decreases expression ISO BCL2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of BCL2 protein CTD PMID:22743290 aflatoxin B1 decreases phosphorylation ISO Bcl2 (Mus musculus) 6480464 Aflatoxin B1 results in decreased phosphorylation of BCL2 protein CTD PMID:34396909 aflatoxin B1 decreases methylation ISO BCL2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of BCL2 intron CTD PMID:30157460 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of BCL2 mRNA CTD PMID:27288928 more ... aflatoxin B1 multiple interactions EXP 6480464 [Curcumin analog co-treated with Hydrogels] inhibits the reaction [Aflatoxin B1 results in decreased expression of BCL2 mRNA] CTD PMID:27288928 aflatoxin B1 multiple interactions ISO Bcl2 (Mus musculus) 6480464 deoxynivalenol promotes the reaction [Aflatoxin B1 results in decreased expression of BCL2 mRNA] and PRKN protein affects the reaction [Aflatoxin B1 results in decreased expression of BCL2 protein] CTD PMID:25445755 and PMID:35304092 aflatoxin B1 decreases expression ISO Bcl2 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of BCL2 mRNA and Aflatoxin B1 results in decreased expression of BCL2 protein CTD PMID:19770486 more ... aflatoxin B1 multiple interactions ISO BCL2 (Homo sapiens) 6480464 Methoxsalen inhibits the reaction [Aflatoxin B1 results in decreased expression of BCL2 protein] and Nicotine inhibits the reaction [Aflatoxin B1 results in decreased expression of BCL2 protein] CTD PMID:22743290 aflatoxin M1 multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Aflatoxin M1 co-treated with ochratoxin A] results in decreased expression of BCL2 protein CTD PMID:34126166 agomelatine multiple interactions EXP 6480464 agomelatine inhibits the reaction [Galactose results in decreased expression of BCL2 protein] CTD PMID:34673010 AH23848 multiple interactions ISO BCL2 (Homo sapiens) 6480464 [6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] promotes the reaction [BAD protein binds to BCL2 protein] more ... CTD PMID:19407222 alachlor increases expression ISO BCL2 (Homo sapiens) 6480464 alachlor results in increased expression of BCL2 protein CTD PMID:10545406 alachlor multiple interactions ISO BCL2 (Homo sapiens) 6480464 fulvestrant inhibits the reaction [alachlor results in increased expression of BCL2 protein] and PK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to alachlor] CTD PMID:10545406 and PMID:12730627 alachlor decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to alachlor CTD PMID:12730627 alantolactone increases expression ISO BCL2 (Homo sapiens) 6480464 alantolactone results in increased expression of BCL2 protein CTD PMID:22721982 alantolactone decreases expression ISO BCL2 (Homo sapiens) 6480464 alantolactone results in decreased expression of BCL2 protein CTD PMID:24252419 alborixin decreases expression ISO BCL2 (Homo sapiens) 6480464 alborixin results in decreased expression of BCL2 protein CTD PMID:27378626 albuterol decreases expression ISO BCL2 (Homo sapiens) 6480464 Albuterol results in decreased expression of BCL2 CTD PMID:11802967 aldehydo-D-glucose multiple interactions EXP 6480464 15-Hydroxy-11 alpha more ... CTD PMID:21803128 more ... aldehydo-D-glucose decreases expression ISO Bcl2 (Mus musculus) 6480464 Glucose results in decreased expression of BCL2 protein CTD PMID:31672611 aldehydo-D-glucose multiple interactions ISO Bcl2 (Mus musculus) 6480464 8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one promotes the reaction [[Glucose co-treated with Bupivacaine] results in decreased expression of BCL2 protein] more ... CTD PMID:23108914 more ... aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of BCL2 mRNA and Glucose results in decreased expression of BCL2 protein CTD PMID:21818840 more ... aldehydo-D-glucose affects expression EXP 6480464 Glucose affects the expression of BCL2 mRNA and Glucose affects the expression of BCL2 protein CTD PMID:22524206 and PMID:24349266 aldehydo-D-glucose decreases expression ISO BCL2 (Homo sapiens) 6480464 Glucose results in decreased expression of BCL2 mRNA and Glucose results in decreased expression of BCL2 protein CTD PMID:18088078 more ... aldehydo-D-glucose multiple interactions ISO BCL2 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased expression of BCL2 protein]] more ... CTD PMID:18088078 more ... alginic acid decreases expression ISO Bcl2 (Mus musculus) 6480464 Alginic Acid results in decreased expression of BCL2 protein CTD PMID:35066102 all-trans-acitretin decreases expression ISO BCL2 (Homo sapiens) 6480464 Acitretin results in decreased expression of BCL2 protein CTD PMID:16109552 and PMID:16196285 all-trans-retinoic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 [1 more ... CTD PMID:10713328 more ... all-trans-retinoic acid decreases expression ISO Bcl2 (Mus musculus) 6480464 Tretinoin results in decreased expression of BCL2 protein CTD PMID:11851873 more ... all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of BCL2 protein CTD PMID:17962954 all-trans-retinoic acid increases expression ISO BCL2 (Homo sapiens) 6480464 Tretinoin results in increased expression of BCL2 mRNA and Tretinoin results in increased expression of BCL2 protein CTD PMID:10750663 more ... all-trans-retinoic acid increases phosphorylation ISO BCL2 (Homo sapiens) 6480464 Tretinoin results in increased phosphorylation of BCL2 protein CTD PMID:18098270 all-trans-retinoic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 Tretinoin results in decreased expression of BCL2 more ... CTD PMID:10713328 more ... all-trans-retinol decreases expression EXP 6480464 Vitamin A results in decreased expression of BCL2 protein CTD PMID:16216918 allethrin decreases expression EXP 6480464 Allethrins results in decreased expression of BCL2 protein CTD PMID:25072698 allethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of BCL2 mRNA and [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of BCL2 mRNA CTD PMID:33396045 more ... allethrin decreases expression ISO BCL2 (Homo sapiens) 6480464 Allethrins results in decreased expression of BCL2 protein CTD PMID:24055895 allicin multiple interactions ISO Bcl2 (Mus musculus) 6480464 allicin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein] CTD PMID:32040233 allopurinol multiple interactions EXP 6480464 Allopurinol inhibits the reaction [fipronil results in decreased expression of BCL2 mRNA] CTD PMID:36916050 alloxan decreases expression EXP 6480464 Alloxan results in decreased expression of BCL2 protein CTD PMID:21982801 more ... alloxan multiple interactions EXP 6480464 Taurine inhibits the reaction [Alloxan results in decreased expression of BCL2 protein] CTD PMID:22138235 and PMID:23092809 Allyl chloride decreases expression EXP 6480464 allyl chloride results in decreased expression of BCL2 protein CTD PMID:17194518 Aloe emodin decreases expression ISO BCL2 (Homo sapiens) 6480464 aloe emodin results in decreased expression of BCL2 mRNA and aloe emodin results in decreased expression of BCL2 protein CTD PMID:19928967 and PMID:22210228 Aloperine increases expression EXP 6480464 aloperine results in increased expression of BCL2 mRNA CTD PMID:11218852 alpha-amanitin multiple interactions ISO Bcl2 (Mus musculus) 6480464 3-methyladenine inhibits the reaction [Alpha-Amanitin results in decreased expression of BCL2 protein] CTD PMID:35175747 alpha-amanitin decreases expression ISO Bcl2 (Mus musculus) 6480464 Alpha-Amanitin results in decreased expression of BCL2 protein CTD PMID:35175747 alpha-D-galactose multiple interactions EXP 6480464 agomelatine inhibits the reaction [Galactose results in decreased expression of BCL2 protein] more ... CTD PMID:25892055 more ... alpha-D-galactose multiple interactions ISO BCL2 (Homo sapiens) 6480464 Phycocyanin inhibits the reaction [Galactose results in decreased expression of BCL2 protein] CTD PMID:23036742 alpha-D-galactose decreases expression ISO BCL2 (Homo sapiens) 6480464 Galactose results in decreased expression of BCL2 protein CTD PMID:23036742 alpha-D-galactose decreases expression EXP 6480464 Galactose results in decreased expression of BCL2 mRNA and Galactose results in decreased expression of BCL2 protein CTD PMID:25892055 more ... alpha-mangostin decreases expression ISO BCL2 (Homo sapiens) 6480464 mangostin results in decreased expression of BCL2 protein CTD PMID:24480042 alpha-mangostin multiple interactions ISO BCL2 (Homo sapiens) 6480464 mangostin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA] CTD PMID:26357513 alpha-phellandrene increases phosphorylation ISO BCL2 (Homo sapiens) 6480464 alpha phellandrene results in increased phosphorylation of BCL2 protein CTD PMID:25649747 alpha-Zearalanol multiple interactions ISO BCL2 (Homo sapiens) 6480464 Zeranol inhibits the reaction [Homocysteine results in decreased expression of BCL2 protein] CTD PMID:16757814 alpha-Zearalanol increases expression ISO BCL2 (Homo sapiens) 6480464 Zeranol results in increased expression of BCL2 protein CTD PMID:27224899 alpinumisoflavone decreases expression ISO BCL2 (Homo sapiens) 6480464 alpinumisoflavone results in decreased expression of BCL2 protein CTD PMID:23850732 aluminium atom multiple interactions ISO BCL2 (Homo sapiens) 6480464 [aluminum chlorhydrate results in increased abundance of Aluminum] which results in decreased expression of BCL2 protein and Fulvestrant inhibits the reaction [[aluminum chlorhydrate results in increased abundance of Aluminum] which results in decreased expression of BCL2 protein] CTD PMID:31945389 aluminium atom multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Aluminum Chloride results in increased abundance of Aluminum] which results in decreased expression of BCL2 mRNA more ... CTD PMID:34547296 aluminium(0) multiple interactions ISO BCL2 (Homo sapiens) 6480464 [aluminum chlorhydrate results in increased abundance of Aluminum] which results in decreased expression of BCL2 protein and Fulvestrant inhibits the reaction [[aluminum chlorhydrate results in increased abundance of Aluminum] which results in decreased expression of BCL2 protein] CTD PMID:31945389 aluminium(0) multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Aluminum Chloride results in increased abundance of Aluminum] which results in decreased expression of BCL2 mRNA more ... CTD PMID:34547296 alvocidib decreases expression ISO BCL2 (Homo sapiens) 6480464 alvocidib results in decreased expression of BCL2 mRNA and alvocidib results in decreased expression of BCL2 protein CTD PMID:10887097 more ... alvocidib decreases expression ISO Bcl2 (Mus musculus) 6480464 alvocidib results in decreased expression of BCL2 protein CTD PMID:12734434 alvocidib decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein mutant form results in decreased susceptibility to alvocidib and BCL2 protein results in decreased susceptibility to alvocidib CTD PMID:12170773 and PMID:12517783 alvocidib multiple interactions ISO BCL2 (Homo sapiens) 6480464 [alvocidib co-treated with Gemcitabine] results in decreased expression of BCL2 protein more ... CTD PMID:12170773 more ... alvocidib increases expression ISO BCL2 (Homo sapiens) 6480464 alvocidib results in increased expression of BCL2 CTD PMID:10995888 AM-251 increases expression ISO Bcl2 (Mus musculus) 6480464 AM 251 results in increased expression of BCL2 protein CTD PMID:26967640 AM-251 multiple interactions ISO Bcl2 (Mus musculus) 6480464 AM 251 inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein] CTD PMID:26967640 amentoflavone multiple interactions ISO Bcl2 (Mus musculus) 6480464 amentoflavone inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:28185818 amentoflavone multiple interactions ISO BCL2 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [amentoflavone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]] and amentoflavone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein] CTD PMID:28185818 amidotrizoic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Diatrizoate co-treated with Iodine] results in increased expression of BCL2 protein CTD PMID:17173243 amifostine multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Amifostine co-treated with Doxorubicin] results in decreased expression of BCL2 mRNA CTD PMID:15985719 amino acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 Amino Acids inhibits the reaction [KL gene mutant form results in decreased expression of BCL2 protein] and H 1356 inhibits the reaction [Amino Acids inhibits the reaction [KL gene mutant form results in decreased expression of BCL2 protein]] CTD PMID:25309793 aminoguanidine multiple interactions ISO Bcl2 (Mus musculus) 6480464 [pimagedine results in decreased activity of NOS2 protein] which results in decreased expression of BCL2 mRNA and pimagedine inhibits the reaction [Cardiotoxins results in increased phosphorylation of BCL2 protein] CTD PMID:17135264 and PMID:17786558 aminoguanidine multiple interactions ISO BCL2 (Homo sapiens) 6480464 [pimagedine results in decreased nitrosation of and results in increased ubiquitination of and results in increased degradation of BCL2 protein] which results in increased susceptibility to Chromates more ... CTD PMID:16980304 aminophylline multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Aminophylline co-treated with Gemcitabine] results in decreased expression of BCL2 protein CTD PMID:15645133 amiodarone multiple interactions ISO BCL2 (Homo sapiens) 6480464 [3-methyladenine co-treated with Amiodarone] results in decreased expression of BCL2 protein more ... CTD PMID:23912912 and PMID:34434487 amiodarone decreases expression ISO BCL2 (Homo sapiens) 6480464 Amiodarone results in decreased expression of BCL2 mRNA and Amiodarone results in decreased expression of BCL2 protein CTD PMID:34434487 amiodarone decreases expression EXP 6480464 Amiodarone results in decreased expression of BCL2 protein CTD PMID:21224497 amitriptyline multiple interactions EXP 6480464 Amitriptyline inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein] CTD PMID:19135049 amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of BCL2 mRNA CTD PMID:30047161 amlexanox multiple interactions ISO Bcl2 (Mus musculus) 6480464 amlexanox inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein] and amlexanox inhibits the reaction [Palmitic Acid results in decreased expression of BCL2 protein] CTD PMID:31697998 and PMID:32905826 amlodipine multiple interactions ISO BCL2 (Homo sapiens) 6480464 Amlodipine inhibits the reaction [AGT results in decreased expression of BCL2 mRNA] more ... CTD PMID:21376258 and PMID:36207783 amlodipine multiple interactions EXP 6480464 Amlodipine inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] more ... CTD PMID:17234320 more ... ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of BCL2 mRNA CTD PMID:16483693 Ammothamnine multiple interactions ISO BCL2 (Homo sapiens) 6480464 oxymatrine analog inhibits the reaction [TNF protein results in increased expression of BCL2 protein] CTD PMID:34459104 amodiaquine decreases expression ISO BCL2 (Homo sapiens) 6480464 Amodiaquine results in decreased expression of BCL2 protein CTD PMID:31629065 amodiaquine multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Ketoconazole inhibits the reaction [CYP3A4 protein results in increased susceptibility to Amodiaquine]] which results in decreased expression of BCL2 protein and [Rifampin inhibits the reaction [CYP2C8 protein results in increased susceptibility to Amodiaquine]] which results in decreased expression of BCL2 protein CTD PMID:31629065 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of BCL2 mRNA CTD PMID:30779732 amphetamine decreases expression ISO Bcl2 (Mus musculus) 6480464 Amphetamine results in decreased expression of BCL2 protein CTD PMID:15731293 amsacrine decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to Amsacrine CTD PMID:10920913 andrographolide multiple interactions ISO BCL2 (Homo sapiens) 6480464 [andrographolide co-treated with Cisplatin] results in decreased expression of BCL2 mRNA CTD PMID:24563380 andrographolide decreases expression ISO BCL2 (Homo sapiens) 6480464 andrographolide results in decreased expression of BCL2 protein CTD PMID:23845849 and PMID:35917943 Anemoside B4 multiple interactions ISO Bcl2 (Mus musculus) 6480464 anemoside B4 inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] CTD PMID:32991863 anethole multiple interactions EXP 6480464 anethole inhibits the reaction [Isoproterenol results in increased expression of BCL2 mRNA] CTD PMID:35430261 anthocyanin multiple interactions EXP 6480464 Anthocyanins inhibits the reaction [Paraquat results in decreased expression of BCL2 mRNA] more ... CTD PMID:28856781 and PMID:30403199 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO BCL2 (Homo sapiens) 6480464 pyrazolanthrone inhibits the reaction [1 more ... CTD PMID:14724571 more ... anthra[1,9-cd]pyrazol-6(2H)-one decreases phosphorylation EXP 6480464 pyrazolanthrone results in decreased phosphorylation of BCL2 protein CTD PMID:24833599 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in decreased expression of BCL2 mRNA] more ... CTD PMID:19428505 more ... anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO Bcl2 (Mus musculus) 6480464 pyrazolanthrone inhibits the reaction [Cardiotoxins results in increased phosphorylation of BCL2 protein] CTD PMID:17786558 antimony(0) multiple interactions EXP 6480464 666-15 compound promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of BCL2 protein] and [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of BCL2 protein CTD PMID:32920012 antimony(0) multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of BCL2 protein CTD PMID:32920012 antimycin A multiple interactions ISO BCL2 (Homo sapiens) 6480464 PK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to Antimycin A] CTD PMID:12730627 antimycin A decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to Antimycin A CTD PMID:12730627 Antrocin decreases expression ISO BCL2 (Homo sapiens) 6480464 antrocin analog results in decreased expression of BCL2 protein more ... CTD PMID:21158420 and PMID:36565974 apigenin decreases expression ISO BCL2 (Homo sapiens) 6480464 Apigenin results in decreased expression of BCL2 protein CTD PMID:15486995 apigenin multiple interactions EXP 6480464 (2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide inhibits the reaction [Apigenin inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 protein]] more ... CTD PMID:25557508 more ... apigenin multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Polylactic Acid-Polyglycolic Acid Copolymer co-treated with Apigenin] results in decreased expression of BCL2 mRNA more ... CTD PMID:24070738 and PMID:29247770 apigenin decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to Apigenin CTD PMID:15486995 apocynin multiple interactions EXP 6480464 acetovanillone analog inhibits the reaction [Chlorpyrifos results in decreased expression of BCL2 protein] and acetovanillone inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of BCL2 protein] CTD PMID:22431579 and PMID:29859868 apocynin multiple interactions ISO Bcl2 (Mus musculus) 6480464 acetovanillone inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in decreased expression of BCL2 protein] CTD PMID:30366073 aprepitant multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Aprepitant] results in decreased expression of BCL2 mRNA CTD PMID:30145367 arachidonic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 1 more ... CTD PMID:19540902 and PMID:19620254 arachidonic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 Arachidonic Acid results in decreased expression of BCL2 protein CTD PMID:19540902 and PMID:19720122 arachidonyl-2'-chloroethylamide multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Streptozocin co-treated with arachidonyl-2-chloroethylamide] results in increased expression of BCL2 protein CTD PMID:30607903 arachidonyl-2'-chloroethylamide increases expression ISO Bcl2 (Mus musculus) 6480464 arachidonyl-2-chloroethylamide results in increased expression of BCL2 protein CTD PMID:30607903 arecoline decreases expression ISO BCL2 (Homo sapiens) 6480464 Arecoline results in decreased expression of BCL2 protein CTD PMID:22108589 arecoline decreases expression EXP 6480464 Arecoline results in decreased expression of BCL2 protein CTD PMID:33929070 aristolochic acid A decreases expression ISO Bcl2 (Mus musculus) 6480464 aristolochic acid I results in decreased expression of BCL2 protein CTD PMID:26656393 and PMID:31048001 aristolochic acid A increases expression ISO Bcl2 (Mus musculus) 6480464 aristolochic acid I results in increased expression of BCL2 mRNA CTD PMID:33186629 aristolochic acid A decreases expression EXP 6480464 aristolochic acid I results in decreased expression of BCL2 mRNA and aristolochic acid I results in decreased expression of BCL2 protein CTD PMID:34167444 more ... aristolochic acid A multiple interactions EXP 6480464 Curcumin inhibits the reaction [aristolochic acid I results in decreased expression of BCL2 mRNA] more ... CTD PMID:35850572 and PMID:36037877 aristolochic acid A decreases expression ISO BCL2 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of BCL2 mRNA and aristolochic acid I results in decreased expression of BCL2 protein CTD PMID:31048001 and PMID:33212167 arjunolic acid multiple interactions EXP 6480464 arjunolic acid inhibits the reaction [Streptozocin results in increased expression of BCL2 protein] CTD PMID:19682444 arjunolic acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 arjunolic acid inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein] CTD PMID:21420465 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of BCL2 mRNA and Chlorodiphenyl (54% Chlorine) results in increased expression of BCL2 protein CTD PMID:23281070 Aroclor 1254 decreases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of BCL2 protein CTD PMID:35822628 Aroclor 1254 decreases expression ISO Bcl2 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of BCL2 protein CTD PMID:24216299 Aroclor 1254 multiple interactions ISO Bcl2 (Mus musculus) 6480464 2 more ... CTD PMID:24216299 Aroclor 1254 multiple interactions EXP 6480464 2-(1' more ... CTD PMID:23281070 and PMID:35822628 arotinoid acid decreases expression ISO BCL2 (Homo sapiens) 6480464 4-(2-(5 more ... CTD PMID:16109544 and PMID:16909596 arsane increases expression EXP 6480464 Arsenic results in increased expression of BCL2 protein CTD PMID:11756236 arsane multiple interactions ISO Bcl2 (Mus musculus) 6480464 [sodium arsenite results in increased abundance of Arsenic] promotes the reaction [[Sodium Fluoride results in increased abundance of Fluorides] which results in decreased expression of BCL2 mRNA] more ... CTD PMID:35714946 arsane decreases expression EXP 6480464 Arsenic results in decreased expression of BCL2 mRNA CTD PMID:32246071 arsane multiple interactions EXP 6480464 [Lead co-treated with Manganese co-treated with Cadmium co-treated with Arsenic] results in decreased expression of BCL2 mRNA more ... CTD PMID:30835071 more ... arsane multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Palmitic Acid co-treated with Arsenic] results in increased expression of BCL2 mRNA CTD PMID:33736254 arsane affects expression ISO Bcl2 (Mus musculus) 6480464 Arsenic affects the expression of BCL2 protein CTD PMID:27289040 arsane affects methylation ISO BCL2 (Homo sapiens) 6480464 Arsenic affects the methylation of BCL2 gene CTD PMID:25304211 arsane increases expression ISO BCL2 (Homo sapiens) 6480464 Arsenic results in increased expression of BCL2 mRNA and Arsenic results in increased expression of BCL2 protein CTD PMID:12899209 more ... arsenic acid increases expression ISO Bcl2 (Mus musculus) 6480464 arsenic acid results in increased expression of BCL2 mRNA CTD PMID:8946558 arsenic atom increases expression ISO BCL2 (Homo sapiens) 6480464 Arsenic results in increased expression of BCL2 mRNA and Arsenic results in increased expression of BCL2 protein CTD PMID:12899209 more ... arsenic atom multiple interactions ISO Bcl2 (Mus musculus) 6480464 [sodium arsenite results in increased abundance of Arsenic] promotes the reaction [[Sodium Fluoride results in increased abundance of Fluorides] which results in decreased expression of BCL2 mRNA] more ... CTD PMID:35714946 arsenic atom decreases expression EXP 6480464 Arsenic results in decreased expression of BCL2 mRNA CTD PMID:32246071 arsenic atom multiple interactions EXP 6480464 [Lead co-treated with Manganese co-treated with Cadmium co-treated with Arsenic] results in decreased expression of BCL2 mRNA more ... CTD PMID:30835071 more ... arsenic atom multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Palmitic Acid co-treated with Arsenic] results in increased expression of BCL2 mRNA CTD PMID:33736254 arsenic atom affects expression ISO Bcl2 (Mus musculus) 6480464 Arsenic affects the expression of BCL2 protein CTD PMID:27289040 arsenic atom affects methylation ISO BCL2 (Homo sapiens) 6480464 Arsenic affects the methylation of BCL2 gene CTD PMID:25304211 arsenic atom increases expression EXP 6480464 Arsenic results in increased expression of BCL2 protein CTD PMID:11756236 arsenite(3-) decreases expression ISO BCL2 (Homo sapiens) 6480464 arsenite results in decreased expression of BCL2 mRNA alternative form and arsenite results in decreased expression of BCL2 protein CTD PMID:20083129 and PMID:26677073 arsenite(3-) multiple interactions ISO Bcl2 (Mus musculus) 6480464 CALR protein affects the reaction [arsenite results in decreased expression of BCL2 protein] CTD PMID:32443253 arsenite(3-) decreases expression ISO Bcl2 (Mus musculus) 6480464 arsenite results in decreased expression of BCL2 protein CTD PMID:32443253 arsenite(3-) decreases expression EXP 6480464 arsenite results in decreased expression of BCL2 protein CTD PMID:29324385 arsenite(3-) multiple interactions ISO BCL2 (Homo sapiens) 6480464 Heparin inhibits the reaction [arsenite results in decreased expression of BCL2 protein] and Thapsigargin promotes the reaction [arsenite results in decreased expression of BCL2 protein] CTD PMID:26677073 arsenite(3-) increases expression ISO BCL2 (Homo sapiens) 6480464 arsenite results in increased expression of BCL2 mRNA and arsenite results in increased expression of BCL2 protein CTD PMID:28444938 arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of BCL2 protein CTD PMID:18077580 arsenite(3-) multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [arsenite results in increased expression of BCL2 protein] CTD PMID:18077580 arsenous acid increases expression ISO BCL2 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of BCL2 mRNA and Arsenic Trioxide results in increased expression of BCL2 protein CTD PMID:16966277 more ... arsenous acid multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvianolic acid B inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]] more ... CTD PMID:17487067 more ... arsenous acid decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to Arsenic Trioxide and BCL2 results in decreased susceptibility to Arsenic Trioxide CTD PMID:11775218 more ... arsenous acid increases expression ISO Bcl2 (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of BCL2 protein CTD PMID:10712780 arsenous acid affects expression EXP 6480464 Arsenic Trioxide affects the expression of BCL2 mRNA and Arsenic Trioxide affects the expression of BCL2 protein CTD PMID:12725324 and PMID:18618274 arsenous acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 18alpha more ... CTD PMID:21078540 more ... arsenous acid increases degradation ISO BCL2 (Homo sapiens) 6480464 Arsenic Trioxide results in increased degradation of BCL2 protein CTD PMID:19468689 arsenous acid affects folding ISO BCL2 (Homo sapiens) 6480464 Arsenic Trioxide affects the folding of BCL2 protein CTD PMID:20403207 arsenous acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of BCL2 protein] more ... CTD PMID:11775218 more ... arsenous acid increases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 mutant form results in increased susceptibility to Arsenic Trioxide CTD PMID:14642526 arsenous acid affects response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein affects the susceptibility to Arsenic Trioxide CTD PMID:10648417 and PMID:18726487 arsenous acid increases cleavage ISO Bcl2 (Mus musculus) 6480464 Arsenic Trioxide results in increased cleavage of BCL2 protein CTD PMID:15761769 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of BCL2 mRNA and Arsenic Trioxide results in decreased expression of BCL2 protein CTD PMID:19260322 more ... arsenous acid increases phosphorylation ISO BCL2 (Homo sapiens) 6480464 Arsenic Trioxide results in increased phosphorylation of BCL2 protein CTD PMID:12181429 and PMID:18412143 arsenous acid affects expression ISO BCL2 (Homo sapiens) 6480464 Arsenic Trioxide affects the expression of BCL2 protein CTD PMID:12962562 more ... arsenous acid decreases expression ISO Bcl2 (Mus musculus) 6480464 Arsenic Trioxide results in decreased expression of BCL2 mRNA and Arsenic Trioxide results in decreased expression of BCL2 protein CTD PMID:10721769 more ... arsenous acid increases cleavage ISO BCL2 (Homo sapiens) 6480464 Arsenic Trioxide results in increased cleavage of BCL2 protein CTD PMID:11739184 arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of BCL2 mRNA CTD PMID:17487067 arsenous acid decreases expression ISO BCL2 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of BCL2 more ... CTD PMID:10340400 more ... artesunate multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with artesunate] results in decreased expression of BCL2 protein CTD PMID:29031619 artesunate multiple interactions ISO BCL2 (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [Artesunate results in decreased expression of BCL2 protein] more ... CTD PMID:33002460 artesunate decreases expression ISO BCL2 (Homo sapiens) 6480464 Artesunate results in decreased expression of BCL2 protein CTD PMID:24704559 and PMID:33002460 asarone decreases expression ISO BCL2 (Homo sapiens) 6480464 asarone results in decreased expression of BCL2 mRNA CTD PMID:29174417 asbestos increases expression ISO BCL2 (Homo sapiens) 6480464 Asbestos results in increased expression of BCL2 mRNA CTD PMID:22076105 and PMID:22398240 asiatic acid multiple interactions EXP 6480464 asiatic acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of BCL2 protein] CTD PMID:29108773 asiatic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 asiatic acid inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA] more ... CTD PMID:30802477 aspartame multiple interactions EXP 6480464 [Aspartame co-treated with Methotrexate] results in decreased expression of BCL2 mRNA and [Aspartame co-treated with Methotrexate] results in decreased expression of BCL2 protein CTD PMID:25009784 aspartame decreases expression ISO Bcl2 (Mus musculus) 6480464 Aspartame results in decreased expression of BCL2 mRNA CTD PMID:32951320 Aspidin decreases expression ISO BCL2 (Homo sapiens) 6480464 aspidin BB results in decreased expression of BCL2 protein CTD PMID:23628508 astemizole decreases expression EXP 6480464 Astemizole results in decreased expression of BCL2 mRNA CTD PMID:20221588 astilbin multiple interactions ISO BCL2 (Homo sapiens) 6480464 astilbin inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] CTD PMID:29471006 astragaloside IV multiple interactions ISO BCL2 (Homo sapiens) 6480464 astragaloside A inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in decreased expression of BCL2 protein] more ... CTD PMID:33285147 and PMID:36322813 atorvastatin calcium decreases expression ISO BCL2 (Homo sapiens) 6480464 Atorvastatin results in decreased expression of BCL2 mRNA and Atorvastatin results in decreased expression of BCL2 protein CTD PMID:16470222 and PMID:31423616 atorvastatin calcium multiple interactions ISO Bcl2 (Mus musculus) 6480464 Atorvastatin inhibits the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of BCL2 protein] CTD PMID:37121058 atorvastatin calcium multiple interactions EXP 6480464 [Atorvastatin co-treated with dapagliflozin] inhibits the reaction [[Fructose co-treated with Dietary Fats] results in decreased expression of BCL2 protein] CTD PMID:32259528 atorvastatin calcium multiple interactions ISO BCL2 (Homo sapiens) 6480464 2-tert-butylhydroquinone inhibits the reaction [Atorvastatin results in decreased expression of BCL2 protein] and RHOA mutant form inhibits the reaction [Atorvastatin results in decreased expression of BCL2 protein] CTD PMID:16470222 and PMID:31423616 ATP multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Adenosine Triphosphate binds to P2RY11 protein] which results in decreased expression of BCL2 protein CTD PMID:21503959 Atranorin decreases expression ISO BCL2 (Homo sapiens) 6480464 atranorin results in decreased expression of BCL2 protein CTD PMID:22285236 atrasentan multiple interactions EXP 6480464 atrasentan inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of BCL2 protein] CTD PMID:22431579 atrazine affects expression EXP 6480464 Atrazine affects the expression of BCL2 and Atrazine affects the expression of BCL2 mRNA CTD PMID:21726175 and PMID:26075868 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of BCL2 mRNA and Atrazine results in decreased expression of BCL2 protein CTD PMID:30084861 more ... atrazine decreases expression ISO Bcl2 (Mus musculus) 6480464 Atrazine results in decreased expression of BCL2 mRNA and Atrazine results in decreased expression of BCL2 protein CTD PMID:33485040 atrazine multiple interactions EXP 6480464 Carnitine inhibits the reaction [Atrazine results in decreased expression of BCL2 mRNA] and kolaviron inhibits the reaction [Atrazine affects the expression of BCL2] CTD PMID:21726175 and PMID:36282381 atrazine multiple interactions ISO BCL2 (Homo sapiens) 6480464 kolaviron inhibits the reaction [Atrazine results in decreased expression of BCL2 mRNA] and kolaviron inhibits the reaction [Atrazine results in decreased expression of BCL2 protein] CTD PMID:21333729 atrazine decreases expression ISO BCL2 (Homo sapiens) 6480464 Atrazine results in decreased expression of BCL2 mRNA and Atrazine results in decreased expression of BCL2 protein CTD PMID:21333729 auranofin multiple interactions ISO BCL2 (Homo sapiens) 6480464 BCL2 protein inhibits the reaction [Auranofin results in increased activity of CASP3 protein] CTD PMID:18789312 aurantio-obtusin decreases expression ISO BCL2 (Homo sapiens) 6480464 aurantio-obtusin results in decreased expression of BCL2 protein CTD PMID:35995123 Auriculasin multiple interactions ISO BCL2 (Homo sapiens) 6480464 [auriculasin co-treated with TNFSF10 protein] results in decreased expression of BCL2 protein and TNFRSF10B protein affects the reaction [[auriculasin co-treated with TNFSF10 protein] results in decreased expression of BCL2 protein] CTD PMID:30817944 Auriculasin decreases expression ISO BCL2 (Homo sapiens) 6480464 auriculasin results in decreased expression of BCL2 protein CTD PMID:30236598 avermectin decreases expression ISO BCL2 (Homo sapiens) 6480464 avermectin results in decreased expression of BCL2 protein CTD PMID:33381906 azadirachtin A decreases expression ISO BCL2 (Homo sapiens) 6480464 azadirachtin results in decreased expression of BCL2 mRNA and azadirachtin results in decreased expression of BCL2 protein CTD PMID:20429769 azide multiple interactions ISO BCL2 (Homo sapiens) 6480464 BCL2 protein inhibits the reaction [Azides affects the localization of BAX protein] and BCL2 protein inhibits the reaction [Azides results in increased activity of BAX protein] CTD PMID:21160028 azide decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to Azides CTD PMID:21160028 aziridines decreases expression ISO BCL2 (Homo sapiens) 6480464 Aziridines analog results in decreased expression of BCL2 protein CTD PMID:15174162 bafilomycin A1 decreases expression ISO Bcl2 (Mus musculus) 6480464 bafilomycin A1 results in decreased expression of BCL2 mRNA CTD PMID:31310755 bafilomycin A1 multiple interactions EXP 6480464 bafilomycin A1 promotes the reaction [Methamphetamine results in decreased expression of BCL2 protein] CTD PMID:34374793 baicalein multiple interactions ISO Bcl2 (Mus musculus) 6480464 5-hydroxydecanoic acid inhibits the reaction [baicalein inhibits the reaction [Bleomycin results in decreased expression of BCL2 protein]] more ... CTD PMID:20850421 and PMID:37783230 baicalein decreases expression ISO BCL2 (Homo sapiens) 6480464 baicalein results in decreased expression of BCL2 protein CTD PMID:33838155 baicalein multiple interactions ISO BCL2 (Homo sapiens) 6480464 MIR3663 mRNA promotes the reaction [baicalein results in decreased expression of BCL2 protein] CTD PMID:33838155 baicalin multiple interactions EXP 6480464 baicalin inhibits the reaction [Rotenone affects the expression of BCL2 protein] CTD PMID:25423838 baicalin multiple interactions ISO Bcl2 (Mus musculus) 6480464 baicalin inhibits the reaction [Gentamicins results in decreased expression of BCL2 mRNA] and baicalin inhibits the reaction [Gentamicins results in decreased expression of BCL2 protein] CTD PMID:31021006 baicalin decreases expression ISO BCL2 (Homo sapiens) 6480464 baicalin results in decreased expression of BCL2 protein CTD PMID:36446982 baicalin multiple interactions ISO BCL2 (Homo sapiens) 6480464 baicalin affects the reaction [Rotenone results in decreased expression of BCL2 mRNA] and baicalin inhibits the reaction [Rotenone results in decreased expression of BCL2 protein] CTD PMID:36446982 bathocuproine disulfonic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 bathocuproine sulfonate results in decreased expression of BCL2 protein CTD PMID:24614111 Bavachinin decreases expression ISO BCL2 (Homo sapiens) 6480464 bavachinin results in decreased expression of BCL2 protein CTD PMID:37358659 Bay-K-8644 decreases expression ISO Bcl2 (Mus musculus) 6480464 3-Pyridinecarboxylic acid more ... CTD PMID:37308051 Bay-K-8644 multiple interactions ISO Bcl2 (Mus musculus) 6480464 3-nitropropionic acid inhibits the reaction [ginsenoside Re inhibits the reaction [3-Pyridinecarboxylic acid more ... CTD PMID:37308051 beauvericin multiple interactions ISO BCL2 (Homo sapiens) 6480464 [zearalenol co-treated with beauvericin] results in increased expression of BCL2 mRNA CTD PMID:32956828 beauvericin increases expression ISO BCL2 (Homo sapiens) 6480464 beauvericin results in increased expression of BCL2 mRNA CTD PMID:29203277 and PMID:32956828 belinostat decreases expression ISO BCL2 (Homo sapiens) 6480464 belinostat results in decreased expression of BCL2 mRNA CTD PMID:26272509 belinostat multiple interactions ISO BCL2 (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2 mRNA CTD PMID:27188386 benazepril increases expression EXP 6480464 benazepril results in increased expression of BCL2 protein CTD PMID:20026869 benomyl multiple interactions ISO BCL2 (Homo sapiens) 6480464 Benomyl inhibits the reaction [BCL2 protein binds to BAX protein] CTD PMID:16903866 benomyl increases phosphorylation ISO BCL2 (Homo sapiens) 6480464 Benomyl results in increased phosphorylation of BCL2 protein CTD PMID:16903866 benzene increases expression ISO BCL2 (Homo sapiens) 6480464 Benzene results in increased expression of BCL2 protein CTD PMID:20850422 benzene decreases expression EXP 6480464 Benzene results in decreased expression of BCL2 mRNA CTD PMID:21143203 benzene multiple interactions EXP 6480464 decitabine inhibits the reaction [Benzene results in decreased expression of BCL2 mRNA] and trichostatin A inhibits the reaction [Benzene results in decreased expression of BCL2 mRNA] CTD PMID:21143203 benzene decreases expression ISO BCL2 (Homo sapiens) 6480464 Benzene results in decreased expression of BCL2 mRNA CTD PMID:18724895 and PMID:19162166 benzene multiple interactions ISO Bcl2 (Mus musculus) 6480464 TRP53 protein affects the reaction [Benzene results in increased expression of BCL2 mRNA] CTD PMID:11896287 benzene affects expression ISO Bcl2 (Mus musculus) 6480464 Benzene affects the expression of BCL2 mRNA CTD PMID:11896287 benzo[a]pyrene multiple interactions ISO BCL2 (Homo sapiens) 6480464 2 more ... CTD PMID:16041517 more ... benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of BCL2 protein CTD PMID:36736873 benzo[a]pyrene increases methylation ISO BCL2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of BCL2 promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions EXP 6480464 Catechin analog inhibits the reaction [Benzo(a)pyrene results in decreased expression of BCL2 mRNA] more ... CTD PMID:31568845 and PMID:34027802 benzo[a]pyrene increases expression ISO BCL2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of BCL2 mRNA and Benzo(a)pyrene results in increased expression of BCL2 protein CTD PMID:18174961 more ... benzo[a]pyrene increases expression ISO Bcl2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of BCL2 mRNA and Benzo(a)pyrene results in increased expression of BCL2 protein CTD PMID:18656336 more ... benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of BCL2 mRNA and Benzo(a)pyrene results in decreased expression of BCL2 protein CTD PMID:23510837 more ... benzo[a]pyrene decreases expression ISO BCL2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of BCL2 mRNA and Benzo(a)pyrene results in decreased expression of BCL2 protein CTD PMID:11782367 more ... benzo[a]pyrene decreases expression ISO Bcl2 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of BCL2 mRNA and Benzo(a)pyrene results in decreased expression of BCL2 protein CTD PMID:19770486 more ... benzo[a]pyrene multiple interactions ISO Bcl2 (Mus musculus) 6480464 [corannulene co-treated with Benzo(a)pyrene] results in increased expression of BCL2 mRNA more ... CTD PMID:18656336 more ... benzo[a]pyrene diol epoxide I increases expression ISO BCL2 (Homo sapiens) 6480464 7 more ... CTD PMID:28593498 benzo[b]fluoranthene increases expression ISO BCL2 (Homo sapiens) 6480464 benzo(b)fluoranthene results in increased expression of BCL2 protein CTD PMID:21776270 benzoates decreases expression ISO BCL2 (Homo sapiens) 6480464 Benzoates analog results in decreased expression of BCL2 mRNA CTD PMID:29472718 benzoic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 Benzoic Acid analog inhibits the reaction [STAT3 protein binds to BCL2 promoter] CTD PMID:26088127 benzophenanthridine decreases expression ISO BCL2 (Homo sapiens) 6480464 Benzophenanthridines analog results in decreased expression of BCL2 mRNA CTD PMID:23117580 benzothiazoles decreases expression ISO BCL2 (Homo sapiens) 6480464 Benzothiazoles metabolite results in decreased expression of BCL2 mRNA CTD PMID:23339777 berberine decreases expression ISO BCL2 (Homo sapiens) 6480464 Berberine results in decreased expression of BCL2 mRNA and Berberine results in decreased expression of BCL2 protein CTD PMID:16505103 and PMID:20656010 berberine increases expression EXP 6480464 Berberine results in increased expression of BCL2 protein CTD PMID:25600690 berberine multiple interactions EXP 6480464 Berberine inhibits the reaction [Chlorpyrifos results in decreased expression of BCL2 mRNA] more ... CTD PMID:24751971 more ... berberine multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Berberine co-treated with Cisplatin] results in decreased expression of BCL2 protein more ... CTD PMID:23954465 more ... berberine increases expression ISO BCL2 (Homo sapiens) 6480464 Berberine results in increased expression of BCL2 protein CTD PMID:23954465 Berberrubine multiple interactions ISO BCL2 (Homo sapiens) 6480464 [dehydrocostus lactone co-treated with berberrubine] results in decreased expression of BCL2 protein CTD PMID:37142148 Bergenin multiple interactions EXP 6480464 bergenin inhibits the reaction [Cadmium results in decreased expression of BCL2 protein] CTD PMID:37949422 Besigomsin multiple interactions ISO Bcl2 (Mus musculus) 6480464 schizandrol B promotes the reaction [Acetaminophen results in increased expression of BCL2 protein] CTD PMID:25319358 Besigomsin increases expression ISO Bcl2 (Mus musculus) 6480464 schizandrol B results in increased expression of BCL2 protein CTD PMID:25319358 beta-aminopropionitrile decreases expression ISO BCL2 (Homo sapiens) 6480464 Aminopropionitrile results in decreased expression of BCL2 protein CTD PMID:24614111 beta-carotene decreases expression ISO BCL2 (Homo sapiens) 6480464 beta Carotene results in decreased expression of BCL2 protein CTD PMID:26733226 beta-Elemonic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 beta-elemonic acid results in decreased expression of BCL2 protein CTD PMID:33878321 beta-ionone decreases expression ISO BCL2 (Homo sapiens) 6480464 beta-ionone results in decreased expression of BCL2 protein CTD PMID:23100158 more ... beta-ionone multiple interactions ISO BCL2 (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [beta-ionone results in decreased expression of BCL2 protein] more ... CTD PMID:36843289 beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of BCL2 mRNA CTD PMID:22687991 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BCL2 mRNA CTD PMID:21295105 Beta-Solamarine decreases expression ISO BCL2 (Homo sapiens) 6480464 beta-solamarine results in decreased expression of BCL2 protein CTD PMID:17619073 and PMID:20647040 Betanin multiple interactions EXP 6480464 6-chloro-2 more ... CTD PMID:33661552 betulin multiple interactions ISO BCL2 (Homo sapiens) 6480464 [betulin co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein CTD PMID:33181113 betulinic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 Betulinic Acid results in decreased expression of BCL2 protein CTD PMID:30136359 betulinic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Betulinic Acid co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein CTD PMID:33181113 bezafibrate decreases expression EXP 6480464 Bezafibrate results in decreased expression of BCL2 mRNA CTD PMID:12704018 bezafibrate multiple interactions EXP 6480464 Bezafibrate inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2 protein] CTD PMID:12704018 bicalutamide increases expression ISO BCL2 (Homo sapiens) 6480464 bicalutamide results in increased expression of BCL2 CTD PMID:11845989 bicalutamide multiple interactions ISO BCL2 (Homo sapiens) 6480464 bicalutamide promotes the reaction [Niclosamide results in decreased expression of BCL2 protein] and Niclosamide promotes the reaction [bicalutamide results in decreased expression of BCL2 protein] CTD PMID:28500234 bifenthrin decreases expression ISO Bcl2 (Mus musculus) 6480464 bifenthrin results in decreased expression of BCL2 mRNA CTD PMID:26071804 more ... biochanin A decreases expression ISO BCL2 (Homo sapiens) 6480464 biochanin A results in decreased expression of BCL2 protein CTD PMID:12791511 bis(2-chloroethyl) sulfide decreases expression ISO BCL2 (Homo sapiens) 6480464 Mustard Gas results in decreased expression of BCL2 protein CTD PMID:11428642 and PMID:9665388 bis(2-chloroethyl) sulfide affects localization ISO Bcl2 (Mus musculus) 6480464 Mustard Gas affects the localization of BCL2 protein CTD PMID:19560481 bis(2-ethylhexyl) phthalate decreases expression ISO Bcl2 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of BCL2 mRNA and Diethylhexyl Phthalate results in decreased expression of BCL2 protein CTD PMID:26678702 more ... bis(2-ethylhexyl) phthalate multiple interactions ISO BCL2 (Homo sapiens) 6480464 Diethylhexyl Phthalate inhibits the reaction [Camptothecin results in decreased expression of BCL2 protein] CTD PMID:36394428 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of BCL2 protein CTD PMID:32050098 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA and Hesperidin inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of BCL2 protein] CTD PMID:32050098 and PMID:35762964 bis(2-ethylhexyl) phthalate multiple interactions ISO Bcl2 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of BCL2 mRNA more ... CTD PMID:28013214 more ... bis(2-ethylhexyl) phthalate increases expression ISO Bcl2 (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of BCL2 mRNA and Diethylhexyl Phthalate results in increased expression of BCL2 protein CTD PMID:25701202 and PMID:33484791 bis(2-ethylhexyl) phthalate decreases expression ISO BCL2 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in decreased expression of BCL2 mRNA and Diethylhexyl Phthalate results in decreased expression of BCL2 protein CTD PMID:22155658 and PMID:31163220 bisphenol A decreases expression ISO BCL2 (Homo sapiens) 6480464 bisphenol A results in decreased expression of BCL2 mRNA and bisphenol A results in decreased expression of BCL2 protein CTD PMID:21277958 more ... bisphenol A affects methylation ISO BCL2 (Homo sapiens) 6480464 bisphenol A affects the methylation of BCL2 gene CTD PMID:31601247 bisphenol A decreases activity ISO Bcl2 (Mus musculus) 6480464 bisphenol A results in decreased activity of BCL2 protein CTD PMID:33485121 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of BCL2 gene CTD PMID:28505145 bisphenol A increases expression ISO BCL2 (Homo sapiens) 6480464 bisphenol A analog results in increased expression of BCL2 mRNA more ... CTD PMID:15461258 more ... bisphenol A increases expression ISO Bcl2 (Mus musculus) 6480464 bisphenol A results in increased expression of BCL2 mRNA and bisphenol A results in increased expression of BCL2 protein CTD PMID:23900028 more ... bisphenol A multiple interactions EXP 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [bisphenol A results in decreased expression of BCL2] more ... CTD PMID:25963729 more ... bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of BCL2 more ... CTD PMID:16909604 more ... bisphenol A decreases expression ISO Bcl2 (Mus musculus) 6480464 bisphenol A results in decreased expression of BCL2 mRNA and bisphenol A results in decreased expression of BCL2 protein CTD PMID:11906184 more ... bisphenol A affects expression ISO Bcl2 (Mus musculus) 6480464 bisphenol A affects the expression of BCL2 mRNA and bisphenol A affects the expression of BCL2 protein CTD PMID:26746108 and PMID:33509759 bisphenol A affects expression ISO BCL2 (Homo sapiens) 6480464 bisphenol A affects the expression of BCL2 mRNA and bisphenol A affects the expression of BCL2 protein CTD PMID:24156707 and PMID:31916403 bisphenol A multiple interactions ISO Bcl2 (Mus musculus) 6480464 4-methyl-N1-(3-phenylpropyl)benzene-1 more ... CTD PMID:22269103 more ... bisphenol A multiple interactions ISO BCL2 (Homo sapiens) 6480464 [bisphenol A co-treated with 4-cumylphenol] results in increased expression of BCL2 mRNA more ... CTD PMID:19270784 more ... Bisphenol A diglycidyl ether multiple interactions ISO BCL2 (Homo sapiens) 6480464 2 and 2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [1-(methylimino-N-oxy)-6-(2-morpholinoethoxy)-3-phenyl-1H-indene-2-carboxylic acid ethyl ester inhibits the reaction [VEGFA protein results in increased expression of BCL2 protein]] CTD PMID:21769449 Bisphenol A diglycidyl ether multiple interactions EXP 6480464 2 more ... CTD PMID:29953732 and PMID:34409680 bisphenol F decreases expression EXP 6480464 bisphenol F results in decreased expression of BCL2 protein CTD PMID:37601897 bleomycin A2 increases expression EXP 6480464 Bleomycin results in increased expression of BCL2 protein CTD PMID:23656969 bleomycin A2 decreases expression ISO Bcl2 (Mus musculus) 6480464 Bleomycin results in decreased expression of BCL2 protein CTD PMID:37783230 bleomycin A2 multiple interactions ISO Bcl2 (Mus musculus) 6480464 5-hydroxydecanoic acid inhibits the reaction [baicalein inhibits the reaction [Bleomycin results in decreased expression of BCL2 protein]] more ... CTD PMID:32278510 and PMID:37783230 bleomycin A2 decreases expression EXP 6480464 Bleomycin results in decreased expression of BCL2 mRNA CTD PMID:24822179 and PMID:26093215 bleomycin A2 multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Polyphenols co-treated with Bleomycin] results in increased expression of BCL2 mRNA and [Tea co-treated with Bleomycin] results in increased expression of BCL2 mRNA CTD PMID:26800624 bleomycin A2 multiple interactions EXP 6480464 [Bleomycin co-treated with Bee Venoms] results in decreased expression of BCL2 mRNA more ... CTD PMID:23656969 more ... boric acid increases expression ISO Bcl2 (Mus musculus) 6480464 boric acid results in increased expression of BCL2 mRNA CTD PMID:31368021 boric acid decreases expression ISO BCL2 (Homo sapiens) 6480464 boric acid results in decreased expression of BCL2 mRNA CTD PMID:34175401 boric acid multiple interactions EXP 6480464 [boric acid results in increased abundance of Boron] which results in decreased expression of BCL2 mRNA and [boric acid results in increased abundance of Boron] which results in decreased expression of BCL2 protein CTD PMID:33137424 boron atom multiple interactions EXP 6480464 [boric acid results in increased abundance of Boron] which results in decreased expression of BCL2 mRNA and [boric acid results in increased abundance of Boron] which results in decreased expression of BCL2 protein CTD PMID:33137424 borrelidin decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to borrelidin CTD PMID:24155182 bortezomib multiple interactions ISO BCL2 (Homo sapiens) 6480464 [arsenic trioxide co-treated with Bortezomib] results in decreased expression of BCL2 mRNA more ... CTD PMID:15173093 more ... bortezomib increases expression ISO BCL2 (Homo sapiens) 6480464 Bortezomib results in increased expression of BCL2 mRNA and Bortezomib results in increased expression of BCL2 protein CTD PMID:17895889 and PMID:20051518 bortezomib increases cleavage ISO BCL2 (Homo sapiens) 6480464 Bortezomib results in increased cleavage of BCL2 protein modified form CTD PMID:16118318 bortezomib decreases expression ISO BCL2 (Homo sapiens) 6480464 Bortezomib results in decreased expression of BCL2 mRNA and Bortezomib results in decreased expression of BCL2 protein CTD PMID:16022909 more ... BQ 123 multiple interactions EXP 6480464 [cyclo(Trp-Asp-Pro-Val-Leu) binds to and results in decreased activity of EDNRA protein] which results in decreased expression of BCL2 protein CTD PMID:14736733 BQ 123 multiple interactions ISO BCL2 (Homo sapiens) 6480464 [cyclo(Trp-Asp-Pro-Val-Leu) co-treated with BQ 788] inhibits the reaction [EDN1 protein results in increased expression of BCL2 protein] CTD PMID:20369390 BQ 485 multiple interactions EXP 6480464 [BQ 485 binds to and results in decreased activity of EDNRA protein] which results in decreased expression of BCL2 protein CTD PMID:14736733 brassinin decreases expression ISO BCL2 (Homo sapiens) 6480464 brassinin analog results in decreased expression of BCL2 mRNA CTD PMID:24747292 brassinolide decreases expression ISO BCL2 (Homo sapiens) 6480464 brassinolide results in decreased expression of BCL2 protein CTD PMID:17557751 and PMID:20833159 brazilin decreases expression ISO BCL2 (Homo sapiens) 6480464 brazilin results in decreased expression of BCL2 protein CTD PMID:28063998 bromuconazole decreases expression EXP 6480464 bromuconazole results in decreased expression of BCL2 mRNA CTD PMID:36370923 brucine decreases expression ISO BCL2 (Homo sapiens) 6480464 brucine results in decreased expression of BCL2 protein CTD PMID:16443926 Brusatol decreases expression ISO BCL2 (Homo sapiens) 6480464 brusatol results in decreased expression of BCL2 protein CTD PMID:33465425 bucladesine multiple interactions ISO BCL2 (Homo sapiens) 6480464 adenosine-3' more ... CTD PMID:16822680 bucladesine decreases expression ISO BCL2 (Homo sapiens) 6480464 Bucladesine results in decreased expression of BCL2 protein CTD PMID:10697531 budesonide decreases expression ISO BCL2 (Homo sapiens) 6480464 Budesonide results in decreased expression of BCL2 protein CTD PMID:15475437 bufalin decreases expression ISO BCL2 (Homo sapiens) 6480464 bufalin results in decreased expression of BCL2 mRNA and bufalin results in decreased expression of BCL2 protein CTD PMID:27444971 and PMID:7658701 bupivacaine decreases expression ISO Bcl2 (Mus musculus) 6480464 Bupivacaine results in decreased expression of BCL2 protein CTD PMID:31672611 and PMID:34793778 bupivacaine multiple interactions ISO Bcl2 (Mus musculus) 6480464 8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one promotes the reaction [[Glucose co-treated with Bupivacaine] results in decreased expression of BCL2 protein] more ... CTD PMID:31672611 and PMID:34793778 buprofezin decreases expression ISO BCL2 (Homo sapiens) 6480464 buprofezin results in decreased expression of BCL2 mRNA and buprofezin results in decreased expression of BCL2 protein CTD PMID:36287832 butanal decreases expression ISO BCL2 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of BCL2 mRNA CTD PMID:26079696 butane-2,3-dione decreases expression ISO Bcl2 (Mus musculus) 6480464 Diacetyl results in decreased expression of BCL2 mRNA CTD PMID:37399938 butein decreases expression ISO Bcl2 (Mus musculus) 6480464 butein results in decreased expression of BCL2 protein CTD PMID:11055382 Butralin increases expression EXP 6480464 butralin results in increased expression of BCL2 mRNA CTD PMID:32488703 Butylbenzyl phthalate multiple interactions ISO Bcl2 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of BCL2 mRNA and [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA CTD PMID:28013214 and PMID:37021957 Butylbenzyl phthalate decreases methylation ISO BCL2 (Homo sapiens) 6480464 butylbenzyl phthalate results in decreased methylation of BCL2 promoter CTD PMID:35487445 Butylbenzyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA CTD PMID:35762964 Butylbenzyl phthalate increases expression ISO BCL2 (Homo sapiens) 6480464 butylbenzyl phthalate results in increased expression of BCL2 mRNA CTD PMID:31016752 and PMID:35487445 butyric acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9 more ... CTD PMID:25478867 butyric acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Butyric Acid co-treated with Sulfaphenazole] inhibits the reaction [Oxalic Acid results in decreased expression of BCL2 mRNA] CTD PMID:37414240 C.I. Natural Red 20 decreases expression ISO BCL2 (Homo sapiens) 6480464 shikonin results in decreased expression of BCL2 protein CTD PMID:25591861 C.I. Natural Red 20 multiple interactions EXP 6480464 1 more ... CTD PMID:35028790 cadmium atom multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cadmium results in decreased expression of BCL2 protein] more ... CTD PMID:20455018 more ... cadmium atom decreases expression ISO BCL2 (Homo sapiens) 6480464 Cadmium results in decreased expression of BCL2 mRNA and Cadmium results in decreased expression of BCL2 protein CTD PMID:27687512 and PMID:32976933 cadmium atom multiple interactions ISO BCL2 (Homo sapiens) 6480464 [[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with fenvalerate] results in increased expression of BCL2 protein more ... CTD PMID:28949029 more ... cadmium atom decreases expression ISO Bcl2 (Mus musculus) 6480464 Cadmium results in decreased expression of BCL2 protein CTD PMID:22356713 cadmium atom multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of BCL2 protein more ... CTD PMID:30796935 and PMID:33359024 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of BCL2 protein CTD PMID:11781163 and PMID:23741317 cadmium atom increases expression ISO BCL2 (Homo sapiens) 6480464 Cadmium results in increased expression of BCL2 mRNA CTD PMID:21694771 and PMID:33559965 cadmium atom decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to Cadmium CTD PMID:11781163 cadmium atom decreases response to substance EXP 6480464 BCL2 results in decreased susceptibility to Cadmium CTD PMID:12189181 cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of BCL2 mRNA and Cadmium results in decreased expression of BCL2 protein CTD PMID:20455018 more ... cadmium dichloride multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of BCL2 protein more ... CTD PMID:17706638 more ... cadmium dichloride multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]] more ... CTD PMID:24492640 more ... cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of BCL2 mRNA and Cadmium Chloride results in decreased expression of BCL2 protein CTD PMID:23405080 more ... cadmium dichloride decreases expression ISO BCL2 (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of BCL2 mRNA and Cadmium Chloride results in decreased expression of BCL2 protein CTD PMID:23485651 more ... cadmium dichloride decreases expression ISO Bcl2 (Mus musculus) 6480464 Cadmium Chloride results in decreased expression of BCL2 mRNA and Cadmium Chloride results in decreased expression of BCL2 protein CTD PMID:15501611 more ... cadmium dichloride increases expression ISO Bcl2 (Mus musculus) 6480464 Cadmium Chloride results in increased expression of BCL2 protein CTD PMID:25111876 cadmium dichloride increases expression ISO BCL2 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of BCL2 protein CTD PMID:25111876 cadmium dichloride multiple interactions ISO BCL2 (Homo sapiens) 6480464 [[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with fenvalerate] results in increased expression of BCL2 protein more ... CTD PMID:11341981 more ... cadmium dichloride affects expression ISO BCL2 (Homo sapiens) 6480464 Cadmium Chloride affects the expression of BCL2 mRNA and Cadmium Chloride affects the expression of BCL2 protein CTD PMID:23941782 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of BCL2 CTD PMID:11170127 cadmium nitrate multiple interactions EXP 6480464 [cadmium nitrate results in increased abundance of Cadmium] which results in decreased expression of BCL2 mRNA CTD PMID:28413886 cadmium sulfide decreases expression ISO BCL2 (Homo sapiens) 6480464 cadmium sulfide results in decreased expression of BCL2 mRNA CTD PMID:27866839 cafestol decreases expression ISO BCL2 (Homo sapiens) 6480464 cafestol results in decreased expression of BCL2 protein CTD PMID:21334318 cafestol decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to cafestol CTD PMID:21334318 caffeine decreases expression EXP 6480464 Caffeine results in decreased expression of BCL2 mRNA CTD PMID:35917217 cajanol decreases expression ISO BCL2 (Homo sapiens) 6480464 cajanol results in decreased expression of BCL2 protein CTD PMID:20638373 cajanol multiple interactions ISO BCL2 (Homo sapiens) 6480464 [[[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein] which results in increased activity of CASP3 protein more ... CTD PMID:20638373 calcidiol increases expression ISO BCL2 (Homo sapiens) 6480464 Calcifediol results in increased expression of BCL2 mRNA and Calcifediol results in increased expression of BCL2 protein CTD PMID:21542014 calcidiol multiple interactions ISO BCL2 (Homo sapiens) 6480464 Ketoconazole inhibits the reaction [Calcifediol results in increased expression of BCL2 mRNA] CTD PMID:21542014 calciol increases expression ISO BCL2 (Homo sapiens) 6480464 Cholecalciferol results in increased expression of BCL2 protein CTD PMID:18628207 calcitriol multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Calcitriol co-treated with Genistein] results in decreased expression of BCL2 mRNA more ... CTD PMID:10713328 more ... calcitriol multiple interactions EXP 6480464 2 more ... CTD PMID:29953732 calcitriol increases expression ISO BCL2 (Homo sapiens) 6480464 Calcitriol results in increased expression of BCL2 mRNA and Calcitriol results in increased expression of BCL2 protein CTD PMID:21542014 calcitriol increases expression EXP 6480464 Calcitriol results in increased expression of BCL2 protein CTD PMID:17570329 calcitriol increases expression ISO Bcl2 (Mus musculus) 6480464 Calcitriol results in increased expression of BCL2 CTD PMID:19603526 calcitriol decreases expression ISO BCL2 (Homo sapiens) 6480464 Calcitriol results in decreased expression of BCL2 more ... CTD PMID:10614618 more ... calcium oxalate multiple interactions ISO BCL2 (Homo sapiens) 6480464 SIRT1 protein inhibits the reaction [Calcium Oxalate results in decreased expression of BCL2 protein] CTD PMID:34333021 calcium oxalate decreases expression ISO BCL2 (Homo sapiens) 6480464 Calcium Oxalate results in decreased expression of BCL2 protein CTD PMID:34333021 calycosin-7-O-beta-D-glucoside decreases expression ISO Bcl2 (Mus musculus) 6480464 calycosin-7-O-beta-D-glucoside results in decreased expression of BCL2 mRNA and calycosin-7-O-beta-D-glucoside results in decreased expression of BCL2 protein CTD PMID:36812960 calycosin-7-O-beta-D-glucoside decreases expression ISO BCL2 (Homo sapiens) 6480464 calycosin-7-O-beta-D-glucoside results in decreased expression of BCL2 mRNA and calycosin-7-O-beta-D-glucoside results in decreased expression of BCL2 protein CTD PMID:36812960 calycosin-7-O-beta-D-glucoside multiple interactions ISO BCL2 (Homo sapiens) 6480464 TXN protein affects the reaction [calycosin-7-O-beta-D-glucoside results in decreased expression of BCL2 mRNA] and TXN protein affects the reaction [calycosin-7-O-beta-D-glucoside results in decreased expression of BCL2 protein] CTD PMID:36812960 camalexin decreases expression ISO BCL2 (Homo sapiens) 6480464 camalexin metabolite results in decreased expression of BCL2 mRNA CTD PMID:23339777 camptothecin multiple interactions ISO BCL2 (Homo sapiens) 6480464 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole promotes the reaction [Camptothecin results in decreased expression of BCL2 protein] more ... CTD PMID:19481069 more ... camptothecin multiple interactions ISO Bcl2 (Mus musculus) 6480464 Camptothecin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BCL2 protein] CTD PMID:25449198 camptothecin increases expression ISO BCL2 (Homo sapiens) 6480464 Camptothecin results in increased expression of BCL2 mRNA CTD PMID:24726431 camptothecin decreases expression ISO BCL2 (Homo sapiens) 6480464 Camptothecin results in decreased expression of BCL2 mRNA and Camptothecin results in decreased expression of BCL2 protein CTD PMID:10692111 more ... camptothecin decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 results in decreased susceptibility to Camptothecin CTD PMID:10896673 Candesartan cilexetil increases expression EXP 6480464 candesartan cilexetil results in increased expression of BCL2 protein CTD PMID:22120037 cannabidiol multiple interactions EXP 6480464 Cannabidiol inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] CTD PMID:27430346 cannabidiol multiple interactions ISO BCL2 (Homo sapiens) 6480464 Cannabidiol inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of BCL2 mRNA] and Cannabidiol inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of BCL2 protein] CTD PMID:36988283 cannabidiol multiple interactions ISO Bcl2 (Mus musculus) 6480464 Cannabidiol inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of BCL2 mRNA] and Cannabidiol inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of BCL2 protein] CTD PMID:36988283 cannabidiol increases expression ISO BCL2 (Homo sapiens) 6480464 Cannabidiol results in increased expression of BCL2 protein CTD PMID:27932991 cannabidiol decreases expression ISO BCL2 (Homo sapiens) 6480464 Cannabidiol results in decreased expression of BCL2 mRNA and Cannabidiol results in decreased expression of BCL2 protein CTD PMID:31349651 more ... cantharidin decreases expression ISO BCL2 (Homo sapiens) 6480464 Cantharidin results in decreased expression of BCL2 protein CTD PMID:16117893 more ... cantharidin decreases expression EXP 6480464 Cantharidin results in decreased expression of BCL2 protein CTD PMID:35398186 capillarisin decreases expression ISO BCL2 (Homo sapiens) 6480464 capillarisin results in decreased expression of BCL2 mRNA and capillarisin results in decreased expression of BCL2 protein CTD PMID:24333736 capsaicin decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to Capsaicin CTD PMID:9580328 capsaicin affects expression ISO BCL2 (Homo sapiens) 6480464 Capsaicin affects the expression of BCL2 protein CTD PMID:34939720 capsaicin increases expression ISO BCL2 (Homo sapiens) 6480464 Capsaicin results in increased expression of BCL2 mRNA CTD PMID:19502594 more ... capsaicin decreases expression ISO Bcl2 (Mus musculus) 6480464 Capsaicin results in decreased expression of BCL2 protein CTD PMID:15595419 more ... capsaicin decreases expression ISO BCL2 (Homo sapiens) 6480464 Capsaicin results in decreased expression of BCL2 and Capsaicin results in decreased expression of BCL2 protein CTD PMID:11275362 more ... capsazepine multiple interactions ISO Bcl2 (Mus musculus) 6480464 capsazepine inhibits the reaction [Acrolein results in decreased expression of BCL2 protein] CTD PMID:24376112 captan decreases expression ISO Bcl2 (Mus musculus) 6480464 Captan results in decreased expression of BCL2 mRNA and Captan results in decreased expression of BCL2 protein CTD PMID:34303901 carbachol increases expression ISO Bcl2 (Mus musculus) 6480464 Carbachol results in increased expression of BCL2 protein CTD PMID:19200344 carbachol multiple interactions ISO Bcl2 (Mus musculus) 6480464 Carbachol inhibits the reaction [APP protein modified form results in decreased expression of BCL2 protein] CTD PMID:10758335 carbachol increases expression EXP 6480464 Carbachol results in increased expression of BCL2 protein CTD PMID:17708838 carbamate ester affects expression ISO Bcl2 (Mus musculus) 6480464 Carbamates affects the expression of BCL2 mRNA CTD PMID:21303328 carbamazepine increases expression EXP 6480464 Carbamazepine results in increased expression of BCL2 mRNA and Carbamazepine results in increased expression of BCL2 protein CTD PMID:18719996 carbendazim decreases expression EXP 6480464 carbendazim results in decreased expression of BCL2 mRNA CTD PMID:35437878 and PMID:35513110 CARBENOXOLONE affects expression ISO BCL2 (Homo sapiens) 6480464 Carbenoxolone affects the expression of BCL2 mRNA CTD PMID:23678415 CARBENOXOLONE multiple interactions ISO BCL2 (Homo sapiens) 6480464 [perfluorooctanoic acid co-treated with Carbenoxolone] results in decreased expression of BCL2 protein CTD PMID:32971237 CARBENOXOLONE multiple interactions EXP 6480464 [[lead acetate results in increased abundance of Lead] which co-treated with Carbenoxolone] results in decreased expression of BCL2 protein CTD PMID:33242459 carbidopa multiple interactions ISO Bcl2 (Mus musculus) 6480464 [sarpogrelate co-treated with Carbidopa] inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] more ... CTD PMID:34560070 and PMID:35202708 carbidopa multiple interactions ISO BCL2 (Homo sapiens) 6480464 [sarpogrelate co-treated with Carbidopa] inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] and Carbidopa inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] CTD PMID:34560070 carbofuran decreases expression EXP 6480464 Carbofuran results in decreased expression of BCL2 protein CTD PMID:30471306 carbon disulfide decreases expression ISO Bcl2 (Mus musculus) 6480464 Carbon Disulfide results in decreased expression of BCL2 mRNA and Carbon Disulfide results in decreased expression of BCL2 protein CTD PMID:24080331 carbon nanotube decreases expression ISO Bcl2 (Mus musculus) 6480464 Nanotubes and Carbon analog results in decreased expression of BCL2 mRNA CTD PMID:21624382 carbon nanotube multiple interactions ISO Bcl2 (Mus musculus) 6480464 Nanotubes and Carbon inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] CTD PMID:32068018 carbon nanotube decreases expression ISO BCL2 (Homo sapiens) 6480464 Nanotubes and Carbon results in decreased expression of BCL2 protein CTD PMID:28673683 and PMID:32493873 carbon nanotube multiple interactions EXP 6480464 Vitamin E inhibits the reaction [Nanotubes and Carbon results in decreased expression of BCL2 protein] CTD PMID:22020378 carbon nanotube decreases expression EXP 6480464 Nanotubes and Carbon results in decreased expression of BCL2 protein CTD PMID:22020378 carbon nanotube increases expression ISO BCL2 (Homo sapiens) 6480464 Nanotubes and Carbon results in increased expression of BCL2 mRNA CTD PMID:22076105 carboplatin decreases expression ISO BCL2 (Homo sapiens) 6480464 Carboplatin results in decreased expression of BCL2 mRNA and Carboplatin results in decreased expression of BCL2 protein CTD PMID:15576332 more ... carboxy-PTIO multiple interactions ISO BCL2 (Homo sapiens) 6480464 1 more ... CTD PMID:16980304 Cardamonin multiple interactions EXP 6480464 cardamonin inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of BCL2 protein] CTD PMID:28966130 Cardanol increases expression ISO BCL2 (Homo sapiens) 6480464 cardanol results in increased expression of BCL2 mRNA CTD PMID:26694491 carmustine multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Fenretinide co-treated with Carmustine] results in decreased expression of BCL2 protein CTD PMID:16187019 carmustine affects response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein affects the susceptibility to Carmustine CTD PMID:15332326 and PMID:18430789 carmustine decreases expression ISO BCL2 (Homo sapiens) 6480464 Carmustine results in decreased expression of BCL2 protein CTD PMID:15332326 and PMID:20920327 carnosic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [salvin results in decreased expression of BCL2 protein] more ... CTD PMID:25446857 more ... carnosic acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 salvin inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein] CTD PMID:29854073 carnosic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 salvin results in decreased expression of BCL2 protein CTD PMID:28918123 carnosic acid multiple interactions EXP 6480464 salvin inhibits the reaction [Oxidopamine results in decreased expression of BCL2 protein] CTD PMID:25446857 carnosine multiple interactions EXP 6480464 Carnosine inhibits the reaction [Sodium Nitrite results in decreased expression of BCL2 protein] CTD PMID:28266762 carnosine multiple interactions ISO BCL2 (Homo sapiens) 6480464 asiatic acid promotes the reaction [Carnosine inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA]] more ... CTD PMID:30802477 Carnosol multiple interactions ISO Bcl2 (Mus musculus) 6480464 carnosol inhibits the reaction [Dietary Fats results in decreased expression of BCL2 protein] more ... CTD PMID:34678374 carvacrol multiple interactions EXP 6480464 carvacrol inhibits the reaction [Ethanol results in decreased expression of BCL2 protein] CTD PMID:37499997 carvedilol multiple interactions EXP 6480464 carvedilol inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA] more ... CTD PMID:15380674 more ... carvedilol affects expression EXP 6480464 carvedilol affects the expression of BCL2 protein CTD PMID:22000973 carvedilol increases expression EXP 6480464 carvedilol results in increased expression of BCL2 mRNA CTD PMID:16780994 and PMID:16909474 casticin decreases expression ISO BCL2 (Homo sapiens) 6480464 casticin results in decreased expression of BCL2 protein CTD PMID:27862857 and PMID:29098808 casticin multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Fluorouracil co-treated with casticin] results in decreased expression of BCL2 protein CTD PMID:32270916 catalpol multiple interactions ISO Bcl2 (Mus musculus) 6480464 catalpol inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein] CTD PMID:37436358 catalpol multiple interactions ISO BCL2 (Homo sapiens) 6480464 6-chloro-2 more ... CTD PMID:37436358 CEDRELONE decreases expression ISO BCL2 (Homo sapiens) 6480464 cedrelone analog results in decreased expression of BCL2 protein CTD PMID:31857088 celastrol decreases expression ISO BCL2 (Homo sapiens) 6480464 celastrol results in decreased expression of BCL2 protein CTD PMID:21466843 celastrol multiple interactions ISO Bcl2 (Mus musculus) 6480464 celastrol inhibits the reaction [Plant Preparations results in decreased expression of BCL2 protein] CTD PMID:29643811 celastrol increases expression ISO Bcl2 (Mus musculus) 6480464 celastrol results in increased expression of BCL2 mRNA CTD PMID:29643811 celecoxib decreases expression ISO BCL2 (Homo sapiens) 6480464 Celecoxib results in decreased expression of BCL2 protein CTD PMID:15911099 more ... celecoxib multiple interactions ISO Bcl2 (Mus musculus) 6480464 Celecoxib promotes the reaction [Dihematoporphyrin Ether results in increased cleavage of BCL2 protein] CTD PMID:16230411 celecoxib increases expression ISO BCL2 (Homo sapiens) 6480464 Celecoxib results in increased expression of BCL2 mRNA CTD PMID:17342322 celecoxib multiple interactions ISO BCL2 (Homo sapiens) 6480464 BCL2 protein inhibits the reaction [ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP3 protein]] more ... CTD PMID:15688368 more ... ceric oxide decreases expression ISO BCL2 (Homo sapiens) 6480464 ceric oxide results in decreased expression of BCL2 protein CTD PMID:24987704 ceritinib decreases expression ISO BCL2 (Homo sapiens) 6480464 ceritinib analog results in decreased expression of BCL2 protein CTD PMID:35803438 ceruletide increases expression ISO Bcl2 (Mus musculus) 6480464 Ceruletide results in increased expression of BCL2 mRNA and Ceruletide results in increased expression of BCL2 protein CTD PMID:34423886 ceruletide multiple interactions ISO Bcl2 (Mus musculus) 6480464 coumermycin inhibits the reaction [limonin inhibits the reaction [Ceruletide results in increased expression of BCL2 protein]] more ... CTD PMID:34423886 cetrorelix decreases expression ISO BCL2 (Homo sapiens) 6480464 cetrorelix results in decreased expression of BCL2 protein CTD PMID:21062912 cetrorelix decreases expression EXP 6480464 cetrorelix results in decreased expression of BCL2 mRNA CTD PMID:18829022 chalcones decreases expression ISO BCL2 (Homo sapiens) 6480464 Chalcones analog results in decreased expression of BCL2 mRNA more ... CTD PMID:23562496 more ... chalcones multiple interactions ISO BCL2 (Homo sapiens) 6480464 BCL2 protein inhibits the reaction [Chalcones analog results in decreased expression of BID protein] more ... CTD PMID:30576621 chelerythrine multiple interactions EXP 6480464 chelerythrine inhibits the reaction [sodium arsenite inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]] CTD PMID:12690470 chelerythrine multiple interactions ISO BCL2 (Homo sapiens) 6480464 chelerythrine inhibits the reaction [Resveratrol affects the expression of BCL2 protein] CTD PMID:31151226 chelidonine affects expression ISO BCL2 (Homo sapiens) 6480464 chelidonine affects the expression of BCL2 mRNA CTD PMID:25265580 Chikusetsusaponin-IV decreases expression ISO BCL2 (Homo sapiens) 6480464 araloside A results in decreased expression of BCL2 protein CTD PMID:31004595 Chikusetsusaponin-V multiple interactions ISO BCL2 (Homo sapiens) 6480464 chikusetsusaponin V inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein] CTD PMID:25073091 CHIR 99021 multiple interactions ISO BCL2 (Homo sapiens) 6480464 Chir 99021 inhibits the reaction [SC-66 compound results in decreased expression of BCL2 protein] CTD PMID:34687144 chitosan multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Fluorouracil co-treated with Chitosan co-treated with polyaspartate] results in decreased expression of BCL2 protein CTD PMID:18567086 chitosan multiple interactions EXP 6480464 [Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of BCL2 protein] and Chitosan analog inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] CTD PMID:28732690 and PMID:30928397 chlorambucil decreases expression ISO BCL2 (Homo sapiens) 6480464 Chlorambucil results in decreased expression of BCL2 mRNA and Chlorambucil results in decreased expression of BCL2 protein CTD PMID:11699414 and PMID:8822937 chlorambucil multiple interactions ISO BCL2 (Homo sapiens) 6480464 IL4 protein inhibits the reaction [Chlorambucil results in decreased expression of BCL2 protein] CTD PMID:8822937 chlordecone increases expression ISO Bcl2 (Mus musculus) 6480464 Chlordecone results in increased expression of BCL2 mRNA CTD PMID:17578864 chloroacetic acid decreases expression ISO Bcl2 (Mus musculus) 6480464 chloroacetic acid results in decreased expression of BCL2 mRNA CTD PMID:23103613 chloroacetic acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 SB 203580 inhibits the reaction [chloroacetic acid results in decreased expression of BCL2 mRNA] CTD PMID:23103613 chlorogenic acid multiple interactions EXP 6480464 Chlorogenic Acid inhibits the reaction [Glucose results in decreased expression of BCL2 protein] and Chlorogenic Acid inhibits the reaction [Methotrexate results in decreased expression of BCL2 protein] CTD PMID:28479099 and PMID:34801538 chlorogenic acid decreases expression ISO Bcl2 (Mus musculus) 6480464 Chlorogenic Acid results in decreased expression of BCL2 mRNA and Chlorogenic Acid results in decreased expression of BCL2 protein CTD PMID:33058431 chlorogenic acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 Chlorogenic Acid inhibits the reaction [Aluminum Chloride results in decreased expression of BCL2 protein] and Chlorogenic Acid inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA] CTD PMID:28623112 and PMID:33242462 chloroprene decreases expression ISO Bcl2 (Mus musculus) 6480464 Chloroprene results in decreased expression of BCL2 mRNA CTD PMID:23125180 chloroquine multiple interactions ISO BCL2 (Homo sapiens) 6480464 Chloroquine inhibits the reaction [formosanin C results in decreased expression of BCL2 protein] CTD PMID:27180204 chloroquine multiple interactions EXP 6480464 Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of BCL2 protein]] and Chloroquine inhibits the reaction [Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased expression of BCL2 protein]] CTD PMID:28713934 and PMID:35104487 chlorothalonil decreases expression ISO Bcl2 (Mus musculus) 6480464 tetrachloroisophthalonitrile results in decreased expression of BCL2 protein CTD PMID:30586609 chlorpyrifos decreases expression ISO BCL2 (Homo sapiens) 6480464 Chlorpyrifos results in decreased expression of BCL2 mRNA and Chlorpyrifos results in decreased expression of BCL2 protein CTD PMID:18155347 and PMID:36058312 chlorpyrifos affects expression ISO Bcl2 (Mus musculus) 6480464 Chlorpyrifos affects the expression of BCL2 protein CTD PMID:30378422 chlorpyrifos increases expression ISO Bcl2 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of BCL2 protein CTD PMID:32120800 chlorpyrifos multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Chlorpyrifos co-treated with Ethylenethiourea] results in decreased expression of BCL2 mRNA and ginsenoside Rg1 inhibits the reaction [Chlorpyrifos results in decreased expression of BCL2 protein] CTD PMID:27905518 and PMID:36811218 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of BCL2 mRNA and Chlorpyrifos results in decreased expression of BCL2 protein CTD PMID:29859868 more ... chlorpyrifos multiple interactions EXP 6480464 3-(indol-3-yl)propionic acid inhibits the reaction [Chlorpyrifos results in decreased expression of BCL2 protein] more ... CTD PMID:29859868 more ... chlorpyrifos decreases expression ISO Bcl2 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of BCL2 mRNA and Chlorpyrifos results in decreased expression of BCL2 protein CTD PMID:27117976 more ... chlorpyrifos multiple interactions ISO BCL2 (Homo sapiens) 6480464 [[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Cisplatin] which results in increased expression of BCL2 mRNA more ... CTD PMID:32800223 Cholestane-3,5,6-triol multiple interactions EXP 6480464 Sodium Selenite inhibits the reaction [cholestane-3 more ... CTD PMID:16039982 Cholestane-3,5,6-triol increases expression EXP 6480464 cholestane-3 more ... CTD PMID:16039982 cholesterol decreases expression EXP 6480464 Cholesterol analog results in decreased expression of BCL2 mRNA CTD PMID:19477266 cholesterol multiple interactions ISO Bcl2 (Mus musculus) 6480464 Cholesterol inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein] CTD PMID:29486218 choline multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Dietary Fats co-treated with cyanoginosin LR] results in decreased expression of BCL2 protein more ... CTD PMID:20938992 and PMID:34416350 chromium(3+) trichloride decreases expression ISO BCL2 (Homo sapiens) 6480464 chromic chloride results in decreased expression of BCL2 protein CTD PMID:14741615 chromium(6+) affects response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein affects the susceptibility to chromium hexavalent ion CTD PMID:19556603 chromium(6+) multiple interactions ISO Bcl2 (Mus musculus) 6480464 [sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in decreased expression of BCL2 mRNA more ... CTD PMID:35643323 chromium(6+) decreases expression EXP 6480464 chromium hexavalent ion results in decreased expression of BCL2 protein CTD PMID:35024197 chromium(6+) multiple interactions EXP 6480464 [6-chloro-2 more ... CTD PMID:30974164 more ... chromium(6+) increases expression ISO BCL2 (Homo sapiens) 6480464 chromium hexavalent ion results in increased expression of BCL2 protein CTD PMID:22666341 more ... chromium(6+) multiple interactions ISO BCL2 (Homo sapiens) 6480464 Luteolin inhibits the reaction [chromium hexavalent ion results in increased expression of BCL2 protein] CTD PMID:25448439 chrysazin decreases expression ISO BCL2 (Homo sapiens) 6480464 danthron results in decreased expression of BCL2 protein CTD PMID:21126053 chrysin multiple interactions EXP 6480464 chrysin inhibits the reaction [Testosterone results in increased expression of BCL2 mRNA] CTD PMID:29247772 chrysin multiple interactions ISO BCL2 (Homo sapiens) 6480464 BCL2 protein inhibits the reaction [chrysin results in decreased expression of XIAP protein] more ... CTD PMID:16215670 and PMID:25770930 chrysin decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to chrysin CTD PMID:16215670 cidofovir anhydrous decreases expression ISO BCL2 (Homo sapiens) 6480464 Cidofovir results in decreased expression of BCL2 CTD PMID:12700662 ciglitazone decreases expression ISO BCL2 (Homo sapiens) 6480464 ciglitazone results in decreased expression of BCL2 protein CTD PMID:15492468 cilnidipine multiple interactions ISO BCL2 (Homo sapiens) 6480464 cilnidipine inhibits the reaction [Iohexol results in decreased expression of BCL2 protein] CTD PMID:36207783 cilnidipine multiple interactions EXP 6480464 cilnidipine inhibits the reaction [Iohexol results in decreased expression of BCL2 protein] CTD PMID:36207783 cilostazol multiple interactions ISO BCL2 (Homo sapiens) 6480464 cilostazol inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein] CTD PMID:16822680 cilostazol affects expression EXP 6480464 cilostazol affects the expression of BCL2 protein CTD PMID:15978173 cilostazol decreases expression ISO BCL2 (Homo sapiens) 6480464 cilostazol results in decreased expression of BCL2 protein CTD PMID:20131233 cimetidine decreases expression ISO BCL2 (Homo sapiens) 6480464 Cimetidine results in decreased expression of BCL2 protein CTD PMID:20127008 cimetidine multiple interactions ISO Bcl2 (Mus musculus) 6480464 Cimetidine inhibits the reaction [Ethanol results in decreased expression of BCL2 protein] CTD PMID:27983966 Cinobufagin decreases expression ISO BCL2 (Homo sapiens) 6480464 cinobufagin results in decreased expression of BCL2 protein CTD PMID:23164673 ciprofloxacin multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Etoposide co-treated with Ciprofloxacin] results in decreased expression of BCL2 protein and BCL2 protein inhibits the reaction [Ciprofloxacin results in increased localization of BAX protein] CTD PMID:11832715 and PMID:12063570 cisplatin multiple interactions ISO BCL2 (Homo sapiens) 6480464 6-hydroxy-2 more ... CTD PMID:10891529 more ... cisplatin affects expression EXP 6480464 Cisplatin affects the expression of BCL2 protein CTD PMID:30125553 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of BCL2 protein CTD PMID:28414026 cisplatin increases expression ISO BCL2 (Homo sapiens) 6480464 Cisplatin results in increased expression of BCL2 protein CTD PMID:17619073 more ... cisplatin decreases expression ISO BCL2 (Homo sapiens) 6480464 Cisplatin results in decreased expression of BCL2 more ... CTD PMID:10891529 more ... cisplatin decreases expression ISO Bcl2 (Mus musculus) 6480464 Cisplatin results in decreased expression of BCL2 mRNA and Cisplatin results in decreased expression of BCL2 protein CTD PMID:20566416 more ... cisplatin increases expression ISO Bcl2 (Mus musculus) 6480464 Cisplatin results in increased expression of BCL2 mRNA and Cisplatin results in increased expression of BCL2 protein CTD PMID:19833167 more ... cisplatin affects expression ISO BCL2 (Homo sapiens) 6480464 Cisplatin affects the expression of BCL2 protein CTD PMID:24799992 cisplatin decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to Cisplatin and BCL2 results in decreased susceptibility to Cisplatin CTD PMID:10896673 more ... cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of BCL2 mRNA and Cisplatin results in decreased expression of BCL2 protein CTD PMID:12690470 more ... cisplatin multiple interactions EXP 6480464 2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in decreased expression of BCL2 mRNA] more ... CTD PMID:12690470 more ... cisplatin decreases response to substance EXP 6480464 BCL2 protein results in decreased susceptibility to Cisplatin CTD PMID:15315938 cisplatin affects response to substance ISO Bcl2 (Mus musculus) 6480464 BCL2 protein affects the susceptibility to Cisplatin CTD PMID:15746559 cisplatin multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Cisplatin co-treated with TNF protein] results in decreased expression of BCL2 mRNA more ... CTD PMID:19833167 more ... Citreoviridin decreases expression EXP 6480464 citreoviridin results in decreased expression of BCL2 protein CTD PMID:31419397 Citreoviridin decreases expression ISO Bcl2 (Mus musculus) 6480464 citreoviridin results in decreased expression of BCL2 protein CTD PMID:31419397 Citreoviridin multiple interactions ISO Bcl2 (Mus musculus) 6480464 Sodium Selenite inhibits the reaction [citreoviridin results in decreased expression of BCL2 protein] and Thiamine inhibits the reaction [citreoviridin results in decreased expression of BCL2 protein] CTD PMID:31419397 Citreoviridin multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [citreoviridin results in decreased expression of BCL2 protein] more ... CTD PMID:31419397 citric acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Citric Acid co-treated with zinc chloride] results in decreased expression of BCL2 protein and [Silver analog co-treated with Citric Acid] results in increased expression of BCL2 mRNA CTD PMID:16624386 and PMID:27021274 citronellal multiple interactions EXP 6480464 citronellal inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] and Lithium Chloride inhibits the reaction [citronellal inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]] CTD PMID:34813134 cladribine multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Cladribine co-treated with Cyclophosphamide co-treated with Mitoxantrone] results in decreased expression of BCL2 protein more ... CTD PMID:15516989 and PMID:15582267 cladribine decreases expression ISO BCL2 (Homo sapiens) 6480464 Cladribine results in decreased expression of BCL2 protein CTD PMID:15582267 clofibrate multiple interactions ISO Bcl2 (Mus musculus) 6480464 Clofibrate inhibits the reaction [[Fatty Acids and Nonesterified binds to ALB protein] which results in decreased expression of BCL2 protein] CTD PMID:21338618 clonazepam increases expression EXP 6480464 Clonazepam results in increased expression of BCL2 protein CTD PMID:17456340 clonidine decreases expression ISO BCL2 (Homo sapiens) 6480464 Clonidine results in decreased expression of BCL2 protein CTD PMID:28115640 clonidine (amino form) decreases expression ISO BCL2 (Homo sapiens) 6480464 Clonidine results in decreased expression of BCL2 protein CTD PMID:28115640 clonidine (imino form) decreases expression ISO BCL2 (Homo sapiens) 6480464 Clonidine results in decreased expression of BCL2 protein CTD PMID:28115640 clorgyline multiple interactions ISO BCL2 (Homo sapiens) 6480464 Clorgyline inhibits the reaction [Carbon Tetrachloride results in decreased expression of BCL2 protein] more ... CTD PMID:35202708 clozapine increases expression EXP 6480464 Clozapine results in increased expression of BCL2 mRNA and Clozapine results in increased expression of BCL2 protein CTD PMID:15126120 cobalt atom decreases expression ISO BCL2 (Homo sapiens) 6480464 Cobalt results in decreased expression of BCL2 protein CTD PMID:21598295 cobalt atom multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Cobalt binds to Schiff Bases] which results in decreased expression of BCL2 protein CTD PMID:34157415 cobalt dichloride increases expression ISO BCL2 (Homo sapiens) 6480464 cobaltous chloride results in increased expression of BCL2 protein CTD PMID:16827160 cobalt dichloride multiple interactions EXP 6480464 Plant Extracts inhibits the reaction [cobaltous chloride results in decreased expression of BCL2 protein] CTD PMID:30551423 cobalt dichloride decreases expression ISO Bcl2 (Mus musculus) 6480464 cobaltous chloride results in decreased expression of BCL2 mRNA CTD PMID:24265542 cobalt dichloride multiple interactions ISO Bcl2 (Mus musculus) 6480464 [cobaltous chloride co-treated with 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole] results in decreased expression of BCL2 mRNA CTD PMID:24265542 cobalt dichloride decreases expression ISO BCL2 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of BCL2 mRNA and cobaltous chloride results in decreased expression of BCL2 protein CTD PMID:14741615 and PMID:17786326 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of BCL2 protein CTD PMID:19520152 and PMID:30551423 cobalt dichloride multiple interactions ISO BCL2 (Homo sapiens) 6480464 cobaltous chloride inhibits the reaction [Cyclosporine results in decreased expression of BCL2 protein] more ... CTD PMID:17786326 more ... cocaine affects expression ISO Bcl2 (Mus musculus) 6480464 Cocaine affects the expression of BCL2 mRNA CTD PMID:15681117 cocaine decreases expression ISO Bcl2 (Mus musculus) 6480464 Cocaine results in decreased expression of BCL2 protein CTD PMID:29673861 and PMID:30393195 cocaine multiple interactions ISO Bcl2 (Mus musculus) 6480464 IL6 protein affects the reaction [Cocaine results in decreased expression of BCL2 protein] more ... CTD PMID:29673861 and PMID:30393195 cocaine increases phosphorylation EXP 6480464 Cocaine results in increased phosphorylation of BCL2 protein CTD PMID:19879923 cocaine multiple interactions EXP 6480464 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Cocaine results in increased phosphorylation of BCL2 protein] more ... CTD PMID:19879923 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of BCL2 mRNA and Cocaine results in decreased expression of BCL2 protein CTD PMID:11392460 more ... cocaine increases expression EXP 6480464 Cocaine results in increased expression of BCL2 protein CTD PMID:17084983 and PMID:18974856 codeinone decreases expression ISO BCL2 (Homo sapiens) 6480464 6-codeinone results in decreased expression of BCL2 protein CTD PMID:12894543 coenzyme Q10 increases expression EXP 6480464 coenzyme Q10 results in increased expression of BCL2 mRNA CTD PMID:18817789 coenzyme Q10 multiple interactions ISO Bcl2 (Mus musculus) 6480464 [coenzyme Q10 co-treated with TNFSF11 protein] results in decreased expression of BCL2 mRNA more ... CTD PMID:33754447 and PMID:34186417 coenzyme Q10 multiple interactions EXP 6480464 [epigallocatechin gallate co-treated with coenzyme Q10] inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] more ... CTD PMID:27087047 more ... colforsin daropate hydrochloride multiple interactions ISO BCL2 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:36336211 and PMID:37544576 colistin decreases expression EXP 6480464 Colistin results in decreased expression of BCL2 protein CTD PMID:28465020 and PMID:30138604 colistin multiple interactions ISO BCL2 (Homo sapiens) 6480464 Sirolimus inhibits the reaction [Colistin results in decreased expression of BCL2 protein] CTD PMID:35378205 colistin decreases expression ISO BCL2 (Homo sapiens) 6480464 Colistin results in decreased expression of BCL2 protein CTD PMID:35378205 colistin decreases expression ISO Bcl2 (Mus musculus) 6480464 Colistin results in decreased expression of BCL2 mRNA and Colistin results in decreased expression of BCL2 protein CTD PMID:34560125 and PMID:35378205 colistin multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rhodioloside inhibits the reaction [Colistin results in decreased expression of BCL2 protein]] more ... CTD PMID:28465020 more ... colistin increases phosphorylation EXP 6480464 Colistin results in increased phosphorylation of BCL2 protein CTD PMID:28842171 conjugated linoleic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 Linoleic Acids and Conjugated results in decreased expression of BCL2 protein CTD PMID:15961301 conjugated linoleic acid decreases expression ISO Bcl2 (Mus musculus) 6480464 Linoleic Acids and Conjugated results in decreased expression of BCL2 protein CTD PMID:20155912 copper atom decreases expression ISO Bcl2 (Mus musculus) 6480464 Copper analog results in decreased expression of BCL2 protein and Copper results in decreased expression of BCL2 protein CTD PMID:22000994 and PMID:34676557 copper atom increases expression EXP 6480464 Copper results in increased expression of BCL2 protein CTD PMID:30556269 copper atom multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Copper Sulfate results in increased abundance of Copper] which results in decreased expression of BCL2 mRNA and [Copper Sulfate results in increased abundance of Copper] which results in decreased expression of BCL2 protein CTD PMID:31491480 copper atom multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in decreased expression of BCL2 protein and [Copper co-treated with Disulfiram] results in decreased expression of BCL2 protein CTD PMID:23033007 and PMID:30911355 copper atom multiple interactions EXP 6480464 [Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2 mRNA more ... CTD PMID:22085843 more ... copper atom decreases expression ISO BCL2 (Homo sapiens) 6480464 Copper results in decreased expression of BCL2 mRNA and Copper results in decreased expression of BCL2 protein CTD PMID:16391388 and PMID:16962711 copper(0) decreases expression ISO Bcl2 (Mus musculus) 6480464 Copper analog results in decreased expression of BCL2 protein and Copper results in decreased expression of BCL2 protein CTD PMID:22000994 and PMID:34676557 copper(0) increases expression EXP 6480464 Copper results in increased expression of BCL2 protein CTD PMID:30556269 copper(0) multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Copper Sulfate results in increased abundance of Copper] which results in decreased expression of BCL2 mRNA and [Copper Sulfate results in increased abundance of Copper] which results in decreased expression of BCL2 protein CTD PMID:31491480 copper(0) multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in decreased expression of BCL2 protein and [Copper co-treated with Disulfiram] results in decreased expression of BCL2 protein CTD PMID:23033007 and PMID:30911355 copper(0) multiple interactions EXP 6480464 [Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2 mRNA more ... CTD PMID:22085843 more ... copper(0) decreases expression ISO BCL2 (Homo sapiens) 6480464 Copper results in decreased expression of BCL2 mRNA and Copper results in decreased expression of BCL2 protein CTD PMID:16391388 and PMID:16962711 copper(II) chloride multiple interactions EXP 6480464 [cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in decreased expression of BCL2 mRNA more ... CTD PMID:20920558 copper(II) chloride multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Disulfiram co-treated with cupric chloride] results in decreased expression of BCL2 protein CTD PMID:21911303 copper(II) chloride decreases expression ISO Bcl2 (Mus musculus) 6480464 cupric chloride results in decreased expression of BCL2 protein CTD PMID:23313662 and PMID:24170445 copper(II) sulfate decreases expression ISO BCL2 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of BCL2 mRNA CTD PMID:19549813 copper(II) sulfate decreases expression EXP 6480464 Copper Sulfate results in decreased expression of BCL2 mRNA CTD PMID:30431687 copper(II) sulfate multiple interactions EXP 6480464 [Copper Sulfate results in increased abundance of Copper] which results in decreased expression of BCL2 mRNA more ... CTD PMID:30431687 more ... copper(II) sulfate multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Copper Sulfate results in increased abundance of Copper] which results in decreased expression of BCL2 mRNA and [Copper Sulfate results in increased abundance of Copper] which results in decreased expression of BCL2 protein CTD PMID:31491480 copper(II) sulfate decreases expression ISO Bcl2 (Mus musculus) 6480464 Copper Sulfate results in decreased expression of BCL2 mRNA CTD PMID:25216733 copper(II) sulfate multiple interactions ISO BCL2 (Homo sapiens) 6480464 Copper Sulfate inhibits the reaction [Trientine results in increased expression of BCL2 protein] CTD PMID:14513838 coptisine decreases expression ISO BCL2 (Homo sapiens) 6480464 coptisine analog results in decreased expression of BCL2 protein CTD PMID:30472432 cordycepin decreases expression ISO BCL2 (Homo sapiens) 6480464 cordycepin results in decreased expression of BCL2 mRNA and cordycepin results in decreased expression of BCL2 protein CTD PMID:21310227 more ... cordycepin multiple interactions EXP 6480464 cordycepin inhibits the reaction [testosterone enanthate results in increased expression of BCL2 mRNA] and cordycepin inhibits the reaction [testosterone enanthate results in increased expression of BCL2 protein] CTD PMID:36015278 cordycepin multiple interactions ISO BCL2 (Homo sapiens) 6480464 [cordycepin co-treated with apatinib] results in decreased expression of BCL2 protein and Acetylcysteine inhibits the reaction [cordycepin results in decreased expression of BCL2 protein] CTD PMID:21310227 and PMID:33014856 corilagin multiple interactions EXP 6480464 corilagin inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] and corilagin inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2 protein] CTD PMID:34605098 and PMID:35103375 corosolic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 corosolic acid results in decreased expression of BCL2 mRNA and corosolic acid results in decreased expression of BCL2 protein CTD PMID:28506699 corosolic acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 corosolic acid inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] CTD PMID:34296331 corosolic acid multiple interactions EXP 6480464 corosolic acid inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] more ... CTD PMID:34296331 corticosterone affects expression EXP 6480464 Corticosterone affects the expression of BCL2 mRNA CTD PMID:27988398 corticosterone multiple interactions EXP 6480464 Estradiol inhibits the reaction [Corticosterone results in decreased expression of BCL2 protein] more ... CTD PMID:27988398 and PMID:29625166 corticosterone decreases expression EXP 6480464 Corticosterone results in decreased expression of BCL2 protein CTD PMID:29625166 Corynoxine B multiple interactions ISO BCL2 (Homo sapiens) 6480464 corynoxine B inhibits the reaction [manganese chloride promotes the reaction [BCL2 protein binds to BECN1 protein]] CTD PMID:30578841 coumarin decreases expression ISO BCL2 (Homo sapiens) 6480464 coumarin analog results in decreased expression of BCL2 mRNA and coumarin results in decreased expression of BCL2 protein CTD PMID:15964220 and PMID:32578917 coumarins decreases expression ISO BCL2 (Homo sapiens) 6480464 Coumarins analog results in decreased expression of BCL2 protein CTD PMID:25231984 coumermycin A1 multiple interactions ISO Bcl2 (Mus musculus) 6480464 coumermycin inhibits the reaction [limonin inhibits the reaction [Arginine results in increased expression of BCL2 protein]] and coumermycin inhibits the reaction [limonin inhibits the reaction [Ceruletide results in increased expression of BCL2 protein]] CTD PMID:34423886 coumermycin A1 increases expression ISO Bcl2 (Mus musculus) 6480464 coumermycin results in increased expression of BCL2 protein CTD PMID:34423886 coumestrol multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BCL2 mRNA CTD PMID:19167446 coumestrol affects binding ISO BCL2 (Homo sapiens) 6480464 Coumestrol binds to BCL2 protein CTD PMID:28986287 coumestrol decreases expression ISO BCL2 (Homo sapiens) 6480464 Coumestrol results in decreased expression of BCL2 protein CTD PMID:20623010 and PMID:28986287 crocidolite asbestos multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Asbestos more ... CTD PMID:22608188 crocidolite asbestos increases expression EXP 6480464 Asbestos and Crocidolite results in increased expression of BCL2 mRNA CTD PMID:12909582 crocin-1 multiple interactions EXP 6480464 crocin inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 mRNA] and crocin inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein] CTD PMID:32920515 crocin-1 decreases expression ISO BCL2 (Homo sapiens) 6480464 crocin results in decreased expression of BCL2 mRNA CTD PMID:32886819 crocin-1 multiple interactions ISO Bcl2 (Mus musculus) 6480464 [crocin co-treated with Paraquat] results in decreased expression of BCL2 mRNA CTD PMID:31911963 crotonaldehyde decreases expression EXP 6480464 2-butenal results in decreased expression of BCL2 protein CTD PMID:31345100 and PMID:33749501 crystal violet decreases expression ISO BCL2 (Homo sapiens) 6480464 Gentian Violet results in decreased expression of BCL2 protein CTD PMID:27373978 CU-O LINKAGE decreases expression ISO BCL2 (Homo sapiens) 6480464 cupric oxide results in decreased expression of BCL2 mRNA CTD PMID:32285662 CU-O LINKAGE decreases expression ISO Bcl2 (Mus musculus) 6480464 cupric oxide results in decreased expression of BCL2 mRNA CTD PMID:25701151 CU-O LINKAGE multiple interactions ISO Bcl2 (Mus musculus) 6480464 trans-sodium crocetinate inhibits the reaction [cupric oxide results in decreased expression of BCL2 mRNA] CTD PMID:25701151 cucurbitacin B multiple interactions ISO Bcl2 (Mus musculus) 6480464 cucurbitacin B inhibits the reaction [Carbon Tetrachloride results in increased expression of BCL2 mRNA] CTD PMID:29250925 cucurbitacin E decreases expression ISO BCL2 (Homo sapiens) 6480464 cucurbitacin E results in decreased expression of BCL2 protein CTD PMID:27106530 cucurbitacin E decreases expression EXP 6480464 cucurbitacin E results in decreased expression of BCL2 protein CTD PMID:27363783 cudraflavone B multiple interactions ISO BCL2 (Homo sapiens) 6480464 resveratrol inhibits the reaction [cudraflavone B results in decreased expression of BCL2 protein] and sirtinol promotes the reaction [cudraflavone B results in decreased expression of BCL2 protein] CTD PMID:23881456 cudraflavone B decreases expression ISO BCL2 (Homo sapiens) 6480464 cudraflavone B results in decreased expression of BCL2 protein CTD PMID:23881456 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of BCL2 mRNA CTD PMID:25704630 curcumin multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Curcumin] affects the expression of BCL2 protein more ... CTD PMID:14724571 more ... curcumin increases expression EXP 6480464 Curcumin results in increased expression of BCL2 mRNA and Curcumin results in increased expression of BCL2 protein CTD PMID:25963729 more ... curcumin increases expression ISO Bcl2 (Mus musculus) 6480464 Curcumin results in increased expression of BCL2 protein CTD PMID:21793155 more ... curcumin decreases expression ISO Bcl2 (Mus musculus) 6480464 Curcumin results in decreased expression of BCL2 mRNA and Curcumin results in decreased expression of BCL2 protein CTD PMID:18829502 more ... curcumin decreases expression ISO BCL2 (Homo sapiens) 6480464 Curcumin analog results in decreased expression of BCL2 mRNA more ... CTD PMID:12497104 more ... curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of BCL2 mRNA and Curcumin results in decreased expression of BCL2 protein CTD PMID:17531121 and PMID:36305173 curcumin multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Curcumin co-treated with Gemcitabine] results in decreased expression of BCL2 protein more ... CTD PMID:17440100 more ... curcumin multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Curcumin results in decreased expression of BCL2 mRNA] more ... CTD PMID:15569404 more ... cyanamide multiple interactions EXP 6480464 [Ethanol co-treated with Cyanamide] results in increased expression of BCL2 mRNA CTD PMID:12003908 Cyanoginosin increases expression EXP 6480464 microcystin results in increased expression of BCL2 CTD PMID:12411203 cycloheximide multiple interactions ISO BCL2 (Homo sapiens) 6480464 BCL2 protein inhibits the reaction [[Cycloheximide co-treated with TNFSF10 protein] results in increased activity of CASP3 protein] and Cycloheximide inhibits the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein] CTD PMID:11726273 and PMID:22343715 Cyclopamine multiple interactions ISO Bcl2 (Mus musculus) 6480464 cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA] and cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]] CTD PMID:27481074 cyclophosphamide multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Cladribine co-treated with Cyclophosphamide co-treated with Mitoxantrone] results in decreased expression of BCL2 protein more ... CTD PMID:11723234 more ... cyclophosphamide multiple interactions ISO Bcl2 (Mus musculus) 6480464 Fungal Polysaccharides inhibits the reaction [Cyclophosphamide results in decreased expression of BCL2 protein] and ganoderic acid A inhibits the reaction [Cyclophosphamide results in decreased expression of BCL2 protein] CTD PMID:29753871 and PMID:30506662 cyclophosphamide decreases expression ISO Bcl2 (Mus musculus) 6480464 Cyclophosphamide results in decreased expression of BCL2 mRNA and Cyclophosphamide results in decreased expression of BCL2 protein CTD PMID:29753871 more ... cyclophosphamide multiple interactions EXP 6480464 Plant Extracts inhibits the reaction [Cyclophosphamide results in decreased expression of BCL2 mRNA] more ... CTD PMID:25446862 and PMID:32197949 cyclophosphamide decreases expression EXP 6480464 Cyclophosphamide results in decreased expression of BCL2 mRNA and Cyclophosphamide results in decreased expression of BCL2 protein CTD PMID:25446862 and PMID:32197949 cyclophosphamide increases expression ISO BCL2 (Homo sapiens) 6480464 Cyclophosphamide results in increased expression of BCL2 mRNA CTD PMID:14503796 cyclosporin A multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Cyclosporine co-treated with NGF protein] results in decreased expression of BCL2 mRNA more ... CTD PMID:12086014 more ... cyclosporin A multiple interactions ISO Bcl2 (Mus musculus) 6480464 Cyclosporine inhibits the reaction [3-Pyridinecarboxylic acid more ... CTD PMID:37308051 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of BCL2 protein CTD PMID:32569592 cyclosporin A multiple interactions EXP 6480464 Curcumin inhibits the reaction [Cyclosporine results in decreased expression of BCL2 protein] CTD PMID:32569592 cyclosporin A increases methylation ISO BCL2 (Homo sapiens) 6480464 Cyclosporine results in increased methylation of BCL2 promoter CTD PMID:27989131 cyclosporin A decreases expression ISO BCL2 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of BCL2 mRNA and Cyclosporine results in decreased expression of BCL2 protein CTD PMID:12086014 more ... cyclosporin A affects expression EXP 6480464 Cyclosporine affects the expression of BCL2 CTD PMID:25299210 cyclosporin A increases expression ISO Bcl2 (Mus musculus) 6480464 Cyclosporine results in increased expression of BCL2 protein CTD PMID:10205001 cyfluthrin increases expression ISO BCL2 (Homo sapiens) 6480464 cyfluthrin results in increased expression of BCL2 mRNA CTD PMID:31330490 cyhalothrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of BCL2 mRNA and [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of BCL2 mRNA CTD PMID:33396045 more ... cyhalothrin decreases expression EXP 6480464 cyhalothrin results in decreased expression of BCL2 protein CTD PMID:30029170 cylindrospermopsin decreases expression ISO BCL2 (Homo sapiens) 6480464 cylindrospermopsin results in decreased expression of BCL2 mRNA CTD PMID:23726867 cylindrospermopsin decreases expression EXP 6480464 cylindrospermopsin results in decreased expression of BCL2 mRNA and cylindrospermopsin results in decreased expression of BCL2 protein CTD PMID:34687773 cypermethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of BCL2 mRNA more ... CTD PMID:22048644 more ... cypermethrin increases expression ISO BCL2 (Homo sapiens) 6480464 cypermethrin results in increased expression of BCL2 mRNA CTD PMID:27704156 and PMID:32028016 cypermethrin decreases expression EXP 6480464 cypermethrin results in decreased expression of BCL2 mRNA and cypermethrin results in decreased expression of BCL2 protein CTD PMID:22048644 more ... cytarabine multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Doxorubicin co-treated with Dexamethasone co-treated with Vincristine co-treated with Cytarabine co-treated with Mercaptopurine co-treated with Methotrexate co-treated with Cyclophosphamide co-treated with Enzymes and Coenzymes] results in increased expression of BCL2 protein more ... CTD PMID:21182165 more ... cytarabine increases degradation ISO BCL2 (Homo sapiens) 6480464 Cytarabine results in increased degradation of BCL2 protein CTD PMID:12853972 cytarabine decreases expression ISO BCL2 (Homo sapiens) 6480464 Cytarabine results in decreased expression of BCL2 mRNA and Cytarabine results in decreased expression of BCL2 protein CTD PMID:1450413 more ... cytochalasin B decreases expression ISO BCL2 (Homo sapiens) 6480464 Cytochalasin B results in decreased expression of BCL2 protein CTD PMID:27640744 cytochalasin B multiple interactions ISO BCL2 (Homo sapiens) 6480464 1 more ... CTD PMID:27640744 D-glucose multiple interactions EXP 6480464 15-Hydroxy-11 alpha more ... CTD PMID:21803128 more ... D-glucose decreases expression ISO Bcl2 (Mus musculus) 6480464 Glucose results in decreased expression of BCL2 protein CTD PMID:31672611 D-glucose multiple interactions ISO Bcl2 (Mus musculus) 6480464 8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one promotes the reaction [[Glucose co-treated with Bupivacaine] results in decreased expression of BCL2 protein] more ... CTD PMID:23108914 more ... D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of BCL2 mRNA and Glucose results in decreased expression of BCL2 protein CTD PMID:21818840 more ... D-glucose affects expression EXP 6480464 Glucose affects the expression of BCL2 mRNA and Glucose affects the expression of BCL2 protein CTD PMID:22524206 and PMID:24349266 D-glucose decreases expression ISO BCL2 (Homo sapiens) 6480464 Glucose results in decreased expression of BCL2 mRNA and Glucose results in decreased expression of BCL2 protein CTD PMID:18088078 more ... D-glucose multiple interactions ISO BCL2 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased expression of BCL2 protein]] more ... CTD PMID:18088078 more ... D-mannitol increases expression EXP 6480464 Mannitol results in increased expression of BCL2 protein CTD PMID:15786717 D-penicillamine decreases expression ISO BCL2 (Homo sapiens) 6480464 Penicillamine results in decreased expression of BCL2 mRNA and Penicillamine results in decreased expression of BCL2 protein CTD PMID:22843330 daidzein decreases expression ISO BCL2 (Homo sapiens) 6480464 daidzein results in decreased expression of BCL2 protein CTD PMID:12791511 dantrolene increases expression EXP 6480464 Dantrolene results in increased expression of BCL2 protein CTD PMID:10854250 dapagliflozin multiple interactions EXP 6480464 [Atorvastatin co-treated with dapagliflozin] inhibits the reaction [[Fructose co-treated with Dietary Fats] results in decreased expression of BCL2 protein] more ... CTD PMID:28807765 more ... dapoxetine multiple interactions EXP 6480464 dapoxetine inhibits the reaction [Testosterone results in increased expression of BCL2 protein] CTD PMID:27687055 DAPT decreases expression EXP 6480464 N-(N-(3 and 5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of BCL2 protein CTD PMID:21209419 DAPT multiple interactions EXP 6480464 N-(N-(3 and 5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in decreased expression of BCL2 protein]] CTD PMID:34897970 daunorubicin multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Bortezomib co-treated with Daunorubicin] results in decreased expression of BCL2 mRNA more ... CTD PMID:19421372 more ... daunorubicin decreases expression EXP 6480464 Daunorubicin results in decreased expression of BCL2 protein CTD PMID:37178933 daunorubicin multiple interactions EXP 6480464 TRPC6 protein promotes the reaction [Daunorubicin results in decreased expression of BCL2 protein] CTD PMID:37178933 daunorubicin affects expression ISO BCL2 (Homo sapiens) 6480464 Daunorubicin affects the expression of BCL2 mRNA CTD PMID:27780733 daunorubicin decreases expression ISO BCL2 (Homo sapiens) 6480464 Daunorubicin results in decreased expression of BCL2 mRNA CTD PMID:19421372 daunorubicin decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 results in decreased susceptibility to Daunorubicin CTD PMID:21595920 DDE increases expression ISO BCL2 (Homo sapiens) 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of BCL2 mRNA and Dichlorodiphenyl Dichloroethylene results in increased expression of BCL2 protein CTD PMID:19545618 DDT multiple interactions ISO BCL2 (Homo sapiens) 6480464 [DDT results in increased activity of ESR1 protein] which results in increased expression of BCL2 mRNA CTD PMID:22403704 DDT decreases expression ISO Bcl2 (Mus musculus) 6480464 DDT results in decreased expression of BCL2 protein CTD PMID:28263910 decabromodiphenyl ether decreases expression ISO Bcl2 (Mus musculus) 6480464 decabromobiphenyl ether results in decreased expression of BCL2 mRNA and decabromobiphenyl ether results in decreased expression of BCL2 protein CTD PMID:28572024 more ... decabromodiphenyl ether multiple interactions ISO Bcl2 (Mus musculus) 6480464 Dizocilpine Maleate inhibits the reaction [decabromobiphenyl ether results in decreased expression of BCL2 protein] CTD PMID:29151189 decabromodiphenyl ether decreases expression ISO BCL2 (Homo sapiens) 6480464 decabromobiphenyl ether results in decreased expression of BCL2 mRNA CTD PMID:26206603 deferiprone multiple interactions ISO BCL2 (Homo sapiens) 6480464 Deferiprone inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in decreased expression of BCL2 protein] CTD PMID:33285147 deguelin decreases expression ISO BCL2 (Homo sapiens) 6480464 deguelin results in decreased expression of BCL2 mRNA and deguelin results in decreased expression of BCL2 protein CTD PMID:19365708 more ... deguelin multiple interactions ISO BCL2 (Homo sapiens) 6480464 deguelin inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA] CTD PMID:22623043 dehydroascorbic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Dehydroascorbic Acid co-treated with Lipopolysaccharides] results in increased expression of BCL2 protein CTD PMID:20166893 dehydroascorbic acid increases expression ISO BCL2 (Homo sapiens) 6480464 Dehydroascorbic Acid results in increased expression of BCL2 protein CTD PMID:20166893 dehydrocostus lactone decreases expression ISO BCL2 (Homo sapiens) 6480464 dehydrocostus lactone results in decreased expression of BCL2 protein CTD PMID:37142148 dehydrocostus lactone multiple interactions ISO BCL2 (Homo sapiens) 6480464 [dehydrocostus lactone co-treated with berberrubine] results in decreased expression of BCL2 protein CTD PMID:37142148 dehydroepiandrosterone multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [Dehydroepiandrosterone results in increased expression of BCL2 protein] more ... CTD PMID:16407456 dehydroepiandrosterone decreases expression EXP 6480464 Dehydroepiandrosterone results in decreased expression of BCL2 protein CTD PMID:21062263 dehydroepiandrosterone increases expression EXP 6480464 Dehydroepiandrosterone results in increased expression of BCL2 protein CTD PMID:16407456 dehydroepiandrosterone sulfate increases expression EXP 6480464 Dehydroepiandrosterone Sulfate results in increased expression of BCL2 protein CTD PMID:16407456 dehydroepiandrosterone sulfate multiple interactions EXP 6480464 Pertussis Toxin inhibits the reaction [Dehydroepiandrosterone Sulfate results in increased expression of BCL2 protein] CTD PMID:16407456 delphinidin decreases expression ISO BCL2 (Homo sapiens) 6480464 delphinidin results in decreased expression of BCL2 protein CTD PMID:15740068 more ... delphinidin multiple interactions ISO BCL2 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [delphinidin inhibits the reaction [TGFB1 results in decreased expression of BCL2 protein]] and delphinidin inhibits the reaction [TGFB1 results in decreased expression of BCL2 protein] CTD PMID:30365941 delphinidin increases expression ISO BCL2 (Homo sapiens) 6480464 delphinidin results in increased expression of BCL2 protein CTD PMID:19818742 demethoxycurcumin decreases expression ISO BCL2 (Homo sapiens) 6480464 demethoxycurcumin results in decreased expression of BCL2 protein CTD PMID:34291863 demethoxyfumitremorgin C decreases expression ISO BCL2 (Homo sapiens) 6480464 demethoxyfumitremorgin C results in decreased expression of BCL2 protein CTD PMID:28359723 Dendrobine multiple interactions ISO BCL2 (Homo sapiens) 6480464 dendrobine inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] CTD PMID:36058301 deoxycholic acid decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to Deoxycholic Acid CTD PMID:12507930 deoxynivalenol decreases expression ISO BCL2 (Homo sapiens) 6480464 deoxynivalenol results in decreased expression of BCL2 mRNA and deoxynivalenol results in decreased expression of BCL2 protein CTD PMID:17166419 and PMID:22269384 deoxynivalenol decreases expression ISO Bcl2 (Mus musculus) 6480464 deoxynivalenol results in decreased expression of BCL2 mRNA and deoxynivalenol results in decreased expression of BCL2 protein CTD PMID:35817260 deoxynivalenol multiple interactions ISO Bcl2 (Mus musculus) 6480464 Curcumin inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 mRNA] more ... CTD PMID:25445755 and PMID:35817260 deoxynivalenol multiple interactions ISO BCL2 (Homo sapiens) 6480464 Ascorbic Acid inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein] CTD PMID:17166419 deoxynivalenol increases expression ISO BCL2 (Homo sapiens) 6480464 deoxynivalenol results in increased expression of BCL2 mRNA CTD PMID:22269384 Deoxyschizandrin multiple interactions ISO BCL2 (Homo sapiens) 6480464 MEG3 protein affects the reaction [schizandrin A results in decreased expression of BCL2 protein] and schizandrin A inhibits the reaction [Mycophenolic Acid results in decreased expression of BCL2 protein] CTD PMID:32057180 and PMID:35321622 Deoxyschizandrin decreases expression ISO BCL2 (Homo sapiens) 6480464 schizandrin A results in decreased expression of BCL2 protein CTD PMID:32057180 desferrioxamine B multiple interactions EXP 6480464 Deferoxamine inhibits the reaction [[Copper Sulfate results in increased abundance of Copper] which results in decreased expression of BCL2 mRNA] and Deferoxamine inhibits the reaction [Copper Sulfate results in decreased expression of BCL2 mRNA] CTD PMID:30431687 and PMID:34577062 desferrioxamine B decreases expression ISO BCL2 (Homo sapiens) 6480464 Deferoxamine results in decreased expression of BCL2 mRNA CTD PMID:33962019 desferrioxamine B multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Deferoxamine co-treated with tert-Butylhydroperoxide] results in decreased expression of BCL2 mRNA more ... CTD PMID:33962019 and PMID:35690295 desipramine increases expression EXP 6480464 Desipramine results in increased expression of BCL2 mRNA and Desipramine results in increased expression of BCL2 protein CTD PMID:17510525 desloratadine decreases expression ISO BCL2 (Homo sapiens) 6480464 desloratadine results in decreased expression of BCL2 mRNA and desloratadine results in decreased expression of BCL2 protein CTD PMID:36617552 Destruxin B multiple interactions ISO BCL2 (Homo sapiens) 6480464 Sorafenib promotes the reaction [destruxin B results in decreased expression of BCL2 protein] CTD PMID:24434019 Destruxin B decreases expression ISO BCL2 (Homo sapiens) 6480464 destruxin B results in decreased expression of BCL2 and destruxin B results in decreased expression of BCL2 protein CTD PMID:22465936 more ... dexamethasone multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Doxorubicin co-treated with Dexamethasone co-treated with Vincristine co-treated with Cytarabine co-treated with Mercaptopurine co-treated with Methotrexate co-treated with Cyclophosphamide co-treated with Enzymes and Coenzymes] results in increased expression of BCL2 protein more ... CTD PMID:15867202 more ... dexamethasone decreases response to substance ISO Bcl2 (Mus musculus) 6480464 BCL2 protein results in decreased susceptibility to Dexamethasone CTD PMID:19997594 dexamethasone increases expression ISO Bcl2 (Mus musculus) 6480464 Dexamethasone results in increased expression of BCL2 mRNA CTD PMID:21041162 dexamethasone decreases expression ISO Bcl2 (Mus musculus) 6480464 Dexamethasone results in decreased expression of BCL2 mRNA and Dexamethasone results in decreased expression of BCL2 protein CTD PMID:16644695 more ... dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of BCL2 protein CTD PMID:11319611 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of BCL2 mRNA and Dexamethasone results in decreased expression of BCL2 protein CTD PMID:19080409 and PMID:30506661 dexamethasone multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [Dehydroepiandrosterone results in increased expression of BCL2 protein] and fludarabine inhibits the reaction [Dexamethasone results in decreased expression of BCL2 protein] CTD PMID:16407456 and PMID:30506661 dexamethasone multiple interactions ISO Bcl2 (Mus musculus) 6480464 [2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:11751460 more ... dexamethasone increases expression ISO BCL2 (Homo sapiens) 6480464 Dexamethasone results in increased expression of BCL2 and Dexamethasone results in increased expression of BCL2 protein CTD PMID:11319611 and PMID:21244764 dexamethasone decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to Dexamethasone CTD PMID:16505121 dexamethasone increases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in increased susceptibility to Dexamethasone CTD PMID:10200551 dexmedetomidine multiple interactions EXP 6480464 Dexmedetomidine inhibits the reaction [Isoflurane results in decreased expression of BCL2 protein] CTD PMID:20003127 dextran sulfate multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BCL2 protein more ... CTD PMID:25449198 and PMID:37209277 dextran sulfate decreases expression ISO Bcl2 (Mus musculus) 6480464 Dextran Sulfate results in decreased expression of BCL2 protein CTD PMID:37209277 dextromethorphan multiple interactions EXP 6480464 traxoprodil mesylate inhibits the reaction [Dextromethorphan results in decreased expression of BCL2 protein] CTD PMID:28916251 dextromethorphan decreases expression EXP 6480464 Dextromethorphan results in decreased expression of BCL2 protein CTD PMID:28916251 Di-n-hexyl phthalate decreases expression ISO BCL2 (Homo sapiens) 6480464 di-n-hexyl phthalate results in decreased expression of BCL2 mRNA CTD PMID:33043605 diallyl disulfide decreases expression EXP 6480464 diallyl disulfide results in decreased expression of BCL2 protein CTD PMID:16052692 diallyl disulfide decreases expression ISO BCL2 (Homo sapiens) 6480464 diallyl disulfide results in decreased expression of BCL2 mRNA and diallyl disulfide results in decreased expression of BCL2 protein CTD PMID:14522920 more ... Diallyl sulfide multiple interactions ISO BCL2 (Homo sapiens) 6480464 [allyl sulfide co-treated with Resveratrol] results in decreased expression of BCL2 mRNA more ... CTD PMID:18512326 and PMID:34724321 Diallyl sulfide multiple interactions EXP 6480464 allyl sulfide inhibits the reaction [Ethylene Chlorohydrin results in decreased expression of BCL2 protein] and allyl sulfide promotes the reaction [Bleomycin results in increased expression of BCL2 protein] CTD PMID:23656969 and PMID:31585129 Diallyl sulfide decreases expression ISO BCL2 (Homo sapiens) 6480464 allyl sulfide results in decreased expression of BCL2 mRNA and allyl sulfide results in decreased expression of BCL2 protein CTD PMID:17647244 and PMID:34724321 diallyl trisulfide decreases expression ISO BCL2 (Homo sapiens) 6480464 diallyl trisulfide results in decreased expression of BCL2 more ... CTD PMID:17513609 more ... diallyl trisulfide multiple interactions EXP 6480464 diallyl trisulfide inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] CTD PMID:29087013 diallyl trisulfide multiple interactions ISO BCL2 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [diallyl trisulfide results in decreased expression of BCL2 protein] and diallyl trisulfide inhibits the reaction [Glucose results in decreased expression of BCL2 protein] CTD PMID:22578287 and PMID:31115753 diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of BCL2 mRNA CTD PMID:17487067 diarsenic trioxide increases cleavage ISO BCL2 (Homo sapiens) 6480464 Arsenic Trioxide results in increased cleavage of BCL2 protein CTD PMID:11739184 diarsenic trioxide decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to Arsenic Trioxide and BCL2 results in decreased susceptibility to Arsenic Trioxide CTD PMID:11775218 more ... diarsenic trioxide increases cleavage ISO Bcl2 (Mus musculus) 6480464 Arsenic Trioxide results in increased cleavage of BCL2 protein CTD PMID:15761769 diarsenic trioxide multiple interactions ISO BCL2 (Homo sapiens) 6480464 2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of BCL2 protein] more ... CTD PMID:11775218 more ... diarsenic trioxide increases phosphorylation ISO BCL2 (Homo sapiens) 6480464 Arsenic Trioxide results in increased phosphorylation of BCL2 protein CTD PMID:12181429 and PMID:18412143 diarsenic trioxide affects expression ISO BCL2 (Homo sapiens) 6480464 Arsenic Trioxide affects the expression of BCL2 protein CTD PMID:12962562 more ... diarsenic trioxide affects folding ISO BCL2 (Homo sapiens) 6480464 Arsenic Trioxide affects the folding of BCL2 protein CTD PMID:20403207 diarsenic trioxide multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvianolic acid B inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]] more ... CTD PMID:17487067 more ... diarsenic trioxide affects expression EXP 6480464 Arsenic Trioxide affects the expression of BCL2 mRNA and Arsenic Trioxide affects the expression of BCL2 protein CTD PMID:12725324 and PMID:18618274 diarsenic trioxide decreases expression ISO Bcl2 (Mus musculus) 6480464 Arsenic Trioxide results in decreased expression of BCL2 mRNA and Arsenic Trioxide results in decreased expression of BCL2 protein CTD PMID:10721769 more ... diarsenic trioxide decreases expression ISO BCL2 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of BCL2 more ... CTD PMID:10340400 more ... diarsenic trioxide increases degradation ISO BCL2 (Homo sapiens) 6480464 Arsenic Trioxide results in increased degradation of BCL2 protein CTD PMID:19468689 diarsenic trioxide multiple interactions ISO Bcl2 (Mus musculus) 6480464 18alpha more ... CTD PMID:21078540 more ... diarsenic trioxide increases expression ISO BCL2 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of BCL2 mRNA and Arsenic Trioxide results in increased expression of BCL2 protein CTD PMID:16966277 more ... diarsenic trioxide affects response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein affects the susceptibility to Arsenic Trioxide CTD PMID:10648417 and PMID:18726487 diarsenic trioxide increases expression ISO Bcl2 (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of BCL2 protein CTD PMID:10712780 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of BCL2 mRNA and Arsenic Trioxide results in decreased expression of BCL2 protein CTD PMID:19260322 more ... diarsenic trioxide increases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 mutant form results in increased susceptibility to Arsenic Trioxide CTD PMID:14642526 diazinon affects expression EXP 6480464 Diazinon affects the expression of BCL2 mRNA CTD PMID:22546817 diazinon decreases expression ISO BCL2 (Homo sapiens) 6480464 Diazinon results in decreased expression of BCL2 mRNA CTD PMID:27920530 diazinon multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased expression of BCL2 mRNA] more ... CTD PMID:27920530 diazoxide multiple interactions EXP 6480464 Diazoxide inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein] CTD PMID:20650802 diazoxide multiple interactions ISO Bcl2 (Mus musculus) 6480464 5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Bleomycin results in decreased expression of BCL2 protein]] and Diazoxide inhibits the reaction [Bleomycin results in decreased expression of BCL2 protein] CTD PMID:37783230 dibenziodolium multiple interactions ISO BCL2 (Homo sapiens) 6480464 diphenyleneiodonium inhibits the reaction [Resveratrol affects the expression of BCL2 protein] CTD PMID:31151226 dibenzoylmethane multiple interactions ISO BCL2 (Homo sapiens) 6480464 dibenzoylmethane inhibits the reaction [ESR1 protein binds to BCL2 enhancer] and dibenzoylmethane inhibits the reaction [Estradiol results in increased expression of BCL2 mRNA] CTD PMID:16051634 dibromoacetic acid decreases expression ISO Bcl2 (Mus musculus) 6480464 dibromoacetic acid results in decreased expression of BCL2 mRNA CTD PMID:18628252 dibutyl phthalate increases expression ISO Bcl2 (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of BCL2 mRNA CTD PMID:21266533 dibutyl phthalate decreases methylation ISO BCL2 (Homo sapiens) 6480464 Dibutyl Phthalate results in decreased methylation of BCL2 promoter CTD PMID:35487445 dibutyl phthalate increases expression ISO BCL2 (Homo sapiens) 6480464 Dibutyl Phthalate results in increased expression of BCL2 mRNA CTD PMID:35487445 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of BCL2 protein CTD PMID:28067064 dibutyl phthalate multiple interactions ISO Bcl2 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of BCL2 mRNA more ... CTD PMID:26804720 more ... dibutyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA and taxifolin inhibits the reaction [Dibutyl Phthalate results in decreased expression of BCL2 protein] CTD PMID:32525071 and PMID:35762964 dibutyl phthalate decreases expression ISO Bcl2 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of BCL2 mRNA and Dibutyl Phthalate results in decreased expression of BCL2 protein CTD PMID:23242528 more ... dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of BCL2 protein CTD PMID:32525071 and PMID:35690178 dichloroacetic acid decreases expression ISO Bcl2 (Mus musculus) 6480464 Dichloroacetic Acid results in decreased expression of BCL2 protein CTD PMID:22705712 dichloromethane multiple interactions ISO Bcl2 (Mus musculus) 6480464 [[Particulate Matter co-treated with Methylene Chloride] results in increased abundance of Polycyclic Aromatic Hydrocarbons] which affects the expression of BCL2 mRNA CTD PMID:29335169 dichromium trioxide affects expression ISO BCL2 (Homo sapiens) 6480464 chromic oxide affects the expression of BCL2 protein CTD PMID:26086747 diclofenac increases expression ISO BCL2 (Homo sapiens) 6480464 Diclofenac results in increased expression of BCL2 mRNA CTD PMID:29027214 diclofenac increases expression EXP 6480464 Diclofenac results in increased expression of BCL2 mRNA CTD PMID:29027214 dicrotophos decreases expression ISO BCL2 (Homo sapiens) 6480464 dicrotophos results in decreased expression of BCL2 protein CTD PMID:28302478 Dictamnine decreases expression ISO BCL2 (Homo sapiens) 6480464 dictamnine results in decreased expression of BCL2 mRNA and dictamnine results in decreased expression of BCL2 protein CTD PMID:34861243 Didymin decreases expression ISO BCL2 (Homo sapiens) 6480464 didymin results in decreased expression of BCL2 protein CTD PMID:27899290 Didymin multiple interactions ISO BCL2 (Homo sapiens) 6480464 locostatin inhibits the reaction [didymin results in decreased expression of BCL2 protein] CTD PMID:27899290 dieckol multiple interactions ISO Bcl2 (Mus musculus) 6480464 dieckol inhibits the reaction [9 more ... CTD PMID:33347706 dieckol decreases expression ISO BCL2 (Homo sapiens) 6480464 dieckol results in decreased expression of BCL2 protein CTD PMID:33051972 and PMID:36683349 dieldrin decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to Dieldrin CTD PMID:15183012 dieldrin multiple interactions ISO BCL2 (Homo sapiens) 6480464 BCL2 protein inhibits the reaction [Dieldrin results in increased activity of CASP3 protein] and BCL2 protein inhibits the reaction [Dieldrin results in increased activity of PRKCD protein] CTD PMID:15033812 and PMID:15183012 diepoxybutane increases expression ISO BCL2 (Homo sapiens) 6480464 diepoxybutane results in increased expression of BCL2 mRNA CTD PMID:29792945 diethyl maleate multiple interactions ISO Bcl2 (Mus musculus) 6480464 [diethyl maleate results in decreased abundance of Glutathione] which results in increased expression of BCL2 mRNA CTD PMID:22564015 diethyl maleate increases expression ISO BCL2 (Homo sapiens) 6480464 diethyl maleate results in increased expression of BCL2 mRNA CTD PMID:33545341 diethyl phthalate multiple interactions ISO Bcl2 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of BCL2 mRNA and [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA CTD PMID:28013214 and PMID:37021957 diethyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA CTD PMID:35762964 diethyl sulfate decreases expression ISO BCL2 (Homo sapiens) 6480464 diethyl sulfate results in decreased expression of BCL2 protein CTD PMID:23830811 diethylstilbestrol increases expression ISO Bcl2 (Mus musculus) 6480464 Diethylstilbestrol results in increased expression of BCL2 mRNA CTD PMID:17943652 diethylstilbestrol decreases expression ISO Bcl2 (Mus musculus) 6480464 Diethylstilbestrol results in decreased expression of BCL2 mRNA CTD PMID:15545218 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of BCL2 protein CTD PMID:17009535 dihydroactinidiolide multiple interactions ISO BCL2 (Homo sapiens) 6480464 dihydroactinidiolide inhibits the reaction [amyloid beta-protein (25-35) results in decreased expression of BCL2 protein] more ... CTD PMID:33617922 dihydroactinidiolide multiple interactions ISO Bcl2 (Mus musculus) 6480464 dihydroactinidiolide inhibits the reaction [Scopolamine results in decreased expression of BCL2 protein] CTD PMID:34371027 diiodine multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Diatrizoate co-treated with Iodine] results in increased expression of BCL2 protein CTD PMID:17173243 diisobutyl phthalate multiple interactions ISO Bcl2 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of BCL2 mRNA and [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA CTD PMID:28013214 and PMID:37021957 diisobutyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA CTD PMID:35762964 diisononyl phthalate multiple interactions ISO Bcl2 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of BCL2 mRNA and [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA CTD PMID:28013214 and PMID:37021957 diisononyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA CTD PMID:35762964 dimethomorph multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Sulfur co-treated with quinoxyfen co-treated with dimethomorph] results in decreased expression of BCL2 mRNA CTD PMID:35564597 Dimethyl phthalate increases expression EXP 6480464 dimethyl phthalate results in increased expression of BCL2 mRNA CTD PMID:35598668 dimethyl sulfoxide decreases expression EXP 6480464 Dimethyl Sulfoxide results in decreased expression of BCL2 protein CTD PMID:36305173 dimethyl sulfoxide multiple interactions EXP 6480464 [lipopolysaccharide and E coli O55-B5 co-treated with Dimethyl Sulfoxide] results in decreased expression of BCL2 protein CTD PMID:37365769 dimethylarsinic acid increases expression ISO Bcl2 (Mus musculus) 6480464 Cacodylic Acid results in increased expression of BCL2 mRNA and Cacodylic Acid results in increased expression of BCL2 protein CTD PMID:22246474 dimethylarsinous acid increases expression ISO BCL2 (Homo sapiens) 6480464 dimethylarsinous acid results in increased expression of BCL2 protein CTD PMID:30262279 dioscin multiple interactions ISO Bcl2 (Mus musculus) 6480464 dioscin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein] CTD PMID:22939915 dioscin increases expression ISO Bcl2 (Mus musculus) 6480464 dioscin results in increased expression of BCL2 protein CTD PMID:24742230 dioscin decreases expression ISO BCL2 (Homo sapiens) 6480464 dioscin results in decreased expression of BCL2 mRNA and dioscin results in decreased expression of BCL2 protein CTD PMID:22334414 more ... diosgenin multiple interactions ISO BCL2 (Homo sapiens) 6480464 Diosgenin inhibits the reaction [TNF protein results in increased expression of BCL2 protein] CTD PMID:16331273 diosgenin multiple interactions EXP 6480464 [morroniside co-treated with Diosgenin] inhibits the reaction [Glucose results in decreased expression of BCL2 protein] and Diosgenin inhibits the reaction [Glucose results in decreased expression of BCL2 protein] CTD PMID:28106847 diosgenin decreases expression ISO BCL2 (Homo sapiens) 6480464 Diosgenin results in decreased expression of BCL2 protein CTD PMID:16331273 diosmin multiple interactions EXP 6480464 [Diosmin co-treated with Lipopolysaccharides] results in increased expression of BCL2 protein CTD PMID:21477647 diosmin multiple interactions ISO Bcl2 (Mus musculus) 6480464 Diosmin inhibits the reaction [Benzo(a)pyrene results in decreased expression of BCL2 protein] CTD PMID:32061149 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of BCL2 protein and Oxygen results in increased expression of BCL2 protein CTD PMID:10657591 more ... dioxygen decreases expression ISO BCL2 (Homo sapiens) 6480464 Oxygen deficiency results in decreased expression of BCL2 mRNA and Oxygen deficiency results in decreased expression of BCL2 protein CTD PMID:26516004 and PMID:33181113 dioxygen affects expression ISO Bcl2 (Mus musculus) 6480464 Oxygen deficiency affects the expression of BCL2 protein CTD PMID:24680926 dioxygen increases expression ISO BCL2 (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of BCL2 mRNA CTD PMID:23452621 dioxygen multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein more ... CTD PMID:23108914 more ... dioxygen multiple interactions ISO BCL2 (Homo sapiens) 6480464 [betulin co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein more ... CTD PMID:23452621 more ... dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of BCL2 mRNA and Oxygen deficiency results in decreased expression of BCL2 protein CTD PMID:11042672 more ... dioxygen multiple interactions EXP 6480464 (2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide inhibits the reaction [Apigenin inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 protein]] more ... CTD PMID:11042672 more ... dipentyl phthalate decreases expression EXP 6480464 di-n-pentyl phthalate results in decreased expression of BCL2 mRNA and di-n-pentyl phthalate results in decreased expression of BCL2 protein CTD PMID:33798595 and PMID:36715143 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions EXP 6480464 666-15 compound promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of BCL2 protein] and [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of BCL2 protein CTD PMID:32920012 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of BCL2 protein CTD PMID:32920012 diprotium oxide multiple interactions ISO Bcl2 (Mus musculus) 6480464 [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of BCL2 mRNA CTD PMID:29335169 diquat affects expression ISO Bcl2 (Mus musculus) 6480464 Diquat affects the expression of BCL2 mRNA CTD PMID:26785375 and PMID:27057282 diquat decreases expression EXP 6480464 Diquat results in decreased expression of BCL2 protein CTD PMID:29484840 diquat multiple interactions ISO Bcl2 (Mus musculus) 6480464 procyanidin B2 affects the reaction [Diquat affects the expression of BCL2 mRNA] CTD PMID:27057282 disodium cromoglycate multiple interactions EXP 6480464 [Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of BCL2 protein] CTD PMID:28732690 disodium selenite multiple interactions ISO Bcl2 (Mus musculus) 6480464 Sodium Selenite inhibits the reaction [citreoviridin results in decreased expression of BCL2 protein] and Sodium Selenite promotes the reaction [Buthionine Sulfoximine results in decreased expression of BCL2 mRNA] CTD PMID:17989939 and PMID:31419397 disodium selenite decreases expression ISO BCL2 (Homo sapiens) 6480464 Sodium Selenite results in decreased expression of BCL2 protein CTD PMID:34520753 disodium selenite multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Sodium Selenite co-treated with (1 more ... CTD PMID:28757135 disodium selenite decreases expression ISO Bcl2 (Mus musculus) 6480464 Sodium Selenite results in decreased expression of BCL2 mRNA CTD PMID:16542727 more ... disodium selenite multiple interactions EXP 6480464 Sodium Selenite inhibits the reaction [2-cresol results in increased expression of BCL2 mRNA] more ... CTD PMID:16039982 more ... disodium selenite increases expression EXP 6480464 Sodium Selenite results in increased expression of BCL2 protein CTD PMID:18209489 disulfiram multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Ascorbic Acid co-treated with Disulfiram] results in decreased expression of BCL2 protein more ... CTD PMID:21911303 more ... dithionite(2-) multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]] more ... CTD PMID:21803128 dithionite(2-) multiple interactions ISO BCL2 (Homo sapiens) 6480464 dihydroactinidiolide inhibits the reaction [Dithionite results in decreased expression of BCL2 protein] CTD PMID:33617922 dithionite(2-) decreases expression ISO BCL2 (Homo sapiens) 6480464 Dithionite results in decreased expression of BCL2 protein CTD PMID:33617922 dizocilpine maleate decreases expression EXP 6480464 Dizocilpine Maleate results in decreased expression of BCL2 protein CTD PMID:10859492 dizocilpine maleate multiple interactions EXP 6480464 Dizocilpine Maleate inhibits the reaction [Cocaine results in increased phosphorylation of BCL2 protein] CTD PMID:19879923 dizocilpine maleate multiple interactions ISO Bcl2 (Mus musculus) 6480464 Dizocilpine Maleate inhibits the reaction [decabromobiphenyl ether results in decreased expression of BCL2 protein] CTD PMID:29151189 dobutamine decreases expression ISO Bcl2 (Mus musculus) 6480464 Dobutamine results in decreased expression of BCL2 protein CTD PMID:15052282 Dodecyl gallate decreases expression ISO Bcl2 (Mus musculus) 6480464 lauryl gallate results in decreased expression of BCL2 protein CTD PMID:21856409 domoic acid affects expression ISO BCL2 (Homo sapiens) 6480464 domoic acid affects the expression of BCL2 mRNA CTD PMID:18293405 donepezil hydrochloride multiple interactions EXP 6480464 Donepezil inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] CTD PMID:19345205 donepezil hydrochloride multiple interactions ISO Bcl2 (Mus musculus) 6480464 Donepezil inhibits the reaction [Scopolamine results in decreased expression of BCL2 protein] CTD PMID:34371027 dopamine decreases expression ISO BCL2 (Homo sapiens) 6480464 Dopamine results in decreased expression of BCL2 protein CTD PMID:17603292 and PMID:28980048 dopamine multiple interactions ISO BCL2 (Homo sapiens) 6480464 polydatin inhibits the reaction [Dopamine results in decreased expression of BCL2 protein] and Resveratrol inhibits the reaction [Dopamine results in decreased expression of BCL2 protein] CTD PMID:17603292 and PMID:28980048 dorsomorphin decreases expression ISO BCL2 (Homo sapiens) 6480464 dorsomorphin results in decreased expression of BCL2 protein CTD PMID:31900833 dorsomorphin multiple interactions ISO Bcl2 (Mus musculus) 6480464 dorsomorphin inhibits the reaction [sophoricoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]] CTD PMID:37741537 dorsomorphin multiple interactions EXP 6480464 dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]] and dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of BCL2 protein]] CTD PMID:26054749 and PMID:31433112 dorsomorphin multiple interactions ISO BCL2 (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 more ... doxazosin multiple interactions ISO BCL2 (Homo sapiens) 6480464 BCL2 inhibits the reaction [Doxazosin results in decreased expression of VEGFA] CTD PMID:12576871 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of BCL2 mRNA and Doxorubicin results in decreased expression of BCL2 protein CTD PMID:12505058 more ... doxorubicin affects expression ISO BCL2 (Homo sapiens) 6480464 Doxorubicin affects the expression of BCL2 mRNA CTD PMID:16705698 more ... doxorubicin affects expression EXP 6480464 Doxorubicin affects the expression of BCL2 mRNA and Doxorubicin affects the expression of BCL2 protein CTD PMID:24742701 and PMID:32652078 doxorubicin decreases expression ISO BCL2 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of BCL2 mRNA and Doxorubicin results in decreased expression of BCL2 protein CTD PMID:11779855 more ... doxorubicin decreases expression ISO Bcl2 (Mus musculus) 6480464 Doxorubicin results in decreased expression of BCL2 mRNA and Doxorubicin results in decreased expression of BCL2 protein CTD PMID:15811867 more ... doxorubicin increases expression ISO Bcl2 (Mus musculus) 6480464 Doxorubicin results in increased expression of BCL2 mRNA CTD PMID:15505089 more ... doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of BCL2 protein CTD PMID:11291592 more ... doxorubicin increases expression ISO BCL2 (Homo sapiens) 6480464 Doxorubicin results in increased expression of BCL2 mRNA and Doxorubicin results in increased expression of BCL2 protein CTD PMID:15571967 more ... doxorubicin decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to Doxorubicin CTD PMID:8781438 doxorubicin affects response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein affects the susceptibility to Doxorubicin CTD PMID:16322301 more ... doxorubicin multiple interactions ISO BCL2 (Homo sapiens) 6480464 [[[Doxorubicin co-treated with 2 more ... CTD PMID:15571967 more ... doxorubicin multiple interactions EXP 6480464 2 more ... CTD PMID:15380674 more ... doxorubicin multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Zoledronic Acid co-treated with Doxorubicin] results in decreased expression of BCL2 protein more ... CTD PMID:15538571 more ... doxycycline multiple interactions ISO Bcl2 (Mus musculus) 6480464 Doxycycline inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] CTD PMID:17673183 drimenol decreases expression ISO BCL2 (Homo sapiens) 6480464 drimenol results in decreased expression of BCL2 protein CTD PMID:30935903 dronedarone increases expression EXP 6480464 Dronedarone results in increased expression of BCL2 protein CTD PMID:27197836 ebselen multiple interactions EXP 6480464 ebselen inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein] CTD PMID:30558456 EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor multiple interactions EXP 6480464 Angiotensin-Converting Enzyme Inhibitors inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein] CTD PMID:22429817 Echinocystic acid multiple interactions EXP 6480464 echinocystic acid affects the reaction [Isoproterenol affects the expression of BCL2 mRNA] CTD PMID:19573579 edaravone multiple interactions EXP 6480464 Edaravone inhibits the reaction [APP protein modified form results in decreased expression of BCL2 mRNA] CTD PMID:26111763 edelfosine multiple interactions ISO BCL2 (Homo sapiens) 6480464 edelfosine inhibits the reaction [Nicotine results in increased phosphorylation of BCL2 protein] more ... CTD PMID:12421819 and PMID:9295281 elemental boron multiple interactions EXP 6480464 [boric acid results in increased abundance of Boron] which results in decreased expression of BCL2 mRNA and [boric acid results in increased abundance of Boron] which results in decreased expression of BCL2 protein CTD PMID:33137424 elemental selenium decreases expression ISO BCL2 (Homo sapiens) 6480464 Selenium results in decreased expression of BCL2 protein CTD PMID:17523932 elemental selenium multiple interactions EXP 6480464 Selenium inhibits the reaction [nickel sulfate results in decreased expression of BCL2 protein] CTD PMID:34612572 elemental selenium multiple interactions ISO BCL2 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Selenium inhibits the reaction [nickel sulfate results in decreased expression of BCL2 protein]] more ... CTD PMID:27920530 and PMID:34612572 ellagic acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Ellagic Acid co-treated with resveratrol] inhibits the reaction [9 more ... CTD PMID:20103723 ellagic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 Ellagic Acid results in decreased expression of BCL2 mRNA CTD PMID:35179410 ellagic acid multiple interactions EXP 6480464 Ellagic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of BCL2 protein] and Ellagic Acid inhibits the reaction [sodium arsenate results in decreased expression of BCL2 mRNA] CTD PMID:29854611 and PMID:35236242 ellagic acid increases expression ISO BCL2 (Homo sapiens) 6480464 Ellagic Acid results in increased expression of BCL2 protein CTD PMID:22386815 ellipticine decreases expression ISO BCL2 (Homo sapiens) 6480464 ellipticine results in decreased expression of BCL2 protein CTD PMID:16027529 embelin decreases expression ISO BCL2 (Homo sapiens) 6480464 embelin results in decreased expression of BCL2 protein CTD PMID:24694877 emodin decreases expression ISO BCL2 (Homo sapiens) 6480464 Emodin results in decreased expression of BCL2 mRNA and Emodin results in decreased expression of BCL2 protein CTD PMID:23848338 emodin multiple interactions EXP 6480464 [2 more ... CTD PMID:35753641 emodin affects expression EXP 6480464 Emodin affects the expression of BCL2 protein CTD PMID:19549930 emodin multiple interactions ISO BCL2 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [Emodin affects the expression of BCL2 protein] more ... CTD PMID:27032576 emodin affects expression ISO BCL2 (Homo sapiens) 6480464 Emodin affects the expression of BCL2 protein CTD PMID:27032576 enalapril increases expression EXP 6480464 Enalapril results in increased expression of BCL2 protein CTD PMID:21153712 enalapril multiple interactions EXP 6480464 Enalapril inhibits the reaction [Isoproterenol results in decreased expression of BCL2 protein] CTD PMID:30623541 enalaprilat dihydrate increases expression ISO Bcl2 (Mus musculus) 6480464 Enalaprilat results in increased expression of BCL2 mRNA CTD PMID:17342403 endosulfan increases expression ISO BCL2 (Homo sapiens) 6480464 Endosulfan results in increased expression of BCL2 protein CTD PMID:10821422 endosulfan decreases expression ISO BCL2 (Homo sapiens) 6480464 Endosulfan results in decreased expression of BCL2 protein CTD PMID:29705383 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of BCL2 mRNA CTD PMID:29391264 and PMID:31464424 Enterolactone multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BCL2 mRNA CTD PMID:19167446 entinostat decreases expression ISO BCL2 (Homo sapiens) 6480464 entinostat results in decreased expression of BCL2 mRNA CTD PMID:26272509 entinostat multiple interactions ISO BCL2 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2 mRNA CTD PMID:27188386 entinostat decreases expression ISO Bcl2 (Mus musculus) 6480464 entinostat results in decreased expression of BCL2 protein CTD PMID:21041383 epichlorohydrin increases expression ISO BCL2 (Homo sapiens) 6480464 Epichlorohydrin results in increased expression of BCL2 mRNA CTD PMID:29792945 epoxomicin multiple interactions ISO Bcl2 (Mus musculus) 6480464 epoxomicin inhibits the reaction [troxerutin inhibits the reaction [2 more ... CTD PMID:25639565 erdosteine multiple interactions EXP 6480464 [erdosteine co-treated with Isoproterenol] affects the expression of BCL2 protein CTD PMID:33210414 eriocitrin decreases expression ISO BCL2 (Homo sapiens) 6480464 eriocitrin results in decreased expression of BCL2 protein CTD PMID:34724282 erlotinib hydrochloride increases expression ISO BCL2 (Homo sapiens) 6480464 Erlotinib Hydrochloride results in increased expression of BCL2 mRNA and Erlotinib Hydrochloride results in increased expression of BCL2 protein CTD PMID:23894143 erlotinib hydrochloride multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Erlotinib Hydrochloride co-treated with Arsenic Trioxide] results in decreased expression of BCL2 mRNA more ... CTD PMID:23894143 and PMID:29274334 erythromycin estolate increases expression EXP 6480464 Erythromycin Estolate results in increased expression of BCL2 mRNA CTD PMID:12883083 esculetin affects expression ISO BCL2 (Homo sapiens) 6480464 esculetin affects the expression of BCL2 protein CTD PMID:24995577 esculetin decreases expression ISO BCL2 (Homo sapiens) 6480464 esculetin results in decreased expression of BCL2 protein CTD PMID:26388407 and PMID:31313495 estramustine increases phosphorylation ISO BCL2 (Homo sapiens) 6480464 Estramustine results in increased phosphorylation of BCL2 protein CTD PMID:11763419 ethanol multiple interactions EXP 6480464 [Ethanol co-treated with Carbon Tetrachloride] results in increased expression of BCL2 mRNA more ... CTD PMID:12003908 more ... ethanol increases expression ISO Bcl2 (Mus musculus) 6480464 Ethanol results in increased expression of BCL2 mRNA CTD PMID:30319688 ethanol multiple interactions ISO Bcl2 (Mus musculus) 6480464 Cimetidine inhibits the reaction [Ethanol results in decreased expression of BCL2 protein] more ... CTD PMID:27983966 and PMID:29069573 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of BCL2 mRNA and Ethanol results in decreased expression of BCL2 protein CTD PMID:15353170 more ... ethanol increases expression EXP 6480464 Ethanol results in increased expression of BCL2 mRNA CTD PMID:22446813 more ... ethanol decreases expression ISO Bcl2 (Mus musculus) 6480464 Ethanol results in decreased expression of BCL2 mRNA and Ethanol results in decreased expression of BCL2 protein CTD PMID:19429258 more ... ethanol decreases expression ISO BCL2 (Homo sapiens) 6480464 Ethanol results in decreased expression of BCL2 mRNA and Ethanol results in decreased expression of BCL2 protein CTD PMID:21878650 more ... ethanol affects localization EXP 6480464 Ethanol affects the localization of BCL2 protein CTD PMID:16035105 ethanol multiple interactions ISO BCL2 (Homo sapiens) 6480464 4-benzyl-2-methyl-1 more ... CTD PMID:19429258 more ... ethanol increases expression ISO BCL2 (Homo sapiens) 6480464 Ethanol results in increased expression of BCL2 protein CTD PMID:21410490 ethanol affects expression EXP 6480464 Ethanol affects the expression of BCL2 mRNA and Ethanol affects the expression of BCL2 protein CTD PMID:25859307 and PMID:29085585 ethidium multiple interactions ISO BCL2 (Homo sapiens) 6480464 Ethidium inhibits the reaction [Estradiol results in increased expression of BCL2 mRNA] CTD PMID:15897899 ethylbenzene decreases expression EXP 6480464 ethylbenzene results in decreased expression of BCL2 mRNA and ethylbenzene results in decreased expression of BCL2 protein CTD PMID:20137408 more ... ethylene glycol increases expression EXP 6480464 Ethylene Glycol results in increased expression of BCL2 protein CTD PMID:34468068 ethylene glycol multiple interactions EXP 6480464 caryophyllene inhibits the reaction [Ethylene Glycol results in increased expression of BCL2 protein] CTD PMID:34468068 Ethylenethiourea decreases expression ISO Bcl2 (Mus musculus) 6480464 Ethylenethiourea results in decreased expression of BCL2 mRNA CTD PMID:27905518 Ethylenethiourea multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Chlorpyrifos co-treated with Ethylenethiourea] results in decreased expression of BCL2 mRNA CTD PMID:27905518 etodolac decreases expression ISO BCL2 (Homo sapiens) 6480464 Etodolac results in decreased expression of BCL2 mRNA and Etodolac results in decreased expression of BCL2 protein CTD PMID:16046235 and PMID:16104877 etoposide multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Doxorubicin co-treated with Vincristine co-treated with Etoposide co-treated with Mitotane] results in decreased expression of BCL2 protein more ... CTD PMID:12063570 more ... etoposide decreases expression ISO Bcl2 (Mus musculus) 6480464 Etoposide results in decreased expression of BCL2 mRNA and Etoposide results in decreased expression of BCL2 protein CTD PMID:19408126 etoposide multiple interactions ISO Bcl2 (Mus musculus) 6480464 [G(M3) Ganglioside results in increased expression of BCL2 protein] which results in decreased susceptibility to Etoposide more ... CTD PMID:16571667 and PMID:19408126 eugenol multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Eugenol results in increased activity of sulforaphane] which results in decreased expression of BCL2 and [sulforaphane results in increased activity of Eugenol] which results in decreased expression of BCL2 CTD PMID:21382956 eugenol multiple interactions ISO Bcl2 (Mus musculus) 6480464 Eugenol inhibits the reaction [[9 more ... CTD PMID:20434464 and PMID:20537511 eugenol decreases expression ISO BCL2 (Homo sapiens) 6480464 Eugenol results in decreased expression of BCL2 mRNA CTD PMID:21939359 EUK-134 multiple interactions ISO BCL2 (Homo sapiens) 6480464 EUK-134 inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] and EUK-134 inhibits the reaction [Vitamin K 3 results in decreased expression of BCL2 protein] CTD PMID:25005833 Evodiamine multiple interactions ISO BCL2 (Homo sapiens) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [evodiamine results in increased cleavage of BCL2 protein] and evodiamine inhibits the reaction [TNF protein results in increased expression of BCL2 protein] CTD PMID:15710601 and PMID:20005289 Evodiamine increases cleavage ISO BCL2 (Homo sapiens) 6480464 evodiamine results in increased cleavage of BCL2 protein CTD PMID:20005289 excitatory amino acid agonist multiple interactions ISO Bcl2 (Mus musculus) 6480464 notoginsenoside R1 inhibits the reaction [Excitatory Amino Acid Agonists results in decreased expression of BCL2 protein] CTD PMID:19224577 excitatory amino acid agonist decreases expression ISO Bcl2 (Mus musculus) 6480464 Excitatory Amino Acid Agonists results in decreased expression of BCL2 protein CTD PMID:19224577 farrerol decreases expression ISO BCL2 (Homo sapiens) 6480464 farrerol results in decreased expression of BCL2 mRNA and farrerol results in decreased expression of BCL2 protein CTD PMID:35833306 fasudil increases expression EXP 6480464 fasudil results in increased expression of BCL2 protein CTD PMID:17761835 fasudil multiple interactions EXP 6480464 fasudil inhibits the reaction [Paraquat results in decreased expression of BCL2 mRNA] and fasudil inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein] CTD PMID:22429817 and PMID:30088170 febuxostat multiple interactions EXP 6480464 Febuxostat inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] CTD PMID:26036690 fenbendazole decreases expression ISO BCL2 (Homo sapiens) 6480464 Fenbendazole analog results in decreased expression of BCL2 protein and Fenbendazole results in decreased expression of BCL2 protein CTD PMID:35569513 fenhexamid increases expression ISO BCL2 (Homo sapiens) 6480464 N-(2 more ... CTD PMID:23052036 and PMID:33484789 fenhexamid decreases expression ISO BCL2 (Homo sapiens) 6480464 N-(2 and 3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in decreased expression of BCL2 protein CTD PMID:23052036 fenhexamid multiple interactions ISO BCL2 (Homo sapiens) 6480464 MIR21 mRNA mutant form inhibits the reaction [N-(2 and 3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in decreased expression of BCL2 protein] CTD PMID:23052036 fenitrothion increases expression ISO BCL2 (Homo sapiens) 6480464 Fenitrothion results in increased expression of BCL2 mRNA CTD PMID:21298709 fenitrothion multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Fenitrothion results in decreased expression of BCL2 mRNA] more ... CTD PMID:31173782 and PMID:32572764 fenitrothion decreases expression EXP 6480464 Fenitrothion results in decreased expression of BCL2 mRNA CTD PMID:31173782 and PMID:32572764 fenofibrate multiple interactions EXP 6480464 Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein] CTD PMID:26989860 fenofibrate decreases expression ISO BCL2 (Homo sapiens) 6480464 Fenofibrate results in decreased expression of BCL2 mRNA CTD PMID:15843896 fenpyroximate decreases expression ISO BCL2 (Homo sapiens) 6480464 fenpyroximate results in decreased expression of BCL2 mRNA CTD PMID:36933581 fenvalerate multiple interactions ISO BCL2 (Homo sapiens) 6480464 [[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with fenvalerate] results in increased expression of BCL2 protein CTD PMID:28949029 fenvalerate multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of BCL2 mRNA and [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of BCL2 mRNA CTD PMID:33396045 more ... ferric oxide increases expression ISO Bcl2 (Mus musculus) 6480464 ferric oxide analog results in increased expression of BCL2 protein CTD PMID:25086211 ferric oxide increases expression ISO BCL2 (Homo sapiens) 6480464 ferric oxide results in increased expression of BCL2 mRNA CTD PMID:33554279 ferric oxide increases phosphorylation EXP 6480464 ferric oxide analog results in increased phosphorylation of BCL2 protein CTD PMID:22995439 ferrosoferric oxide multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Ferrosoferric Oxide binds to titanium dioxide] which results in decreased expression of BCL2 protein CTD PMID:30098274 ferrostatin-1 multiple interactions EXP 6480464 ferrostatin-1 inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein] CTD PMID:35195477 ferulic acid multiple interactions EXP 6480464 ferulic acid inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein] more ... CTD PMID:35110471 finasteride multiple interactions EXP 6480464 Finasteride inhibits the reaction [testosterone enanthate results in increased expression of BCL2 mRNA] more ... CTD PMID:25714330 more ... fingolimod hydrochloride decreases expression ISO BCL2 (Homo sapiens) 6480464 Fingolimod Hydrochloride results in decreased expression of BCL2 mRNA CTD PMID:28662296 fipronil decreases expression ISO BCL2 (Homo sapiens) 6480464 fipronil results in decreased expression of BCL2 protein CTD PMID:21296133 fipronil multiple interactions EXP 6480464 Allopurinol inhibits the reaction [fipronil results in decreased expression of BCL2 mRNA] CTD PMID:36916050 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of BCL2 mRNA CTD PMID:34352653 and PMID:36916050 fisetin multiple interactions EXP 6480464 fisetin inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] CTD PMID:25184746 fisetin decreases expression ISO BCL2 (Homo sapiens) 6480464 fisetin results in decreased expression of BCL2 protein CTD PMID:28181380 fisetin multiple interactions ISO Bcl2 (Mus musculus) 6480464 fisetin inhibits the reaction [Lead results in decreased expression of BCL2 protein] CTD PMID:31539617 fisetin multiple interactions ISO BCL2 (Homo sapiens) 6480464 [fisetin co-treated with Paclitaxel] results in increased expression of BCL2 mRNA CTD PMID:26884726 flavanones decreases expression ISO BCL2 (Homo sapiens) 6480464 Flavanones results in decreased expression of BCL2 protein CTD PMID:25446852 flavones increases expression EXP 6480464 Flavones results in increased expression of BCL2 protein CTD PMID:15998571 flavones increases expression ISO BCL2 (Homo sapiens) 6480464 Flavones analog results in increased expression of BCL2 mRNA CTD PMID:20674374 flavonoids multiple interactions ISO BCL2 (Homo sapiens) 6480464 Flavonoids inhibits the reaction [AGT protein results in decreased expression of BCL2 mRNA] more ... CTD PMID:23994555 flavonoids multiple interactions ISO Bcl2 (Mus musculus) 6480464 Flavonoids inhibits the reaction [Carbon Tetrachloride results in decreased expression of BCL2 mRNA] CTD PMID:23279844 flavonoids decreases expression ISO BCL2 (Homo sapiens) 6480464 Flavonoids results in decreased expression of BCL2 mRNA and Flavonoids results in decreased expression of BCL2 protein CTD PMID:23063593 more ... flavonols increases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in increased susceptibility to Flavonols CTD PMID:28235426 fluazinam decreases expression ISO BCL2 (Homo sapiens) 6480464 fluazinam results in decreased expression of BCL2 protein CTD PMID:21907236 flubendazole increases phosphorylation ISO BCL2 (Homo sapiens) 6480464 flubendazole results in increased phosphorylation of BCL2 protein CTD PMID:32652169 flucytosine decreases expression ISO BCL2 (Homo sapiens) 6480464 Flucytosine results in decreased expression of BCL2 protein CTD PMID:15592511 fludioxonil increases expression ISO BCL2 (Homo sapiens) 6480464 fludioxonil results in increased expression of BCL2 mRNA CTD PMID:23052036 fludioxonil multiple interactions ISO BCL2 (Homo sapiens) 6480464 MIR21 mRNA mutant form inhibits the reaction [fludioxonil results in decreased expression of BCL2 protein] CTD PMID:23052036 fludioxonil decreases expression ISO BCL2 (Homo sapiens) 6480464 fludioxonil results in decreased expression of BCL2 protein CTD PMID:23052036 flumethrin decreases expression ISO BCL2 (Homo sapiens) 6480464 flumethrin results in decreased expression of BCL2 mRNA CTD PMID:34142587 fluoxetine decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to Fluoxetine CTD PMID:16076491 fluoxetine multiple interactions ISO Bcl2 (Mus musculus) 6480464 Fluoxetine inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein] CTD PMID:36169195 fluoxetine decreases expression EXP 6480464 Fluoxetine results in decreased expression of BCL2 protein CTD PMID:19298536 fluoxetine decreases expression ISO Bcl2 (Mus musculus) 6480464 Fluoxetine results in decreased expression of BCL2 mRNA CTD PMID:21497159 flutamide increases expression EXP 6480464 Flutamide results in increased expression of BCL2 mRNA and Flutamide results in increased expression of BCL2 protein CTD PMID:20850791 fluvastatin multiple interactions EXP 6480464 Fluvastatin inhibits the reaction [bisphenol A results in decreased expression of BCL2 protein] more ... CTD PMID:35465754 folic acid affects expression ISO BCL2 (Homo sapiens) 6480464 Folic Acid affects the expression of BCL2 mRNA CTD PMID:16611376 folic acid increases expression ISO BCL2 (Homo sapiens) 6480464 Folic Acid results in increased expression of BCL2 mRNA CTD PMID:36354958 folic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 Folic Acid deficiency results in decreased expression of BCL2 protein CTD PMID:28639913 folic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Folic Acid co-treated with Methyl Methanesulfonate] results in increased expression of BCL2 mRNA more ... CTD PMID:27113042 more ... folic acid increases expression EXP 6480464 Folic Acid results in increased expression of BCL2 mRNA CTD PMID:31721048 folic acid decreases expression ISO Bcl2 (Mus musculus) 6480464 Folic Acid results in decreased expression of BCL2 mRNA and Folic Acid results in decreased expression of BCL2 protein CTD PMID:25629700 more ... folic acid affects expression EXP 6480464 Folic Acid affects the expression of BCL2 protein CTD PMID:16933212 folic acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of BCL2 more ... CTD PMID:16672315 more ... folic acid multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with Folic Acid] results in decreased expression of BCL2 mRNA more ... CTD PMID:16933212 more ... folpet multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Sulfur co-treated with folpet] results in decreased expression of BCL2 mRNA CTD PMID:35564597 formaldehyde increases expression ISO BCL2 (Homo sapiens) 6480464 Formaldehyde results in increased expression of BCL2 protein CTD PMID:20347000 formaldehyde decreases expression EXP 6480464 Formaldehyde results in decreased expression of BCL2 protein CTD PMID:37263556 formaldehyde decreases expression ISO BCL2 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of BCL2 protein CTD PMID:24140967 formaldehyde increases expression ISO Bcl2 (Mus musculus) 6480464 Formaldehyde results in increased expression of BCL2 protein CTD PMID:16888403 formaldehyde multiple interactions ISO BCL2 (Homo sapiens) 6480464 PRDX2 protein inhibits the reaction [Formaldehyde results in increased expression of BCL2 protein] CTD PMID:20347000 formononetin multiple interactions EXP 6480464 formononetin promotes the reaction [Cisplatin results in increased expression of BCL2 protein] CTD PMID:28414026 formononetin multiple interactions ISO BCL2 (Homo sapiens) 6480464 formononetin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] CTD PMID:34077701 formononetin decreases expression ISO BCL2 (Homo sapiens) 6480464 formononetin results in decreased expression of BCL2 mRNA CTD PMID:23867903 formoterol fumarate decreases expression ISO BCL2 (Homo sapiens) 6480464 Formoterol Fumarate results in decreased expression of BCL2 mRNA and Formoterol Fumarate results in decreased expression of BCL2 protein CTD PMID:14687023 Forsythiaside multiple interactions ISO Bcl2 (Mus musculus) 6480464 forsythiaside inhibits the reaction [amyloid beta-protein (25-35) results in decreased expression of BCL2 protein] and Rimonabant inhibits the reaction [forsythiaside inhibits the reaction [amyloid beta-protein (25-35) results in decreased expression of BCL2 protein]] CTD PMID:30769029 fraxetin decreases expression ISO BCL2 (Homo sapiens) 125097526 Fraxetin decreases expression of BCL2 protein in colorectum RGD fructose decreases expression ISO Bcl2 (Mus musculus) 6480464 Fructose results in decreased expression of BCL2 protein CTD PMID:27531227 fructose increases expression ISO BCL2 (Homo sapiens) 6480464 Fructose results in increased expression of BCL2 mRNA CTD PMID:31655124 fructose multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Fructose co-treated with Dietary Fats] results in decreased expression of BCL2 mRNA more ... CTD PMID:28916335 fructose multiple interactions EXP 6480464 [Atorvastatin co-treated with dapagliflozin] inhibits the reaction [[Fructose co-treated with Dietary Fats] results in decreased expression of BCL2 protein] more ... CTD PMID:17883899 and PMID:32259528 fructose increases expression EXP 6480464 Fructose results in increased expression of BCL2 protein CTD PMID:17883899 fucoxanthin decreases expression ISO BCL2 (Homo sapiens) 6480464 fucoxanthin results in decreased expression of BCL2 mRNA CTD PMID:35266250 fulvestrant multiple interactions ISO BCL2 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of BCL2 gene more ... CTD PMID:10545406 more ... fulvestrant increases expression EXP 6480464 fulvestrant results in increased expression of BCL2 protein CTD PMID:16951259 fulvestrant multiple interactions EXP 6480464 [fulvestrant co-treated with Estradiol] results in increased expression of BCL2 protein CTD PMID:16951259 fumagillin multiple interactions EXP 6480464 fumagillin inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 mRNA] CTD PMID:15682466 fumonisin B1 decreases expression ISO BCL2 (Homo sapiens) 6480464 fumonisin B1 results in decreased expression of BCL2 mRNA and fumonisin B1 results in decreased expression of BCL2 protein CTD PMID:31891755 fumonisin B1 multiple interactions ISO Bcl2 (Mus musculus) 6480464 fumonisin B1 promotes the reaction [ochratoxin A results in decreased expression of BCL2 mRNA] and fumonisin B1 promotes the reaction [ochratoxin A results in decreased expression of BCL2 protein] CTD PMID:36397609 furan increases expression EXP 6480464 furan results in increased expression of BCL2 mRNA CTD PMID:22079235 furosemide affects expression EXP 6480464 Furosemide affects the expression of BCL2 mRNA CTD PMID:17497460 Fusarenone X increases expression ISO Bcl2 (Mus musculus) 6480464 fusarenon-X results in increased expression of BCL2 mRNA CTD PMID:24983900 Fusarenone X decreases expression ISO Bcl2 (Mus musculus) 6480464 fusarenon-X results in decreased expression of BCL2 mRNA CTD PMID:24983900 gadolinium atom multiple interactions ISO BCL2 (Homo sapiens) 6480464 [gadolinium chloride results in increased abundance of Gadolinium] which results in decreased expression of BCL2 protein CTD PMID:34878122 gadolinium trichloride multiple interactions ISO BCL2 (Homo sapiens) 6480464 [gadolinium chloride results in increased abundance of Gadolinium] which results in decreased expression of BCL2 protein CTD PMID:34878122 galactose multiple interactions EXP 6480464 agomelatine inhibits the reaction [Galactose results in decreased expression of BCL2 protein] more ... CTD PMID:25892055 more ... galactose multiple interactions ISO BCL2 (Homo sapiens) 6480464 Phycocyanin inhibits the reaction [Galactose results in decreased expression of BCL2 protein] CTD PMID:23036742 galactose decreases expression ISO BCL2 (Homo sapiens) 6480464 Galactose results in decreased expression of BCL2 protein CTD PMID:23036742 galactose decreases expression EXP 6480464 Galactose results in decreased expression of BCL2 mRNA and Galactose results in decreased expression of BCL2 protein CTD PMID:25892055 more ... galangin decreases expression ISO BCL2 (Homo sapiens) 6480464 galangin results in decreased expression of BCL2 protein CTD PMID:25450235 galanthamine multiple interactions EXP 152995414 Galan inhibits the reaction [2 more ... RGD Galbanic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 galbanic acid results in decreased expression of BCL2 mRNA CTD PMID:31576639 gallein multiple interactions EXP 6480464 gallein inhibits the reaction [N(6)-cyclopentyladenosine results in increased expression of BCL2 protein] CTD PMID:35901927 gallic acid multiple interactions EXP 6480464 Gallic Acid inhibits the reaction [1 more ... CTD PMID:19723098 and PMID:31925992 gallic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 Gallic Acid results in decreased expression of BCL2 protein CTD PMID:22245431 gallic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 Gallic Acid inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA] CTD PMID:21420233 gallic acid decreases expression EXP 6480464 Gallic Acid results in decreased expression of BCL2 protein CTD PMID:19723098 gamma-aminobutyric acid increases expression EXP 6480464 gamma-Aminobutyric Acid results in increased expression of BCL2 protein CTD PMID:29708300 gamma-hexachlorocyclohexane decreases expression ISO BCL2 (Homo sapiens) 6480464 Hexachlorocyclohexane results in decreased expression of BCL2 protein CTD PMID:14688026 gamma-hexachlorocyclohexane increases expression ISO BCL2 (Homo sapiens) 6480464 Hexachlorocyclohexane results in increased expression of BCL2 mRNA and Hexachlorocyclohexane results in increased expression of BCL2 protein CTD PMID:14688026 and PMID:18174961 gamma-hexachlorocyclohexane multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Hexachlorocyclohexane co-treated with Estradiol] results in increased expression of BCL2 protein CTD PMID:18174961 gamma-hexachlorocyclohexane multiple interactions EXP 6480464 Hexachlorocyclohexane promotes the reaction [BECN1 protein binds to BCL2 protein] CTD PMID:19041923 gamma-tocopherol increases expression ISO Bcl2 (Mus musculus) 6480464 Tocopherols results in increased expression of BCL2 mRNA and Tocopherols results in increased expression of BCL2 protein CTD PMID:8970189 gamma-tocopherol multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Fluorouracil co-treated with gamma-Tocopherol] results in decreased expression of BCL2 mRNA CTD PMID:31587439 gamma-tocopherol decreases expression ISO BCL2 (Homo sapiens) 6480464 gamma-Tocopherol results in decreased expression of BCL2 mRNA CTD PMID:31587439 gamma-tocopherol decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to Tocopherols CTD PMID:16001965 ganciclovir decreases expression ISO BCL2 (Homo sapiens) 6480464 Ganciclovir results in decreased expression of BCL2 protein CTD PMID:15592511 Ganoderic acid A multiple interactions ISO Bcl2 (Mus musculus) 6480464 ganoderic acid A inhibits the reaction [Cyclophosphamide results in decreased expression of BCL2 protein] CTD PMID:30506662 Garcinol decreases expression ISO BCL2 (Homo sapiens) 6480464 garcinol results in decreased expression of BCL2 protein CTD PMID:16052481 gardenin B decreases expression ISO BCL2 (Homo sapiens) 6480464 gardenin B results in decreased expression of BCL2 protein CTD PMID:27423764 Gastrodin multiple interactions ISO Bcl2 (Mus musculus) 6480464 gastrodin promotes the reaction [RELA protein binds to BCL2 promoter] CTD PMID:23578476 Gastrodin increases expression ISO Bcl2 (Mus musculus) 6480464 gastrodin results in increased expression of BCL2 mRNA CTD PMID:23578476 geldanamycin multiple interactions ISO BCL2 (Homo sapiens) 6480464 [geldanamycin co-treated with Bortezomib] results in decreased expression of BCL2 protein and geldanamycin inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA] CTD PMID:15781649 and PMID:37586545 geldanamycin decreases expression ISO BCL2 (Homo sapiens) 6480464 geldanamycin results in decreased expression of BCL2 protein CTD PMID:28673683 gemcitabine decreases expression ISO BCL2 (Homo sapiens) 6480464 Gemcitabine results in decreased expression of BCL2 protein CTD PMID:15476743 gemcitabine multiple interactions ISO BCL2 (Homo sapiens) 6480464 [alvocidib co-treated with Gemcitabine] results in decreased expression of BCL2 protein more ... CTD PMID:15476743 more ... gemcitabine multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Curcumin co-treated with Gemcitabine] results in decreased expression of BCL2 protein CTD PMID:17440100 Genipin decreases expression ISO BCL2 (Homo sapiens) 6480464 genipin results in decreased expression of BCL2 mRNA CTD PMID:22245672 Geniposide decreases expression ISO BCL2 (Homo sapiens) 6480464 geniposide metabolite results in decreased expression of BCL2 mRNA and geniposide metabolite results in decreased expression of BCL2 protein CTD PMID:22245672 genistein multiple interactions ISO BCL2 (Homo sapiens) 6480464 [ASRGL1 protein co-treated with Genistein] results in decreased expression of BCL2 protein more ... CTD PMID:15288519 more ... genistein increases expression ISO Bcl2 (Mus musculus) 6480464 Genistein results in increased expression of BCL2 mRNA CTD PMID:30056207 genistein multiple interactions EXP 6480464 Genistein inhibits the reaction [Ethanol results in increased expression of BCL2 mRNA] and Genistein inhibits the reaction [lead acetate results in decreased expression of BCL2 protein] CTD PMID:23274713 and PMID:26797587 genistein decreases expression EXP 6480464 Genistein results in decreased expression of BCL2 mRNA CTD PMID:21782745 genistein decreases expression ISO BCL2 (Homo sapiens) 6480464 Genistein results in decreased expression of BCL2 protein CTD PMID:12791511 more ... genistein decreases expression ISO Bcl2 (Mus musculus) 6480464 Genistein results in decreased expression of BCL2 mRNA and Genistein results in decreased expression of BCL2 protein CTD PMID:21078540 and PMID:31593742 genistein multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Genistein co-treated with Arsenic Trioxide] results in decreased expression of BCL2 protein and Genistein inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] CTD PMID:21078540 and PMID:30734460 gentamycin decreases response to substance ISO Bcl2 (Mus musculus) 6480464 BCL2 protein results in decreased susceptibility to Gentamicins CTD PMID:19151550 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of BCL2 mRNA CTD PMID:33387578 gentamycin decreases expression ISO Bcl2 (Mus musculus) 6480464 Gentamicins results in decreased expression of BCL2 mRNA and Gentamicins results in decreased expression of BCL2 protein CTD PMID:29751043 and PMID:31021006 gentamycin multiple interactions ISO Bcl2 (Mus musculus) 6480464 baicalin inhibits the reaction [Gentamicins results in decreased expression of BCL2 mRNA] more ... CTD PMID:29751043 and PMID:31021006 gentamycin affects expression EXP 6480464 Gentamicins affects the expression of BCL2 mRNA CTD PMID:26779593 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of BCL2 protein CTD PMID:19698708 gentamycin multiple interactions EXP 6480464 Amlodipine inhibits the reaction [Gentamicins results in decreased expression of BCL2 protein] more ... CTD PMID:19698708 and PMID:26779593 Gentiopicrin multiple interactions ISO Bcl2 (Mus musculus) 6480464 gentiopicroside inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of BCL2 protein] CTD PMID:20558151 Geraniin increases phosphorylation ISO BCL2 (Homo sapiens) 6480464 Geraniin results in increased phosphorylation of BCL2 protein CTD PMID:27097871 geraniol multiple interactions ISO Bcl2 (Mus musculus) 6480464 geraniol inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:22760862 more ... geraniol multiple interactions EXP 6480464 geraniol inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA] CTD PMID:34343525 geraniol decreases expression ISO BCL2 (Homo sapiens) 6480464 geraniol results in decreased expression of BCL2 mRNA and geraniol results in decreased expression of BCL2 protein CTD PMID:21371438 more ... geraniol increases expression EXP 6480464 geraniol results in increased expression of BCL2 protein CTD PMID:21445532 geranyl acetate decreases expression ISO BCL2 (Homo sapiens) 6480464 geranyl acetate results in decreased expression of BCL2 protein CTD PMID:29745075 gingerol decreases expression ISO BCL2 (Homo sapiens) 6480464 gingerol results in decreased expression of BCL2 mRNA and gingerol results in decreased expression of BCL2 protein CTD PMID:18030663 more ... gingerol multiple interactions ISO Bcl2 (Mus musculus) 155882488 gingerol inhibits the reaction [hypoxia-reoxygenation decreases expression of Bcl2 protein in neural crest-derived cells] RGD gingerol multiple interactions ISO Bcl2 (Mus musculus) 6480464 gingerol inhibits the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of BCL2 protein] more ... CTD PMID:18030663 and PMID:37121058 gingerol multiple interactions ISO BCL2 (Homo sapiens) 6480464 [gingerol co-treated with Hydrogen Peroxide] results in increased expression of BCL2 protein more ... CTD PMID:18030663 more ... ginkgetin multiple interactions ISO BCL2 (Homo sapiens) 6480464 ginkgetin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein] CTD PMID:25968939 ginkgetin multiple interactions ISO Bcl2 (Mus musculus) 6480464 ginkgetin inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:25968939 Ginkgoic acid decreases expression ISO BCL2 (Homo sapiens) 127284886 Ginkgoic acid decreases expression of BCL2 mRNA and protein in stomach RGD Ginkgolide C multiple interactions EXP 6480464 ginkgolide C inhibits the reaction [Paraquat results in decreased expression of BCL2 protein] CTD PMID:35707280 ginsenoside Rd multiple interactions EXP 6480464 ginsenoside Rd inhibits the reaction [APP protein modified form results in decreased expression of BCL2 mRNA] CTD PMID:26111763 ginsenoside Re increases expression ISO Bcl2 (Mus musculus) 6480464 ginsenoside Re results in increased expression of BCL2 mRNA and ginsenoside Re results in increased expression of BCL2 protein CTD PMID:15621629 ginsenoside Re multiple interactions ISO Bcl2 (Mus musculus) 6480464 3-((3 more ... CTD PMID:29467000 and PMID:37308051 ginsenoside Rg1 decreases expression ISO Bcl2 (Mus musculus) 6480464 ginsenoside Rg1 results in decreased expression of BCL2 protein CTD PMID:28371286 ginsenoside Rg1 multiple interactions ISO Bcl2 (Mus musculus) 6480464 ginsenoside Rg1 inhibits the reaction [Chlorpyrifos results in decreased expression of BCL2 protein] CTD PMID:36811218 ginsenoside Rg1 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ginsenoside Rg1 inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]] more ... CTD PMID:26593335 and PMID:34859534 ginsenoside Rg2 multiple interactions EXP 6480464 ginsenoside Rg2 inhibits the reaction [APP protein modified form results in decreased expression of BCL2 protein] CTD PMID:28756148 glabridin multiple interactions ISO BCL2 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [glabridin results in decreased expression of BCL2 protein] and AKT activator SC79 inhibits the reaction [glabridin results in decreased expression of BCL2 protein] CTD PMID:36029289 glabridin multiple interactions ISO Bcl2 (Mus musculus) 6480464 [glabridin co-treated with Paclitaxel] results in decreased expression of BCL2 protein CTD PMID:37419298 glabridin decreases expression ISO BCL2 (Homo sapiens) 6480464 glabridin results in decreased expression of BCL2 protein CTD PMID:36029289 gliclazide multiple interactions ISO BCL2 (Homo sapiens) 6480464 Gliclazide inhibits the reaction [Glucose results in decreased expression of BCL2 protein] CTD PMID:18088078 glucaric acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9 more ... CTD PMID:25478867 glucose multiple interactions EXP 6480464 15-Hydroxy-11 alpha more ... CTD PMID:21803128 more ... glucose decreases expression ISO Bcl2 (Mus musculus) 6480464 Glucose results in decreased expression of BCL2 protein CTD PMID:31672611 glucose multiple interactions ISO Bcl2 (Mus musculus) 6480464 8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one promotes the reaction [[Glucose co-treated with Bupivacaine] results in decreased expression of BCL2 protein] more ... CTD PMID:23108914 more ... glucose decreases expression EXP 6480464 Glucose results in decreased expression of BCL2 mRNA and Glucose results in decreased expression of BCL2 protein CTD PMID:21818840 more ... glucose affects expression EXP 6480464 Glucose affects the expression of BCL2 mRNA and Glucose affects the expression of BCL2 protein CTD PMID:22524206 and PMID:24349266 glucose decreases expression ISO BCL2 (Homo sapiens) 6480464 Glucose results in decreased expression of BCL2 mRNA and Glucose results in decreased expression of BCL2 protein CTD PMID:18088078 more ... glucose multiple interactions ISO BCL2 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased expression of BCL2 protein]] more ... CTD PMID:18088078 more ... glutathione multiple interactions ISO BCL2 (Homo sapiens) 6480464 Glutathione inhibits the reaction [3-oxo-29-noroleana-1 more ... CTD PMID:17640567 more ... glutathione multiple interactions ISO Bcl2 (Mus musculus) 6480464 [diethyl maleate results in decreased abundance of Glutathione] which results in increased expression of BCL2 mRNA and Glutathione inhibits the reaction [Acrolein results in decreased expression of BCL2 protein] CTD PMID:22564015 and PMID:24376112 glutathione decreases export ISO Bcl2 (Mus musculus) 6480464 BCL2 protein results in decreased export of Glutathione CTD PMID:15561710 glyburide multiple interactions EXP 6480464 Glyburide inhibits the reaction [sodium bisulfide results in increased expression of BCL2 protein] and Glyburide inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein] CTD PMID:21800153 and PMID:33724628 glycerol multiple interactions EXP 6480464 2 more ... CTD PMID:34409680 glycerol decreases expression EXP 6480464 Glycerol results in decreased expression of BCL2 protein CTD PMID:34409680 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of BCL2 mRNA CTD PMID:24915197 glycine betaine affects binding ISO BCL2 (Homo sapiens) 6480464 Betaine analog binds to BCL2 protein CTD PMID:25765238 glycine betaine increases expression EXP 6480464 Betaine results in increased expression of BCL2 protein CTD PMID:25080425 glycyrrhetinate multiple interactions EXP 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [bisphenol A results in decreased expression of BCL2] and 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of BCL2 protein] CTD PMID:28414158 and PMID:35699857 glycyrrhetinate multiple interactions ISO BCL2 (Homo sapiens) 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein co-treated with PDGFB protein] results in increased expression of BCL2 protein] CTD PMID:31325423 glycyrrhetinic acid multiple interactions EXP 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [bisphenol A results in decreased expression of BCL2] and 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of BCL2 protein] CTD PMID:28414158 and PMID:35699857 glycyrrhetinic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein co-treated with PDGFB protein] results in increased expression of BCL2 protein] CTD PMID:31325423 glycyrrhizinic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 Glycyrrhizic Acid results in decreased expression of BCL2 mRNA CTD PMID:35844403 glyoxylic acid decreases expression ISO Bcl2 (Mus musculus) 6480464 glyoxylic acid results in decreased expression of BCL2 protein CTD PMID:34333021 glyoxylic acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 Resveratrol inhibits the reaction [glyoxylic acid results in decreased expression of BCL2 protein] CTD PMID:34333021 glyphosate multiple interactions EXP 6480464 [Surface-Active Agents co-treated with Glyphosate] results in decreased expression of BCL2 protein CTD PMID:23099315 glyphosate decreases expression ISO Bcl2 (Mus musculus) 6480464 Glyphosate results in decreased expression of BCL2 mRNA and Glyphosate results in decreased expression of BCL2 protein CTD PMID:29908847 and PMID:31352102 glyphosate increases expression ISO Bcl2 (Mus musculus) 6480464 Glyphosate results in increased expression of BCL2 mRNA CTD PMID:30785197 glyphosate decreases expression ISO BCL2 (Homo sapiens) 6480464 Glyphosate results in decreased expression of BCL2 mRNA and Glyphosate results in decreased expression of BCL2 protein CTD PMID:30907447 and PMID:31874349 glyphosate increases expression ISO BCL2 (Homo sapiens) 6480464 Glyphosate results in increased expression of BCL2 mRNA and Glyphosate results in increased expression of BCL2 protein CTD PMID:24073338 and PMID:31751608 glyphosate multiple interactions ISO BCL2 (Homo sapiens) 6480464 [[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Cisplatin] which results in increased expression of BCL2 mRNA more ... CTD PMID:32800223 gold atom multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Gold analog co-treated with Platinum] results in decreased expression of BCL2 mRNA and [Quercetin analog co-treated with Gold analog] results in decreased expression of BCL2 protein CTD PMID:25846798 and PMID:27470402 gold atom multiple interactions EXP 6480464 [Gold binds to NKCT1 protein and Naja kaouthia] which results in decreased expression of BCL2 protein CTD PMID:27836789 gold(0) multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Gold analog co-treated with Platinum] results in decreased expression of BCL2 mRNA and [Quercetin analog co-treated with Gold analog] results in decreased expression of BCL2 protein CTD PMID:25846798 and PMID:27470402 gold(0) multiple interactions EXP 6480464 [Gold binds to NKCT1 protein and Naja kaouthia] which results in decreased expression of BCL2 protein CTD PMID:27836789 Goserelin increases expression ISO BCL2 (Homo sapiens) 6480464 Goserelin results in increased expression of BCL2 protein CTD PMID:16973256 gossypol multiple interactions ISO Bcl2 (Mus musculus) 6480464 [gossypol acetic acid results in increased abundance of Gossypol] promotes the reaction [ponatinib results in decreased expression of BCL2 mRNA] more ... CTD PMID:34699866 graphene oxide decreases expression ISO BCL2 (Homo sapiens) 6480464 graphene oxide results in decreased expression of BCL2 mRNA and graphene oxide results in decreased expression of BCL2 protein CTD PMID:30239936 and PMID:32070776 graphite multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Graphite analog co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of BCL2 protein CTD PMID:25446327 Grifolin decreases expression ISO BCL2 (Homo sapiens) 6480464 grifolin results in decreased expression of BCL2 protein CTD PMID:15949805 GSK690693 multiple interactions ISO BCL2 (Homo sapiens) 6480464 GSK690693 promotes the reaction [1 and 4-naphthoquinone analog results in decreased expression of BCL2 protein] CTD PMID:30871965 guanidines affects response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein affects the susceptibility to Guanidines analog CTD PMID:23147571 guggulsterone multiple interactions ISO BCL2 (Homo sapiens) 6480464 pregna-4 more ... CTD PMID:15322087 Gyrophoric acid decreases expression ISO BCL2 (Homo sapiens) 6480464 gyrophoric acid results in decreased expression of BCL2 protein CTD PMID:22285236 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of BCL2 protein CTD PMID:17069804 hemin decreases expression ISO BCL2 (Homo sapiens) 6480464 Hemin results in decreased expression of BCL2 protein CTD PMID:27815112 hemin multiple interactions EXP 6480464 Hemin inhibits the reaction [lead acetate results in decreased expression of BCL2 protein] CTD PMID:29797346 heparin increases expression ISO BCL2 (Homo sapiens) 6480464 Heparin results in increased expression of BCL2 protein CTD PMID:11787776 more ... heparin multiple interactions ISO BCL2 (Homo sapiens) 6480464 Heparin inhibits the reaction [arsenite results in decreased expression of BCL2 protein] CTD PMID:26677073 heptachlor increases expression EXP 6480464 Heptachlor results in increased expression of BCL2 protein CTD PMID:14678745 hesperetin affects expression ISO BCL2 (Homo sapiens) 6480464 hesperetin affects the expression of BCL2 protein CTD PMID:15975156 hesperetin multiple interactions ISO BCL2 (Homo sapiens) 6480464 hesperetin promotes the reaction [Cisplatin results in increased expression of BCL2 protein] CTD PMID:31153982 hesperetin multiple interactions ISO Bcl2 (Mus musculus) 6480464 hesperetin promotes the reaction [Cisplatin results in increased expression of BCL2 protein] CTD PMID:31153982 hesperetin decreases expression ISO BCL2 (Homo sapiens) 6480464 hesperetin analog results in decreased expression of BCL2 protein and hesperetin results in decreased expression of BCL2 protein CTD PMID:22142698 and PMID:37487865 hesperetin decreases expression EXP 6480464 hesperetin analog results in decreased expression of BCL2 mRNA CTD PMID:20564462 hesperidin multiple interactions EXP 6480464 [Hesperidin co-treated with Chlorpyrifos] results in decreased expression of BCL2 mRNA more ... CTD PMID:22093918 more ... hesperidin decreases expression ISO Bcl2 (Mus musculus) 6480464 Hesperidin results in decreased expression of BCL2 mRNA CTD PMID:29481770 hesperidin multiple interactions ISO Bcl2 (Mus musculus) 6480464 Doxorubicin promotes the reaction [Hesperidin results in decreased expression of BCL2 mRNA] CTD PMID:29481770 hexachlorophene decreases expression EXP 6480464 Hexachlorophene results in decreased expression of BCL2 mRNA CTD PMID:25497112 hexadecanoic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 Palmitic Acid results in decreased expression of BCL2 CTD PMID:15945276 hexadecanoic acid multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in decreased expression of BCL2 protein]] more ... CTD PMID:34897970 hexadecanoic acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 amlexanox inhibits the reaction [Palmitic Acid results in decreased expression of BCL2 protein] more ... CTD PMID:32905826 and PMID:34678374 hexadecanoic acid decreases expression ISO Bcl2 (Mus musculus) 6480464 Palmitic Acid results in decreased expression of BCL2 protein CTD PMID:32905826 and PMID:34678374 hexadecanoic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 3-N-1(spermine)-7 more ... CTD PMID:32369900 and PMID:33736254 hexadecanoic acid decreases expression EXP 6480464 Palmitic Acid results in decreased expression of BCL2 and Palmitic Acid results in decreased expression of BCL2 protein CTD PMID:15945276 and PMID:34897970 hexaflumuron decreases expression EXP 6480464 hexafluoron results in decreased expression of BCL2 mRNA CTD PMID:35773501 hexane increases expression EXP 6480464 n-hexane metabolite results in increased expression of BCL2 protein CTD PMID:17492505 hinokiflavone decreases expression ISO Bcl2 (Mus musculus) 6480464 hinokiflavone results in decreased expression of BCL2 protein CTD PMID:30575109 and PMID:32252563 histamine decreases expression EXP 6480464 Histamine results in decreased expression of BCL2 mRNA CTD PMID:36565801 homocysteine multiple interactions ISO BCL2 (Homo sapiens) 6480464 Folic Acid affects the reaction [Homocysteine affects the expression of BCL2 mRNA] more ... CTD PMID:16757814 and PMID:29250709 homocysteine affects expression ISO BCL2 (Homo sapiens) 6480464 Homocysteine affects the expression of BCL2 mRNA and Homocysteine affects the expression of BCL2 protein CTD PMID:29250709 homocysteine multiple interactions EXP 6480464 [Homocysteine co-treated with Sodium Glutamate] affects the expression of BCL2 mRNA more ... CTD PMID:22169520 homocysteine decreases expression ISO BCL2 (Homo sapiens) 6480464 Homocysteine results in decreased expression of BCL2 protein CTD PMID:16757814 homoeriodictyol multiple interactions ISO BCL2 (Homo sapiens) 6480464 homoeriodictyol inhibits the reaction [Hydrogen Peroxide affects the expression of BCL2 protein] CTD PMID:29902531 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of BCL2 mRNA and Hydrogen Peroxide results in decreased expression of BCL2 protein CTD PMID:14505808 more ... hydrogen peroxide affects expression ISO BCL2 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of BCL2 protein CTD PMID:29902531 hydrogen peroxide affects expression ISO Bcl2 (Mus musculus) 6480464 Hydrogen Peroxide affects the expression of BCL2 mRNA CTD PMID:27057282 hydrogen peroxide multiple interactions ISO Bcl2 (Mus musculus) 6480464 Grape Seed Proanthocyanidins inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] and procyanidin B2 affects the reaction [Hydrogen Peroxide affects the expression of BCL2 mRNA] CTD PMID:25242411 and PMID:27057282 hydrogen peroxide decreases expression ISO Bcl2 (Mus musculus) 6480464 Hydrogen Peroxide results in decreased expression of BCL2 protein CTD PMID:25242411 hydrogen peroxide increases phosphorylation ISO BCL2 (Homo sapiens) 6480464 Hydrogen Peroxide results in increased phosphorylation of BCL2 protein CTD PMID:15142122 hydrogen peroxide decreases expression ISO BCL2 (Homo sapiens) 6480464 Hydrogen Peroxide results in decreased expression of BCL2 mRNA and Hydrogen Peroxide results in decreased expression of BCL2 protein CTD PMID:12672908 more ... hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of BCL2 mRNA and Hydrogen Peroxide affects the expression of BCL2 protein CTD PMID:17204550 and PMID:17570061 hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of BCL2 protein CTD PMID:16157298 hydrogen peroxide affects response to substance ISO Bcl2 (Mus musculus) 6480464 BCL2 protein affects the susceptibility to Hydrogen Peroxide CTD PMID:15746559 hydrogen peroxide increases expression ISO BCL2 (Homo sapiens) 6480464 Hydrogen Peroxide results in increased expression of BCL2 protein CTD PMID:8781438 hydrogen peroxide multiple interactions ISO BCL2 (Homo sapiens) 6480464 2''-galloylhyperin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] more ... CTD PMID:12672908 more ... hydrogen peroxide decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to Hydrogen Peroxide CTD PMID:9989825 hydrogen peroxide multiple interactions EXP 6480464 2-(4-((dimethylamino)methyl)benzylidene)-5 more ... CTD PMID:14505808 more ... hydroquinone increases expression ISO BCL2 (Homo sapiens) 6480464 hydroquinone results in increased expression of BCL2 mRNA and hydroquinone results in increased expression of BCL2 protein CTD PMID:27515134 more ... hydroquinone multiple interactions ISO Bcl2 (Mus musculus) 6480464 hydroquinone promotes the reaction [XBP1 protein affects the expression of BCL2 mRNA] and XBP1 protein affects the reaction [hydroquinone results in decreased expression of BCL2 mRNA] CTD PMID:24053669 hydroquinone decreases expression ISO BCL2 (Homo sapiens) 6480464 hydroquinone results in decreased expression of BCL2 protein CTD PMID:23288922 more ... hydroquinone decreases expression ISO Bcl2 (Mus musculus) 6480464 hydroquinone results in decreased expression of BCL2 mRNA and hydroquinone results in decreased expression of BCL2 protein CTD PMID:24053669 and PMID:27606422 hydroquinone multiple interactions ISO BCL2 (Homo sapiens) 6480464 [PARP1 protein affects the susceptibility to hydroquinone] which affects the expression of BCL2 protein more ... CTD PMID:28444915 more ... hydroxamic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 Hydroxamic Acids analog results in decreased expression of BCL2 protein and Hydroxamic Acids results in decreased expression of BCL2 protein CTD PMID:25824412 and PMID:26088127 hydroxychloroquine multiple interactions ISO BCL2 (Homo sapiens) 6480464 Hydroxychloroquine inhibits the reaction [beta-ionone results in decreased expression of BCL2 protein] CTD PMID:36843289 hydroxytyrosol increases phosphorylation ISO BCL2 (Homo sapiens) 6480464 3 and 4-dihydroxyphenylethanol results in increased phosphorylation of BCL2 protein CTD PMID:12482581 hydroxytyrosol multiple interactions EXP 6480464 3 more ... CTD PMID:29414845 hymexazol decreases expression EXP 6480464 hymexazol results in decreased expression of BCL2 mRNA CTD PMID:35773501 hyperforin multiple interactions EXP 6480464 hyperforin inhibits the reaction [aluminum maltolate results in decreased expression of BCL2 mRNA] CTD PMID:30481499 hyperforin increases expression ISO BCL2 (Homo sapiens) 6480464 hyperforin results in increased expression of BCL2 mRNA CTD PMID:30481499 hyperforin increases expression EXP 6480464 hyperforin results in increased expression of BCL2 mRNA CTD PMID:30481499 hyperforin multiple interactions ISO BCL2 (Homo sapiens) 6480464 hyperforin inhibits the reaction [aluminum maltolate results in decreased expression of BCL2 mRNA] CTD PMID:30481499 hypoxanthine multiple interactions ISO BCL2 (Homo sapiens) 6480464 [3-hydrogenkwadaphnin co-treated with Hypoxanthine] results in decreased expression of BCL2 protein more ... CTD PMID:21396949 icariin affects expression EXP 6480464 icariin affects the expression of BCL2 protein CTD PMID:25472572 icariin multiple interactions ISO BCL2 (Homo sapiens) 6480464 icariin inhibits the reaction [[Oxygen co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein] CTD PMID:25472572 icariside II decreases expression ISO BCL2 (Homo sapiens) 6480464 baohuoside I results in decreased expression of BCL2 protein CTD PMID:22687635 ICI 118551 multiple interactions ISO BCL2 (Homo sapiens) 6480464 [ICI 118551 co-treated with Gemcitabine] results in decreased expression of BCL2 protein CTD PMID:21570961 icosanoid multiple interactions EXP 6480464 Eicosanoids analog inhibits the reaction [Cisplatin results in decreased expression of BCL2 mRNA] CTD PMID:23603837 idelalisib multiple interactions ISO BCL2 (Homo sapiens) 6480464 [FASLG protein co-treated with idelalisib] results in decreased expression of BCL2 protein and AKT activator SC79 inhibits the reaction [[FASLG protein co-treated with idelalisib] results in decreased expression of BCL2 protein] CTD PMID:31445927 Idoxifene multiple interactions EXP 6480464 idoxifene inhibits the reaction [Dimethylnitrosamine results in decreased expression of BCL2 protein] CTD PMID:14659978 ifosfamide multiple interactions ISO BCL2 (Homo sapiens) 6480464 BCL2 protein inhibits the reaction [Ifosfamide results in increased activity of CASP9 protein] CTD PMID:11723234 ifosfamide decreases expression EXP 6480464 Ifosfamide results in decreased expression of BCL2 mRNA CTD PMID:23213347 and PMID:31722249 ifosfamide multiple interactions EXP 6480464 Carnitine inhibits the reaction [Ifosfamide results in decreased expression of BCL2 mRNA] and morin inhibits the reaction [Ifosfamide results in decreased expression of BCL2 mRNA] CTD PMID:23213347 and PMID:31722249 Ilimaquinone decreases expression ISO BCL2 (Homo sapiens) 6480464 ilimaquinone results in decreased expression of BCL2 protein CTD PMID:24930757 imidacloprid multiple interactions EXP 6480464 Thymol inhibits the reaction [imidacloprid results in decreased expression of BCL2 mRNA] CTD PMID:34171690 imidacloprid decreases expression EXP 6480464 imidacloprid results in decreased expression of BCL2 mRNA CTD PMID:34171690 Imipenem-cilastatin increases expression EXP 6480464 Cilastatin and Imipenem Drug Combination results in increased expression of BCL2 protein CTD PMID:30721722 imiquimod decreases expression ISO BCL2 (Homo sapiens) 6480464 imiquimod results in decreased expression of BCL2 protein CTD PMID:20033192 indirubin multiple interactions ISO BCL2 (Homo sapiens) 6480464 [arsenic disulfide co-treated with indirubin] results in decreased expression of BCL2 mRNA CTD PMID:25789073 indole-3-methanol decreases expression ISO BCL2 (Homo sapiens) 6480464 indole-3-carbinol results in decreased expression of BCL2 CTD PMID:16082211 indole-3-methanol decreases expression ISO Bcl2 (Mus musculus) 6480464 indole-3-carbinol results in decreased expression of BCL2 protein CTD PMID:29775573 indole-3-methanol multiple interactions ISO BCL2 (Homo sapiens) 6480464 indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of BCL2 protein] CTD PMID:15811958 indometacin decreases expression ISO BCL2 (Homo sapiens) 6480464 Indomethacin results in decreased expression of BCL2 mRNA and Indomethacin results in decreased expression of BCL2 protein CTD PMID:10785260 more ... indometacin increases expression ISO BCL2 (Homo sapiens) 6480464 Indomethacin results in increased expression of BCL2 mRNA CTD PMID:29027214 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of BCL2 mRNA CTD PMID:29027214 indometacin multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Indomethacin co-treated with juglone] results in decreased expression of BCL2 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of BCL2 mRNA CTD PMID:28628672 and PMID:31916655 indometacin decreases expression EXP 6480464 Indomethacin results in decreased expression of BCL2 mRNA CTD PMID:19220725 indometacin multiple interactions EXP 6480464 Indomethacin inhibits the reaction [COL2A1 results in increased expression of BCL2 protein] more ... CTD PMID:17570061 more ... inositol multiple interactions ISO Bcl2 (Mus musculus) 6480464 Inositol inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] CTD PMID:37863467 inositol multiple interactions ISO BCL2 (Homo sapiens) 6480464 Inositol inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] CTD PMID:37863467 iodoacetic acid decreases expression ISO Bcl2 (Mus musculus) 6480464 Iodoacetic Acid results in decreased expression of BCL2 mRNA CTD PMID:31693920 iohexol decreases expression ISO BCL2 (Homo sapiens) 6480464 Iohexol results in decreased expression of BCL2 protein CTD PMID:36207783 iohexol multiple interactions ISO BCL2 (Homo sapiens) 6480464 Amlodipine inhibits the reaction [Iohexol results in decreased expression of BCL2 protein] more ... CTD PMID:36207783 iohexol multiple interactions EXP 6480464 Amlodipine inhibits the reaction [Iohexol results in decreased expression of BCL2 protein] more ... CTD PMID:36207783 iohexol decreases expression EXP 6480464 Iohexol results in decreased expression of BCL2 protein CTD PMID:36207783 Ioversol multiple interactions EXP 6480464 Irbesartan inhibits the reaction [ioversol results in decreased expression of BCL2 mRNA] CTD PMID:16828304 Ioversol decreases expression EXP 6480464 ioversol results in decreased expression of BCL2 mRNA CTD PMID:16828304 iprodione decreases expression EXP 6480464 iprodione results in decreased expression of BCL2 protein CTD PMID:33586219 and PMID:34060014 iprodione multiple interactions EXP 6480464 Chlorpyrifos promotes the reaction [iprodione results in decreased expression of BCL2 protein] and iprodione promotes the reaction [Chlorpyrifos results in decreased expression of BCL2 protein] CTD PMID:33586219 and PMID:34060014 irbesartan multiple interactions EXP 6480464 irbesartan inhibits the reaction [ioversol results in decreased expression of BCL2 mRNA] CTD PMID:16828304 irbesartan multiple interactions ISO Bcl2 (Mus musculus) 6480464 Irbesartan inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein] CTD PMID:31967706 irinotecan affects response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein affects the susceptibility to Irinotecan CTD PMID:18949393 irinotecan multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Fluorouracil co-treated with Irinotecan co-treated with Vorinostat] results in decreased expression of BCL2 protein more ... CTD PMID:15754201 and PMID:16391804 iron atom multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Arachidonic Acid co-treated with Iron] results in decreased expression of BCL2 protein more ... CTD PMID:19620254 and PMID:33285147 iron dextran multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Iron-Dextran Complex results in increased abundance of Iron] which results in decreased expression of BCL2 protein more ... CTD PMID:33285147 iron(0) multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Arachidonic Acid co-treated with Iron] results in decreased expression of BCL2 protein more ... CTD PMID:19620254 and PMID:33285147 iron(2+) sulfate (anhydrous) decreases expression EXP 6480464 ferrous sulfate results in decreased expression of BCL2 protein CTD PMID:28583816 iron(2+) sulfate (anhydrous) increases expression ISO BCL2 (Homo sapiens) 6480464 ferrous sulfate results in increased expression of BCL2 mRNA CTD PMID:33554279 iron(2+) sulfate (anhydrous) multiple interactions EXP 6480464 2-tert-butylhydroquinone inhibits the reaction [ferrous sulfate results in decreased expression of BCL2 protein] CTD PMID:28583816 isocarbophos decreases expression ISO BCL2 (Homo sapiens) 6480464 isocarbophos analog results in decreased expression of BCL2 protein CTD PMID:20688129 isoflavones decreases expression EXP 6480464 Isoflavones results in decreased expression of BCL2 protein CTD PMID:25035168 isoflavones increases expression EXP 6480464 Isoflavones results in increased expression of BCL2 mRNA CTD PMID:25035168 isoflavones multiple interactions EXP 6480464 [Folic Acid co-treated with Isoflavones] results in increased expression of BCL2 protein CTD PMID:20060418 isoflavones multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Curcumin co-treated with Isoflavones] results in decreased expression of BCL2 protein CTD PMID:18640131 isoflurane multiple interactions EXP 6480464 [Antagomirs results in decreased expression of MIR140 mRNA] inhibits the reaction [Isoflurane results in decreased expression of BCL2 protein] more ... CTD PMID:16249675 more ... isoflurane affects expression EXP 6480464 Isoflurane affects the expression of BCL2 protein CTD PMID:29289695 isoflurane decreases expression EXP 6480464 Isoflurane results in decreased expression of BCL2 protein CTD PMID:20003127 and PMID:32062618 Isoliensinine decreases expression ISO BCL2 (Homo sapiens) 6480464 isoliensinine results in decreased expression of BCL2 mRNA and isoliensinine results in decreased expression of BCL2 protein CTD PMID:26389520 Isoliensinine affects expression ISO BCL2 (Homo sapiens) 6480464 isoliensinine affects the expression of BCL2 protein CTD PMID:26219228 Isoliensinine multiple interactions ISO Bcl2 (Mus musculus) 6480464 isoliensinine inhibits the reaction [RELA protein binds to BCL2 promoter] CTD PMID:26389520 Isoliensinine multiple interactions ISO BCL2 (Homo sapiens) 6480464 isoliensinine inhibits the reaction [RELA protein binds to BCL2 promoter] CTD PMID:26389520 Isoliensinine decreases expression ISO Bcl2 (Mus musculus) 6480464 isoliensinine results in decreased expression of BCL2 mRNA and isoliensinine results in decreased expression of BCL2 protein CTD PMID:26389520 isoliquiritigenin decreases phosphorylation ISO BCL2 (Homo sapiens) 6480464 isoliquiritigenin results in decreased phosphorylation of BCL2 protein CTD PMID:23747687 isoniazide multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Isoniazid co-treated with Rifampin] results in decreased expression of BCL2 protein and Ursodeoxycholic Acid inhibits the reaction [[Isoniazid co-treated with Rifampin] results in decreased expression of BCL2 protein] CTD PMID:21419764 isoniazide multiple interactions ISO BCL2 (Homo sapiens) 6480464 Quercetin inhibits the reaction [Isoniazid results in decreased expression of BCL2 protein] CTD PMID:31332904 isoniazide decreases expression ISO BCL2 (Homo sapiens) 6480464 Isoniazid results in decreased expression of BCL2 protein CTD PMID:20433247 and PMID:31332904 isoniazide decreases expression ISO Bcl2 (Mus musculus) 6480464 Isoniazid results in decreased expression of BCL2 mRNA CTD PMID:33771660 isoorientin multiple interactions EXP 6480464 homoorientin inhibits the reaction [Ethanol results in increased expression of BCL2 mRNA] CTD PMID:22446813 isoprenaline multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of BCL2 protein] more ... CTD PMID:19573579 more ... isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of BCL2 mRNA CTD PMID:11218852 and PMID:30303030 isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of BCL2 mRNA and Isoproterenol results in decreased expression of BCL2 protein CTD PMID:12791704 more ... isoprenaline decreases expression ISO Bcl2 (Mus musculus) 6480464 Isoproterenol results in decreased expression of BCL2 protein CTD PMID:15052282 isoquinoline-1,5-diol multiple interactions ISO BCL2 (Homo sapiens) 6480464 [1 and 5-dihydroxyisoquinoline co-treated with Tretinoin] results in decreased expression of BCL2 protein CTD PMID:10713328 isorhamnetin decreases expression ISO BCL2 (Homo sapiens) 6480464 3-methylquercetin results in decreased expression of BCL2 mRNA and 3-methylquercetin results in decreased expression of BCL2 protein CTD PMID:22992727 isotretinoin decreases expression ISO BCL2 (Homo sapiens) 6480464 Isotretinoin results in decreased expression of BCL2 and Isotretinoin results in decreased expression of BCL2 protein CTD PMID:16109544 and PMID:16909596 isotretinoin decreases expression ISO Bcl2 (Mus musculus) 6480464 Isotretinoin results in decreased expression of BCL2 more ... CTD PMID:18380168 more ... isotretinoin increases expression ISO BCL2 (Homo sapiens) 6480464 Isotretinoin results in increased expression of BCL2 mRNA and Isotretinoin results in increased expression of BCL2 protein CTD PMID:21159604 ivermectin decreases expression ISO BCL2 (Homo sapiens) 6480464 Ivermectin results in decreased expression of BCL2 protein CTD PMID:34904774 ivermectin multiple interactions ISO BCL2 (Homo sapiens) 6480464 Glutathione inhibits the reaction [Ivermectin results in decreased expression of BCL2 protein] CTD PMID:34904774 JBIR-99 decreases expression ISO BCL2 (Homo sapiens) 6480464 JBIR-99 results in decreased expression of BCL2 protein CTD PMID:31433962 juglone multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Indomethacin co-treated with juglone] results in decreased expression of BCL2 mRNA CTD PMID:31916655 juglone decreases expression ISO BCL2 (Homo sapiens) 6480464 juglone results in decreased expression of BCL2 mRNA CTD PMID:31916655 kaempferol decreases expression ISO BCL2 (Homo sapiens) 6480464 kaempferol results in decreased expression of BCL2 protein CTD PMID:19028473 kaempferol multiple interactions EXP 6480464 kaempferol inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 protein] CTD PMID:36940862 kahweol multiple interactions ISO BCL2 (Homo sapiens) 6480464 kahweol inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] CTD PMID:31306736 kainic acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 4-benzyl-2-methyl-1 more ... CTD PMID:25453207 kainic acid decreases expression EXP 6480464 Kainic Acid results in decreased expression of BCL2 mRNA CTD PMID:31430510 kainic acid multiple interactions EXP 6480464 oridonin inhibits the reaction [Kainic Acid results in decreased expression of BCL2 mRNA] CTD PMID:31430510 kainic acid decreases expression ISO Bcl2 (Mus musculus) 6480464 Kainic Acid results in decreased expression of BCL2 protein CTD PMID:25453207 ketamine multiple interactions ISO BCL2 (Homo sapiens) 6480464 LEP protein promotes the reaction [lipoxin A4 methyl ester inhibits the reaction [Ketamine results in decreased expression of BCL2 protein]] and lipoxin A4 methyl ester inhibits the reaction [Ketamine results in decreased expression of BCL2 protein] CTD PMID:36907275 ketamine decreases expression ISO BCL2 (Homo sapiens) 6480464 Ketamine results in decreased expression of BCL2 protein CTD PMID:36907275 ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of BCL2 mRNA and Ketamine results in decreased expression of BCL2 protein CTD PMID:33536391 and PMID:36305173 ketamine multiple interactions EXP 6480464 Curcumin affects the reaction [Ketamine results in decreased expression of BCL2 protein] more ... CTD PMID:33536391 and PMID:36305173 ketoconazole multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Ketoconazole inhibits the reaction [CYP3A4 protein results in increased susceptibility to Amodiaquine]] which results in decreased expression of BCL2 protein and Ketoconazole inhibits the reaction [Calcifediol results in increased expression of BCL2 mRNA] CTD PMID:21542014 and PMID:31629065 KN-93 multiple interactions ISO Bcl2 (Mus musculus) 6480464 KN 93 inhibits the reaction [Vincristine results in decreased expression of BCL2 mRNA] and KN 93 inhibits the reaction [Vincristine results in decreased expression of BCL2 protein] CTD PMID:34286406 Kukoamine B multiple interactions ISO BCL2 (Homo sapiens) 6480464 kukoamine B inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] and kukoamine B inhibits the reaction [N-Methylaspartate results in decreased expression of BCL2 protein] CTD PMID:26065936 and PMID:26164594 L-1,4-dithiothreitol multiple interactions ISO BCL2 (Homo sapiens) 6480464 Dithiothreitol inhibits the reaction [arsenic trioxide results in increased expression of BCL2 protein] CTD PMID:18022205 L-arginine multiple interactions ISO Bcl2 (Mus musculus) 6480464 coumermycin inhibits the reaction [limonin inhibits the reaction [Arginine results in increased expression of BCL2 protein]] more ... CTD PMID:34423886 L-arginine increases expression ISO Bcl2 (Mus musculus) 6480464 Arginine results in increased expression of BCL2 mRNA and Arginine results in increased expression of BCL2 protein CTD PMID:34423886 L-ascorbic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 Ascorbic Acid results in decreased expression of BCL2 mRNA CTD PMID:21919647 L-ascorbic acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 Ascorbic Acid inhibits the reaction [glycidamide results in decreased expression of BCL2 mRNA] CTD PMID:32632975 L-ascorbic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 [arsenic trioxide co-treated with Ascorbic Acid co-treated with Disulfiram] results in decreased expression of BCL2 protein more ... CTD PMID:17166419 more ... L-ascorbic acid multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with Ascorbic Acid] inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 mRNA] more ... CTD PMID:17959157 more ... L-ascorbic acid increases abundance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in increased abundance of Ascorbic Acid CTD PMID:15449323 L-dehydroascorbic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Dehydroascorbic Acid co-treated with Lipopolysaccharides] results in increased expression of BCL2 protein CTD PMID:20166893 L-dehydroascorbic acid increases expression ISO BCL2 (Homo sapiens) 6480464 Dehydroascorbic Acid results in increased expression of BCL2 protein CTD PMID:20166893 L-gamma-glutamyl-L-cysteine multiple interactions EXP 6480464 gamma-glutamylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BCL2 protein] CTD PMID:34767868 L-glutamic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 dihydroactinidiolide inhibits the reaction [Glutamic Acid results in decreased expression of BCL2 protein] CTD PMID:33617922 L-glutamic acid decreases expression EXP 6480464 Glutamic Acid results in decreased expression of BCL2 protein CTD PMID:32092300 and PMID:35028790 L-glutamic acid multiple interactions EXP 6480464 1 more ... CTD PMID:32092300 and PMID:35028790 L-glutamic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 Glutamic Acid results in decreased expression of BCL2 protein CTD PMID:33617922 L-methionine multiple interactions EXP 6480464 Folic Acid inhibits the reaction [Methionine results in decreased methylation of BCL2 gene] more ... CTD PMID:16213988 and PMID:22611939 L-methionine increases expression EXP 6480464 Methionine results in increased expression of BCL2 mRNA and Methionine results in increased expression of BCL2 protein CTD PMID:22611939 L-methionine decreases methylation EXP 6480464 Methionine results in decreased methylation of BCL2 gene CTD PMID:22611939 L-methionine multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Dietary Fats co-treated with cyanoginosin LR] results in decreased expression of BCL2 protein more ... CTD PMID:20938992 and PMID:34416350 L-methionine decreases expression EXP 6480464 Methionine results in decreased expression of BCL2 protein CTD PMID:16213988 L-mimosine affects expression ISO BCL2 (Homo sapiens) 6480464 Mimosine affects the expression of BCL2 protein CTD PMID:18058236 lactacystin decreases expression EXP 6480464 lactacystin results in decreased expression of BCL2 protein CTD PMID:18640276 lactacystin multiple interactions ISO BCL2 (Homo sapiens) 6480464 lactacystin inhibits the reaction [sodium bichromate results in decreased expression of BCL2 protein] CTD PMID:18544562 lactacystin multiple interactions EXP 6480464 lactacystin inhibits the reaction [[pirinixic acid results in increased expression of UCP2 protein] which results in increased degradation of BCL2 protein] and Sirolimus inhibits the reaction [lactacystin results in decreased expression of BCL2 protein] CTD PMID:18640276 and PMID:19361538 lamivudine multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Zidovudine co-treated with Lamivudine] results in decreased expression of BCL2 mRNA CTD PMID:18313992 lamotrigine increases expression EXP 6480464 lamotrigine results in increased expression of BCL2 mRNA and lamotrigine results in increased expression of BCL2 protein CTD PMID:18719996 lansoprazole multiple interactions EXP 6480464 Lansoprazole inhibits the reaction [Diatrizoate Meglumine results in decreased expression of BCL2 mRNA] CTD PMID:28412091 lapatinib decreases expression ISO BCL2 (Homo sapiens) 6480464 Lapatinib results in decreased expression of BCL2 protein CTD PMID:29387217 lapatinib multiple interactions ISO BCL2 (Homo sapiens) 6480464 AKT activator SC79 inhibits the reaction [Lapatinib inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein]] more ... CTD PMID:32890875 lead diacetate multiple interactions EXP 6480464 [[lead acetate results in increased abundance of Lead] which co-treated with Carbenoxolone] results in decreased expression of BCL2 protein more ... CTD PMID:17959157 more ... lead diacetate affects expression ISO BCL2 (Homo sapiens) 6480464 lead acetate affects the expression of BCL2 protein CTD PMID:26542248 lead diacetate multiple interactions ISO BCL2 (Homo sapiens) 6480464 NFE2L2 protein inhibits the reaction [lead acetate results in decreased expression of BCL2 protein] CTD PMID:26498409 lead diacetate decreases expression ISO BCL2 (Homo sapiens) 6480464 lead acetate results in decreased expression of BCL2 protein CTD PMID:26498409 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of BCL2 mRNA and lead acetate results in decreased expression of BCL2 protein CTD PMID:23146751 more ... lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of BCL2 protein CTD PMID:17959157 more ... lead diacetate increases expression ISO Bcl2 (Mus musculus) 6480464 lead acetate results in increased expression of BCL2 mRNA CTD PMID:22609695 lead diacetate affects expression EXP 6480464 lead acetate affects the expression of BCL2 mRNA CTD PMID:18618274 lead nitrate decreases expression ISO Bcl2 (Mus musculus) 6480464 lead nitrate results in decreased expression of BCL2 protein CTD PMID:23451106 lead nitrate multiple interactions ISO BCL2 (Homo sapiens) 6480464 [lead nitrate results in increased abundance of Lead] which results in decreased expression of BCL2 mRNA CTD PMID:30738203 lead nitrate multiple interactions ISO Bcl2 (Mus musculus) 6480464 mangiferin inhibits the reaction [lead nitrate results in decreased expression of BCL2 protein] CTD PMID:23451106 lead(0) multiple interactions EXP 6480464 [[lead acetate results in increased abundance of Lead] which co-treated with Carbenoxolone] results in decreased expression of BCL2 protein more ... CTD PMID:22129743 more ... lead(0) decreases expression ISO BCL2 (Homo sapiens) 6480464 Lead results in decreased expression of BCL2 protein CTD PMID:32976933 lead(0) decreases expression ISO Bcl2 (Mus musculus) 6480464 Lead results in decreased expression of BCL2 protein CTD PMID:31539617 lead(0) multiple interactions ISO BCL2 (Homo sapiens) 6480464 [lead nitrate results in increased abundance of Lead] which results in decreased expression of BCL2 mRNA CTD PMID:30738203 lead(0) multiple interactions ISO Bcl2 (Mus musculus) 6480464 fisetin inhibits the reaction [Lead results in decreased expression of BCL2 protein] CTD PMID:31539617 lead(0) decreases expression EXP 6480464 Lead results in decreased expression of BCL2 mRNA and Lead results in decreased expression of BCL2 protein CTD PMID:22129743 more ... lead(II) chloride decreases expression ISO BCL2 (Homo sapiens) 6480464 lead chloride results in decreased expression of BCL2 protein CTD PMID:24419708 leptomycin B multiple interactions ISO BCL2 (Homo sapiens) 6480464 leptomycin B inhibits the reaction [Tretinoin results in decreased expression of BCL2 protein] CTD PMID:14592536 letrozole multiple interactions EXP 6480464 ADM protein inhibits the reaction [Letrozole results in decreased expression of BCL2 protein] CTD PMID:33491863 letrozole decreases expression EXP 6480464 Letrozole results in decreased expression of BCL2 protein CTD PMID:33491863 leuprolide increases expression EXP 6480464 Leuprolide results in increased expression of BCL2 mRNA CTD PMID:18829022 levamisole decreases expression ISO BCL2 (Homo sapiens) 6480464 Levamisole results in decreased expression of BCL2 protein CTD PMID:11139434 levetiracetam decreases expression EXP 6480464 Levetiracetam results in decreased expression of BCL2 protein CTD PMID:37098359 levetiracetam multiple interactions EXP 6480464 Quercetin inhibits the reaction [Levetiracetam results in decreased expression of BCL2 protein] CTD PMID:37098359 levonorgestrel decreases expression ISO BCL2 (Homo sapiens) 6480464 Levonorgestrel results in decreased expression of BCL2 protein CTD PMID:16019350 Licochalcone A increases expression ISO BCL2 (Homo sapiens) 6480464 licochalcone A results in increased expression of BCL2 mRNA CTD PMID:30055311 Licochalcone B decreases expression ISO BCL2 (Homo sapiens) 6480464 licochalcone B results in decreased expression of BCL2 protein CTD PMID:24384411 lignan decreases expression ISO BCL2 (Homo sapiens) 6480464 Lignans analog results in decreased expression of BCL2 protein and Lignans results in decreased expression of BCL2 protein CTD PMID:26620693 limonene decreases expression ISO BCL2 (Homo sapiens) 6480464 limonene results in decreased expression of BCL2 protein CTD PMID:12921557 limonin multiple interactions ISO Bcl2 (Mus musculus) 6480464 coumermycin inhibits the reaction [limonin inhibits the reaction [Arginine results in increased expression of BCL2 protein]] more ... CTD PMID:34423886 linalool decreases expression ISO BCL2 (Homo sapiens) 6480464 linalool results in decreased expression of BCL2 mRNA CTD PMID:28567457 linoleic acid multiple interactions EXP 6480464 [Linoleic Acid co-treated with Glucose] affects the reaction [Azoxymethane affects the expression of BCL2 protein] and Linoleic Acid affects the reaction [Azoxymethane affects the expression of BCL2 protein] CTD PMID:22467055 linsidomine decreases expression ISO BCL2 (Homo sapiens) 6480464 linsidomine results in decreased expression of BCL2 and linsidomine results in decreased expression of BCL2 protein CTD PMID:16291239 and PMID:23174672 linsidomine multiple interactions ISO Bcl2 (Mus musculus) 6480464 [linsidomine results in increased abundance of Nitric Oxide] which results in increased expression of BCL2 mRNA more ... CTD PMID:12880480 and PMID:7706495 linsidomine multiple interactions ISO BCL2 (Homo sapiens) 6480464 MT1A inhibits the reaction [linsidomine results in decreased expression of BCL2] and Plant Extracts inhibits the reaction [linsidomine results in decreased expression of BCL2 protein] CTD PMID:16291239 and PMID:23174672 linsidomine decreases expression ISO Bcl2 (Mus musculus) 6480464 linsidomine results in decreased expression of BCL2 protein CTD PMID:12880480 lipoic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 Thioctic Acid inhibits the reaction [Zinc deficiency results in decreased expression of BCL2 protein] more ... CTD PMID:16990509 more ... lipoic acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 Thioctic Acid inhibits the reaction [Dietary Fats results in decreased expression of BCL2 mRNA] CTD PMID:27260466 lipoic acid multiple interactions EXP 6480464 Thioctic Acid inhibits the reaction [[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of BCL2 mRNA] more ... CTD PMID:23830814 more ... lipoic acid decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to Thioctic Acid CTD PMID:16990509 lipopolysaccharide multiple interactions ISO BCL2 (Homo sapiens) 6480464 (+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2 mRNA] more ... CTD PMID:11805214 more ... lipopolysaccharide affects expression ISO Bcl2 (Mus musculus) 6480464 Lipopolysaccharides affects the expression of BCL2 protein CTD PMID:30261164 lipopolysaccharide increases expression ISO Bcl2 (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of BCL2 protein CTD PMID:21299906 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of BCL2 protein CTD PMID:12704018 more ... lipopolysaccharide decreases expression EXP 6480464 Lipopolysaccharides results in decreased expression of BCL2 protein CTD PMID:23200736 more ... lipopolysaccharide affects expression EXP 6480464 Lipopolysaccharides affects the expression of BCL2 mRNA CTD PMID:21127968 lipopolysaccharide decreases expression ISO Bcl2 (Mus musculus) 6480464 Lipopolysaccharides results in decreased expression of BCL2 protein CTD PMID:23170834 more ... lipopolysaccharide multiple interactions ISO Bcl2 (Mus musculus) 6480464 2-(3-benzoyl)-4-hydroxy-1 more ... CTD PMID:10205001 more ... lipopolysaccharide multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ginsenoside Rg1 inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]] more ... CTD PMID:12704018 more ... lipopolysaccharide increases expression ISO BCL2 (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of BCL2 mRNA and Lipopolysaccharides results in increased expression of BCL2 protein CTD PMID:20166893 and PMID:25725100 lipopolysaccharide decreases expression ISO BCL2 (Homo sapiens) 6480464 Lipopolysaccharides results in decreased expression of BCL2 protein CTD PMID:11805214 more ... lipoxin A4 multiple interactions ISO BCL2 (Homo sapiens) 6480464 lipoxin A4 inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein] CTD PMID:23063943 liraglutide multiple interactions ISO BCL2 (Homo sapiens) 6480464 Liraglutide inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] and Wortmannin inhibits the reaction [Liraglutide inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]] CTD PMID:31173752 liraglutide multiple interactions EXP 6480464 Liraglutide inhibits the reaction [Methotrexate results in decreased expression of BCL2 protein] CTD PMID:31362085 lisinopril dihydrate decreases expression ISO BCL2 (Homo sapiens) 6480464 Lisinopril results in decreased expression of BCL2 CTD PMID:10075388 lithium atom multiple interactions EXP 6480464 Lithium inhibits the reaction [APP protein alternative form results in decreased expression of BCL2 protein] more ... CTD PMID:10762662 more ... lithium atom multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Lithium Chloride results in increased abundance of Lithium] promotes the reaction [Paraquat results in increased expression of BCL2 mRNA] more ... CTD PMID:21878650 and PMID:26074776 lithium atom increases expression EXP 6480464 Lithium results in increased expression of BCL2 more ... CTD PMID:10762662 more ... lithium chloride increases expression ISO BCL2 (Homo sapiens) 6480464 Lithium Chloride results in increased expression of BCL2 mRNA and Lithium Chloride results in increased expression of BCL2 protein CTD PMID:18830594 and PMID:19101580 lithium chloride multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Lithium Chloride results in increased abundance of Lithium] promotes the reaction [Paraquat results in increased expression of BCL2 mRNA] more ... CTD PMID:26074776 lithium chloride multiple interactions EXP 6480464 Lithium Chloride inhibits the reaction [citronellal inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]] more ... CTD PMID:30926361 more ... lithium chloride increases expression EXP 6480464 Lithium Chloride results in increased expression of BCL2 mRNA CTD PMID:17404573 lithium chloride multiple interactions ISO Bcl2 (Mus musculus) 6480464 Lithium Chloride inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] more ... CTD PMID:19408126 more ... lithium hydride multiple interactions EXP 6480464 Lithium inhibits the reaction [APP protein alternative form results in decreased expression of BCL2 protein] more ... CTD PMID:10762662 more ... lithium hydride multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Lithium Chloride results in increased abundance of Lithium] promotes the reaction [Paraquat results in increased expression of BCL2 mRNA] more ... CTD PMID:21878650 and PMID:26074776 lithium hydride increases expression EXP 6480464 Lithium results in increased expression of BCL2 more ... CTD PMID:10762662 more ... loganin increases expression ISO Bcl2 (Mus musculus) 6480464 loganin results in increased expression of BCL2 mRNA CTD PMID:20966881 lonafarnib multiple interactions ISO BCL2 (Homo sapiens) 6480464 lonafarnib inhibits the reaction [TNF protein results in increased expression of BCL2 protein] and lonafarnib promotes the reaction [Bortezomib results in increased cleavage of BCL2 protein modified form] CTD PMID:15090542 and PMID:16118318 Longikaurin A decreases expression ISO BCL2 (Homo sapiens) 6480464 longikaurin A results in decreased expression of BCL2 protein CTD PMID:28801140 lonidamine multiple interactions ISO BCL2 (Homo sapiens) 6480464 BCL2 protein inhibits the reaction [[arsenic trioxide co-treated with lonidamine] results in increased cleavage of and results in increased activity of CASP8 protein] more ... CTD PMID:21889928 loperamide decreases expression ISO BCL2 (Homo sapiens) 6480464 Loperamide results in decreased expression of BCL2 mRNA CTD PMID:34719826 loperamide multiple interactions ISO BCL2 (Homo sapiens) 6480464 Loperamide promotes the reaction [Doxorubicin results in decreased expression of BCL2 mRNA] CTD PMID:34719826 losartan multiple interactions EXP 6480464 Losartan promotes the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of BCL2 mRNA] CTD PMID:15502641 losartan affects expression EXP 6480464 Losartan affects the expression of BCL2 protein CTD PMID:22000973 losartan increases expression EXP 6480464 Losartan results in increased expression of BCL2 protein CTD PMID:19298698 and PMID:21153712 losartan decreases expression EXP 6480464 Losartan results in decreased expression of BCL2 protein CTD PMID:12623880 lovastatin decreases expression EXP 6480464 Lovastatin results in decreased expression of BCL2 protein CTD PMID:11178870 lovastatin multiple interactions EXP 6480464 Lovastatin inhibits the reaction [Cholesterol more ... CTD PMID:11178870 and PMID:35734936 lovastatin multiple interactions ISO BCL2 (Homo sapiens) 6480464 Mevalonic Acid inhibits the reaction [Lovastatin results in decreased expression of BCL2 protein] CTD PMID:12094262 lovastatin decreases expression ISO BCL2 (Homo sapiens) 6480464 Lovastatin results in decreased expression of BCL2 protein CTD PMID:10473109 and PMID:12094262 Lupalbigenin decreases expression ISO BCL2 (Homo sapiens) 6480464 lupalbigenin results in decreased expression of BCL2 protein CTD PMID:25964563 lupeol multiple interactions ISO BCL2 (Homo sapiens) 6480464 lupeol inhibits the reaction [mancozeb results in decreased expression of BCL2 mRNA] CTD PMID:27235710 lupeol multiple interactions EXP 6480464 lupeol inhibits the reaction [COL2A1 results in increased expression of BCL2 protein] CTD PMID:35446470 lupeol decreases expression ISO BCL2 (Homo sapiens) 6480464 lupeol results in decreased expression of BCL2 mRNA and lupeol results in decreased expression of BCL2 protein CTD PMID:30506710 and PMID:31112703 Lupiwighteone decreases expression ISO BCL2 (Homo sapiens) 6480464 lupiwighteone results in decreased expression of BCL2 protein CTD PMID:31604113 lutein decreases expression ISO BCL2 (Homo sapiens) 6480464 Lutein results in decreased expression of BCL2 protein CTD PMID:17455471 luteolin multiple interactions ISO BCL2 (Homo sapiens) 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Luteolin results in decreased expression of BCL2 protein] more ... CTD PMID:19557821 more ... luteolin decreases expression ISO BCL2 (Homo sapiens) 6480464 Luteolin results in decreased expression of BCL2 protein CTD PMID:27474067 and PMID:32268164 luteolin 7-O-beta-D-glucoside multiple interactions ISO BCL2 (Homo sapiens) 6480464 luteolin-7-glucoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein] and luteolin-7-glucoside inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] CTD PMID:31157476 and PMID:31381935 luteolin 7-O-beta-D-glucoside decreases expression ISO BCL2 (Homo sapiens) 6480464 luteolin-7-glucoside results in decreased expression of BCL2 protein CTD PMID:34165247 LY294002 increases expression ISO BCL2 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of BCL2 mRNA CTD PMID:22046442 LY294002 multiple interactions ISO Bcl2 (Mus musculus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin inhibits the reaction [trimethyltin results in decreased expression of BCL2 protein]] CTD PMID:25895139 LY294002 decreases expression ISO BCL2 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of BCL2 protein CTD PMID:20386985 more ... LY294002 increases phosphorylation EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased phosphorylation of BCL2 protein CTD PMID:16018989 LY294002 multiple interactions ISO BCL2 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [Emodin affects the expression of BCL2 protein] more ... CTD PMID:20856197 more ... LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [5-aminoisoquinolinone inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]] more ... CTD PMID:21800153 more ... lycopene multiple interactions EXP 6480464 [S-allylcysteine co-treated with Lycopene] inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein] more ... CTD PMID:16030430 more ... lycopene increases expression EXP 6480464 Lycopene results in increased expression of BCL2 mRNA CTD PMID:26900785 and PMID:32153214 lycopene multiple interactions ISO Bcl2 (Mus musculus) 6480464 lycopene inhibits the reaction [Sodium Fluoride results in decreased expression of BCL2 mRNA] CTD PMID:27871895 maculosin multiple interactions ISO Bcl2 (Mus musculus) 6480464 maculosin inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein] CTD PMID:34726822 madecassoside multiple interactions ISO BCL2 (Homo sapiens) 6480464 madecassoside inhibits the reaction [Cisplatin results in decreased expression of BCL2 mRNA] CTD PMID:37087747 magnesium atom multiple interactions EXP 6480464 [1 more ... CTD PMID:30542433 magnesium oxide multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased expression of BCL2 mRNA] and Magnesium Oxide analog inhibits the reaction [Diazinon results in decreased expression of BCL2 mRNA] CTD PMID:27920530 Magnolol multiple interactions ISO Bcl2 (Mus musculus) 6480464 magnolol inhibits the reaction [trimethyltin results in decreased expression of BCL2 protein] CTD PMID:26756313 malaoxon increases expression ISO BCL2 (Homo sapiens) 6480464 malaoxon results in increased expression of BCL2 mRNA CTD PMID:30673264 malathion decreases expression EXP 6480464 Malathion results in decreased expression of BCL2 mRNA CTD PMID:23774768 malathion increases expression ISO BCL2 (Homo sapiens) 6480464 Malathion results in increased expression of BCL2 mRNA CTD PMID:30673264 malathion increases expression ISO Bcl2 (Mus musculus) 6480464 Malathion results in increased expression of BCL2 protein CTD PMID:32120800 malathion decreases expression ISO BCL2 (Homo sapiens) 6480464 Malathion results in decreased expression of BCL2 protein CTD PMID:30769050 malathion multiple interactions ISO BCL2 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [Malathion results in decreased expression of BCL2 protein] CTD PMID:30769050 malonic acid decreases expression EXP 6480464 malonic acid results in decreased expression of BCL2 mRNA CTD PMID:16242643 malvidin decreases expression ISO BCL2 (Homo sapiens) 6480464 malvidin results in decreased expression of BCL2 protein CTD PMID:15964118 mancozeb decreases expression ISO BCL2 (Homo sapiens) 6480464 mancozeb results in decreased expression of BCL2 mRNA CTD PMID:27235710 mancozeb decreases expression ISO Bcl2 (Mus musculus) 6480464 mancozeb results in decreased expression of BCL2 protein CTD PMID:35617905 mancozeb multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Sulfur co-treated with mancozeb co-treated with metrafenone] results in decreased expression of BCL2 mRNA more ... CTD PMID:27235710 and PMID:35564597 mancozeb multiple interactions EXP 6480464 alpha-Tocopherol inhibits the reaction [mancozeb results in decreased expression of BCL2 protein] CTD PMID:16005924 mancozeb decreases expression EXP 6480464 mancozeb results in decreased expression of BCL2 protein CTD PMID:16005924 maneb multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Maneb co-treated with Paraquat] results in decreased expression of BCL2 mRNA more ... CTD PMID:23963992 and PMID:36117858 maneb increases expression ISO BCL2 (Homo sapiens) 6480464 Maneb results in increased expression of BCL2 mRNA and Maneb results in increased expression of BCL2 protein CTD PMID:18266926 manganese atom multiple interactions EXP 6480464 [Lead co-treated with Manganese co-treated with Cadmium co-treated with Arsenic] results in decreased expression of BCL2 mRNA more ... CTD PMID:30844427 more ... manganese atom decreases expression EXP 6480464 Manganese results in decreased expression of BCL2 mRNA and Manganese results in decreased expression of BCL2 protein CTD PMID:31161640 and PMID:32246071 manganese atom multiple interactions ISO Bcl2 (Mus musculus) 6480464 [manganese chloride results in increased abundance of Manganese] which results in decreased expression of BCL2 protein CTD PMID:31676349 manganese(0) decreases expression EXP 6480464 Manganese results in decreased expression of BCL2 mRNA and Manganese results in decreased expression of BCL2 protein CTD PMID:31161640 and PMID:32246071 manganese(0) multiple interactions ISO Bcl2 (Mus musculus) 6480464 [manganese chloride results in increased abundance of Manganese] which results in decreased expression of BCL2 protein CTD PMID:31676349 manganese(0) multiple interactions EXP 6480464 [Lead co-treated with Manganese co-treated with Cadmium co-treated with Arsenic] results in decreased expression of BCL2 mRNA more ... CTD PMID:30844427 more ... manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of BCL2 mRNA and manganese chloride results in decreased expression of BCL2 protein CTD PMID:17623882 and PMID:25732873 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of BCL2 mRNA CTD PMID:28801915 manganese(II) chloride increases expression ISO BCL2 (Homo sapiens) 6480464 manganese chloride results in increased expression of BCL2 protein CTD PMID:30578841 manganese(II) chloride decreases expression ISO Bcl2 (Mus musculus) 6480464 manganese chloride results in decreased expression of BCL2 protein CTD PMID:29183790 manganese(II) chloride multiple interactions ISO BCL2 (Homo sapiens) 6480464 corynoxine B inhibits the reaction [manganese chloride promotes the reaction [BCL2 protein binds to BECN1 protein]] more ... CTD PMID:28856835 and PMID:30578841 manganese(II) chloride increases nitrosation ISO BCL2 (Homo sapiens) 6480464 manganese chloride results in increased nitrosation of BCL2 protein CTD PMID:28856835 manganese(II) chloride multiple interactions EXP 6480464 [manganese chloride results in increased abundance of Manganese] promotes the reaction [Ethanol results in decreased expression of BCL2 protein] more ... CTD PMID:21704098 more ... manganese(II) chloride multiple interactions ISO Bcl2 (Mus musculus) 6480464 [manganese chloride results in increased abundance of Manganese] which results in decreased expression of BCL2 protein more ... CTD PMID:26064043 more ... mangiferin multiple interactions ISO BCL2 (Homo sapiens) 6480464 mangiferin inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA] CTD PMID:21420233 mangiferin multiple interactions EXP 6480464 mangiferin inhibits the reaction [Galactosamine results in decreased expression of BCL2 protein] CTD PMID:22118634 mangiferin multiple interactions ISO Bcl2 (Mus musculus) 6480464 mangiferin inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:23451106 and PMID:24095822 mebendazole affects response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein affects the susceptibility to Mebendazole CTD PMID:18667591 mebendazole multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Mebendazole results in increased phosphorylation of BCL2 protein] inhibits the reaction [BCL2 protein binds to BAX protein] CTD PMID:18667591 mebendazole increases phosphorylation ISO BCL2 (Homo sapiens) 6480464 Mebendazole results in increased phosphorylation of BCL2 protein CTD PMID:18667591 Mecamylamine multiple interactions ISO BCL2 (Homo sapiens) 6480464 Mecamylamine inhibits the reaction [N'-nitrosonornicotine results in increased expression of BCL2 mRNA] CTD PMID:16835749 mechlorethamine decreases expression ISO BCL2 (Homo sapiens) 6480464 Mechlorethamine results in decreased expression of BCL2 protein CTD PMID:16738803 and PMID:22285227 meglumine amidotrizoate increases expression ISO BCL2 (Homo sapiens) 6480464 Diatrizoate Meglumine results in increased expression of BCL2 protein CTD PMID:17173243 meglumine amidotrizoate decreases expression EXP 6480464 Diatrizoate Meglumine results in decreased expression of BCL2 mRNA CTD PMID:28412091 meglumine amidotrizoate multiple interactions EXP 6480464 Lansoprazole inhibits the reaction [Diatrizoate Meglumine results in decreased expression of BCL2 mRNA] CTD PMID:28412091 MeIQx increases expression ISO BCL2 (Homo sapiens) 6480464 2-amino-3 more ... CTD PMID:23810796 melamine decreases expression ISO BCL2 (Homo sapiens) 6480464 melamine results in decreased expression of BCL2 protein CTD PMID:22915474 melamine increases expression ISO Bcl2 (Mus musculus) 6480464 melamine results in increased expression of BCL2 protein CTD PMID:29254411 Melarsoprol decreases expression ISO BCL2 (Homo sapiens) 6480464 Melarsoprol results in decreased expression of BCL2 mRNA and Melarsoprol results in decreased expression of BCL2 protein CTD PMID:9226155 melatonin multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Doxorubicin co-treated with Melatonin] results in decreased expression of BCL2 protein more ... CTD PMID:10965999 more ... melatonin decreases expression ISO BCL2 (Homo sapiens) 6480464 Melatonin results in decreased expression of BCL2 mRNA and Melatonin results in decreased expression of BCL2 protein CTD PMID:33507000 melatonin decreases expression EXP 6480464 Melatonin results in decreased expression of BCL2 mRNA CTD PMID:16499559 melatonin multiple interactions EXP 6480464 [Puromycin Aminonucleoside co-treated with Melatonin] results in increased expression of BCL2 protein more ... CTD PMID:14993511 more ... melatonin decreases expression ISO Bcl2 (Mus musculus) 6480464 Melatonin results in decreased expression of BCL2 protein CTD PMID:14690559 melatonin multiple interactions ISO Bcl2 (Mus musculus) 6480464 Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of BCL2 mRNA] more ... CTD PMID:21138475 more ... melatonin increases expression ISO Bcl2 (Mus musculus) 6480464 Melatonin results in increased expression of BCL2 protein CTD PMID:12220328 melatonin increases expression ISO BCL2 (Homo sapiens) 6480464 Melatonin results in increased expression of BCL2 protein CTD PMID:18078454 melatonin affects localization ISO BCL2 (Homo sapiens) 6480464 Melatonin affects the localization of BCL2 protein CTD PMID:18339127 melittin multiple interactions ISO Bcl2 (Mus musculus) 6480464 Melitten affects the reaction [TGFB1 protein affects the localization of BCL2 protein] CTD PMID:21871910 melittin decreases expression ISO Bcl2 (Mus musculus) 6480464 Melitten results in decreased expression of BCL2 protein CTD PMID:37678661 melittin multiple interactions EXP 6480464 Melitten inhibits the reaction [[IL6 protein co-treated with IL6R protein] results in increased expression of BCL2 mRNA] and Melitten inhibits the reaction [[IL6 protein co-treated with IL6R protein] results in increased expression of BCL2 protein] CTD PMID:21354845 melittin decreases expression ISO BCL2 (Homo sapiens) 6480464 Melitten analog results in decreased expression of BCL2 mRNA more ... CTD PMID:21456063 more ... melphalan decreases expression ISO BCL2 (Homo sapiens) 6480464 Melphalan results in decreased expression of BCL2 protein CTD PMID:22285227 memantine multiple interactions EXP 6480464 Memantine analog inhibits the reaction [Glutamic Acid results in decreased expression of BCL2 protein] and Memantine inhibits the reaction [Glutamic Acid results in decreased expression of BCL2 protein] CTD PMID:32092300 memantine decreases expression ISO BCL2 (Homo sapiens) 6480464 Memantine results in decreased expression of BCL2 protein CTD PMID:29226720 menadione multiple interactions ISO BCL2 (Homo sapiens) 6480464 [sodium arsenite co-treated with Vitamin K 3] results in decreased expression of BCL2 protein more ... CTD PMID:19082730 and PMID:25005833 menadione decreases expression ISO BCL2 (Homo sapiens) 6480464 Vitamin K 3 results in decreased expression of BCL2 protein CTD PMID:25005833 menadione decreases expression EXP 6480464 Vitamin K 3 results in decreased expression of BCL2 mRNA and Vitamin K 3 results in decreased expression of BCL2 protein CTD PMID:19265712 menadione multiple interactions EXP 6480464 Acetaminophen inhibits the reaction [Vitamin K 3 results in decreased expression of BCL2 mRNA] and Acetaminophen inhibits the reaction [Vitamin K 3 results in decreased expression of BCL2 protein] CTD PMID:19265712 menaquinone multiple interactions EXP 6480464 Vitamin K 2 inhibits the reaction [[Warfarin co-treated with Vitamin K 1] results in decreased expression of BCL2 protein] CTD PMID:27212383 mercaptopurine decreases expression ISO Bcl2 (Mus musculus) 6480464 Mercaptopurine results in decreased expression of BCL2 protein CTD PMID:9058596 mercaptopurine multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Doxorubicin co-treated with Dexamethasone co-treated with Vincristine co-treated with Cytarabine co-treated with Mercaptopurine co-treated with Methotrexate co-treated with Cyclophosphamide co-treated with Enzymes and Coenzymes] results in increased expression of BCL2 protein CTD PMID:21182165 mercury atom decreases expression EXP 6480464 Mercury results in decreased expression of BCL2 protein CTD PMID:21186712 mercury dichloride decreases expression ISO Bcl2 (Mus musculus) 6480464 Mercuric Chloride results in decreased expression of BCL2 mRNA and Mercuric Chloride results in decreased expression of BCL2 protein CTD PMID:21373768 more ... mercury dichloride decreases expression ISO BCL2 (Homo sapiens) 6480464 Mercuric Chloride results in decreased expression of BCL2 protein CTD PMID:37172713 mercury dichloride decreases expression EXP 6480464 Mercuric Chloride results in decreased expression of BCL2 protein CTD PMID:24751971 and PMID:25600690 mercury dichloride multiple interactions EXP 6480464 Berberine inhibits the reaction [Mercuric Chloride results in decreased expression of BCL2 protein] CTD PMID:24751971 and PMID:25600690 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of BCL2 mRNA CTD PMID:8872981 mercury dichloride increases expression ISO BCL2 (Homo sapiens) 6480464 Mercuric Chloride results in increased expression of BCL2 protein CTD PMID:11068922 mercury(0) decreases expression EXP 6480464 Mercury results in decreased expression of BCL2 protein CTD PMID:21186712 mesalamine multiple interactions EXP 6480464 Mesalamine inhibits the reaction [Acetic Acid results in decreased expression of BCL2 mRNA] more ... CTD PMID:24637189 more ... metaproterenol decreases expression ISO Bcl2 (Mus musculus) 6480464 Metaproterenol results in decreased expression of BCL2 protein CTD PMID:15052282 metformin decreases expression ISO BCL2 (Homo sapiens) 6480464 Metformin results in decreased expression of BCL2 protein CTD PMID:21388661 and PMID:29226720 metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] more ... CTD PMID:26492952 more ... metformin multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Paclitaxel co-treated with Metformin] results in decreased expression of BCL2 mRNA and Cisplatin promotes the reaction [Metformin results in decreased expression of BCL2 protein] CTD PMID:21388661 and PMID:29309887 methamphetamine affects response to substance ISO Bcl2 (Mus musculus) 6480464 BCL2 protein affects the susceptibility to Methamphetamine CTD PMID:12050851 methamphetamine increases expression ISO Bcl2 (Mus musculus) 6480464 Methamphetamine results in increased expression of BCL2 protein CTD PMID:32203791 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of BCL2 protein CTD PMID:15276877 more ... methamphetamine multiple interactions ISO BCL2 (Homo sapiens) 6480464 [N-Methyl-3 more ... CTD PMID:23820845 more ... methamphetamine decreases expression ISO BCL2 (Homo sapiens) 6480464 Methamphetamine results in decreased expression of BCL2 mRNA and Methamphetamine results in decreased expression of BCL2 protein CTD PMID:23820845 more ... methamphetamine multiple interactions ISO Bcl2 (Mus musculus) 6480464 3-((3 more ... CTD PMID:11457507 more ... methamphetamine decreases expression ISO Bcl2 (Mus musculus) 6480464 Methamphetamine results in decreased expression of BCL2 protein CTD PMID:11457507 more ... methamphetamine multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [Methamphetamine results in decreased expression of BCL2 protein] more ... CTD PMID:15276877 more ... methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of BCL2 mRNA CTD PMID:30047161 methomyl decreases expression ISO Bcl2 (Mus musculus) 6480464 Methomyl results in decreased expression of BCL2 mRNA CTD PMID:34676817 methotrexate decreases expression ISO BCL2 (Homo sapiens) 6480464 Methotrexate results in decreased expression of BCL2 mRNA and Methotrexate results in decreased expression of BCL2 protein CTD PMID:17132110 and PMID:23799623 methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of BCL2 mRNA CTD PMID:29027214 methotrexate increases expression ISO BCL2 (Homo sapiens) 6480464 Methotrexate results in increased expression of BCL2 mRNA CTD PMID:29027214 methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of BCL2 mRNA and Methotrexate results in decreased expression of BCL2 protein CTD PMID:18803016 more ... methotrexate multiple interactions EXP 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of BCL2 protein] more ... CTD PMID:18803016 more ... methotrexate affects expression ISO BCL2 (Homo sapiens) 6480464 Methotrexate affects the expression of BCL2 mRNA CTD PMID:23792648 and PMID:25330300 methotrexate multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Doxorubicin co-treated with Dexamethasone co-treated with Vincristine co-treated with Cytarabine co-treated with Mercaptopurine co-treated with Methotrexate co-treated with Cyclophosphamide co-treated with Enzymes and Coenzymes] results in increased expression of BCL2 protein more ... CTD PMID:21182165 more ... methoxsalen multiple interactions ISO BCL2 (Homo sapiens) 6480464 Methoxsalen inhibits the reaction [Aflatoxin B1 results in decreased expression of BCL2 protein] CTD PMID:22743290 methoxsalen decreases expression ISO BCL2 (Homo sapiens) 6480464 Methoxsalen results in decreased expression of BCL2 protein CTD PMID:22796345 methoxychlor decreases response to substance ISO Bcl2 (Mus musculus) 6480464 BCL2 protein results in decreased susceptibility to Methoxychlor CTD PMID:14973267 and PMID:16081520 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of BCL2 gene CTD PMID:35440735 methoxychlor multiple interactions ISO Bcl2 (Mus musculus) 6480464 [ESR1 gene mutant form results in increased susceptibility to Methoxychlor] which results in increased expression of BCL2 mRNA CTD PMID:22306526 methoxychlor increases expression ISO Bcl2 (Mus musculus) 6480464 Methoxychlor metabolite results in increased expression of BCL2 protein and Methoxychlor results in increased expression of BCL2 protein CTD PMID:15525693 methoxychlor decreases expression ISO Bcl2 (Mus musculus) 6480464 Methoxychlor results in decreased expression of BCL2 mRNA CTD PMID:16081520 methyl caffeate multiple interactions ISO BCL2 (Homo sapiens) 6480464 methyl caffeate binds to and results in decreased expression of BCL2 protein CTD PMID:26415618 methyl methanesulfonate decreases expression ISO Bcl2 (Mus musculus) 6480464 Methyl Methanesulfonate results in decreased expression of BCL2 protein CTD PMID:16019050 methyl methanesulfonate multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Folic Acid co-treated with Methyl Methanesulfonate] results in increased expression of BCL2 mRNA CTD PMID:30581319 methylene blue multiple interactions EXP 6480464 Methylene Blue inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of BCL2 protein] CTD PMID:31428839 methylglyoxal multiple interactions ISO BCL2 (Homo sapiens) 6480464 naringenin inhibits the reaction [Pyruvaldehyde results in decreased expression of BCL2 protein] and salvin inhibits the reaction [Pyruvaldehyde results in decreased expression of BCL2 protein] CTD PMID:26577515 and PMID:31254498 methylglyoxal multiple interactions EXP 6480464 Phosphocreatine inhibits the reaction [Pyruvaldehyde results in decreased expression of BCL2 protein] CTD PMID:34455488 methylglyoxal decreases expression EXP 6480464 Pyruvaldehyde results in decreased expression of BCL2 protein CTD PMID:34455488 methylglyoxal decreases expression ISO BCL2 (Homo sapiens) 6480464 Pyruvaldehyde results in decreased expression of BCL2 mRNA and Pyruvaldehyde results in decreased expression of BCL2 protein CTD PMID:26577515 more ... methylisothiazolinone increases expression ISO BCL2 (Homo sapiens) 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of BCL2 protein CTD PMID:29110394 methylmercury chloride decreases expression ISO Bcl2 (Mus musculus) 6480464 methylmercuric chloride results in decreased expression of BCL2 mRNA and methylmercuric chloride results in decreased expression of BCL2 protein CTD PMID:23202902 and PMID:33338554 methylmercury chloride multiple interactions ISO Bcl2 (Mus musculus) 6480464 LEP protein affects the reaction [methylmercuric chloride results in decreased expression of BCL2 protein] CTD PMID:33338554 methylmercury chloride multiple interactions EXP 6480464 1 more ... CTD PMID:32061141 and PMID:35678294 methylmercury chloride increases expression ISO BCL2 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of BCL2 mRNA CTD PMID:28001369 methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of BCL2 mRNA and methylmercuric chloride results in decreased expression of BCL2 protein CTD PMID:28821999 more ... methylparaben decreases expression ISO BCL2 (Homo sapiens) 6480464 methylparaben results in decreased expression of BCL2 mRNA CTD PMID:28382686 methylseleninic acid affects expression EXP 6480464 methylselenic acid affects the expression of BCL2 protein CTD PMID:12017302 metipranolol multiple interactions EXP 6480464 Metipranolol inhibits the reaction [Zinc results in increased expression of BCL2 protein] and Metipranolol inhibits the reaction [Zinc Sulfate results in increased expression of BCL2 protein] CTD PMID:16799065 metiram multiple interactions ISO BCL2 (Homo sapiens) 6480464 [[Chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with Glyphosate] results in decreased susceptibility to Cisplatin] which results in increased expression of BCL2 mRNA more ... CTD PMID:32800223 metrafenone multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Sulfur co-treated with mancozeb co-treated with metrafenone] results in decreased expression of BCL2 mRNA more ... CTD PMID:35564597 mevalonic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 Mevalonic Acid inhibits the reaction [Lovastatin results in decreased expression of BCL2 protein] CTD PMID:12094262 mevalonic acid multiple interactions EXP 6480464 Mevalonic Acid inhibits the reaction [Lovastatin results in decreased expression of BCL2 protein] CTD PMID:11178870 mevinphos multiple interactions EXP 6480464 HSPD1 protein affects the reaction [Mevinphos affects the expression of BCL2 protein] and Mevinphos affects the reaction [HSPD1 protein binds to BCL2 protein] CTD PMID:17150954 mevinphos affects expression EXP 6480464 Mevinphos affects the expression of BCL2 protein CTD PMID:17150954 microcystin decreases expression EXP 6480464 Microcystins results in decreased expression of BCL2 mRNA and Microcystins results in decreased expression of BCL2 protein CTD PMID:19760617 microcystin RR decreases expression ISO Bcl2 (Mus musculus) 6480464 microcystin RR results in decreased expression of BCL2 protein CTD PMID:20196164 microcystin-LR increases expression ISO BCL2 (Homo sapiens) 6480464 cyanoginosin LR results in increased expression of BCL2 and cyanoginosin LR results in increased expression of BCL2 protein CTD PMID:16624733 and PMID:36115647 microcystin-LR multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Dietary Fats co-treated with cyanoginosin LR] results in decreased expression of BCL2 protein and NLRP3 protein affects the reaction [[Methionine deficiency co-treated with Choline deficiency co-treated with Dietary Fats co-treated with cyanoginosin LR] results in decreased expression of BCL2 protein] CTD PMID:34416350 microcystin-LR increases expression ISO Bcl2 (Mus musculus) 6480464 cyanoginosin LR results in increased expression of BCL2 protein CTD PMID:36115647 microcystin-LR decreases expression ISO Bcl2 (Mus musculus) 6480464 cyanoginosin LR results in decreased expression of BCL2 protein CTD PMID:32142839 microcystin-LR increases phosphorylation ISO BCL2 (Homo sapiens) 6480464 cyanoginosin LR results in increased phosphorylation of BCL2 protein CTD PMID:27352821 microcystin-LR decreases expression EXP 6480464 cyanoginosin LR results in decreased expression of BCL2 protein CTD PMID:25410294 microcystin-LR multiple interactions EXP 6480464 [cyanoginosin LR co-treated with Dietary Fats co-treated with Cholesterol more ... CTD PMID:25410294 and PMID:34740672 microcystin-LR multiple interactions ISO BCL2 (Homo sapiens) 6480464 cyanoginosin LR results in increased expression of and results in increased phosphorylation of BCL2 protein CTD PMID:26506538 microcystin-LR increases phosphorylation ISO Bcl2 (Mus musculus) 6480464 cyanoginosin LR results in increased phosphorylation of BCL2 protein CTD PMID:23891578 microcystin-LR decreases expression ISO BCL2 (Homo sapiens) 6480464 cyanoginosin LR results in decreased expression of BCL2 protein CTD PMID:18214937 midazolam increases expression EXP 6480464 Midazolam results in increased expression of BCL2 CTD PMID:17715682 mifepristone multiple interactions ISO BCL2 (Homo sapiens) 6480464 Mifepristone inhibits the reaction [Dexamethasone results in increased expression of BCL2] CTD PMID:21244764 mifepristone multiple interactions ISO Bcl2 (Mus musculus) 6480464 Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of BCL2 mRNA] and Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of BCL2 protein] CTD PMID:16644695 mifepristone decreases expression ISO BCL2 (Homo sapiens) 6480464 Mifepristone results in decreased expression of BCL2 mRNA and Mifepristone results in decreased expression of BCL2 protein CTD PMID:16009178 more ... miglustat multiple interactions ISO Bcl2 (Mus musculus) 6480464 miglustat inhibits the reaction [ST8SIA1 protein results in increased expression of BCL2 protein] CTD PMID:11574545 minocycline multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Minocycline co-treated with Hydrogen Peroxide co-treated with TGFB2 protein] results in increased expression of BCL2 mRNA and [Minocycline co-treated with Hydrogen Peroxide co-treated with TGFB2] results in increased expression of BCL2 protein CTD PMID:20606027 minocycline increases expression EXP 6480464 Minocycline results in increased expression of BCL2 mRNA and Minocycline results in increased expression of BCL2 protein CTD PMID:15004018 more ... minocycline multiple interactions EXP 6480464 [Minocycline results in increased expression of BCL2 protein] which binds to BAK1 protein more ... CTD PMID:15004018 mitomycin C affects expression ISO BCL2 (Homo sapiens) 6480464 Mitomycin affects the expression of BCL2 CTD PMID:19834285 mitomycin C multiple interactions ISO BCL2 (Homo sapiens) 6480464 Silybin inhibits the reaction [Mitomycin affects the expression of BCL2] and Tamoxifen promotes the reaction [Mitomycin results in increased expression of BCL2 mRNA] CTD PMID:19757172 and PMID:19834285 mitomycin C increases expression ISO BCL2 (Homo sapiens) 6480464 Mitomycin results in increased expression of BCL2 mRNA and Mitomycin results in increased expression of BCL2 protein CTD PMID:11867586 more ... Mitotane increases expression EXP 6480464 Mitotane results in increased expression of BCL2 mRNA CTD PMID:23485034 Mitotane multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Doxorubicin co-treated with Vincristine co-treated with Etoposide co-treated with Mitotane] results in decreased expression of BCL2 protein CTD PMID:9815696 mitoxantrone multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Cladribine co-treated with Cyclophosphamide co-treated with Mitoxantrone] results in decreased expression of BCL2 protein more ... CTD PMID:15582267 and PMID:8840993 mitoxantrone decreases expression ISO BCL2 (Homo sapiens) 6480464 Mitoxantrone results in decreased expression of BCL2 mRNA CTD PMID:8219202 MK-2206 multiple interactions ISO BCL2 (Homo sapiens) 6480464 ESR1 protein alternative form promotes the reaction [MK 2206 inhibits the reaction [Estradiol results in increased expression of BCL2 protein]] and MK 2206 inhibits the reaction [Estradiol results in increased expression of BCL2 protein] CTD PMID:34724321 ML-7 multiple interactions ISO BCL2 (Homo sapiens) 6480464 [ML 7 co-treated with quinocetone] results in decreased expression of BCL2 protein and ML 7 results in increased susceptibility to [quinocetone results in decreased expression of BCL2 protein] CTD PMID:26446980 mono(2-ethylhexyl) phthalate decreases expression ISO BCL2 (Homo sapiens) 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of BCL2 mRNA and mono-(2-ethylhexyl)phthalate results in decreased expression of BCL2 protein CTD PMID:12927354 more ... mono(2-ethylhexyl) phthalate affects expression ISO Bcl2 (Mus musculus) 6480464 mono-(2-ethylhexyl)phthalate affects the expression of BCL2 protein CTD PMID:37286014 mono(2-ethylhexyl) phthalate multiple interactions ISO BCL2 (Homo sapiens) 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of BCL2 mRNA and MIR16-1 mRNA affects the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of BCL2 protein] CTD PMID:26597031 and PMID:35861251 mono(2-ethylhexyl) phthalate multiple interactions ISO Bcl2 (Mus musculus) 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Estradiol] results in decreased expression of BCL2 mRNA more ... CTD PMID:24412242 more ... monobenzyl phthalate multiple interactions ISO Bcl2 (Mus musculus) 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of BCL2 mRNA CTD PMID:31884101 monobenzyl phthalate increases expression ISO BCL2 (Homo sapiens) 6480464 mono-benzyl phthalate results in increased expression of BCL2 mRNA CTD PMID:35487445 monobenzyl phthalate decreases methylation ISO BCL2 (Homo sapiens) 6480464 mono-benzyl phthalate results in decreased methylation of BCL2 promoter CTD PMID:35487445 monobenzyl phthalate multiple interactions ISO BCL2 (Homo sapiens) 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of BCL2 mRNA CTD PMID:35861251 Monobutylphthalate multiple interactions ISO BCL2 (Homo sapiens) 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of BCL2 mRNA CTD PMID:35861251 Monobutylphthalate increases expression ISO BCL2 (Homo sapiens) 6480464 monobutyl phthalate results in increased expression of BCL2 mRNA CTD PMID:35487445 Monobutylphthalate decreases methylation ISO BCL2 (Homo sapiens) 6480464 monobutyl phthalate results in decreased methylation of BCL2 promoter CTD PMID:35487445 monocrotophos multiple interactions EXP 6480464 resveratrol inhibits the reaction [Monocrotophos results in decreased expression of BCL2 mRNA] and resveratrol inhibits the reaction [Monocrotophos results in decreased expression of BCL2 protein] CTD PMID:23833438 monocrotophos increases expression EXP 6480464 Monocrotophos results in increased expression of BCL2 mRNA and Monocrotophos results in increased expression of BCL2 protein CTD PMID:21445290 monocrotophos decreases expression EXP 6480464 Monocrotophos results in decreased expression of BCL2 mRNA and Monocrotophos results in decreased expression of BCL2 protein CTD PMID:20957986 and PMID:23833438 monoethyl phthalate multiple interactions ISO Bcl2 (Mus musculus) 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of BCL2 mRNA CTD PMID:31884101 monoethyl phthalate multiple interactions ISO BCL2 (Homo sapiens) 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of BCL2 mRNA CTD PMID:35861251 monosodium L-glutamate increases expression ISO Bcl2 (Mus musculus) 6480464 Sodium Glutamate results in increased expression of BCL2 mRNA CTD PMID:16782274 monosodium L-glutamate multiple interactions EXP 6480464 [Homocysteine co-treated with Sodium Glutamate] affects the expression of BCL2 mRNA more ... CTD PMID:22169520 and PMID:26900785 monosodium L-glutamate decreases expression EXP 6480464 Sodium Glutamate results in decreased expression of BCL2 mRNA CTD PMID:26900785 monosodium L-glutamate multiple interactions ISO Bcl2 (Mus musculus) 6480464 SB 203580 inhibits the reaction [Sodium Glutamate results in increased expression of BCL2 mRNA] CTD PMID:16782274 montelukast multiple interactions ISO Bcl2 (Mus musculus) 6480464 montelukast inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein] CTD PMID:27702591 morin multiple interactions EXP 6480464 morin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein] more ... CTD PMID:19931519 more ... morin decreases expression ISO BCL2 (Homo sapiens) 6480464 morin results in decreased expression of BCL2 mRNA CTD PMID:28689916 morphine multiple interactions ISO BCL2 (Homo sapiens) 6480464 [[Morphine results in increased expression of BAX protein] co-treated with [Morphine results in decreased expression of BCL2 protein]] results in increased activity of CASP3 protein more ... CTD PMID:10534122 more ... morphine decreases expression ISO BCL2 (Homo sapiens) 6480464 Morphine results in decreased expression of BCL2 protein CTD PMID:10534122 more ... morphine decreases expression EXP 6480464 Morphine results in decreased expression of BCL2 mRNA and Morphine results in decreased expression of BCL2 protein CTD PMID:12196588 and PMID:18976035 morphine multiple interactions EXP 6480464 Lithium inhibits the reaction [Morphine results in decreased expression of BCL2 mRNA] CTD PMID:18976035 Morroniside multiple interactions EXP 6480464 [morroniside co-treated with Diosgenin] inhibits the reaction [Glucose results in decreased expression of BCL2 protein] and morroniside inhibits the reaction [Glucose results in decreased expression of BCL2 protein] CTD PMID:28106847 Morroniside increases expression ISO Bcl2 (Mus musculus) 6480464 morroniside results in increased expression of BCL2 mRNA CTD PMID:20966881 morusin decreases expression ISO BCL2 (Homo sapiens) 6480464 morusin results in decreased expression of BCL2 protein CTD PMID:33035517 mycophenolic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Mycophenolic Acid co-treated with Hypoxanthine] results in decreased expression of BCL2 protein more ... CTD PMID:16505121 more ... mycophenolic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 Mycophenolic Acid results in decreased expression of BCL2 protein CTD PMID:35321622 myricetin decreases expression ISO BCL2 (Homo sapiens) 6480464 myricetin results in decreased expression of BCL2 protein CTD PMID:15748703 and PMID:29698783 myricetin multiple interactions ISO BCL2 (Homo sapiens) 6480464 Tetradecanoylphorbol Acetate inhibits the reaction [myricetin results in decreased expression of BCL2 protein] CTD PMID:15748703 myricitrin multiple interactions ISO BCL2 (Homo sapiens) 6480464 myricitrin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] CTD PMID:23639522 myristicin decreases expression ISO BCL2 (Homo sapiens) 6480464 myristicin results in decreased expression of BCL2 mRNA CTD PMID:29174417 Myrtucommulone A decreases expression ISO Bcl2 (Mus musculus) 6480464 myrtucommulone A results in decreased expression of BCL2 mRNA CTD PMID:26032814 N'-Nitrosonornicotine increases expression ISO BCL2 (Homo sapiens) 6480464 N'-nitrosonornicotine results in increased expression of BCL2 mRNA CTD PMID:16582591 and PMID:16835749 N'-Nitrosonornicotine multiple interactions ISO BCL2 (Homo sapiens) 6480464 Mecamylamine inhibits the reaction [N'-nitrosonornicotine results in increased expression of BCL2 mRNA] CTD PMID:16835749 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine decreases expression ISO BCL2 (Homo sapiens) 6480464 N more ... CTD PMID:33645215 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions ISO BCL2 (Homo sapiens) 6480464 N more ... CTD PMID:19887557 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of BCL2 gene CTD PMID:33148267 N,N-dimethylsphingosine multiple interactions ISO BCL2 (Homo sapiens) 6480464 N and N-dimethylsphingosine inhibits the reaction [ASAH2 protein results in increased expression of BCL2 protein] CTD PMID:15498114 N-(6-acetamidohexyl)acetamide affects expression ISO BCL2 (Homo sapiens) 6480464 hexamethylene bisacetamide affects the expression of BCL2 CTD PMID:15543656 N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohexanecarboxamide multiple interactions ISO Bcl2 (Mus musculus) 6480464 N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in decreased expression of BCL2 protein] CTD PMID:30366073 N-[2-amino-6-[(4-fluorophenyl)methylamino]-3-pyridinyl]carbamic acid ethyl ester increases expression ISO BCL2 (Homo sapiens) 6480464 flupirtine results in increased expression of BCL2 protein CTD PMID:9804146 N-acetyl-L-cysteine multiple interactions ISO BCL2 (Homo sapiens) 127284846 N-acetyl-L-cysteine inhibits the reaction [apigenin-7-O-gentiobioside decreases expression of BCL2 protein in the stomach) RGD N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [7-ketocholesterol results in decreased expression of BCL2 protein] more ... CTD PMID:17041759 more ... N-acetyl-L-cysteine multiple interactions ISO Bcl2 (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [1 more ... CTD PMID:21549813 more ... N-acetyl-L-cysteine decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 results in decreased susceptibility to Acetylcysteine CTD PMID:17395010 N-acetyl-L-cysteine decreases expression ISO BCL2 (Homo sapiens) 6480464 Acetylcysteine results in decreased expression of BCL2 protein CTD PMID:17395010 and PMID:37209937 N-acetyl-L-cysteine multiple interactions ISO BCL2 (Homo sapiens) 6480464 4-phenylbutyric acid promotes the reaction [Acetylcysteine inhibits the reaction [tris(1 more ... CTD PMID:11341981 more ... N-acetylsphingosine multiple interactions ISO BCL2 (Homo sapiens) 6480464 BCL2 protein inhibits the reaction [N-acetylsphingosine results in decreased phosphorylation of and results in decreased activity of AKT1 protein] more ... CTD PMID:16215670 and PMID:24420784 N-acetylsphingosine decreases expression ISO BCL2 (Homo sapiens) 6480464 N-acetylsphingosine results in decreased expression of BCL2 mRNA and N-acetylsphingosine results in decreased expression of BCL2 protein CTD PMID:24420784 and PMID:9295281 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO BCL2 (Homo sapiens) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Arachidonic Acid results in decreased expression of BCL2 protein] more ... CTD PMID:19540902 more ... N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO Bcl2 (Mus musculus) 6480464 benzyloxycarbonyl-valyl-alanyl-aspartic acid promotes the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of BCL2 protein] and MitoTEMPO inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of BCL2 protein] CTD PMID:20449726 and PMID:34418242 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression ISO Bcl2 (Mus musculus) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of BCL2 and benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of BCL2 protein CTD PMID:20100472 more ... N-ethyl-N-nitrosourea increases expression ISO Bcl2 (Mus musculus) 6480464 Ethylnitrosourea results in increased expression of BCL2 mRNA CTD PMID:30944280 N-methyl-4-phenylpyridinium multiple interactions EXP 6480464 [1-Methyl-4-phenylpyridinium co-treated with Quercetin] results in increased expression of BCL2 mRNA more ... CTD PMID:19135049 more ... N-methyl-4-phenylpyridinium multiple interactions ISO Bcl2 (Mus musculus) 6480464 dorsomorphin inhibits the reaction [sophoricoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]] more ... CTD PMID:34967706 and PMID:37741537 N-methyl-4-phenylpyridinium affects expression ISO BCL2 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium affects the expression of BCL2 protein CTD PMID:29575151 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA and 1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein CTD PMID:18496573 more ... N-methyl-4-phenylpyridinium increases expression ISO BCL2 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of BCL2 mRNA and 1-Methyl-4-phenylpyridinium results in increased expression of BCL2 protein CTD PMID:24399507 and PMID:33472166 N-methyl-4-phenylpyridinium decreases expression ISO BCL2 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA and 1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein CTD PMID:17266988 more ... N-methyl-4-phenylpyridinium decreases expression ISO Bcl2 (Mus musculus) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA and 1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein CTD PMID:12880480 more ... N-methyl-4-phenylpyridinium multiple interactions ISO BCL2 (Homo sapiens) 6480464 2 more ... CTD PMID:17266988 more ... N-methyl-D-aspartic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 kukoamine B inhibits the reaction [N-Methylaspartate results in decreased expression of BCL2 protein] CTD PMID:26065936 N-methyl-D-aspartic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 N-Methylaspartate results in decreased expression of BCL2 protein CTD PMID:26065936 N-methyl-N'-nitro-N-nitrosoguanidine decreases expression ISO Bcl2 (Mus musculus) 6480464 Methylnitronitrosoguanidine results in decreased expression of BCL2 protein CTD PMID:16019050 N-methyl-N'-nitro-N-nitrosoguanidine increases expression EXP 6480464 Methylnitronitrosoguanidine results in increased expression of BCL2 protein CTD PMID:35103375 N-methyl-N'-nitro-N-nitrosoguanidine increases expression ISO Bcl2 (Mus musculus) 6480464 Methylnitronitrosoguanidine results in increased expression of BCL2 mRNA and Methylnitronitrosoguanidine results in increased expression of BCL2 protein CTD PMID:20434464 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO Bcl2 (Mus musculus) 6480464 Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2 mRNA] and Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2 protein] CTD PMID:20434464 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions EXP 6480464 [Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein more ... CTD PMID:16030430 and PMID:35103375 N-methyl-N-nitrosourea multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of BCL2 protein more ... CTD PMID:16011256 more ... N-methyl-N-nitrosourea increases expression ISO Bcl2 (Mus musculus) 6480464 Methylnitrosourea results in increased expression of BCL2 mRNA CTD PMID:15240709 and PMID:24463056 N-methyl-N-nitrosourea decreases expression EXP 6480464 Methylnitrosourea results in decreased expression of BCL2 protein CTD PMID:16011256 and PMID:16047940 N-methylnicotinate multiple interactions ISO BCL2 (Homo sapiens) 6480464 [trigonelline co-treated with Cisplatin] results in decreased expression of BCL2 protein and [trigonelline co-treated with Etoposide] results in decreased expression of BCL2 protein CTD PMID:33148531 N-methylnicotinate multiple interactions EXP 6480464 trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein] CTD PMID:31935362 N-nitrosodiethylamine increases expression ISO Bcl2 (Mus musculus) 127285675 N-nitrosodiethylamine increases expression of Bcl2 mRNA in liver RGD N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of BCL2 mRNA and Diethylnitrosamine results in increased expression of BCL2 protein CTD PMID:15682466 more ... N-nitrosodiethylamine increases expression ISO BCL2 (Homo sapiens) 6480464 Diethylnitrosamine results in increased expression of BCL2 protein CTD PMID:21776270 N-nitrosodiethylamine increases expression ISO Bcl2 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of BCL2 mRNA and Diethylnitrosamine results in increased expression of BCL2 protein CTD PMID:24535843 and PMID:34726822 N-nitrosodiethylamine multiple interactions EXP 6480464 [2-aminofluorene co-treated with Diethylnitrosamine] results in increased expression of BCL2 protein more ... CTD PMID:11915028 more ... N-nitrosodiethylamine decreases response to substance ISO Bcl2 (Mus musculus) 6480464 BCL2 protein results in decreased susceptibility to Diethylnitrosamine CTD PMID:12000706 N-nitrosodiethylamine multiple interactions ISO Bcl2 (Mus musculus) 6480464 BCL2 protein inhibits the reaction [TGFA protein results in increased susceptibility to Diethylnitrosamine] more ... CTD PMID:12000706 and PMID:34726822 N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of BCL2 protein CTD PMID:14659978 N-nitrosodimethylamine multiple interactions EXP 6480464 Estradiol inhibits the reaction [Dimethylnitrosamine results in decreased expression of BCL2 protein] and idoxifene inhibits the reaction [Dimethylnitrosamine results in decreased expression of BCL2 protein] CTD PMID:14659978 N-phosphocreatine multiple interactions EXP 6480464 Phosphocreatine inhibits the reaction [Pyruvaldehyde results in decreased expression of BCL2 protein] and Phosphocreatine inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein] CTD PMID:34455488 N-phosphocreatine multiple interactions ISO BCL2 (Homo sapiens) 6480464 Phosphocreatine inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] CTD PMID:37648050 N-tosyl-L-phenylalanyl chloromethyl ketone increases cleavage ISO BCL2 (Homo sapiens) 6480464 Tosylphenylalanyl Chloromethyl Ketone results in increased cleavage of BCL2 protein CTD PMID:19679660 N-tosyl-L-phenylalanyl chloromethyl ketone multiple interactions ISO BCL2 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [Tosylphenylalanyl Chloromethyl Ketone results in increased cleavage of BCL2 protein] CTD PMID:19679660 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions ISO BCL2 (Homo sapiens) 6480464 Ranitidine inhibits the reaction [Rotenone results in decreased expression of BCL2 protein] CTD PMID:19723537 nabumetone decreases expression ISO BCL2 (Homo sapiens) 6480464 nabumetone results in decreased expression of BCL2 protein CTD PMID:16019514 NAD zwitterion increases expression ISO BCL2 (Homo sapiens) 6480464 NAD results in increased expression of BCL2 protein CTD PMID:12390773 NAD(+) increases expression ISO BCL2 (Homo sapiens) 6480464 NAD results in increased expression of BCL2 protein CTD PMID:12390773 naloxone multiple interactions ISO BCL2 (Homo sapiens) 6480464 Naloxone inhibits the reaction [Morphine inhibits the reaction [Dactinomycin results in decreased expression of BCL2 protein]] CTD PMID:12927789 naloxone increases expression EXP 6480464 Naloxone results in increased expression of BCL2 protein CTD PMID:16004788 naphthalene increases expression ISO BCL2 (Homo sapiens) 6480464 naphthalene results in increased expression of BCL2 protein CTD PMID:14595851 naphthalenes decreases expression ISO BCL2 (Homo sapiens) 6480464 Naphthalenes results in decreased expression of BCL2 protein CTD PMID:17224139 naringin multiple interactions EXP 6480464 [naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in decreased expression of BCL2 mRNA] more ... CTD PMID:21945202 and PMID:30130594 naringin multiple interactions ISO Bcl2 (Mus musculus) 6480464 CHAC2 protein promotes the reaction [naringin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein]] more ... CTD PMID:30878453 more ... naringin multiple interactions ISO BCL2 (Homo sapiens) 6480464 naringin inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein] CTD PMID:28422390 Neferine multiple interactions EXP 6480464 neferine inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 mRNA] and neferine inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein] CTD PMID:30423403 neoastilbin multiple interactions ISO BCL2 (Homo sapiens) 6480464 astilbin inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] CTD PMID:29471006 neomycin multiple interactions ISO Bcl2 (Mus musculus) 6480464 peoniflorin inhibits the reaction [Neomycin results in decreased expression of BCL2 mRNA] and peoniflorin inhibits the reaction [Neomycin results in decreased expression of BCL2 protein] CTD PMID:29292089 neomycin decreases expression ISO Bcl2 (Mus musculus) 6480464 Neomycin results in decreased expression of BCL2 mRNA and Neomycin results in decreased expression of BCL2 protein CTD PMID:29292089 nerolidol decreases expression ISO BCL2 (Homo sapiens) 6480464 nerolidol results in decreased expression of BCL2 mRNA CTD PMID:35357761 nickel atom multiple interactions ISO BCL2 (Homo sapiens) 6480464 [cobalt ferrite binds to Nickel] which results in decreased expression of BCL2 protein and [Quercetin analog co-treated with Nickel] results in decreased expression of BCL2 protein CTD PMID:20577783 and PMID:36073959 nickel atom decreases expression ISO BCL2 (Homo sapiens) 6480464 Nickel results in decreased expression of BCL2 protein CTD PMID:31953414 nickel atom decreases expression EXP 6480464 Nickel analog results in decreased expression of BCL2 protein CTD PMID:27257140 nickel atom affects expression ISO BCL2 (Homo sapiens) 6480464 Nickel analog affects the expression of BCL2 protein CTD PMID:23776134 nickel dichloride decreases expression ISO BCL2 (Homo sapiens) 6480464 nickel chloride results in decreased expression of BCL2 mRNA CTD PMID:17442357 nickel dichloride multiple interactions ISO Bcl2 (Mus musculus) 6480464 Melatonin inhibits the reaction [nickel chloride results in decreased expression of BCL2 mRNA] more ... CTD PMID:36421005 nickel dichloride decreases expression ISO Bcl2 (Mus musculus) 6480464 nickel chloride results in decreased expression of BCL2 mRNA and nickel chloride results in decreased expression of BCL2 protein CTD PMID:36421005 nickel dichloride decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to nickel chloride CTD PMID:23828460 nickel dichloride decreases expression EXP 6480464 nickel chloride results in decreased expression of BCL2 protein CTD PMID:20391133 nickel dichloride increases expression ISO BCL2 (Homo sapiens) 6480464 nickel chloride results in increased expression of BCL2 protein CTD PMID:21837363 nickel ferrite decreases expression ISO BCL2 (Homo sapiens) 6480464 nickel ferrite analog results in decreased expression of BCL2 mRNA and nickel ferrite results in decreased expression of BCL2 mRNA CTD PMID:21382431 and PMID:25966046 nickel subsulfide decreases expression ISO BCL2 (Homo sapiens) 6480464 nickel subsulfide results in decreased expression of BCL2 protein CTD PMID:20112989 nickel sulfate increases expression ISO BCL2 (Homo sapiens) 6480464 nickel sulfate results in increased expression of BCL2 protein CTD PMID:21776270 nickel sulfate decreases expression EXP 6480464 nickel sulfate results in decreased expression of BCL2 protein CTD PMID:34612572 nickel sulfate decreases expression ISO BCL2 (Homo sapiens) 6480464 nickel sulfate results in decreased expression of BCL2 mRNA and nickel sulfate results in decreased expression of BCL2 protein CTD PMID:34612572 and PMID:35499276 nickel sulfate multiple interactions EXP 6480464 Selenium inhibits the reaction [nickel sulfate results in decreased expression of BCL2 protein] CTD PMID:34612572 nickel sulfate multiple interactions ISO BCL2 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Selenium inhibits the reaction [nickel sulfate results in decreased expression of BCL2 protein]] more ... CTD PMID:34612572 and PMID:35499276 nickel sulfate decreases expression ISO Bcl2 (Mus musculus) 6480464 nickel sulfate results in decreased expression of BCL2 protein CTD PMID:23317420 nickel sulfate multiple interactions ISO Bcl2 (Mus musculus) 6480464 sesamin inhibits the reaction [nickel sulfate results in decreased expression of BCL2 protein] CTD PMID:23317420 niclosamide multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Niclosamide binds to Polyethyleneimine] which results in decreased expression of BCL2 mRNA more ... CTD PMID:20215516 more ... niclosamide decreases expression ISO BCL2 (Homo sapiens) 6480464 Niclosamide analog results in decreased expression of BCL2 protein and Niclosamide results in decreased expression of BCL2 protein CTD PMID:23894143 more ... nicorandil multiple interactions EXP 6480464 Nicorandil inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] CTD PMID:31376360 nicotinamide multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9 more ... CTD PMID:25478867 nicotinamide multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Berberine co-treated with Niacinamide] results in decreased expression of BCL2 protein and Niacinamide promotes the reaction [[Oxygen co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein] CTD PMID:25472572 and PMID:26712469 nicotine multiple interactions ISO BCL2 (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [Nicotine results in decreased expression of BCL2 protein] more ... CTD PMID:12421819 more ... nicotine increases expression EXP 6480464 Nicotine results in increased expression of BCL2 protein CTD PMID:34153408 nicotine multiple interactions EXP 6480464 Folic Acid inhibits the reaction [Nicotine results in decreased expression of BCL2 protein] CTD PMID:29972271 nicotine multiple interactions ISO Bcl2 (Mus musculus) 6480464 royal jelly inhibits the reaction [Nicotine results in decreased expression of BCL2 mRNA] CTD PMID:30896085 nicotine increases expression ISO Bcl2 (Mus musculus) 6480464 Nicotine results in increased expression of BCL2 protein CTD PMID:31783125 nicotine decreases expression ISO BCL2 (Homo sapiens) 6480464 Nicotine results in decreased expression of BCL2 protein CTD PMID:33010382 nicotine increases expression ISO BCL2 (Homo sapiens) 6480464 Nicotine results in increased expression of BCL2 mRNA more ... CTD PMID:18448488 more ... nicotine decreases expression ISO Bcl2 (Mus musculus) 6480464 Nicotine results in decreased expression of BCL2 mRNA CTD PMID:15831280 and PMID:30896085 nicotine increases phosphorylation ISO BCL2 (Homo sapiens) 6480464 Nicotine results in increased phosphorylation of BCL2 protein CTD PMID:12421819 nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of BCL2 mRNA and Nicotine results in decreased expression of BCL2 protein CTD PMID:20339300 and PMID:29972271 nifedipine decreases expression ISO BCL2 (Homo sapiens) 6480464 Nifedipine results in decreased expression of BCL2 CTD PMID:10075388 nifedipine multiple interactions ISO BCL2 (Homo sapiens) 6480464 Nifedipine inhibits the reaction [Iohexol results in decreased expression of BCL2 protein] and Nifedipine results in increased expression of and affects the localization of BCL2 protein CTD PMID:10695937 and PMID:36207783 nifedipine multiple interactions EXP 6480464 Nifedipine inhibits the reaction [Gentamicins results in decreased expression of BCL2 protein] and Nifedipine inhibits the reaction [Iohexol results in decreased expression of BCL2 protein] CTD PMID:19698708 and PMID:36207783 nilotinib decreases expression ISO BCL2 (Homo sapiens) 6480464 nilotinib results in decreased expression of BCL2 protein CTD PMID:26549707 nimesulide decreases expression ISO BCL2 (Homo sapiens) 6480464 nimesulide results in decreased expression of BCL2 mRNA and nimesulide results in decreased expression of BCL2 protein CTD PMID:18564172 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of BCL2 protein CTD PMID:19772912 nimesulide affects localization EXP 6480464 nimesulide affects the localization of BCL2 protein CTD PMID:19772912 nimodipine decreases expression ISO BCL2 (Homo sapiens) 6480464 Nimodipine results in decreased expression of BCL2 protein CTD PMID:17490525 nimodipine multiple interactions EXP 6480464 Nimodipine inhibits the reaction [Sevoflurane results in decreased expression of BCL2 protein] CTD PMID:33171207 Nitidine decreases expression ISO BCL2 (Homo sapiens) 6480464 nitidine results in decreased expression of BCL2 protein CTD PMID:36175965 nitrendipine multiple interactions EXP 6480464 Nitrendipine promotes the reaction [Gentamicins results in decreased expression of BCL2 protein] CTD PMID:19698708 nitric oxide decreases expression ISO BCL2 (Homo sapiens) 6480464 Nitric Oxide results in decreased expression of BCL2 protein CTD PMID:15126337 nitric oxide affects expression ISO Bcl2 (Mus musculus) 6480464 Nitric Oxide affects the expression of BCL2 mRNA CTD PMID:17135264 nitric oxide multiple interactions ISO Bcl2 (Mus musculus) 6480464 [3 more ... CTD PMID:17135264 and PMID:7706495 nitric oxide multiple interactions ISO BCL2 (Homo sapiens) 6480464 1 more ... CTD PMID:10828028 and PMID:16980304 nitrofen multiple interactions EXP 6480464 FOXA2 protein inhibits the reaction [nitrofen results in decreased expression of BCL2 protein] CTD PMID:31843527 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of BCL2 protein CTD PMID:31843527 nitroglycerin decreases expression EXP 6480464 Nitroglycerin results in decreased expression of BCL2 protein CTD PMID:17678976 nitroprusside decreases expression ISO BCL2 (Homo sapiens) 6480464 Nitroprusside results in decreased expression of BCL2 and Nitroprusside results in decreased expression of BCL2 protein CTD PMID:15708893 and PMID:23665936 nitroprusside multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Nitroprusside results in increased nitrosation of and results in decreased ubiquitination of and results in decreased degradation of BCL2 protein] which results in decreased susceptibility to Chromates CTD PMID:16980304 nitroprusside decreases expression EXP 6480464 Nitroprusside results in decreased expression of BCL2 protein CTD PMID:10203697 nitroprusside multiple interactions EXP 6480464 FGF2 protein inhibits the reaction [Nitroprusside results in decreased expression of BCL2 protein] and IGF1 protein inhibits the reaction [Nitroprusside results in decreased expression of BCL2 protein] CTD PMID:10203697 nitroxoline multiple interactions ISO BCL2 (Homo sapiens) 6480464 nitroxoline inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] CTD PMID:31638783 nobiletin multiple interactions ISO BCL2 (Homo sapiens) 6480464 nobiletin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] CTD PMID:29687528 nocodazole increases phosphorylation ISO BCL2 (Homo sapiens) 6480464 Nocodazole results in increased phosphorylation of BCL2 protein CTD PMID:15907805 nocodazole decreases expression ISO BCL2 (Homo sapiens) 6480464 Nocodazole analog results in decreased expression of BCL2 protein CTD PMID:28412508 nocodazole multiple interactions ISO BCL2 (Homo sapiens) 6480464 TYMP inhibits the reaction [Nocodazole results in increased phosphorylation of BCL2 protein] CTD PMID:15907805 Nodularin increases expression ISO BCL2 (Homo sapiens) 6480464 nodularin results in increased expression of BCL2 mRNA CTD PMID:30562542 Nonylphenol increases expression ISO Bcl2 (Mus musculus) 6480464 nonylphenol results in increased expression of BCL2 protein CTD PMID:24604882 Nonylphenol decreases expression ISO Bcl2 (Mus musculus) 6480464 nonylphenol results in decreased expression of BCL2 protein CTD PMID:23677851 Norbinaltorphimine multiple interactions ISO Bcl2 (Mus musculus) 6480464 3-((3 more ... CTD PMID:29467000 NORCANTHARIDIN increases phosphorylation ISO BCL2 (Homo sapiens) 6480464 norcantharidin results in increased phosphorylation of BCL2 protein CTD PMID:21266192 NORCANTHARIDIN decreases expression ISO BCL2 (Homo sapiens) 6480464 norcantharidin results in decreased expression of BCL2 protein CTD PMID:29193574 Norethindrone enanthate multiple interactions EXP 6480464 [norethindrone enanthate co-treated with Estradiol] results in decreased expression of BCL2 mRNA CTD PMID:18829022 norfloxacin decreases expression ISO BCL2 (Homo sapiens) 6480464 Norfloxacin results in decreased expression of BCL2 protein CTD PMID:32320760 norwogonin multiple interactions EXP 6480464 norwogonin inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 mRNA] and norwogonin inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 protein] CTD PMID:33413359 norwogonin decreases expression ISO BCL2 (Homo sapiens) 6480464 norwogonin results in decreased expression of BCL2 protein CTD PMID:32862589 notoginsenoside R1 multiple interactions EXP 6480464 15-Hydroxy-11 alpha more ... CTD PMID:24975829 and PMID:25305180 notoginsenoside R1 increases expression EXP 6480464 notoginsenoside R1 results in increased expression of BCL2 CTD PMID:20023602 notoginsenoside R1 multiple interactions ISO Bcl2 (Mus musculus) 6480464 notoginsenoside R1 inhibits the reaction [Excitatory Amino Acid Agonists results in decreased expression of BCL2 protein] and notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein] CTD PMID:19224577 and PMID:23170834 NS 1619 multiple interactions ISO BCL2 (Homo sapiens) 6480464 NS 1619 inhibits the reaction [Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]] CTD PMID:21413024 NS-398 multiple interactions ISO BCL2 (Homo sapiens) 6480464 [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide co-treated with rosiglitazone] results in decreased expression of BCL2 mRNA and [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide co-treated with rosiglitazone] results in decreased expression of BCL2 protein CTD PMID:19056168 NS-398 multiple interactions ISO Bcl2 (Mus musculus) 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide promotes the reaction [Dihematoporphyrin Ether results in increased cleavage of BCL2 protein] CTD PMID:16230411 NS-398 decreases expression ISO BCL2 (Homo sapiens) 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of BCL2 mRNA and N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of BCL2 protein CTD PMID:19056168 Nutlin-3 decreases expression ISO BCL2 (Homo sapiens) 6480464 nutlin 3 results in decreased expression of BCL2 and nutlin 3 results in decreased expression of BCL2 protein CTD PMID:20422343 and PMID:35213076 Nutlin-3 multiple interactions ISO BCL2 (Homo sapiens) 6480464 PVT1 protein inhibits the reaction [nutlin 3 results in decreased expression of BCL2 protein] CTD PMID:35213076 o-anisidine decreases expression ISO BCL2 (Homo sapiens) 6480464 2-anisidine results in decreased expression of BCL2 mRNA CTD PMID:28089782 o-cresol increases expression EXP 6480464 2-cresol results in increased expression of BCL2 mRNA CTD PMID:21705299 o-cresol multiple interactions EXP 6480464 Sodium Selenite inhibits the reaction [2-cresol results in increased expression of BCL2 mRNA] CTD PMID:21705299 Obacunone decreases expression ISO BCL2 (Homo sapiens) 6480464 obacunone results in decreased expression of BCL2 mRNA and obacunone results in decreased expression of BCL2 protein CTD PMID:21333732 and PMID:25592883 obeticholic acid increases expression ISO BCL2 (Homo sapiens) 6480464 obeticholic acid results in increased expression of BCL2 mRNA CTD PMID:27939613 obeticholic acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Dietary Fats co-treated with obeticholic acid] results in decreased expression of BCL2 protein CTD PMID:35267068 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of BCL2 mRNA CTD PMID:12700408 ochratoxin A decreases expression ISO Bcl2 (Mus musculus) 6480464 ochratoxin A results in decreased expression of BCL2 mRNA and ochratoxin A results in decreased expression of BCL2 protein CTD PMID:36397609 ochratoxin A multiple interactions ISO Bcl2 (Mus musculus) 6480464 fumonisin B1 promotes the reaction [ochratoxin A results in decreased expression of BCL2 mRNA] and fumonisin B1 promotes the reaction [ochratoxin A results in decreased expression of BCL2 protein] CTD PMID:36397609 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of BCL2 mRNA CTD PMID:23208426 ochratoxin A multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Aflatoxin M1 co-treated with ochratoxin A] results in decreased expression of BCL2 protein more ... CTD PMID:33465424 more ... ochratoxin A decreases expression ISO BCL2 (Homo sapiens) 6480464 ochratoxin A results in decreased expression of BCL2 mRNA and ochratoxin A results in decreased expression of BCL2 protein CTD PMID:20549612 more ... ochratoxin A decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to ochratoxin A CTD PMID:20549612 octyl gallate decreases expression ISO Bcl2 (Mus musculus) 6480464 octyl gallate results in decreased expression of BCL2 protein CTD PMID:21856409 okadaic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 Okadaic Acid results in decreased expression of BCL2 protein CTD PMID:18937299 okadaic acid increases expression ISO BCL2 (Homo sapiens) 6480464 Okadaic Acid results in increased expression of BCL2 mRNA CTD PMID:31926150 olanzapine multiple interactions EXP 6480464 olanzapine inhibits the reaction [Methamphetamine results in decreased expression of BCL2 protein] CTD PMID:15276877 olanzapine increases expression EXP 6480464 olanzapine results in increased expression of BCL2 mRNA and olanzapine results in increased expression of BCL2 protein CTD PMID:15126120 olaparib decreases expression ISO BCL2 (Homo sapiens) 6480464 olaparib results in decreased expression of BCL2 protein CTD PMID:25531448 oleanolic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 Oleanolic Acid analog results in decreased expression of BCL2 protein and Oleanolic Acid results in decreased expression of BCL2 protein CTD PMID:22678527 more ... oleanolic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Oleanolic Acid results in increased susceptibility to Doxorubicin] which affects the expression of BCL2 mRNA more ... CTD PMID:31306688 more ... oleic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 3-N-1(spermine)-7 more ... CTD PMID:32369900 oleuropein multiple interactions EXP 6480464 oleuropein inhibits the reaction [Acrolein results in decreased expression of BCL2 mRNA] more ... CTD PMID:28595958 and PMID:29414845 oleuropein multiple interactions ISO Bcl2 (Mus musculus) 6480464 oleuropein affects the reaction [Rotenone results in decreased expression of BCL2 protein] CTD PMID:36774383 oligomycin A multiple interactions ISO Bcl2 (Mus musculus) 6480464 oligomycin A inhibits the reaction [bisphenol A results in increased expression of BCL2 protein] CTD PMID:24909818 oligopeptide decreases expression ISO BCL2 (Homo sapiens) 6480464 Oligopeptides analog results in decreased expression of BCL2 protein CTD PMID:24875536 Olmesartan medoxomil multiple interactions EXP 6480464 Olmesartan Medoxomil inhibits the reaction [Acetic Acid results in decreased expression of BCL2 protein] CTD PMID:30594690 omacetaxine mepesuccinate decreases expression ISO BCL2 (Homo sapiens) 6480464 Homoharringtonine results in decreased expression of BCL2 protein CTD PMID:23980369 and PMID:31726078 omeprazole multiple interactions ISO BCL2 (Homo sapiens) 6480464 Omeprazole inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] CTD PMID:30452898 Ophiopogonin D multiple interactions ISO BCL2 (Homo sapiens) 6480464 3-(2 and 4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [ophiopogonin D results in decreased expression of BCL2 protein] CTD PMID:35905946 Ophiopogonin D decreases expression ISO BCL2 (Homo sapiens) 6480464 ophiopogonin D results in decreased expression of BCL2 protein CTD PMID:35905946 orciprenaline decreases expression ISO Bcl2 (Mus musculus) 6480464 Metaproterenol results in decreased expression of BCL2 protein CTD PMID:15052282 organoselenium compound multiple interactions EXP 6480464 Organoselenium Compounds inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein] CTD PMID:25301743 oridonin decreases expression ISO BCL2 (Homo sapiens) 6480464 oridonin analog results in decreased expression of BCL2 protein and oridonin results in decreased expression of BCL2 protein CTD PMID:16019488 and PMID:31594861 oridonin multiple interactions EXP 6480464 oridonin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA] and oridonin inhibits the reaction [Kainic Acid results in decreased expression of BCL2 mRNA] CTD PMID:31430510 orlistat multiple interactions EXP 6480464 Orlistat inhibits the reaction [Dietary Fats results in decreased expression of BCL2 mRNA] CTD PMID:32450208 oroxylin A decreases expression ISO BCL2 (Homo sapiens) 6480464 5 and 7-dihydroxy-6-methoxy-2-phenylchromen-4-one results in decreased expression of BCL2 protein CTD PMID:19135124 osthole decreases expression ISO BCL2 (Homo sapiens) 6480464 osthol results in decreased expression of BCL2 protein CTD PMID:29319219 and PMID:31870840 ouabain decreases expression ISO BCL2 (Homo sapiens) 6480464 Ouabain results in decreased expression of BCL2 protein CTD PMID:31436044 oxalic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Butyric Acid co-treated with Sulfaphenazole] inhibits the reaction [Oxalic Acid results in decreased expression of BCL2 mRNA] and Sulfaphenazole inhibits the reaction [Oxalic Acid results in decreased expression of BCL2 mRNA] CTD PMID:37414240 oxalic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 Oxalic Acid results in decreased expression of BCL2 mRNA CTD PMID:37414240 oxaliplatin multiple interactions EXP 6480464 oxaliplatin results in increased phosphorylation of and results in decreased activity of BCL2 protein more ... CTD PMID:19428505 oxaliplatin decreases expression ISO Bcl2 (Mus musculus) 6480464 Oxaliplatin results in decreased expression of BCL2 mRNA and Oxaliplatin results in decreased expression of BCL2 protein CTD PMID:30031110 and PMID:36812960 oxaliplatin decreases expression ISO BCL2 (Homo sapiens) 6480464 oxaliplatin results in decreased expression of BCL2 mRNA and oxaliplatin results in decreased expression of BCL2 protein CTD PMID:16024531 and PMID:23792648 oxidopamine multiple interactions EXP 6480464 5 more ... CTD PMID:16480889 more ... oxidopamine decreases expression ISO Bcl2 (Mus musculus) 6480464 Oxidopamine results in decreased expression of BCL2 protein CTD PMID:33571554 oxidopamine multiple interactions ISO Bcl2 (Mus musculus) 6480464 [2-chloro-5-hydroxyphenylglycine co-treated with Oxidopamine] results in decreased expression of BCL2 protein and [6-methyl-2-(phenylethynyl)pyridine co-treated with Oxidopamine] results in decreased expression of BCL2 protein CTD PMID:33571554 oxidopamine decreases expression ISO BCL2 (Homo sapiens) 6480464 Oxidopamine results in decreased expression of BCL2 mRNA and Oxidopamine results in decreased expression of BCL2 protein CTD PMID:25446857 more ... oxidopamine decreases expression EXP 6480464 Oxidopamine results in decreased expression of BCL2 protein CTD PMID:16480889 more ... oxidopamine multiple interactions ISO BCL2 (Homo sapiens) 6480464 PINK1 protein affects the reaction [salvin inhibits the reaction [Oxidopamine results in decreased expression of BCL2 protein]] more ... CTD PMID:25446857 more ... oxomalononitrile multiple interactions ISO BCL2 (Homo sapiens) 6480464 PK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to mesoxalonitrile] CTD PMID:12730627 oxomalononitrile decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to mesoxalonitrile CTD PMID:12730627 oxytocin increases expression EXP 6480464 Oxytocin results in increased expression of BCL2 protein CTD PMID:23707249 ozone increases expression EXP 6480464 Ozone results in increased expression of BCL2 protein CTD PMID:23988432 ozone multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Air Pollutants results in increased abundance of Ozone] which affects the expression of BCL2 mRNA CTD PMID:35430440 ozone affects expression ISO BCL2 (Homo sapiens) 6480464 Ozone affects the expression of BCL2 mRNA CTD PMID:35936665 ozone increases expression ISO Bcl2 (Mus musculus) 6480464 Ozone results in increased expression of BCL2 mRNA CTD PMID:33026818 ozone multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of BCL2 mRNA more ... CTD PMID:29202868 and PMID:34911549 p-menthan-3-ol decreases expression ISO BCL2 (Homo sapiens) 6480464 Menthol results in decreased expression of BCL2 mRNA CTD PMID:26760959 Pachymic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 pachymic acid results in decreased expression of BCL2 mRNA CTD PMID:35524978 Pachymic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 dorsomorphin inhibits the reaction [pachymic acid results in decreased expression of BCL2 mRNA] and ursodoxicoltaurine inhibits the reaction [pachymic acid results in decreased expression of BCL2 mRNA] CTD PMID:35524978 paclitaxel multiple interactions ISO BCL2 (Homo sapiens) 6480464 3 more ... CTD PMID:10822281 more ... paclitaxel decreases expression ISO Bcl2 (Mus musculus) 6480464 Paclitaxel results in decreased expression of BCL2 mRNA and Paclitaxel results in decreased expression of BCL2 protein CTD PMID:35584731 and PMID:35995259 paclitaxel decreases expression EXP 6480464 Paclitaxel results in decreased expression of BCL2 mRNA and Paclitaxel results in decreased expression of BCL2 protein CTD PMID:35921949 and PMID:36966900 paclitaxel multiple interactions ISO Bcl2 (Mus musculus) 6480464 [glabridin co-treated with Paclitaxel] results in decreased expression of BCL2 protein and rottlerin promotes the reaction [Paclitaxel results in decreased expression of BCL2 protein] CTD PMID:35995259 and PMID:37419298 paclitaxel multiple interactions EXP 6480464 Hesperidin inhibits the reaction [Paclitaxel results in decreased expression of BCL2 mRNA] and Hesperidin inhibits the reaction [Paclitaxel results in decreased expression of BCL2 protein] CTD PMID:35921949 and PMID:36966900 paclitaxel increases cleavage ISO BCL2 (Homo sapiens) 6480464 Paclitaxel results in increased cleavage of BCL2 protein CTD PMID:10822281 paclitaxel decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 mRNA results in decreased susceptibility to Paclitaxel and BCL2 protein results in decreased susceptibility to Paclitaxel CTD PMID:16275990 and PMID:16322897 paclitaxel affects response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein affects the susceptibility to Paclitaxel CTD PMID:20610805 paclitaxel decreases degradation ISO BCL2 (Homo sapiens) 6480464 Paclitaxel results in decreased degradation of BCL2 protein CTD PMID:12126962 paclitaxel affects localization ISO BCL2 (Homo sapiens) 6480464 Paclitaxel affects the localization of BCL2 protein CTD PMID:12126962 paclitaxel decreases activity ISO BCL2 (Homo sapiens) 6480464 Paclitaxel results in decreased activity of BCL2 protein CTD PMID:10881025 paclitaxel increases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein mutant form results in increased susceptibility to Paclitaxel CTD PMID:20610805 paclitaxel increases expression ISO BCL2 (Homo sapiens) 6480464 Paclitaxel results in increased expression of BCL2 mRNA CTD PMID:26884726 paclitaxel decreases expression ISO BCL2 (Homo sapiens) 6480464 Paclitaxel results in decreased expression of BCL2 mRNA and Paclitaxel results in decreased expression of BCL2 protein CTD PMID:10822281 more ... paclitaxel increases phosphorylation ISO BCL2 (Homo sapiens) 6480464 Paclitaxel results in increased phosphorylation of BCL2 protein CTD PMID:10502406 more ... paeoniflorin multiple interactions EXP 6480464 peoniflorin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA] CTD PMID:27053303 paeoniflorin multiple interactions ISO Bcl2 (Mus musculus) 6480464 peoniflorin inhibits the reaction [Neomycin results in decreased expression of BCL2 mRNA] and peoniflorin inhibits the reaction [Neomycin results in decreased expression of BCL2 protein] CTD PMID:29292089 Paeonol multiple interactions ISO Bcl2 (Mus musculus) 6480464 paeonol inhibits the reaction [Epirubicin results in decreased expression of BCL2 protein] CTD PMID:26646421 and PMID:29505745 Paeonol multiple interactions EXP 6480464 [Doxorubicin co-treated with paeonol] results in increased expression of BCL2 mRNA CTD PMID:31307187 palmatine multiple interactions ISO Bcl2 (Mus musculus) 6480464 palmatine inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein] CTD PMID:36169195 Palmitic acid(d3) decreases expression ISO BCL2 (Homo sapiens) 242905211 Palmitic acid decreases expression of BCL2 mRNA in cardiomyocytes RGD Palmitic acid(d3) multiple interactions ISO BCL2 (Homo sapiens) 242905211 ghrelin inhibits the reaction [Palmitic acid decreases expression of BCL2 mRNA in cardiomyocytes] RGD pamidronate decreases expression ISO BCL2 (Homo sapiens) 6480464 pamidronate results in decreased expression of BCL2 protein CTD PMID:10780527 Panaxynol increases expression EXP 6480464 falcarinol results in increased expression of BCL2 protein CTD PMID:19800326 Panduratin A decreases expression ISO BCL2 (Homo sapiens) 6480464 panduratin A results in decreased expression of BCL2 protein CTD PMID:16497706 panobinostat multiple interactions ISO BCL2 (Homo sapiens) 6480464 (+)-JQ1 compound promotes the reaction [Panobinostat affects the expression of BCL2 mRNA] more ... CTD PMID:24435446 more ... panobinostat decreases expression ISO BCL2 (Homo sapiens) 6480464 panobinostat results in decreased expression of BCL2 mRNA and panobinostat results in decreased expression of BCL2 protein CTD PMID:24435446 and PMID:26272509 panobinostat affects expression ISO BCL2 (Homo sapiens) 6480464 panobinostat affects the expression of BCL2 mRNA CTD PMID:26733615 paracetamol decreases expression ISO BCL2 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of BCL2 mRNA CTD PMID:9444671 paracetamol increases expression ISO BCL2 (Homo sapiens) 6480464 Acetaminophen results in increased expression of BCL2 mRNA CTD PMID:26690555 and PMID:29067470 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of BCL2 mRNA and Acetaminophen results in decreased expression of BCL2 protein CTD PMID:22093918 and PMID:26767949 paracetamol decreases expression ISO Bcl2 (Mus musculus) 6480464 Acetaminophen results in decreased expression of BCL2 protein CTD PMID:18467506 more ... paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of BCL2 mRNA and Acetaminophen results in increased expression of BCL2 protein modified form CTD PMID:20166895 and PMID:33387578 paracetamol multiple interactions EXP 6480464 Acetaminophen inhibits the reaction [Vitamin K 3 results in decreased expression of BCL2 mRNA] more ... CTD PMID:19265712 more ... paracetamol increases expression ISO Bcl2 (Mus musculus) 6480464 Acetaminophen results in increased expression of BCL2 mRNA and Acetaminophen results in increased expression of BCL2 protein CTD PMID:12540782 more ... paracetamol multiple interactions ISO Bcl2 (Mus musculus) 6480464 Acetaminophen promotes the reaction [saikosaponin D results in increased expression of BCL2 mRNA] more ... CTD PMID:12540782 more ... paraoxon decreases expression ISO Bcl2 (Mus musculus) 6480464 Paraoxon results in decreased expression of BCL2 mRNA CTD PMID:27117976 paraoxon decreases expression EXP 6480464 Paraoxon results in decreased expression of BCL2 mRNA and Paraoxon results in decreased expression of BCL2 protein CTD PMID:28603072 and PMID:31493121 paraquat multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Lithium Chloride results in increased abundance of Lithium] promotes the reaction [Paraquat results in increased expression of BCL2 mRNA] more ... CTD PMID:26074776 more ... paraquat increases expression EXP 6480464 Paraquat results in increased expression of BCL2 mRNA CTD PMID:30112919 paraquat decreases expression ISO Bcl2 (Mus musculus) 6480464 Paraquat results in decreased expression of BCL2 mRNA and Paraquat results in decreased expression of BCL2 protein CTD PMID:25628599 more ... paraquat decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to Paraquat CTD PMID:15475374 paraquat increases expression ISO BCL2 (Homo sapiens) 6480464 Paraquat results in increased expression of BCL2 mRNA CTD PMID:22230393 more ... paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of BCL2 mRNA and Paraquat results in decreased expression of BCL2 protein CTD PMID:12714668 more ... paraquat multiple interactions EXP 6480464 [Paraquat co-treated with Decitabine] results in decreased expression of BCL2 protein more ... CTD PMID:12714668 more ... paraquat multiple interactions ISO Bcl2 (Mus musculus) 6480464 [crocin co-treated with Paraquat] results in decreased expression of BCL2 mRNA more ... CTD PMID:12654481 more ... paraquat decreases expression ISO BCL2 (Homo sapiens) 6480464 Paraquat results in decreased expression of BCL2 mRNA and Paraquat results in decreased expression of BCL2 protein CTD PMID:18836921 more ... parathion decreases expression ISO BCL2 (Homo sapiens) 6480464 Parathion results in decreased expression of BCL2 protein CTD PMID:36058312 paricalcitol multiple interactions ISO BCL2 (Homo sapiens) 6480464 [paricalcitol co-treated with arsenic trioxide] results in decreased expression of BCL2 CTD PMID:15781666 parthenolide multiple interactions ISO BCL2 (Homo sapiens) 6480464 [[parthenolide results in decreased activity of RELA protein] which results in decreased expression of BCL2 protein] which results in increased susceptibility to Tamoxifen more ... CTD PMID:20154269 and PMID:21928377 parthenolide decreases expression ISO BCL2 (Homo sapiens) 6480464 parthenolide results in decreased expression of BCL2 mRNA and parthenolide results in decreased expression of BCL2 protein CTD PMID:21928377 pefloxacin decreases expression ISO BCL2 (Homo sapiens) 6480464 Pefloxacin metabolite results in decreased expression of BCL2 protein CTD PMID:29275239 pemetrexed multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Cisplatin co-treated with Pemetrexed co-treated with Valproic Acid] results in decreased expression of BCL2 protein and [Cisplatin co-treated with Pemetrexed co-treated with Vorinostat] results in decreased expression of BCL2 protein CTD PMID:19351772 pendimethalin decreases expression EXP 6480464 pendimethalin results in decreased expression of BCL2 mRNA CTD PMID:30459330 Pendulone decreases expression ISO BCL2 (Homo sapiens) 6480464 pendulone results in decreased expression of BCL2 protein CTD PMID:35288263 pentanal decreases expression ISO BCL2 (Homo sapiens) 6480464 pentanal results in decreased expression of BCL2 mRNA CTD PMID:26079696 pentobarbital increases expression EXP 6480464 Pentobarbital results in increased expression of BCL2 CTD PMID:17715682 perfluoroheptanoic acid increases expression EXP 6480464 perfluoro-n-heptanoic acid results in increased expression of BCL2 protein CTD PMID:33220336 perfluorohexanesulfonic acid increases expression ISO Bcl2 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of BCL2 mRNA CTD PMID:37995155 perfluorononanoic acid decreases expression EXP 6480464 perfluoro-n-nonanoic acid results in decreased expression of BCL2 mRNA and perfluoro-n-nonanoic acid results in decreased expression of BCL2 protein CTD PMID:19196829 more ... perfluorononanoic acid increases expression ISO BCL2 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in increased expression of BCL2 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of BCL2 mRNA and perfluorooctane sulfonic acid results in decreased expression of BCL2 protein CTD PMID:19468714 more ... perfluorooctane-1-sulfonic acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 Cannabidiol inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of BCL2 mRNA] and Cannabidiol inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of BCL2 protein] CTD PMID:36988283 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of BCL2 protein CTD PMID:31588057 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of BCL2 mRNA and perfluorooctane sulfonic acid results in decreased expression of BCL2 protein CTD PMID:24616003 more ... perfluorooctane-1-sulfonic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of BCL2 mRNA] more ... CTD PMID:22976841 more ... perfluorooctane-1-sulfonic acid increases expression ISO Bcl2 (Mus musculus) 6480464 perfluorooctane sulfonic acid results in increased expression of BCL2 mRNA CTD PMID:23562911 perfluorooctane-1-sulfonic acid decreases expression ISO Bcl2 (Mus musculus) 6480464 perfluorooctane sulfonic acid results in decreased expression of BCL2 mRNA and perfluorooctane sulfonic acid results in decreased expression of BCL2 protein CTD PMID:21115943 more ... perfluorooctanoic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of BCL2 mRNA and perfluorooctanoic acid results in decreased expression of BCL2 protein CTD PMID:19468714 more ... perfluorooctanoic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 [perfluorooctanoic acid co-treated with Carbenoxolone] results in decreased expression of BCL2 protein and Tretinoin inhibits the reaction [perfluorooctanoic acid results in decreased expression of BCL2 protein] CTD PMID:32971237 perfluorooctanoic acid increases expression ISO Bcl2 (Mus musculus) 6480464 perfluorooctanoic acid results in increased expression of BCL2 mRNA CTD PMID:32320774 perfluorooctanoic acid decreases expression ISO Bcl2 (Mus musculus) 6480464 perfluorooctanoic acid results in decreased expression of BCL2 protein CTD PMID:28219760 and PMID:35066053 perfluoroundecanoic acid decreases expression EXP 6480464 perfluoroundecanoic acid results in decreased expression of BCL2 protein CTD PMID:33549592 perillyl alcohol multiple interactions ISO Bcl2 (Mus musculus) 6480464 perillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BCL2 protein] CTD PMID:19161993 permethrin increases expression ISO BCL2 (Homo sapiens) 6480464 Permethrin results in increased expression of BCL2 mRNA mutant form CTD PMID:28624474 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of BCL2 gene CTD PMID:33148267 peroxynitrous acid decreases expression EXP 6480464 Peroxynitrous Acid results in decreased expression of BCL2 mRNA and Peroxynitrous Acid results in decreased expression of BCL2 protein CTD PMID:20869986 peroxynitrous acid multiple interactions EXP 6480464 Curcumin inhibits the reaction [Peroxynitrous Acid results in decreased expression of BCL2 mRNA] and Curcumin inhibits the reaction [Peroxynitrous Acid results in decreased expression of BCL2 protein] CTD PMID:20869986 pevonedistat affects expression ISO BCL2 (Homo sapiens) 6480464 pevonedistat affects the expression of BCL2 mRNA CTD PMID:24634471 phenazine-1-carboxylic acid affects binding ISO BCL2 (Homo sapiens) 6480464 1-phenazinecarboxylic acid analog binds to BCL2 protein CTD PMID:25765238 phenethyl caffeate multiple interactions ISO Bcl2 (Mus musculus) 6480464 caffeic acid phenethyl ester inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein] CTD PMID:34743973 phenethyl isothiocyanate decreases expression ISO BCL2 (Homo sapiens) 6480464 phenethyl isothiocyanate results in decreased expression of BCL2 protein CTD PMID:16054126 phenobarbital multiple interactions ISO Bcl2 (Mus musculus) 6480464 Phenobarbital inhibits the reaction [MYC protein results in decreased expression of BCL2 protein] CTD PMID:10449034 phenobarbital decreases expression ISO Bcl2 (Mus musculus) 6480464 Phenobarbital results in decreased expression of BCL2 mRNA CTD PMID:31170421 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of BCL2 mRNA and Phenobarbital results in increased expression of BCL2 protein CTD PMID:17456340 and PMID:23273579 phenobarbital increases expression ISO Bcl2 (Mus musculus) 6480464 Phenobarbital results in increased expression of BCL2 protein CTD PMID:10426811 phenylephrine multiple interactions EXP 6480464 BCL2 protein affects the reaction [Phenylephrine results in increased expression of TIMP1 protein] more ... CTD PMID:11042672 more ... phenylephrine decreases expression ISO BCL2 (Homo sapiens) 6480464 Phenylephrine results in decreased expression of BCL2 protein CTD PMID:31605733 phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of BCL2 mRNA and Phenylephrine results in increased expression of BCL2 protein CTD PMID:19910689 phenytoin multiple interactions ISO BCL2 (Homo sapiens) 6480464 Phenytoin results in increased expression of and affects the localization of BCL2 protein CTD PMID:10695937 phenytoin decreases expression ISO Bcl2 (Mus musculus) 6480464 Phenytoin results in decreased expression of BCL2 mRNA CTD PMID:9118846 PhIP multiple interactions ISO Bcl2 (Mus musculus) 6480464 [2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine co-treated with [Dexamethasone co-treated with INS protein co-treated with PRL protein]] results in increased expression of BCL2 protein CTD PMID:11751460 PhIP increases expression ISO BCL2 (Homo sapiens) 6480464 2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:18174961 and PMID:23810796 phloretin multiple interactions EXP 6480464 [Ruthenium binds to Phloretin] inhibits the reaction [9 more ... CTD PMID:34896434 phloroglucinol decreases expression ISO BCL2 (Homo sapiens) 6480464 Phloroglucinol metabolite results in decreased expression of BCL2 protein CTD PMID:22796323 phorbol 13-acetate 12-myristate multiple interactions ISO Bcl2 (Mus musculus) 6480464 [9 more ... CTD PMID:15538571 more ... phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 Tetradecanoylphorbol Acetate inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of BCL2 protein] CTD PMID:36925031 phorbol 13-acetate 12-myristate increases expression ISO BCL2 (Homo sapiens) 6480464 Tetradecanoylphorbol Acetate results in increased expression of BCL2 protein CTD PMID:24073338 and PMID:9295281 phorbol 13-acetate 12-myristate decreases expression ISO BCL2 (Homo sapiens) 6480464 Tetradecanoylphorbol Acetate results in decreased expression of BCL2 protein CTD PMID:11139146 phorbol 13-acetate 12-myristate multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Graphite analog co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of BCL2 protein more ... CTD PMID:15748703 more ... phorbol 13-acetate 12-myristate increases expression ISO Bcl2 (Mus musculus) 6480464 Tetradecanoylphorbol Acetate results in increased expression of BCL2 protein CTD PMID:19161993 phosphatidylcholine multiple interactions ISO BCL2 (Homo sapiens) 6480464 [rubitecan co-treated with Phosphatidylcholines] results in decreased expression of BCL2 protein CTD PMID:21695227 phosphoramide mustard decreases expression EXP 6480464 phosphoramide mustard results in decreased expression of BCL2 protein CTD PMID:26708502 phylloquinone multiple interactions ISO BCL2 (Homo sapiens) 6480464 [sorafenib co-treated with Vitamin K 1] results in decreased expression of BCL2 protein CTD PMID:20301194 phylloquinone multiple interactions EXP 6480464 [Warfarin co-treated with Vitamin K 1] results in decreased expression of BCL2 protein and Vitamin K 2 inhibits the reaction [[Warfarin co-treated with Vitamin K 1] results in decreased expression of BCL2 protein] CTD PMID:27212383 phytol multiple interactions ISO Bcl2 (Mus musculus) 6480464 Phytol inhibits the reaction [Benzo(a)pyrene results in decreased expression of BCL2 protein] CTD PMID:30520250 phytosphingosine increases expression ISO BCL2 (Homo sapiens) 6480464 phytosphingosine results in increased expression of BCL2 protein CTD PMID:36334778 piclamilast multiple interactions EXP 6480464 piclamilast inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of BCL2 mRNA] CTD PMID:34627785 picoxystrobin decreases expression ISO BCL2 (Homo sapiens) 6480464 picoxystrobin results in decreased expression of BCL2 mRNA CTD PMID:33512557 pimozide decreases expression ISO BCL2 (Homo sapiens) 6480464 Pimozide results in decreased expression of BCL2 mRNA CTD PMID:12130671 pinostrobin multiple interactions EXP 6480464 pinostrobin inhibits the reaction [Azoxymethane results in increased expression of BCL2 protein] and pinostrobin inhibits the reaction [Cadmium results in decreased expression of BCL2 mRNA] CTD PMID:37342552 and PMID:38078205 pinostrobin decreases expression ISO BCL2 (Homo sapiens) 6480464 pinostrobin results in decreased expression of BCL2 protein CTD PMID:37777166 pioglitazone multiple interactions EXP 6480464 [naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in decreased expression of BCL2 mRNA] and Pioglitazone inhibits the reaction [Quinolinic Acid results in decreased expression of BCL2 mRNA] CTD PMID:30130594 piperazine decreases expression ISO BCL2 (Homo sapiens) 6480464 Piperazine analog results in decreased expression of BCL2 protein CTD PMID:28874085 piperidine multiple interactions ISO Bcl2 (Mus musculus) 6480464 piperidine inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein] CTD PMID:17706638 piperine decreases expression ISO BCL2 (Homo sapiens) 6480464 piperine results in decreased expression of BCL2 protein CTD PMID:28341137 piperine multiple interactions ISO BCL2 (Homo sapiens) 6480464 [piperine analog co-treated with Paclitaxel] results in decreased expression of BCL2 protein and [piperine co-treated with Curcumin] results in decreased expression of BCL2 protein CTD PMID:30935902 and PMID:37244399 Pirarubicin decreases expression ISO Bcl2 (Mus musculus) 6480464 pirarubicin results in decreased expression of BCL2 protein CTD PMID:37471631 Pirarubicin multiple interactions ISO Bcl2 (Mus musculus) 6480464 MIAT affects the reaction [pirarubicin results in decreased expression of BCL2 protein] more ... CTD PMID:37471631 pirinixic acid multiple interactions EXP 6480464 [[pirinixic acid results in increased expression of UCP2 protein] which results in decreased expression of BCL2 protein] which results in increased susceptibility to Potassium Cyanide more ... CTD PMID:19361538 pirinixic acid increases expression ISO Bcl2 (Mus musculus) 6480464 pirinixic acid results in increased expression of BCL2 protein CTD PMID:10426811 PK-11195 multiple interactions ISO BCL2 (Homo sapiens) 6480464 PK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to alachlor] more ... CTD PMID:12730627 PK-11195 decreases expression EXP 6480464 PK 11195 results in decreased expression of BCL2 CTD PMID:11266385 PK-11195 decreases expression ISO BCL2 (Homo sapiens) 6480464 PK 11195 results in decreased expression of BCL2 protein CTD PMID:15519653 platinum multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Gold analog co-treated with Platinum] results in decreased expression of BCL2 mRNA CTD PMID:25846798 platinum(0) multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Gold analog co-treated with Platinum] results in decreased expression of BCL2 mRNA CTD PMID:25846798 platycodin D decreases expression ISO BCL2 (Homo sapiens) 6480464 platycodin D results in decreased expression of BCL2 protein CTD PMID:20412017 more ... plumbagin decreases expression EXP 6480464 plumbagin results in decreased expression of BCL2 protein CTD PMID:34302802 poly(I:C) decreases expression ISO BCL2 (Homo sapiens) 6480464 Poly I-C results in decreased expression of BCL2 protein CTD PMID:21418039 Polygodial decreases expression ISO BCL2 (Homo sapiens) 6480464 polygodial results in decreased expression of BCL2 protein CTD PMID:30935903 polysulfur multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Sulfur co-treated with folpet] results in decreased expression of BCL2 mRNA more ... CTD PMID:35564597 ponatinib multiple interactions ISO BCL2 (Homo sapiens) 6480464 (+)-JQ1 compound promotes the reaction [ponatinib results in decreased expression of BCL2 protein] and ponatinib promotes the reaction [(+)-JQ1 compound results in decreased expression of BCL2 protein] CTD PMID:25053825 ponatinib multiple interactions ISO Bcl2 (Mus musculus) 6480464 [gossypol acetic acid results in increased abundance of Gossypol] promotes the reaction [ponatinib results in decreased expression of BCL2 mRNA] and ponatinib promotes the reaction [[gossypol acetic acid results in increased abundance of Gossypol] which results in decreased expression of BCL2 mRNA] CTD PMID:34699866 ponatinib decreases expression ISO Bcl2 (Mus musculus) 6480464 ponatinib results in decreased expression of BCL2 mRNA CTD PMID:34699866 ponatinib decreases expression ISO BCL2 (Homo sapiens) 6480464 ponatinib results in decreased expression of BCL2 protein CTD PMID:25053825 Ponicidin decreases expression ISO BCL2 (Homo sapiens) 127285620 Ponicidin decreases expression of BCL2 protein in the stomach RGD porphyrins increases expression ISO BCL2 (Homo sapiens) 6480464 Porphyrins results in increased expression of BCL2 mRNA CTD PMID:26468117 potassium bromate increases expression EXP 6480464 potassium bromate results in increased expression of BCL2 protein CTD PMID:33219891 potassium bromate multiple interactions EXP 6480464 Squalene inhibits the reaction [potassium bromate results in increased expression of BCL2 protein] CTD PMID:33219891 potassium cyanide decreases response to substance EXP 6480464 BCL2 protein results in decreased susceptibility to Potassium Cyanide CTD PMID:19361538 potassium cyanide multiple interactions EXP 6480464 [[pirinixic acid results in increased expression of UCP2 protein] which results in decreased expression of BCL2 protein] which results in increased susceptibility to Potassium Cyanide and Potassium Cyanide promotes the reaction [[pirinixic acid results in increased expression of UCP2 protein] which results in increased degradation of BCL2 protein] CTD PMID:19361538 potassium dichromate affects localization EXP 6480464 Potassium Dichromate affects the localization of BCL2 protein CTD PMID:21262251 potassium dichromate decreases expression EXP 6480464 Potassium Dichromate results in decreased expression of BCL2 protein CTD PMID:21262251 more ... potassium dichromate decreases expression ISO Bcl2 (Mus musculus) 6480464 Potassium Dichromate results in decreased expression of BCL2 protein CTD PMID:19219935 potassium dichromate multiple interactions EXP 6480464 [6-chloro-2 more ... CTD PMID:21262251 more ... potassium iodide decreases expression EXP 6480464 Potassium Iodide results in decreased expression of BCL2 protein CTD PMID:32593569 Pramanicin decreases expression ISO BCL2 (Homo sapiens) 6480464 pramanicin analog results in decreased expression of BCL2 mRNA and pramanicin analog results in decreased expression of BCL2 protein CTD PMID:23441183 Pramanicin affects response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein affects the susceptibility to pramanicin CTD PMID:23441183 Pranoprofen decreases expression ISO BCL2 (Homo sapiens) 6480464 pyranoprofen results in decreased expression of BCL2 protein CTD PMID:31765691 pravastatin multiple interactions ISO Bcl2 (Mus musculus) 6480464 [LDLR gene mutant form results in increased susceptibility to Pravastatin] which affects the expression of BCL2 protein CTD PMID:26875785 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of BCL2 mRNA CTD PMID:19162173 proanthocyanidin multiple interactions EXP 6480464 Proanthocyanidins inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA] and Proanthocyanidins inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] CTD PMID:18611398 proanthocyanidin decreases expression ISO BCL2 (Homo sapiens) 6480464 Proanthocyanidins results in decreased expression of BCL2 mRNA and Proanthocyanidins results in decreased expression of BCL2 protein CTD PMID:29654773 probenecid multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Probenecid co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:24768735 probucol multiple interactions EXP 6480464 Probucol inhibits the reaction [APP protein modified form results in decreased expression of BCL2 mRNA] CTD PMID:26111763 procyanidin B2 multiple interactions ISO Bcl2 (Mus musculus) 6480464 procyanidin B2 affects the reaction [Diquat affects the expression of BCL2 mRNA] and procyanidin B2 affects the reaction [Hydrogen Peroxide affects the expression of BCL2 mRNA] CTD PMID:27057282 prodigiosin multiple interactions EXP 6480464 Prodigiosin inhibits the reaction [Aluminum Chloride results in decreased expression of BCL2 protein] CTD PMID:36447373 progesterone increases expression EXP 6480464 Progesterone results in increased expression of BCL2 mRNA and Progesterone results in increased expression of BCL2 protein CTD PMID:15941375 progesterone multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of BCL2 protein more ... CTD PMID:18829022 more ... progesterone multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Progesterone co-treated with Estrogens and Conjugated (USP)] results in increased expression of BCL2 protein CTD PMID:15779298 promethazine decreases expression ISO BCL2 (Homo sapiens) 6480464 Promethazine results in decreased expression of BCL2 protein CTD PMID:31682805 propionic acid decreases expression EXP 6480464 propionic acid results in decreased expression of BCL2 mRNA CTD PMID:26048086 propionic acid multiple interactions EXP 6480464 Bee Venoms inhibits the reaction [propionic acid results in decreased expression of BCL2 mRNA] CTD PMID:26048086 propofol increases expression EXP 6480464 Propofol results in increased expression of BCL2 more ... CTD PMID:19703415 and PMID:23353162 propofol decreases expression ISO BCL2 (Homo sapiens) 6480464 Propofol results in decreased expression of BCL2 protein CTD PMID:28804952 propofol multiple interactions ISO BCL2 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [Propofol results in decreased expression of BCL2 protein] CTD PMID:28804952 propofol increases expression ISO Bcl2 (Mus musculus) 6480464 Propofol results in increased expression of BCL2 protein CTD PMID:21786383 propofol multiple interactions EXP 6480464 [resveratrol co-treated with Propofol] results in increased expression of BCL2 more ... CTD PMID:19703415 more ... propranolol increases expression EXP 6480464 Propranolol results in increased expression of BCL2 mRNA CTD PMID:11218852 propranolol multiple interactions ISO BCL2 (Homo sapiens) 6480464 ANGPT2 protein inhibits the reaction [Propranolol results in decreased expression of BCL2 protein] CTD PMID:31838054 propranolol decreases expression ISO BCL2 (Homo sapiens) 6480464 Propranolol results in decreased expression of BCL2 protein CTD PMID:31838054 propylparaben increases expression ISO BCL2 (Homo sapiens) 6480464 propylparaben results in increased expression of BCL2 mRNA CTD PMID:24481588 propylparaben decreases expression ISO Bcl2 (Mus musculus) 6480464 propylparaben results in decreased expression of BCL2 mRNA CTD PMID:33358972 prostaglandin E2 increases expression ISO BCL2 (Homo sapiens) 6480464 Dinoprostone results in increased expression of BCL2 protein CTD PMID:9443418 prostaglandin E2 multiple interactions ISO Bcl2 (Mus musculus) 6480464 Dinoprostone inhibits the reaction [PTGS1 gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of BCL2 protein]] CTD PMID:25432964 Protolichesterinic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 protolichesterinic acid results in decreased expression of BCL2 protein CTD PMID:22063921 pterostilbene multiple interactions ISO BCL2 (Homo sapiens) 6480464 [pterostilbene co-treated with Quercetin] results in decreased expression of BCL2 protein more ... CTD PMID:18852136 and PMID:31139082 pterostilbene increases expression ISO Bcl2 (Mus musculus) 6480464 pterostilbene results in increased expression of BCL2 protein CTD PMID:20681671 pterostilbene decreases expression ISO BCL2 (Homo sapiens) 6480464 pterostilbene results in decreased expression of BCL2 mRNA and pterostilbene results in decreased expression of BCL2 protein CTD PMID:20152895 and PMID:24936659 puerarin multiple interactions EXP 6480464 puerarin inhibits the reaction [[Ethanol co-treated with Carbon Tetrachloride] results in increased expression of BCL2 mRNA] more ... CTD PMID:16426832 and PMID:27717697 puerarin multiple interactions ISO BCL2 (Homo sapiens) 6480464 Arsenic Trioxide promotes the reaction [puerarin results in decreased expression of BCL2 mRNA] and puerarin inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein] CTD PMID:20416161 and PMID:35331853 puerarin decreases expression ISO BCL2 (Homo sapiens) 6480464 puerarin results in decreased expression of BCL2 mRNA and puerarin results in decreased expression of BCL2 protein CTD PMID:16055262 and PMID:20416161 Punicalagin decreases expression ISO BCL2 (Homo sapiens) 6480464 punicalagin results in decreased expression of BCL2 protein CTD PMID:33720461 Punicalagin multiple interactions EXP 6480464 punicalagin inhibits the reaction [Isoproterenol results in decreased expression of BCL2 protein] CTD PMID:37806379 purine-6-thiol decreases expression ISO Bcl2 (Mus musculus) 6480464 Mercaptopurine results in decreased expression of BCL2 protein CTD PMID:9058596 purine-6-thiol multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Doxorubicin co-treated with Dexamethasone co-treated with Vincristine co-treated with Cytarabine co-treated with Mercaptopurine co-treated with Methotrexate co-treated with Cyclophosphamide co-treated with Enzymes and Coenzymes] results in increased expression of BCL2 protein CTD PMID:21182165 puromycin decreases expression ISO BCL2 (Homo sapiens) 6480464 Puromycin results in decreased expression of BCL2 protein CTD PMID:21244482 puromycin multiple interactions ISO BCL2 (Homo sapiens) 6480464 Melatonin promotes the reaction [Puromycin results in decreased expression of BCL2 protein] CTD PMID:21244482 putrescine decreases expression EXP 6480464 Putrescine results in decreased expression of BCL2 protein CTD PMID:17606387 pyrethrins affects expression ISO BCL2 (Homo sapiens) 6480464 Pyrethrins affects the expression of BCL2 protein CTD PMID:27939866 pyrethrins increases expression EXP 6480464 Pyrethrins results in increased expression of BCL2 mRNA CTD PMID:34896426 and PMID:36053783 pyridaben decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to pyridaben CTD PMID:12730627 pyridaben multiple interactions ISO BCL2 (Homo sapiens) 6480464 PK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to pyridaben] CTD PMID:12730627 Pyridostigmine bromide multiple interactions ISO BCL2 (Homo sapiens) 6480464 SOD2 protein SNP inhibits the reaction [Pyridostigmine Bromide results in decreased expression of BCL2 mRNA] CTD PMID:31175926 Pyridostigmine bromide decreases expression ISO BCL2 (Homo sapiens) 6480464 Pyridostigmine Bromide results in decreased expression of BCL2 mRNA and Pyridostigmine Bromide results in decreased expression of BCL2 protein CTD PMID:31175926 pyridoxal 5'-phosphate decreases expression EXP 6480464 Pyridoxal Phosphate results in decreased expression of BCL2 protein CTD PMID:16690808 pyrovalerone decreases expression ISO BCL2 (Homo sapiens) 6480464 pyrovalerone analog results in decreased expression of BCL2 protein CTD PMID:28578026 pyrroles decreases expression ISO BCL2 (Homo sapiens) 6480464 Pyrroles analog results in decreased expression of BCL2 protein CTD PMID:30543781 pyrroles multiple interactions ISO BCL2 (Homo sapiens) 6480464 pifithrin inhibits the reaction [Pyrroles analog results in decreased expression of BCL2 protein] CTD PMID:30543781 pyrrolidine dithiocarbamate increases phosphorylation ISO BCL2 (Homo sapiens) 6480464 pyrrolidine dithiocarbamic acid results in increased phosphorylation of BCL2 protein CTD PMID:12482581 pyrrolidine dithiocarbamate multiple interactions ISO BCL2 (Homo sapiens) 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [resveratrol results in increased expression of BCL2 mRNA] and pyrrolidine dithiocarbamic acid inhibits the reaction [Testosterone results in increased expression of BCL2 mRNA] CTD PMID:16139439 and PMID:21161674 pyrrolidine dithiocarbamate multiple interactions EXP 6480464 [Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2 mRNA more ... CTD PMID:20920558 and PMID:22085843 pyrroloquinoline quinone multiple interactions ISO BCL2 (Homo sapiens) 6480464 PQQ Cofactor inhibits the reaction [Rotenone affects the expression of BCL2 protein] and PQQ Cofactor inhibits the reaction [Rotenone results in decreased expression of BCL2 protein] CTD PMID:24755484 and PMID:26276080 pyrroloquinoline quinone decreases expression ISO Bcl2 (Mus musculus) 6480464 PQQ Cofactor analog results in decreased expression of BCL2 mRNA and PQQ Cofactor results in decreased expression of BCL2 mRNA CTD PMID:32068067 quartz multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Ascorbic Acid co-treated with Quartz] results in increased expression of BCL2 mRNA and PSMB9 inhibits the reaction [Quartz results in decreased expression of BCL2 protein] CTD PMID:27381660 and PMID:35506645 quartz decreases expression ISO BCL2 (Homo sapiens) 6480464 Quartz results in decreased expression of BCL2 protein CTD PMID:35506645 quercetin decreases expression EXP 6480464 Quercetin analog results in decreased expression of BCL2 protein and Quercetin results in decreased expression of BCL2 protein CTD PMID:23281070 and PMID:23907460 quercetin multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]] more ... CTD PMID:14505808 more ... quercetin increases expression EXP 6480464 Quercetin results in increased expression of BCL2 mRNA CTD PMID:23281070 quercetin affects expression EXP 6480464 Quercetin affects the expression of BCL2 protein CTD PMID:22000973 quercetin increases phosphorylation ISO BCL2 (Homo sapiens) 6480464 Quercetin results in increased phosphorylation of BCL2 protein CTD PMID:16059641 quercetin affects expression ISO BCL2 (Homo sapiens) 6480464 Quercetin affects the expression of BCL2 protein CTD PMID:15975156 quercetin increases expression ISO BCL2 (Homo sapiens) 6480464 Quercetin results in increased expression of BCL2 mRNA CTD PMID:23727915 quercetin decreases expression ISO BCL2 (Homo sapiens) 6480464 Quercetin analog results in decreased expression of BCL2 protein more ... CTD PMID:10437144 more ... quercetin decreases expression ISO Bcl2 (Mus musculus) 6480464 Quercetin results in decreased expression of BCL2 more ... CTD PMID:15538571 more ... quercetin multiple interactions ISO Bcl2 (Mus musculus) 6480464 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Quercetin results in decreased expression of BCL2 mRNA] more ... CTD PMID:15538571 more ... quercetin multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Cisplatin co-treated with Quercetin] results in decreased expression of BCL2 protein more ... CTD PMID:11597122 more ... quercetin 3-O-beta-D-galactopyranoside multiple interactions EXP 6480464 hyperoside inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] CTD PMID:31326407 quercetin 3-O-beta-D-glucofuranoside decreases expression ISO BCL2 (Homo sapiens) 6480464 isoquercitrin results in decreased expression of BCL2 mRNA CTD PMID:30597948 quercetin 3-O-beta-D-glucopyranoside decreases expression ISO BCL2 (Homo sapiens) 6480464 isoquercitrin results in decreased expression of BCL2 mRNA CTD PMID:30597948 quercetin 4'-O-beta-D-glucopyranoside multiple interactions ISO BCL2 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased expression of BCL2 protein]] and spiraeoside inhibits the reaction [Glucose results in decreased expression of BCL2 protein] CTD PMID:32602595 quercetin 4'-O-beta-D-glucopyranoside decreases expression ISO BCL2 (Homo sapiens) 6480464 spiraeoside results in decreased expression of BCL2 protein CTD PMID:34116102 quinazolines multiple interactions ISO BCL2 (Homo sapiens) 6480464 Quinazolines inhibits the reaction [Pt(O and O'-acac)(gamma-acac)(DMS) results in decreased expression of BCL2 protein] CTD PMID:21420390 quinolinic acid decreases expression EXP 6480464 Quinolinic Acid results in decreased expression of BCL2 mRNA CTD PMID:30130594 quinolinic acid multiple interactions EXP 6480464 [naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in decreased expression of BCL2 mRNA] more ... CTD PMID:30130594 quinoxyfen multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Sulfur co-treated with quinoxyfen co-treated with dimethomorph] results in decreased expression of BCL2 mRNA and [Sulfur co-treated with quinoxyfen] results in decreased expression of BCL2 mRNA CTD PMID:35564597 quizartinib multiple interactions ISO BCL2 (Homo sapiens) 6480464 (+)-JQ1 compound promotes the reaction [quizartinib results in decreased expression of BCL2 protein] and quizartinib promotes the reaction [(+)-JQ1 compound results in decreased expression of BCL2 protein] CTD PMID:25053825 quizartinib decreases expression ISO BCL2 (Homo sapiens) 6480464 quizartinib results in decreased expression of BCL2 protein CTD PMID:25053825 rac-lactic acid increases expression ISO BCL2 (Homo sapiens) 6480464 Lactic Acid results in increased expression of BCL2 mRNA CTD PMID:30851411 raloxifene multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Resveratrol co-treated with Raloxifene Hydrochloride] results in decreased expression of BCL2 mRNA CTD PMID:29705353 raloxifene decreases expression ISO BCL2 (Homo sapiens) 6480464 Raloxifene Hydrochloride results in decreased expression of BCL2 mRNA and Raloxifene Hydrochloride results in decreased expression of BCL2 protein CTD PMID:16566921 more ... raloxifene affects expression ISO BCL2 (Homo sapiens) 6480464 Raloxifene Hydrochloride affects the expression of BCL2 protein CTD PMID:16009171 raloxifene increases expression ISO BCL2 (Homo sapiens) 6480464 Raloxifene Hydrochloride results in increased expression of BCL2 protein CTD PMID:16973256 ramipril affects expression EXP 6480464 Ramipril affects the expression of BCL2 protein CTD PMID:10728395 ranitidine multiple interactions ISO BCL2 (Homo sapiens) 6480464 Ranitidine inhibits the reaction [Rotenone results in decreased expression of BCL2 protein] CTD PMID:19723537 reactive oxygen species multiple interactions ISO BCL2 (Homo sapiens) 6480464 [[[CD40LG protein co-treated with IL4 protein] results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased phosphorylation of and results in increased stability of TP53 protein] which results in decreased expression of BCL2 protein more ... CTD PMID:17136320 more ... reactive oxygen species decreases expression ISO BCL2 (Homo sapiens) 6480464 Reactive Oxygen Species results in decreased expression of BCL2 mRNA and Reactive Oxygen Species results in decreased expression of BCL2 protein CTD PMID:25800948 and PMID:26884717 Rebamipide multiple interactions ISO BCL2 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rebamipide results in increased expression of BCL2 protein] more ... CTD PMID:29054700 Rebamipide increases expression ISO BCL2 (Homo sapiens) 6480464 rebamipide results in increased expression of BCL2 protein CTD PMID:29054700 remdesivir decreases expression ISO BCL2 (Homo sapiens) 6480464 remdesivir results in decreased expression of BCL2 protein CTD PMID:35417658 reserpine multiple interactions EXP 6480464 IAPP protein inhibits the reaction [Reserpine results in decreased expression of BCL2 protein] CTD PMID:19463876 reserpine decreases expression EXP 6480464 Reserpine results in decreased expression of BCL2 protein CTD PMID:19463876 resveratrol multiple interactions ISO BCL2 (Homo sapiens) 6480464 [allyl sulfide co-treated with Resveratrol] results in decreased expression of BCL2 mRNA more ... CTD PMID:11577002 more ... resveratrol increases expression ISO Bcl2 (Mus musculus) 6480464 resveratrol results in increased expression of BCL2 mRNA and resveratrol results in increased expression of BCL2 protein CTD PMID:18819863 more ... resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of BCL2 and resveratrol results in decreased expression of BCL2 mRNA CTD PMID:24092990 and PMID:24534837 resveratrol decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to resveratrol CTD PMID:11577002 and PMID:19631782 resveratrol decreases expression ISO Bcl2 (Mus musculus) 6480464 Resveratrol results in decreased expression of BCL2 mRNA and Resveratrol results in decreased expression of BCL2 protein CTD PMID:15637762 resveratrol increases expression ISO BCL2 (Homo sapiens) 6480464 resveratrol results in increased expression of BCL2 mRNA and resveratrol results in increased expression of BCL2 protein CTD PMID:17261084 more ... resveratrol decreases expression ISO BCL2 (Homo sapiens) 6480464 [Resveratrol results in decreased expression of MTA1 protein] which results in decreased expression of BCL2 protein more ... CTD PMID:12060119 more ... resveratrol increases phosphorylation EXP 6480464 resveratrol results in increased phosphorylation of BCL2 protein CTD PMID:15345477 resveratrol increases expression EXP 6480464 Resveratrol results in increased expression of BCL2 and Resveratrol results in increased expression of BCL2 protein CTD PMID:15345477 more ... resveratrol multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Ellagic Acid co-treated with Resveratrol] inhibits the reaction [9 more ... CTD PMID:20103723 more ... resveratrol multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]] more ... CTD PMID:15345477 more ... riboflavin decreases expression ISO BCL2 (Homo sapiens) 6480464 Riboflavin results in decreased expression of BCL2 protein CTD PMID:12654180 rifampicin increases expression ISO BCL2 (Homo sapiens) 6480464 Rifampin results in increased expression of BCL2 protein CTD PMID:11958592 rifampicin multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Rifampin inhibits the reaction [CYP2C8 protein results in increased susceptibility to Amodiaquine]] which results in decreased expression of BCL2 protein CTD PMID:31629065 rifampicin multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Isoniazid co-treated with Rifampin] results in decreased expression of BCL2 protein and Ursodeoxycholic Acid inhibits the reaction [[Isoniazid co-treated with Rifampin] results in decreased expression of BCL2 protein] CTD PMID:21419764 Riluzole increases expression EXP 6480464 Riluzole results in increased expression of BCL2 protein CTD PMID:20885006 rimonabant multiple interactions ISO Bcl2 (Mus musculus) 6480464 Rimonabant inhibits the reaction [forsythiaside inhibits the reaction [amyloid beta-protein (25-35) results in decreased expression of BCL2 protein]] and Rimonabant inhibits the reaction [LEP gene mutant form results in decreased expression of BCL2 protein] CTD PMID:26967640 and PMID:30769029 ritonavir decreases expression ISO BCL2 (Homo sapiens) 6480464 Ritonavir results in decreased expression of BCL2 protein CTD PMID:19386116 rivastigmine multiple interactions EXP 6480464 Rivastigmine inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein] CTD PMID:32805344 Ro 31-8220 multiple interactions EXP 6480464 Ro 31-8220 promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of BCL2 protein] CTD PMID:36925031 rocaglamide decreases expression ISO BCL2 (Homo sapiens) 6480464 rocaglamide results in decreased expression of BCL2 protein CTD PMID:31433962 roflumilast decreases expression ISO BCL2 (Homo sapiens) 6480464 Roflumilast results in decreased expression of BCL2 mRNA and Roflumilast results in decreased expression of BCL2 protein CTD PMID:33757793 roflumilast multiple interactions EXP 6480464 Roflumilast inhibits the reaction [Cisplatin results in decreased expression of BCL2 mRNA] and Roflumilast inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] CTD PMID:33757793 roflumilast multiple interactions ISO BCL2 (Homo sapiens) 6480464 Cisplatin promotes the reaction [Roflumilast results in decreased expression of BCL2 mRNA] more ... CTD PMID:33757793 rolipram multiple interactions EXP 6480464 Rolipram inhibits the reaction [Manganese results in decreased expression of BCL2 protein] CTD PMID:31161640 ropinirole increases expression ISO BCL2 (Homo sapiens) 6480464 ropinirole results in increased expression of BCL2 protein CTD PMID:18242171 rosmarinic acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 Rosmarinic Acid inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] CTD PMID:21526214 rosuvastatin calcium decreases expression ISO BCL2 (Homo sapiens) 6480464 Rosuvastatin Calcium results in decreased expression of BCL2 protein CTD PMID:20852871 rotenone decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to Rotenone CTD PMID:12730627 rotenone multiple interactions ISO Bcl2 (Mus musculus) 6480464 oleuropein affects the reaction [Rotenone results in decreased expression of BCL2 protein] CTD PMID:36774383 rotenone decreases expression ISO Bcl2 (Mus musculus) 6480464 Rotenone results in decreased expression of BCL2 mRNA and Rotenone results in decreased expression of BCL2 protein CTD PMID:26806867 and PMID:36774383 rotenone affects expression EXP 6480464 Rotenone affects the expression of BCL2 protein CTD PMID:25423838 rotenone affects expression ISO BCL2 (Homo sapiens) 6480464 Rotenone affects the expression of BCL2 protein CTD PMID:24755484 rotenone decreases expression ISO BCL2 (Homo sapiens) 6480464 Rotenone results in decreased expression of BCL2 mRNA and Rotenone results in decreased expression of BCL2 protein CTD PMID:19539006 more ... rotenone increases expression ISO Bcl2 (Mus musculus) 6480464 Rotenone results in increased expression of BCL2 and Rotenone results in increased expression of BCL2 mRNA CTD PMID:23186747 and PMID:25481089 rotenone increases expression ISO BCL2 (Homo sapiens) 6480464 Rotenone results in increased expression of BCL2 mRNA and Rotenone results in increased expression of BCL2 protein CTD PMID:16679036 and PMID:16815102 rotenone increases expression EXP 6480464 Rotenone results in increased expression of BCL2 mRNA CTD PMID:18817789 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of BCL2 mRNA and Rotenone results in decreased expression of BCL2 protein CTD PMID:18082360 more ... rotenone multiple interactions EXP 6480464 [3-bromo-2-oxopropionic acid co-treated with Rotenone] results in decreased expression of BCL2 protein more ... CTD PMID:18082360 more ... rotenone multiple interactions ISO BCL2 (Homo sapiens) 6480464 [GAPDH protein polymorphism co-treated with Rotenone] results in decreased expression of BCL2 protein more ... CTD PMID:12730627 more ... rottlerin decreases expression ISO BCL2 (Homo sapiens) 6480464 rottlerin results in decreased expression of BCL2 protein CTD PMID:22902833 rottlerin decreases expression ISO Bcl2 (Mus musculus) 6480464 rottlerin results in decreased expression of BCL2 protein CTD PMID:35995259 rottlerin multiple interactions ISO Bcl2 (Mus musculus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin inhibits the reaction [trimethyltin results in decreased expression of BCL2 protein]] more ... CTD PMID:25895139 more ... royal jelly multiple interactions ISO Bcl2 (Mus musculus) 6480464 royal jelly inhibits the reaction [Nicotine results in decreased expression of BCL2 mRNA] CTD PMID:30896085 royal jelly multiple interactions EXP 6480464 royal jelly inhibits the reaction [Fluorides results in increased expression of BCL2 protein] CTD PMID:34227456 RU 58668 affects expression ISO BCL2 (Homo sapiens) 6480464 RU 58668 affects the expression of BCL2 protein CTD PMID:15868441 rubitecan decreases expression ISO BCL2 (Homo sapiens) 6480464 rubitecan results in decreased expression of BCL2 protein CTD PMID:21695227 rubitecan multiple interactions ISO BCL2 (Homo sapiens) 6480464 [rubitecan co-treated with Phosphatidylcholines] results in decreased expression of BCL2 protein CTD PMID:21695227 ruthenium atom multiple interactions EXP 6480464 [Ruthenium binds to Phloretin] inhibits the reaction [9 more ... CTD PMID:34896434 rutin multiple interactions EXP 6480464 Rutin inhibits the reaction [[Copper Sulfate results in increased abundance of Copper] which results in increased expression of BCL2 protein] more ... CTD PMID:26062544 more ... rutin multiple interactions ISO Bcl2 (Mus musculus) 6480464 Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of BCL2 protein] CTD PMID:29522708 rutin decreases expression ISO BCL2 (Homo sapiens) 6480464 Rutin results in decreased expression of BCL2 protein CTD PMID:28811126 rutin multiple interactions ISO BCL2 (Homo sapiens) 6480464 Rutin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein] CTD PMID:19557821 rutin affects expression ISO BCL2 (Homo sapiens) 6480464 Rutin affects the expression of BCL2 protein CTD PMID:15975156 ruxolitinib multiple interactions ISO BCL2 (Homo sapiens) 6480464 [ruxolitinib co-treated with Arsenic Trioxide] results in decreased expression of BCL2 mRNA CTD PMID:30012499 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO BCL2 (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine results in increased expression of BCL2 protein CTD PMID:15967204 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO BCL2 (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine results in decreased expression of BCL2 mRNA CTD PMID:37544576 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO BCL2 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:36336211 and PMID:37544576 S-allylcysteine multiple interactions EXP 6480464 [S-allylcysteine co-treated with lycopene] inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein] and S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein] CTD PMID:16030430 S-allylcysteine decreases expression ISO BCL2 (Homo sapiens) 6480464 S-allylcysteine results in decreased expression of BCL2 protein CTD PMID:17155983 S-butyl-DL-homocysteine (S,R)-sulfoximine decreases expression ISO Bcl2 (Mus musculus) 6480464 Buthionine Sulfoximine results in decreased expression of BCL2 mRNA and Buthionine Sulfoximine results in decreased expression of BCL2 protein CTD PMID:17989939 and PMID:18552690 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions EXP 6480464 Buthionine Sulfoximine promotes the reaction [cyanoginosin LR results in decreased expression of BCL2 protein] CTD PMID:25410294 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Cadmium Chloride co-treated with Buthionine Sulfoximine] results in increased expression of BCL2 protein and Acetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with Buthionine Sulfoximine] results in increased expression of BCL2 protein] CTD PMID:11341981 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions ISO Bcl2 (Mus musculus) 6480464 Sodium Selenite promotes the reaction [Buthionine Sulfoximine results in decreased expression of BCL2 mRNA] CTD PMID:17989939 S-nitroso-N-acetyl-D-penicillamine decreases expression ISO Bcl2 (Mus musculus) 6480464 S-Nitroso-N-Acetylpenicillamine results in decreased expression of BCL2 mRNA and S-Nitroso-N-Acetylpenicillamine results in decreased expression of BCL2 protein CTD PMID:17135264 and PMID:21138475 S-nitroso-N-acetyl-D-penicillamine multiple interactions ISO Bcl2 (Mus musculus) 6480464 Melatonin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of BCL2 protein] CTD PMID:21138475 S-nitrosoglutathione multiple interactions ISO BCL2 (Homo sapiens) 6480464 [S-Nitrosoglutathione results in increased abundance of Nitric Oxide] which results in decreased expression of BCL2 protein CTD PMID:10828028 safrole decreases expression ISO BCL2 (Homo sapiens) 6480464 Safrole results in decreased expression of BCL2 protein CTD PMID:21591240 Salidroside increases expression ISO Bcl2 (Mus musculus) 6480464 rhodioloside results in increased expression of BCL2 mRNA CTD PMID:24072175 Salidroside multiple interactions ISO BCL2 (Homo sapiens) 6480464 rhodioloside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein] and sirtinol inhibits the reaction [rhodioloside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]] CTD PMID:28851138 Salidroside multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rhodioloside inhibits the reaction [Colistin results in decreased expression of BCL2 protein]] more ... CTD PMID:24072175 and PMID:28465020 Salidroside increases expression EXP 6480464 rhodioloside results in increased expression of BCL2 protein CTD PMID:24072175 Salinomycin decreases expression ISO BCL2 (Homo sapiens) 6480464 salinomycin results in decreased expression of BCL2 mRNA CTD PMID:34806536 Salmeterol xinafoate decreases expression ISO BCL2 (Homo sapiens) 6480464 Salmeterol Xinafoate results in decreased expression of BCL2 mRNA and Salmeterol Xinafoate results in decreased expression of BCL2 protein CTD PMID:14687023 salubrinal multiple interactions ISO BCL2 (Homo sapiens) 6480464 salubrinal inhibits the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein] CTD PMID:20686688 salubrinal multiple interactions EXP 6480464 salubrinal inhibits the reaction [cadmium acetate results in decreased expression of BCL2 protein] CTD PMID:30605698 salubrinal multiple interactions ISO Bcl2 (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [salubrinal promotes the reaction [Cisplatin results in decreased expression of BCL2 protein]] and salubrinal promotes the reaction [Cisplatin results in decreased expression of BCL2 protein] CTD PMID:21616140 Salvianolic acid A multiple interactions EXP 6480464 salvianolic acid A inhibits the reaction [arsenic trioxide results in decreased expression of BCL2 protein] CTD PMID:28391263 salvianolic acid B multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvianolic acid B inhibits the reaction [arsenic trioxide results in decreased expression of BCL2 protein]] more ... CTD PMID:23201927 and PMID:28495616 salvianolic acid B increases expression EXP 6480464 salvianolic acid B results in increased expression of BCL2 protein CTD PMID:23201927 Sanggenon C increases expression EXP 6480464 sanggenone C results in increased expression of BCL2 protein CTD PMID:32240450 Sanggenon C decreases expression ISO BCL2 (Homo sapiens) 6480464 sanggenone C results in decreased expression of BCL2 protein CTD PMID:28849234 and PMID:36256535 Sanggenon C multiple interactions EXP 6480464 sanggenone C inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 protein] CTD PMID:28983604 sanguinarine decreases expression ISO BCL2 (Homo sapiens) 6480464 sanguinarine results in decreased expression of BCL2 protein CTD PMID:22215411 sanguinarine decreases expression EXP 6480464 sanguinarine results in decreased expression of BCL2 mRNA and sanguinarine results in decreased expression of BCL2 protein CTD PMID:24300172 sanguinarine multiple interactions EXP 6480464 NQO1 protein inhibits the reaction [sanguinarine results in decreased expression of BCL2 mRNA] and NQO1 protein inhibits the reaction [sanguinarine results in decreased expression of BCL2 protein] CTD PMID:24300172 sanguinarine multiple interactions ISO BCL2 (Homo sapiens) 6480464 [sanguinarine results in increased chemical synthesis of Reactive Oxygen Species] which results in decreased expression of BCL2 protein CTD PMID:23660334 sappanchalcone decreases expression ISO BCL2 (Homo sapiens) 6480464 sappanchalcone results in decreased expression of BCL2 protein CTD PMID:21963806 and PMID:32590072 sarin decreases expression EXP 6480464 Sarin results in decreased expression of BCL2 protein CTD PMID:27639427 sarin increases expression EXP 6480464 Sarin results in increased expression of BCL2 mRNA CTD PMID:27639427 sarpogrelate multiple interactions ISO Bcl2 (Mus musculus) 6480464 [sarpogrelate co-treated with Carbidopa] inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] more ... CTD PMID:34560070 and PMID:35202708 sarpogrelate multiple interactions ISO BCL2 (Homo sapiens) 6480464 [sarpogrelate co-treated with Carbidopa] inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] more ... CTD PMID:34560070 and PMID:35202708 saxagliptin multiple interactions EXP 6480464 saxagliptin inhibits the reaction [Rotenone results in decreased expression of BCL2 protein] CTD PMID:25446674 SB 203580 multiple interactions ISO BCL2 (Homo sapiens) 6480464 saikosaponin D promotes the reaction [SB 203580 results in decreased expression of BCL2 protein] more ... CTD PMID:16818652 more ... SB 203580 multiple interactions ISO Bcl2 (Mus musculus) 6480464 SB 203580 inhibits the reaction [chloroacetic acid results in decreased expression of BCL2 mRNA] and SB 203580 inhibits the reaction [Sodium Glutamate results in increased expression of BCL2 mRNA] CTD PMID:16782274 and PMID:23103613 SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [Cisplatin results in increased phosphorylation of and results in decreased activity of BCL2 protein] and SB 203580 inhibits the reaction [oxaliplatin results in increased phosphorylation of and results in decreased activity of BCL2 protein] CTD PMID:19428505 SB 203580 decreases expression ISO BCL2 (Homo sapiens) 6480464 SB 203580 results in decreased expression of BCL2 protein CTD PMID:23994742 SB 431542 multiple interactions ISO BCL2 (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 SB-239063 multiple interactions EXP 6480464 SB 239063 inhibits the reaction [Particulate Matter results in decreased expression of BCL2 protein] CTD PMID:26472149 SCH 23390 multiple interactions EXP 6480464 SCH 23390 inhibits the reaction [Cocaine results in increased phosphorylation of BCL2 protein] CTD PMID:19879923 SCH 23390 multiple interactions ISO Bcl2 (Mus musculus) 6480464 SCH 23390 inhibits the reaction [1-(2-thienyl)-2-(methylamino)propane results in decreased expression of BCL2 protein] CTD PMID:30922767 SCH772984 multiple interactions ISO BCL2 (Homo sapiens) 6480464 SCH772984 inhibits the reaction [pachastrissamine analog inhibits the reaction [BCL2 protein binds to BECN1 protein]] CTD PMID:35123989 scoparone decreases expression ISO BCL2 (Homo sapiens) 6480464 scoparone results in decreased expression of BCL2 protein CTD PMID:37449671 scopolamine decreases expression ISO Bcl2 (Mus musculus) 6480464 Scopolamine results in decreased expression of BCL2 mRNA and Scopolamine results in decreased expression of BCL2 protein CTD PMID:17120751 more ... scopolamine multiple interactions ISO Bcl2 (Mus musculus) 6480464 dihydroactinidiolide inhibits the reaction [Scopolamine results in decreased expression of BCL2 protein] and Donepezil inhibits the reaction [Scopolamine results in decreased expression of BCL2 protein] CTD PMID:34371027 Se-methyl-L-selenocysteine decreases expression ISO BCL2 (Homo sapiens) 6480464 selenomethylselenocysteine results in decreased expression of BCL2 mRNA CTD PMID:19360359 Se-methyl-L-selenocysteine decreases expression EXP 6480464 selenomethylselenocysteine results in decreased expression of BCL2 protein CTD PMID:11396176 Se-methyl-L-selenocysteine multiple interactions ISO BCL2 (Homo sapiens) 6480464 [selenomethylselenocysteine results in decreased expression of BCL2 mRNA] which results in increased activity of TNFSF10 protein CTD PMID:19360359 Se-methylselenocysteine decreases expression ISO BCL2 (Homo sapiens) 6480464 selenomethylselenocysteine results in decreased expression of BCL2 mRNA CTD PMID:19360359 Se-methylselenocysteine decreases expression EXP 6480464 selenomethylselenocysteine results in decreased expression of BCL2 protein CTD PMID:11396176 Se-methylselenocysteine multiple interactions ISO BCL2 (Homo sapiens) 6480464 [selenomethylselenocysteine results in decreased expression of BCL2 mRNA] which results in increased activity of TNFSF10 protein CTD PMID:19360359 selenium atom decreases expression ISO BCL2 (Homo sapiens) 6480464 Selenium results in decreased expression of BCL2 protein CTD PMID:17523932 selenium atom multiple interactions EXP 6480464 Selenium inhibits the reaction [nickel sulfate results in decreased expression of BCL2 protein] CTD PMID:34612572 selenium atom multiple interactions ISO BCL2 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Selenium inhibits the reaction [nickel sulfate results in decreased expression of BCL2 protein]] more ... CTD PMID:27920530 and PMID:34612572 selenocystine decreases expression ISO BCL2 (Homo sapiens) 6480464 selenocystine results in decreased expression of BCL2 protein CTD PMID:35863474 serpentine asbestos multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Asbestos more ... CTD PMID:22608188 serpentine asbestos affects response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein affects the susceptibility to Asbestos and Serpentine CTD PMID:16850164 sertraline affects expression ISO Bcl2 (Mus musculus) 6480464 Sertraline affects the expression of BCL2 protein CTD PMID:18403212 sertraline decreases expression ISO BCL2 (Homo sapiens) 6480464 Sertraline results in decreased expression of BCL2 protein CTD PMID:24194395 Sesamol multiple interactions ISO Bcl2 (Mus musculus) 6480464 sesamol affects the reaction [Lipopolysaccharides affects the expression of BCL2 protein] CTD PMID:30261164 sevoflurane multiple interactions EXP 6480464 Dietary Fats promotes the reaction [Sevoflurane results in decreased expression of BCL2 protein] and Nimodipine inhibits the reaction [Sevoflurane results in decreased expression of BCL2 protein] CTD PMID:33171207 and PMID:35174938 sevoflurane decreases expression ISO BCL2 (Homo sapiens) 6480464 Sevoflurane results in decreased expression of BCL2 protein CTD PMID:35472370 sevoflurane decreases expression EXP 6480464 Sevoflurane results in decreased expression of BCL2 protein CTD PMID:33171207 more ... Shikonin decreases expression ISO BCL2 (Homo sapiens) 6480464 shikonin results in decreased expression of BCL2 protein CTD PMID:25591861 Shikonin multiple interactions EXP 6480464 1 more ... CTD PMID:35028790 sibutramine decreases expression ISO BCL2 (Homo sapiens) 6480464 sibutramine results in decreased expression of BCL2 protein CTD PMID:27838152 sildenafil citrate multiple interactions EXP 6480464 Sildenafil Citrate inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA] more ... CTD PMID:20574430 sildenafil citrate multiple interactions ISO Bcl2 (Mus musculus) 6480464 Sildenafil Citrate inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] CTD PMID:15811867 sildenafil citrate increases expression EXP 6480464 Sildenafil Citrate results in increased expression of BCL2 CTD PMID:18373738 silibinin decreases expression ISO BCL2 (Homo sapiens) 6480464 Silybin results in decreased expression of BCL2 mRNA CTD PMID:21969006 silibinin multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Silybin co-treated with Arsenic Trioxide] results in decreased expression of BCL2 mRNA more ... CTD PMID:19834285 more ... silicon dioxide multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Silicon Dioxide co-treated with Lipopolysaccharides] results in decreased expression of BCL2 mRNA more ... CTD PMID:22273745 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of BCL2 mRNA CTD PMID:33749107 silicon dioxide multiple interactions EXP 6480464 Asian ginseng inhibits the reaction [Silicon Dioxide results in decreased expression of BCL2 mRNA] CTD PMID:33749107 silicon dioxide decreases expression ISO Bcl2 (Mus musculus) 6480464 Silicon Dioxide analog results in decreased expression of BCL2 mRNA and Silicon Dioxide analog results in decreased expression of BCL2 protein CTD PMID:26263183 silicon dioxide decreases expression ISO BCL2 (Homo sapiens) 6480464 Silicon Dioxide results in decreased expression of BCL2 mRNA and Silicon Dioxide results in decreased expression of BCL2 protein CTD PMID:21723938 more ... silicon dioxide multiple interactions ISO BCL2 (Homo sapiens) 6480464 ABT-737 inhibits the reaction [Silicon Dioxide promotes the reaction [BCL2 protein binds to BECN1 protein]] more ... CTD PMID:22245848 and PMID:32061152 silver atom decreases expression ISO BCL2 (Homo sapiens) 6480464 Silver results in decreased expression of BCL2 mRNA CTD PMID:21611810 silver atom decreases expression ISO Bcl2 (Mus musculus) 6480464 Silver results in decreased expression of BCL2 mRNA and Silver results in decreased expression of BCL2 protein CTD PMID:27131904 and PMID:29665414 silver atom affects expression ISO BCL2 (Homo sapiens) 6480464 Silver analog affects the expression of BCL2 mRNA and Silver analog affects the expression of BCL2 protein CTD PMID:24849675 silver atom multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Silver analog co-treated with Citric Acid] results in increased expression of BCL2 mRNA and [Silver analog co-treated with Polyethylene Glycols] results in increased expression of BCL2 mRNA CTD PMID:27021274 silver(0) decreases expression ISO BCL2 (Homo sapiens) 6480464 Silver results in decreased expression of BCL2 mRNA CTD PMID:21611810 silver(0) decreases expression ISO Bcl2 (Mus musculus) 6480464 Silver results in decreased expression of BCL2 mRNA and Silver results in decreased expression of BCL2 protein CTD PMID:27131904 and PMID:29665414 silver(0) affects expression ISO BCL2 (Homo sapiens) 6480464 Silver analog affects the expression of BCL2 mRNA and Silver analog affects the expression of BCL2 protein CTD PMID:24849675 silver(0) multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Silver analog co-treated with Citric Acid] results in increased expression of BCL2 mRNA and [Silver analog co-treated with Polyethylene Glycols] results in increased expression of BCL2 mRNA CTD PMID:27021274 simazine decreases expression ISO Bcl2 (Mus musculus) 6480464 Simazine results in decreased expression of BCL2 mRNA CTD PMID:25461544 simvastatin multiple interactions ISO BCL2 (Homo sapiens) 6480464 geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of BCL2 mRNA] more ... CTD PMID:17277159 more ... simvastatin decreases expression ISO Bcl2 (Mus musculus) 6480464 Simvastatin results in decreased expression of BCL2 mRNA CTD PMID:25300705 simvastatin decreases expression EXP 6480464 Simvastatin results in decreased expression of BCL2 protein CTD PMID:25300705 simvastatin increases expression ISO Bcl2 (Mus musculus) 6480464 Simvastatin results in increased expression of BCL2 mRNA and Simvastatin results in increased expression of BCL2 protein CTD PMID:17241114 simvastatin increases expression ISO BCL2 (Homo sapiens) 6480464 Simvastatin results in increased expression of BCL2 protein CTD PMID:17241114 simvastatin decreases expression ISO BCL2 (Homo sapiens) 6480464 Simvastatin results in decreased expression of BCL2 mRNA and Simvastatin results in decreased expression of BCL2 protein CTD PMID:17901590 more ... sinapic acid multiple interactions EXP 6480464 sinapinic acid inhibits the reaction [lead acetate results in decreased expression of BCL2 mRNA] and sinapinic acid inhibits the reaction [Methotrexate results in decreased expression of BCL2 protein] CTD PMID:33720507 and PMID:37471654 sirolimus multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Curcumin co-treated with Sirolimus] results in decreased expression of BCL2 more ... CTD PMID:15571967 more ... sirolimus affects expression ISO Bcl2 (Mus musculus) 6480464 Sirolimus affects the expression of BCL2 protein CTD PMID:30905858 sirolimus multiple interactions EXP 6480464 Sirolimus inhibits the reaction [[Particulate Matter co-treated with Rotenone] results in decreased expression of BCL2 protein] more ... CTD PMID:18640276 and PMID:33823232 sirolimus multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Sirolimus co-treated with IL2 protein] results in increased expression of BCL2 mRNA more ... CTD PMID:11355896 more ... sirolimus decreases expression ISO BCL2 (Homo sapiens) 6480464 Sirolimus results in decreased expression of BCL2 mRNA and Sirolimus results in decreased expression of BCL2 protein CTD PMID:19764996 and PMID:19815708 sirtinol multiple interactions ISO BCL2 (Homo sapiens) 6480464 sirtinol inhibits the reaction [rhodioloside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]] and sirtinol promotes the reaction [cudraflavone B results in decreased expression of BCL2 protein] CTD PMID:23881456 and PMID:28851138 sodium arsenate increases expression ISO Bcl2 (Mus musculus) 6480464 sodium arsenate results in increased expression of BCL2 mRNA CTD PMID:21795629 sodium arsenate decreases expression EXP 6480464 sodium arsenate results in decreased expression of BCL2 mRNA and sodium arsenate results in decreased expression of BCL2 protein CTD PMID:29710533 and PMID:29854611 sodium arsenate multiple interactions EXP 6480464 Ellagic Acid inhibits the reaction [sodium arsenate results in decreased expression of BCL2 mRNA] and thymoquinone inhibits the reaction [sodium arsenate results in decreased expression of BCL2 mRNA] CTD PMID:29710533 and PMID:29854611 sodium arsenate decreases expression ISO Bcl2 (Mus musculus) 6480464 sodium arsenate results in decreased expression of BCL2 mRNA CTD PMID:30953684 sodium arsenite multiple interactions ISO BCL2 (Homo sapiens) 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA] more ... CTD PMID:18501396 more ... sodium arsenite increases expression ISO Bcl2 (Mus musculus) 6480464 sodium arsenite results in increased expression of BCL2 mRNA CTD PMID:28370166 sodium arsenite multiple interactions ISO Bcl2 (Mus musculus) 6480464 [sodium arsenite results in increased abundance of Arsenic] promotes the reaction [[Sodium Fluoride results in increased abundance of Fluorides] which results in decreased expression of BCL2 mRNA] more ... CTD PMID:27723467 more ... sodium arsenite affects methylation ISO BCL2 (Homo sapiens) 6480464 sodium arsenite affects the methylation of BCL2 gene CTD PMID:28589171 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of BCL2 protein CTD PMID:17645694 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of BCL2 mRNA and sodium arsenite results in decreased expression of BCL2 protein CTD PMID:14514659 more ... sodium arsenite decreases expression ISO Bcl2 (Mus musculus) 6480464 sodium arsenite results in decreased expression of BCL2 mRNA and sodium arsenite results in decreased expression of BCL2 protein CTD PMID:11035063 more ... sodium arsenite increases activity EXP 6480464 sodium arsenite results in increased activity of BCL2 protein CTD PMID:18715270 sodium arsenite multiple interactions EXP 6480464 [SERPINF1 protein co-treated with sodium arsenite] results in decreased expression of BCL2 protein more ... CTD PMID:12690470 more ... sodium arsenite increases expression ISO BCL2 (Homo sapiens) 6480464 sodium arsenite results in increased expression of BCL2 mRNA and sodium arsenite results in increased expression of BCL2 protein CTD PMID:12679051 more ... sodium arsenite decreases expression ISO BCL2 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of BCL2 mRNA and sodium arsenite results in decreased expression of BCL2 protein CTD PMID:19615344 more ... sodium arsenite affects phosphorylation ISO BCL2 (Homo sapiens) 6480464 sodium arsenite affects the phosphorylation of BCL2 protein CTD PMID:18501396 sodium azide multiple interactions EXP 6480464 Sodium Azide inhibits the reaction [Minocycline results in increased expression of BCL2 protein] CTD PMID:15004018 sodium chloride multiple interactions EXP 6480464 [Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of BCL2 protein more ... CTD PMID:16030430 and PMID:22431579 sodium cholate multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Cholesterol and Dietary co-treated with Sodium Cholate] results in decreased expression of BCL2 protein CTD PMID:27394961 sodium chromate increases expression ISO BCL2 (Homo sapiens) 6480464 sodium chromate(VI) results in increased expression of BCL2 mRNA CTD PMID:14971655 sodium chromate multiple interactions ISO Bcl2 (Mus musculus) 6480464 [sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in decreased expression of BCL2 mRNA more ... CTD PMID:35643323 sodium dichromate multiple interactions ISO Bcl2 (Mus musculus) 6480464 CAT protein inhibits the reaction [sodium bichromate results in decreased expression of BCL2 protein] and TRP53 mutant form inhibits the reaction [sodium bichromate results in decreased expression of BCL2 protein] CTD PMID:20298709 sodium dichromate increases expression ISO BCL2 (Homo sapiens) 6480464 sodium bichromate results in increased expression of BCL2 protein CTD PMID:28624442 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of BCL2 mRNA CTD PMID:11960910 sodium dichromate multiple interactions ISO BCL2 (Homo sapiens) 6480464 6-anilino-5 more ... CTD PMID:18544562 and PMID:28624442 sodium dichromate decreases expression ISO BCL2 (Homo sapiens) 6480464 sodium bichromate results in decreased expression of BCL2 protein CTD PMID:18544562 and PMID:19556603 sodium dichromate increases ubiquitination ISO BCL2 (Homo sapiens) 6480464 sodium bichromate results in increased ubiquitination of BCL2 protein CTD PMID:18544562 sodium dichromate affects response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein affects the susceptibility to sodium bichromate CTD PMID:19556603 sodium dichromate decreases expression ISO Bcl2 (Mus musculus) 6480464 sodium bichromate results in decreased expression of BCL2 protein CTD PMID:20298709 sodium disulfite decreases expression ISO BCL2 (Homo sapiens) 6480464 sodium metabisulfite results in decreased expression of BCL2 mRNA CTD PMID:33957602 and PMID:35067933 sodium fluoride multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Sodium Fluoride inhibits the reaction [CA2 protein binds to BAD protein]] promotes the reaction [BAD protein binds to BCL2 protein] and Sodium Fluoride promotes the reaction [BAD protein binds to BCL2 protein] CTD PMID:21708216 sodium fluoride decreases expression ISO BCL2 (Homo sapiens) 6480464 Sodium Fluoride results in decreased expression of BCL2 mRNA CTD PMID:28962382 sodium fluoride decreases expression EXP 6480464 Sodium Fluoride results in decreased expression of BCL2 mRNA and Sodium Fluoride results in decreased expression of BCL2 protein CTD PMID:27871895 more ... sodium fluoride multiple interactions EXP 6480464 Hesperidin inhibits the reaction [Sodium Fluoride results in decreased expression of BCL2 mRNA] more ... CTD PMID:26779593 more ... sodium fluoride multiple interactions ISO Bcl2 (Mus musculus) 6480464 [sodium arsenite results in increased abundance of Arsenic] promotes the reaction [[Sodium Fluoride results in increased abundance of Fluorides] which results in decreased expression of BCL2 mRNA] more ... CTD PMID:27871895 and PMID:35714946 sodium fluoride decreases expression ISO Bcl2 (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of BCL2 mRNA and Sodium Fluoride results in decreased expression of BCL2 protein CTD PMID:23578390 more ... sodium nitrite decreases expression EXP 6480464 Sodium Nitrite results in decreased expression of BCL2 mRNA and Sodium Nitrite results in decreased expression of BCL2 protein CTD PMID:28000380 more ... sodium nitrite multiple interactions EXP 6480464 Carnosine inhibits the reaction [Sodium Nitrite results in decreased expression of BCL2 protein] and Quercetin inhibits the reaction [Sodium Nitrite results in decreased expression of BCL2 protein] CTD PMID:28000380 and PMID:28266762 sodium silicate decreases expression EXP 6480464 sodium silicate results in decreased expression of BCL2 protein CTD PMID:37100362 Sophoricoside multiple interactions ISO Bcl2 (Mus musculus) 6480464 dorsomorphin inhibits the reaction [sophoricoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]] more ... CTD PMID:37741537 sorafenib decreases response to substance ISO Bcl2 (Mus musculus) 6480464 BCL2 protein results in decreased susceptibility to sorafenib CTD PMID:28673964 sorafenib increases cleavage ISO BCL2 (Homo sapiens) 6480464 sorafenib results in increased cleavage of BCL2 protein CTD PMID:16109713 sorafenib decreases expression ISO BCL2 (Homo sapiens) 6480464 sorafenib results in decreased expression of BCL2 mRNA and sorafenib results in decreased expression of BCL2 protein CTD PMID:17991738 more ... sorafenib multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Paclitaxel co-treated with sorafenib] results in decreased expression of BCL2 protein more ... CTD PMID:18512153 more ... soybean oil increases expression EXP 6480464 Soybean Oil results in increased expression of BCL2 protein CTD PMID:15309441 spermine increases expression EXP 6480464 Spermine results in increased expression of BCL2 protein CTD PMID:17606387 spermine decreases expression ISO BCL2 (Homo sapiens) 6480464 Spermine results in decreased expression of BCL2 protein CTD PMID:16151648 sphingosine 1-phosphate multiple interactions ISO BCL2 (Homo sapiens) 6480464 sphingosine 1-phosphate inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BCL2 mRNA] more ... CTD PMID:24399507 and PMID:24420784 spironolactone increases expression EXP 6480464 Spironolactone results in increased expression of BCL2 protein CTD PMID:19114643 Spiroquinazoline decreases expression ISO BCL2 (Homo sapiens) 6480464 spiroquinazoline analog results in decreased expression of BCL2 mRNA and spiroquinazoline analog results in decreased expression of BCL2 protein CTD PMID:25743751 squalene multiple interactions EXP 6480464 Squalene inhibits the reaction [potassium bromate results in increased expression of BCL2 protein] CTD PMID:33219891 stattic decreases expression ISO BCL2 (Homo sapiens) 6480464 stattic results in decreased expression of BCL2 protein CTD PMID:24627483 staurosporine multiple interactions ISO BCL2 (Homo sapiens) 6480464 Silybin inhibits the reaction [Staurosporine promotes the reaction [Acetaldehyde results in decreased expression of BCL2 protein]] more ... CTD PMID:15907805 and PMID:35158046 stavudine decreases expression ISO BCL2 (Homo sapiens) 6480464 Stavudine results in decreased expression of BCL2 protein CTD PMID:9007205 sterigmatocystin decreases expression ISO BCL2 (Homo sapiens) 6480464 Sterigmatocystin results in decreased expression of BCL2 mRNA CTD PMID:32553934 stilbenoid decreases expression ISO BCL2 (Homo sapiens) 6480464 Stilbenes analog results in decreased expression of BCL2 mRNA and Stilbenes analog results in decreased expression of BCL2 protein CTD PMID:25980588 streptozocin multiple interactions EXP 6480464 2 more ... CTD PMID:15587404 more ... streptozocin affects expression EXP 6480464 Streptozocin affects the expression of BCL2 protein CTD PMID:25541178 streptozocin multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Diethylhexyl Phthalate co-treated with Streptozocin co-treated with Dietary Fats] results in decreased expression of BCL2 protein more ... CTD PMID:24781736 more ... streptozocin decreases expression ISO Bcl2 (Mus musculus) 6480464 Streptozocin results in decreased expression of BCL2 protein CTD PMID:24781736 more ... streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of BCL2 mRNA and Streptozocin results in decreased expression of BCL2 protein CTD PMID:15056984 more ... streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of BCL2 protein CTD PMID:15976052 and PMID:19682444 styrene increases expression ISO BCL2 (Homo sapiens) 6480464 Styrene results in increased expression of BCL2 protein CTD PMID:15212811 styrene oxide affects expression ISO BCL2 (Homo sapiens) 6480464 styrene oxide affects the expression of BCL2 mRNA CTD PMID:11230554 styrene oxide decreases expression EXP 6480464 styrene oxide results in decreased expression of BCL2 protein CTD PMID:12663515 succimer multiple interactions EXP 6480464 Succimer inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BCL2 mRNA] CTD PMID:32402895 sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of BCL2 mRNA CTD PMID:30047161 sulfaphenazole multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Butyric Acid co-treated with Sulfaphenazole] inhibits the reaction [Oxalic Acid results in decreased expression of BCL2 mRNA] and Sulfaphenazole inhibits the reaction [Oxalic Acid results in decreased expression of BCL2 mRNA] CTD PMID:37414240 sulfasalazine multiple interactions ISO BCL2 (Homo sapiens) 6480464 BCL2 protein inhibits the reaction [Sulfasalazine affects the localization of AIFM1 protein] CTD PMID:12381674 sulfasalazine multiple interactions EXP 152995414 sulfasalazine inhibits the reaction [2 more ... RGD sulfasalazine multiple interactions EXP 6480464 Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of BCL2 protein] CTD PMID:31428839 sulforaphane multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Eugenol results in increased activity of sulforaphane] which results in decreased expression of BCL2 and [sulforaphane results in increased activity of Eugenol] which results in decreased expression of BCL2 CTD PMID:21382956 sulforaphane multiple interactions EXP 6480464 sulforaphane inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BCL2 mRNA] CTD PMID:30835071 sulforaphane decreases expression ISO BCL2 (Homo sapiens) 6480464 sulforaphane results in decreased expression of BCL2 mRNA and sulforaphane results in decreased expression of BCL2 protein CTD PMID:27878984 sulforaphane increases expression ISO Bcl2 (Mus musculus) 6480464 sulforaphane results in increased expression of BCL2 mRNA and sulforaphane results in increased expression of BCL2 protein CTD PMID:29069573 sulforaphane multiple interactions ISO Bcl2 (Mus musculus) 6480464 sulforaphane inhibits the reaction [Ethanol results in decreased expression of BCL2 mRNA] and sulforaphane inhibits the reaction [Ethanol results in decreased expression of BCL2 protein] CTD PMID:29069573 sulfur atom multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Sulfur co-treated with folpet] results in decreased expression of BCL2 mRNA more ... CTD PMID:35564597 sulfur dioxide multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Sulfur Dioxide co-treated with sodium arsenite] results in decreased expression of BCL2 mRNA CTD PMID:30195209 sulfur dioxide decreases expression ISO Bcl2 (Mus musculus) 6480464 Sulfur Dioxide results in decreased expression of BCL2 mRNA CTD PMID:30195209 sulindac decreases expression ISO BCL2 (Homo sapiens) 6480464 Sulindac results in decreased expression of BCL2 protein CTD PMID:15793875 sulindac multiple interactions EXP 6480464 [Olive Oil co-treated with Sulindac] results in decreased expression of BCL2 protein CTD PMID:15309441 sulindac decreases expression ISO Bcl2 (Mus musculus) 6480464 Sulindac results in decreased expression of BCL2 protein CTD PMID:10223192 sulindac multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Sulindac results in increased abundance of Reactive Oxygen Species] which results in increased cleavage of BCL2 protein CTD PMID:17136320 sulindac sulfide decreases expression ISO BCL2 (Homo sapiens) 6480464 sulindac sulfide results in decreased expression of BCL2 protein CTD PMID:18678619 sulpiride multiple interactions ISO Bcl2 (Mus musculus) 6480464 Sulpiride inhibits the reaction [1-(2-thienyl)-2-(methylamino)propane results in decreased expression of BCL2 protein] CTD PMID:30922767 sunitinib increases expression ISO BCL2 (Homo sapiens) 6480464 Sunitinib results in increased expression of BCL2 mRNA CTD PMID:31533062 surfactin multiple interactions ISO BCL2 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [surfactin peptide results in decreased expression of BCL2 protein] and pyrazolanthrone inhibits the reaction [surfactin peptide results in decreased expression of BCL2 protein] CTD PMID:19954742 surfactin decreases expression ISO BCL2 (Homo sapiens) 6480464 surfactin peptide results in decreased expression of BCL2 protein CTD PMID:19954742 and PMID:34850538 surfactin C multiple interactions ISO BCL2 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [surfactin peptide results in decreased expression of BCL2 protein] and pyrazolanthrone inhibits the reaction [surfactin peptide results in decreased expression of BCL2 protein] CTD PMID:19954742 surfactin C decreases expression ISO BCL2 (Homo sapiens) 6480464 surfactin peptide results in decreased expression of BCL2 protein CTD PMID:19954742 and PMID:34850538 Swertiamarin multiple interactions EXP 6480464 swertiamarin inhibits the reaction [Testosterone results in increased expression of BCL2 protein] CTD PMID:27866977 syringic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 syringic acid results in decreased expression of BCL2 mRNA CTD PMID:33759321 syringin decreases expression ISO BCL2 (Homo sapiens) 6480464 syringin results in decreased expression of BCL2 protein CTD PMID:35580997 T-2 toxin increases expression ISO BCL2 (Homo sapiens) 6480464 T-2 Toxin results in increased expression of BCL2 mRNA and T-2 Toxin results in increased expression of BCL2 protein CTD PMID:19524637 and PMID:34581912 T-2 toxin increases activity ISO Bcl2 (Mus musculus) 6480464 T-2 Toxin results in increased activity of BCL2 protein CTD PMID:35289972 T-2 toxin decreases expression EXP 6480464 T-2 Toxin results in decreased expression of BCL2 mRNA CTD PMID:29870751 T-2 toxin decreases expression ISO Bcl2 (Mus musculus) 6480464 T-2 Toxin results in decreased expression of BCL2 mRNA and T-2 Toxin results in decreased expression of BCL2 protein CTD PMID:28697680 and PMID:33508416 T-2 toxin increases expression EXP 6480464 T-2 Toxin results in increased expression of BCL2 mRNA and T-2 Toxin results in increased expression of BCL2 protein CTD PMID:21296132 tacrine increases expression ISO Bcl2 (Mus musculus) 6480464 Tacrine results in increased expression of BCL2 protein CTD PMID:12579951 tacrolimus hydrate multiple interactions ISO Bcl2 (Mus musculus) 6480464 Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in decreased expression of BCL2 protein] CTD PMID:10205001 tacrolimus hydrate decreases expression ISO Bcl2 (Mus musculus) 6480464 Tacrolimus results in decreased expression of BCL2 protein CTD PMID:27606422 tacrolimus hydrate multiple interactions EXP 6480464 [Tacrolimus co-treated with 3-nitropropionic acid] affects the localization of BCL2 protein CTD PMID:15571979 tacrolimus hydrate increases expression ISO Bcl2 (Mus musculus) 6480464 Tacrolimus results in increased expression of BCL2 protein CTD PMID:10205001 tadalafil multiple interactions ISO Bcl2 (Mus musculus) 6480464 Tadalafil inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] CTD PMID:20543097 tadalafil multiple interactions EXP 6480464 Sildenafil Citrate promotes the reaction [Tadalafil inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]] more ... CTD PMID:20574430 and PMID:32621855 taiwanin C decreases expression ISO Bcl2 (Mus musculus) 6480464 taiwanin C results in decreased expression of BCL2 protein CTD PMID:30884126 tamibarotene multiple interactions ISO BCL2 (Homo sapiens) 6480464 Triiodothyronine promotes the reaction [tamibarotene results in decreased expression of BCL2 mRNA] CTD PMID:11201846 tamibarotene decreases expression ISO BCL2 (Homo sapiens) 6480464 tamibarotene results in decreased expression of BCL2 mRNA CTD PMID:11201846 and PMID:15498508 tamibarotene affects expression ISO BCL2 (Homo sapiens) 6480464 tamibarotene affects the expression of BCL2 mRNA CTD PMID:15498508 tamoxifen multiple interactions ISO BCL2 (Homo sapiens) 6480464 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Tamoxifen] results in decreased expression of BCL2 mRNA more ... CTD PMID:16051634 more ... tamoxifen multiple interactions ISO Bcl2 (Mus musculus) 6480464 Tamoxifen inhibits the reaction [manganese chloride results in decreased expression of BCL2 protein] CTD PMID:29183790 tamoxifen decreases expression EXP 6480464 Tamoxifen results in decreased expression of BCL2 protein CTD PMID:17343880 tamoxifen multiple interactions EXP 6480464 [BCL2 co-treated with Tamoxifen] results in increased expression of FASL protein more ... CTD PMID:15606891 and PMID:17343880 tamoxifen decreases expression ISO BCL2 (Homo sapiens) 6480464 Tamoxifen results in decreased expression of BCL2 mRNA and Tamoxifen results in decreased expression of BCL2 protein CTD PMID:10785588 more ... tanespimycin decreases expression ISO BCL2 (Homo sapiens) 6480464 tanespimycin results in decreased expression of BCL2 protein CTD PMID:16923571 and PMID:28673683 Tanshinone I decreases expression ISO BCL2 (Homo sapiens) 6480464 tanshinone results in decreased expression of BCL2 protein CTD PMID:16009009 more ... Tariquidar multiple interactions ISO Bcl2 (Mus musculus) 6480464 tariquidar promotes the reaction [triptolide results in decreased expression of BCL2 protein] CTD PMID:26134275 taurine multiple interactions EXP 6480464 Taurine inhibits the reaction [9 more ... CTD PMID:19429265 more ... taurocholic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 sorafenib inhibits the reaction [Taurocholic Acid results in increased expression of BCL2 protein] CTD PMID:18512153 taurocholic acid increases expression ISO BCL2 (Homo sapiens) 6480464 Taurocholic Acid results in increased expression of BCL2 protein CTD PMID:18512153 tauroursodeoxycholic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 ursodoxicoltaurine inhibits the reaction [[APP gene mutant form co-treated with PSEN1 gene mutant form] results in decreased expression of BCL2 protein] more ... CTD PMID:16923170 and PMID:35524978 tauroursodeoxycholic acid multiple interactions EXP 6480464 ursodoxicoltaurine inhibits the reaction [Glutamic Acid results in decreased expression of BCL2 protein] and ursodoxicoltaurine inhibits the reaction [shikonin inhibits the reaction [Glutamic Acid results in decreased expression of BCL2 protein]] CTD PMID:35028790 tauroursodeoxycholic acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 ursodoxicoltaurine inhibits the reaction [Gentamicins results in decreased expression of BCL2 mRNA] and ursodoxicoltaurine inhibits the reaction [Gentamicins results in decreased expression of BCL2 protein] CTD PMID:29751043 tauroursodeoxycholic acid increases expression EXP 6480464 ursodoxicoltaurine results in increased expression of BCL2 mRNA and ursodoxicoltaurine results in increased expression of BCL2 protein CTD PMID:12721362 and PMID:15255934 tazarotene decreases expression ISO BCL2 (Homo sapiens) 6480464 tazarotene results in decreased expression of BCL2 protein CTD PMID:16109552 and PMID:16196285 tebuconazole decreases expression ISO BCL2 (Homo sapiens) 6480464 tebuconazole results in decreased expression of BCL2 protein CTD PMID:26852204 tebuconazole decreases expression EXP 6480464 tebuconazole results in decreased expression of BCL2 protein CTD PMID:32735800 telmisartan multiple interactions EXP 6480464 telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of BCL2 mRNA] CTD PMID:24831514 temozolomide multiple interactions ISO Bcl2 (Mus musculus) 6480464 [temozolomide co-treated with O(6)-benzylguanine] results in decreased expression of BCL2 protein and TRP53 protein mutant form inhibits the reaction [[temozolomide co-treated with O(6)-benzylguanine] results in decreased expression of BCL2 protein] CTD PMID:20980775 temozolomide multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Temozolomide co-treated with Verapamil] results in decreased expression of BCL2 mRNA more ... CTD PMID:22530672 and PMID:30003979 temozolomide decreases expression ISO BCL2 (Homo sapiens) 6480464 temozolomide analog results in decreased expression of BCL2 protein and temozolomide results in decreased expression of BCL2 protein CTD PMID:19363609 and PMID:22530672 TEMPO decreases expression ISO Bcl2 (Mus musculus) 6480464 TEMPO results in decreased expression of BCL2 protein CTD PMID:25882087 Temsirolimus decreases expression ISO BCL2 (Homo sapiens) 6480464 temsirolimus results in decreased expression of BCL2 mRNA CTD PMID:19764996 terazosin decreases expression ISO BCL2 (Homo sapiens) 6480464 Terazosin results in decreased expression of BCL2 protein CTD PMID:12883741 Terfenadine decreases expression ISO BCL2 (Homo sapiens) 6480464 Terfenadine analog results in decreased expression of BCL2 protein and Terfenadine results in decreased expression of BCL2 protein CTD PMID:12244568 and PMID:19289568 tert-butyl hydroperoxide decreases expression ISO BCL2 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in decreased expression of BCL2 protein CTD PMID:12782109 more ... tert-butyl hydroperoxide decreases expression ISO Bcl2 (Mus musculus) 6480464 tert-Butylhydroperoxide results in decreased expression of BCL2 protein CTD PMID:20510348 tert-butyl hydroperoxide affects localization EXP 6480464 tert-Butylhydroperoxide affects the localization of BCL2 protein CTD PMID:19772912 tert-butyl hydroperoxide decreases expression EXP 6480464 tert-Butylhydroperoxide results in decreased expression of BCL2 mRNA and tert-Butylhydroperoxide results in decreased expression of BCL2 protein CTD PMID:15569404 more ... tert-butyl hydroperoxide multiple interactions EXP 6480464 acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein] more ... CTD PMID:15569404 more ... tert-butyl hydroperoxide multiple interactions ISO BCL2 (Homo sapiens) 6480464 1-(3 more ... CTD PMID:15288519 more ... testosterone multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of BCL2 mRNA more ... CTD PMID:16139439 more ... testosterone multiple interactions EXP 6480464 chrysin inhibits the reaction [Testosterone results in increased expression of BCL2 mRNA] more ... CTD PMID:20574430 more ... testosterone increases expression EXP 6480464 Testosterone deficiency results in increased expression of BCL2 mRNA more ... CTD PMID:20850791 more ... testosterone increases expression ISO Bcl2 (Mus musculus) 6480464 Testosterone results in increased expression of BCL2 protein CTD PMID:18030663 testosterone multiple interactions ISO Bcl2 (Mus musculus) 6480464 gingerol inhibits the reaction [Testosterone results in increased expression of BCL2 protein] CTD PMID:18030663 testosterone increases expression ISO BCL2 (Homo sapiens) 6480464 Testosterone results in increased expression of BCL2 protein CTD PMID:18030663 testosterone decreases expression ISO BCL2 (Homo sapiens) 6480464 Testosterone results in decreased expression of BCL2 mRNA and Testosterone results in decreased expression of BCL2 protein CTD PMID:10455518 and PMID:21592394 testosterone enanthate increases expression EXP 6480464 testosterone enanthate results in increased expression of BCL2 mRNA and testosterone enanthate results in increased expression of BCL2 protein CTD PMID:30154949 and PMID:36015278 testosterone enanthate multiple interactions EXP 6480464 2-Methoxyestradiol inhibits the reaction [testosterone enanthate results in increased expression of BCL2 mRNA] more ... CTD PMID:30154949 and PMID:36015278 tetrachloroethene affects expression ISO BCL2 (Homo sapiens) 6480464 Tetrachloroethylene affects the expression of BCL2 protein CTD PMID:16010555 tetrachloroethene decreases expression ISO BCL2 (Homo sapiens) 6480464 Tetrachloroethylene results in decreased expression of BCL2 protein CTD PMID:12160929 tetrachlorohydroquinone decreases expression ISO BCL2 (Homo sapiens) 6480464 2 more ... CTD PMID:11064002 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of BCL2 mRNA CTD PMID:26062544 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of BCL2 protein CTD PMID:35236242 tetrachloromethane multiple interactions ISO BCL2 (Homo sapiens) 6480464 Clorgyline inhibits the reaction [Carbon Tetrachloride results in decreased expression of BCL2 protein] more ... CTD PMID:35202708 tetrachloromethane decreases expression ISO BCL2 (Homo sapiens) 6480464 Carbon Tetrachloride results in decreased expression of BCL2 protein CTD PMID:35202708 tetrachloromethane increases expression ISO Bcl2 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of BCL2 mRNA and Carbon Tetrachloride results in increased expression of BCL2 protein CTD PMID:25432964 more ... tetrachloromethane decreases expression ISO Bcl2 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of BCL2 mRNA and Carbon Tetrachloride results in decreased expression of BCL2 protein CTD PMID:23279844 more ... tetrachloromethane multiple interactions ISO Bcl2 (Mus musculus) 6480464 AK-1 compound inhibits the reaction [Carbon Tetrachloride results in decreased expression of BCL2 protein] more ... CTD PMID:23279844 more ... tetrachloromethane multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with Folic Acid] results in decreased expression of BCL2 mRNA more ... CTD PMID:16426832 more ... tetrahydropalmatine decreases expression ISO BCL2 (Homo sapiens) 6480464 tetrahydropalmatine results in decreased expression of BCL2 protein CTD PMID:20109541 tetramethylpyrazine multiple interactions EXP 6480464 tetramethylpyrazine inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2 protein] CTD PMID:21586279 tetrathiomolybdate(2-) increases expression ISO BCL2 (Homo sapiens) 6480464 tetrathiomolybdate analog results in increased expression of BCL2 mRNA and tetrathiomolybdate analog results in increased expression of BCL2 protein CTD PMID:19323979 tetrathiomolybdate(2-) decreases expression ISO BCL2 (Homo sapiens) 6480464 tetrathiomolybdate results in decreased expression of BCL2 protein CTD PMID:37290678 thalidomide multiple interactions ISO BCL2 (Homo sapiens) 6480464 [oblimersen co-treated with Thalidomide co-treated with Dexamethasone] results in decreased expression of BCL2 mRNA and [oblimersen co-treated with Thalidomide co-treated with Dexamethasone] results in decreased expression of BCL2 protein CTD PMID:15867202 thalidomide decreases expression ISO BCL2 (Homo sapiens) 6480464 Thalidomide results in decreased expression of BCL2 protein CTD PMID:15982930 thapsigargin increases expression ISO BCL2 (Homo sapiens) 6480464 Thapsigargin results in increased expression of BCL2 mRNA CTD PMID:22378314 thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of BCL2 protein CTD PMID:35028790 thapsigargin multiple interactions EXP 6480464 shikonin inhibits the reaction [Thapsigargin results in decreased expression of BCL2 protein] CTD PMID:35028790 thapsigargin multiple interactions ISO Bcl2 (Mus musculus) 6480464 4-(3-3 more ... CTD PMID:30841431 thapsigargin decreases expression ISO Bcl2 (Mus musculus) 6480464 Thapsigargin results in decreased expression of BCL2 protein CTD PMID:30841431 thapsigargin multiple interactions ISO BCL2 (Homo sapiens) 6480464 Thapsigargin promotes the reaction [arsenite results in decreased expression of BCL2 protein] CTD PMID:26677073 thapsigargin decreases expression ISO BCL2 (Homo sapiens) 6480464 Thapsigargin results in decreased expression of BCL2 protein CTD PMID:35033536 theaflavin multiple interactions ISO Bcl2 (Mus musculus) 6480464 theaflavin inhibits the reaction [Benzo(a)pyrene results in increased expression of BCL2 mRNA] CTD PMID:18656336 theophylline multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Theophylline co-treated with Cisplatin] results in decreased expression of BCL2 protein more ... CTD PMID:10891529 more ... theophylline decreases expression ISO BCL2 (Homo sapiens) 6480464 Theophylline results in decreased expression of BCL2 mRNA and Theophylline results in decreased expression of BCL2 protein CTD PMID:10877050 more ... thiamethoxam decreases expression ISO Bcl2 (Mus musculus) 6480464 Thiamethoxam results in decreased expression of BCL2 protein CTD PMID:33533595 thiamine(1+) chloride multiple interactions ISO Bcl2 (Mus musculus) 6480464 Thiamine inhibits the reaction [citreoviridin results in decreased expression of BCL2 protein] CTD PMID:31419397 thiamine(1+) chloride multiple interactions EXP 6480464 Thiamine inhibits the reaction [citreoviridin results in decreased expression of BCL2 protein] CTD PMID:31419397 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of BCL2 mRNA CTD PMID:29133031 and PMID:30138605 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of BCL2 protein CTD PMID:21885874 and PMID:34792689 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of BCL2 mRNA more ... CTD PMID:21885874 more ... thioacetamide multiple interactions ISO Bcl2 (Mus musculus) 6480464 [TXNIP gene mutant form co-treated with Thioacetamide] results in increased expression of BCL2 protein CTD PMID:20713078 thiostrepton decreases expression ISO BCL2 (Homo sapiens) 6480464 Thiostrepton results in decreased expression of BCL2 protein CTD PMID:22321511 Thiotepa decreases expression ISO BCL2 (Homo sapiens) 6480464 Thiotepa results in decreased expression of BCL2 protein CTD PMID:10822281 Thiotepa increases expression ISO BCL2 (Homo sapiens) 6480464 Thiotepa results in increased expression of BCL2 protein CTD PMID:10822281 Thiotepa increases cleavage ISO BCL2 (Homo sapiens) 6480464 Thiotepa results in increased cleavage of BCL2 protein CTD PMID:10822281 thymol decreases expression ISO BCL2 (Homo sapiens) 6480464 Thymol results in decreased expression of BCL2 protein CTD PMID:21640085 thymol multiple interactions EXP 6480464 Thymol inhibits the reaction [imidacloprid results in decreased expression of BCL2 mRNA] CTD PMID:34171690 thymol sulfate(1-) decreases expression ISO BCL2 (Homo sapiens) 6480464 Thymol results in decreased expression of BCL2 protein CTD PMID:21640085 thymol sulfate(1-) multiple interactions EXP 6480464 Thymol inhibits the reaction [imidacloprid results in decreased expression of BCL2 mRNA] CTD PMID:34171690 thymoquinone decreases expression ISO BCL2 (Homo sapiens) 6480464 thymoquinone results in decreased expression of BCL2 protein CTD PMID:21609759 more ... thymoquinone multiple interactions ISO Bcl2 (Mus musculus) 6480464 thymoquinone inhibits the reaction [Benzo(a)pyrene results in decreased expression of BCL2 protein] CTD PMID:36193556 thymoquinone multiple interactions EXP 6480464 thymoquinone affects the reaction [Ethanol affects the expression of BCL2 mRNA] more ... CTD PMID:29085585 more ... thymoquinone multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Benzo(a)pyrene co-treated with thymoquinone] results in decreased expression of BCL2 mRNA and DDIT3 protein affects the reaction [thymoquinone results in decreased expression of BCL2 protein] CTD PMID:24289642 and PMID:29981725 thyroxine multiple interactions EXP 6480464 Thyroxine inhibits the reaction [Propylthiouracil results in increased expression of BCL2 protein] CTD PMID:35101570 tigecycline multiple interactions EXP 6480464 tigecycline inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein] CTD PMID:23200736 tin(II) chloride (anhydrous) multiple interactions EXP 6480464 [stannous chloride results in increased activity of HMOX1 protein] which results in increased expression of BCL2 protein CTD PMID:16959961 Tiron multiple interactions ISO BCL2 (Homo sapiens) 6480464 1 more ... CTD PMID:17395010 titanium dioxide increases expression ISO Bcl2 (Mus musculus) 6480464 titanium dioxide results in increased expression of BCL2 mRNA CTD PMID:27760801 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of BCL2 mRNA CTD PMID:28844848 titanium dioxide multiple interactions EXP 6480464 morin inhibits the reaction [titanium dioxide results in decreased expression of BCL2 mRNA] CTD PMID:28844848 titanium dioxide multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Ferrosoferric Oxide binds to titanium dioxide] which results in decreased expression of BCL2 protein more ... CTD PMID:27226226 and PMID:30098274 titanium dioxide increases expression ISO BCL2 (Homo sapiens) 6480464 titanium dioxide results in increased expression of BCL2 mRNA and titanium dioxide results in increased expression of BCL2 protein CTD PMID:27226226 titanium dioxide decreases expression ISO BCL2 (Homo sapiens) 6480464 titanium dioxide results in decreased expression of BCL2 mRNA and titanium dioxide results in decreased expression of BCL2 protein CTD PMID:19486931 more ... titanium dioxide decreases expression ISO Bcl2 (Mus musculus) 6480464 titanium dioxide results in decreased expression of BCL2 mRNA and titanium dioxide results in decreased expression of BCL2 protein CTD PMID:20381595 tocopherol decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to Tocopherols CTD PMID:16001965 tocopherol increases expression ISO Bcl2 (Mus musculus) 6480464 Tocopherols results in increased expression of BCL2 mRNA and Tocopherols results in increased expression of BCL2 protein CTD PMID:8970189 Tomentosin decreases expression ISO BCL2 (Homo sapiens) 6480464 tomentosin results in decreased expression of BCL2 protein CTD PMID:27922187 more ... Tomentosin multiple interactions ISO BCL2 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [tomentosin results in decreased expression of BCL2 protein] CTD PMID:30917517 toosendanin decreases expression ISO BCL2 (Homo sapiens) 6480464 toosendanin results in decreased expression of BCL2 protein CTD PMID:23111283 topotecan decreases expression ISO BCL2 (Homo sapiens) 6480464 Topotecan results in decreased expression of BCL2 mRNA CTD PMID:17132110 trametinib multiple interactions ISO Bcl2 (Mus musculus) 6480464 [trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of BCL2 protein CTD PMID:37116855 tranexamic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 Tranexamic Acid inhibits the reaction [Rotenone results in decreased expression of BCL2 protein] CTD PMID:19539006 trans-anethole multiple interactions EXP 6480464 anethole inhibits the reaction [Isoproterenol results in increased expression of BCL2 mRNA] CTD PMID:35430261 trans-cinnamic acid multiple interactions EXP 6480464 cinnamic acid inhibits the reaction [Glucose results in decreased expression of BCL2 protein] CTD PMID:30144576 trans-piceid multiple interactions ISO Bcl2 (Mus musculus) 6480464 cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]] and polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA] CTD PMID:27481074 trans-piceid multiple interactions ISO BCL2 (Homo sapiens) 6480464 polydatin inhibits the reaction [Dopamine results in decreased expression of BCL2 protein] CTD PMID:28980048 tranylcypromine multiple interactions EXP 6480464 Tranylcypromine inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein] CTD PMID:19135049 triacetin multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Biofuels co-treated with Triacetin] results in decreased expression of BCL2 mRNA CTD PMID:30738890 triazoles decreases expression ISO BCL2 (Homo sapiens) 6480464 Triazoles analog results in decreased expression of BCL2 protein CTD PMID:32217108 tributylstannane affects expression ISO Bcl2 (Mus musculus) 6480464 tributyltin affects the expression of BCL2 protein CTD PMID:22223438 tributylstannane decreases expression ISO Bcl2 (Mus musculus) 6480464 tributyltin results in decreased expression of BCL2 protein CTD PMID:33720505 tributylstannane multiple interactions ISO Bcl2 (Mus musculus) 6480464 PRKCD gene mutant form inhibits the reaction [tributyltin results in decreased expression of BCL2 protein] CTD PMID:25895139 tributylstannane multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [tributyltin results in decreased expression of BCL2 protein] CTD PMID:26079211 tributylstannane decreases expression EXP 6480464 tributyltin results in decreased expression of BCL2 protein CTD PMID:23743147 more ... tributylstannane decreases expression ISO BCL2 (Homo sapiens) 6480464 tributyltin results in decreased expression of BCL2 protein CTD PMID:25743928 Tributyltin oxide decreases expression EXP 6480464 bis(tri-n-butyltin)oxide results in decreased expression of BCL2 mRNA CTD PMID:17553608 tributyrin decreases expression ISO BCL2 (Homo sapiens) 6480464 tributyrin results in decreased expression of BCL2 mRNA CTD PMID:11876963 tricetin multiple interactions ISO BCL2 (Homo sapiens) 6480464 tricetin inhibits the reaction [Oxidopamine results in decreased expression of BCL2 mRNA] and tricetin inhibits the reaction [Oxidopamine results in decreased expression of BCL2 protein] CTD PMID:31176653 trichlorfon multiple interactions ISO BCL2 (Homo sapiens) 6480464 Tetradecanoylphorbol Acetate inhibits the reaction [Trichlorfon results in decreased expression of BCL2 protein] CTD PMID:19631781 trichlorfon decreases expression ISO BCL2 (Homo sapiens) 6480464 Trichlorfon results in decreased expression of BCL2 protein CTD PMID:19631781 trichloroethene decreases expression ISO BCL2 (Homo sapiens) 6480464 Trichloroethylene results in decreased expression of BCL2 protein CTD PMID:12160929 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of BCL2 mRNA CTD PMID:33387578 trichloroethene increases activity ISO BCL2 (Homo sapiens) 6480464 Trichloroethylene results in increased activity of BCL2 protein CTD PMID:12160929 trichostatin A decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to trichostatin A CTD PMID:21527555 trichostatin A increases expression ISO BCL2 (Homo sapiens) 6480464 trichostatin A results in increased expression of BCL2 mRNA CTD PMID:24935251 trichostatin A multiple interactions EXP 6480464 trichostatin A inhibits the reaction [Benzene results in decreased expression of BCL2 mRNA] CTD PMID:21143203 trichostatin A multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Plant Extracts co-treated with trichostatin A] results in decreased expression of BCL2 protein more ... CTD PMID:18709356 and PMID:19887557 trichostatin A decreases expression ISO BCL2 (Homo sapiens) 6480464 trichostatin A results in decreased expression of BCL2 mRNA and trichostatin A results in decreased expression of BCL2 protein CTD PMID:16010430 more ... triclosan decreases expression ISO BCL2 (Homo sapiens) 6480464 Triclosan results in decreased expression of BCL2 mRNA CTD PMID:30510588 triclosan increases expression ISO BCL2 (Homo sapiens) 6480464 Triclosan results in increased expression of BCL2 mRNA CTD PMID:34681664 triclosan decreases expression ISO Bcl2 (Mus musculus) 6480464 Triclosan results in decreased expression of BCL2 protein CTD PMID:34160118 trifluoperazine decreases expression ISO BCL2 (Homo sapiens) 6480464 Trifluoperazine results in decreased expression of BCL2 protein CTD PMID:21475906 trilobatin multiple interactions EXP 6480464 trilobatin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] CTD PMID:30104959 trimethyltin decreases expression ISO Bcl2 (Mus musculus) 6480464 trimethyltin results in decreased expression of BCL2 protein CTD PMID:25895139 and PMID:26756313 trimethyltin multiple interactions ISO Bcl2 (Mus musculus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin inhibits the reaction [trimethyltin results in decreased expression of BCL2 protein]] more ... CTD PMID:25895139 and PMID:26756313 triphenyl phosphate decreases expression ISO Bcl2 (Mus musculus) 6480464 triphenyl phosphate results in decreased expression of BCL2 protein CTD PMID:37149271 triphenylstannane decreases expression ISO BCL2 (Homo sapiens) 6480464 triphenyltin results in decreased expression of BCL2 protein CTD PMID:25743928 Triptolide decreases expression EXP 6480464 triptolide results in decreased expression of BCL2 protein CTD PMID:25169008 more ... Triptolide decreases expression ISO BCL2 (Homo sapiens) 6480464 triptolide results in decreased expression of BCL2 protein CTD PMID:30394310 Triptolide increases expression ISO Bcl2 (Mus musculus) 6480464 triptolide results in increased expression of BCL2 protein CTD PMID:26990902 Triptolide multiple interactions ISO Bcl2 (Mus musculus) 6480464 ABCB1A mutant form promotes the reaction [triptolide results in decreased expression of BCL2 protein] more ... CTD PMID:26134275 more ... Triptolide decreases expression ISO Bcl2 (Mus musculus) 6480464 triptolide results in decreased expression of BCL2 protein CTD PMID:25169008 more ... Triptolide affects expression EXP 6480464 triptolide affects the expression of BCL2 protein CTD PMID:26277538 Triptolide multiple interactions EXP 6480464 Lithium Chloride inhibits the reaction [triptolide results in decreased expression of BCL2 protein] more ... CTD PMID:25169008 more ... triptonide decreases expression ISO BCL2 (Homo sapiens) 6480464 triptonide results in decreased expression of BCL2 protein CTD PMID:28666825 troglitazone multiple interactions ISO BCL2 (Homo sapiens) 6480464 [troglitazone co-treated with Tretinoin] results in decreased expression of BCL2 protein CTD PMID:9671760 troglitazone decreases expression ISO BCL2 (Homo sapiens) 6480464 troglitazone results in decreased expression of BCL2 mRNA and troglitazone results in decreased expression of BCL2 protein CTD PMID:15100737 more ... troglitazone increases expression EXP 6480464 troglitazone results in increased expression of BCL2 protein CTD PMID:12840598 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of BCL2 mRNA CTD PMID:15767042 Tubeimoside I multiple interactions ISO BCL2 (Homo sapiens) 6480464 [tubeimoside I co-treated with Cisplatin] results in decreased expression of BCL2 protein CTD PMID:21687949 tubocurarine multiple interactions ISO BCL2 (Homo sapiens) 6480464 Tubocurarine inhibits the reaction [PTMA protein results in decreased expression of BCL2] CTD PMID:16644063 tunicamycin decreases expression ISO Bcl2 (Mus musculus) 6480464 Tunicamycin results in decreased expression of BCL2 mRNA CTD PMID:17127020 tunicamycin increases expression ISO BCL2 (Homo sapiens) 6480464 Tunicamycin results in increased expression of BCL2 mRNA CTD PMID:33545341 tunicamycin increases expression ISO Bcl2 (Mus musculus) 6480464 Tunicamycin results in increased expression of BCL2 mRNA CTD PMID:17127020 tyrphostin AG 1478 multiple interactions ISO BCL2 (Homo sapiens) 6480464 ESR1 protein alternative form promotes the reaction [RTKI cpd inhibits the reaction [Estradiol results in increased expression of BCL2 protein]] and RTKI cpd inhibits the reaction [Estradiol results in increased expression of BCL2 protein] CTD PMID:34724321 umbelliferone decreases expression ISO BCL2 (Homo sapiens) 6480464 7-hydroxycoumarin results in decreased expression of BCL2 protein CTD PMID:15964220 umbelliferone multiple interactions EXP 6480464 2 more ... CTD PMID:34409680 urethane multiple interactions ISO Bcl2 (Mus musculus) 6480464 IFNG protein inhibits the reaction [Urethane results in decreased expression of BCL2 mRNA] CTD PMID:11091364 urethane decreases expression ISO Bcl2 (Mus musculus) 6480464 Urethane results in decreased expression of BCL2 mRNA CTD PMID:11091364 ursodeoxycholic acid multiple interactions EXP 6480464 Ursodeoxycholic Acid inhibits the reaction [Rotenone results in decreased expression of BCL2 mRNA] more ... CTD PMID:14514686 and PMID:25502462 ursodeoxycholic acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 Ursodeoxycholic Acid inhibits the reaction [[Isoniazid co-treated with Rifampin] results in decreased expression of BCL2 protein] CTD PMID:21419764 ursodeoxycholic acid decreases expression EXP 6480464 Ursodeoxycholic Acid results in decreased expression of BCL2 protein CTD PMID:15970352 ursodeoxycholic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 Ursodeoxycholic Acid results in decreased expression of BCL2 CTD PMID:17461466 ursolic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 Ursolic Acid results in decreased expression of BCL2 mRNA and Ursolic Acid results in decreased expression of BCL2 protein CTD PMID:16012738 and PMID:28868958 ursolic acid increases phosphorylation ISO BCL2 (Homo sapiens) 6480464 Ursolic Acid results in increased phosphorylation of BCL2 protein CTD PMID:24802810 ursolic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Ursolic Acid results in increased phosphorylation of BCL2 protein] inhibits the reaction [BCL2 protein binds to BECN1 protein] more ... CTD PMID:24802810 and PMID:36587836 usnic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 usnic acid results in decreased expression of BCL2 protein CTD PMID:22285236 more ... valproic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Cisplatin co-treated with Pemetrexed co-treated with Valproic Acid] results in decreased expression of BCL2 protein more ... CTD PMID:19351772 more ... valproic acid increases expression ISO BCL2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of BCL2 mRNA CTD PMID:19101580 more ... valproic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of BCL2 mRNA CTD PMID:23179753 valproic acid multiple interactions EXP 6480464 Valproic Acid inhibits the reaction [Methamphetamine results in decreased expression of BCL2 protein] and Valproic Acid inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 protein] CTD PMID:19149911 and PMID:22711276 valproic acid decreases response to substance ISO Bcl2 (Mus musculus) 6480464 BCL2 protein results in decreased susceptibility to Valproic Acid CTD PMID:19060243 valproic acid increases expression ISO Bcl2 (Mus musculus) 6480464 Valproic Acid results in increased expression of BCL2 mRNA CTD PMID:9098922 valproic acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 4-benzyl-2-methyl-1 more ... CTD PMID:19060243 and PMID:25453207 valsartan multiple interactions ISO Bcl2 (Mus musculus) 6480464 Valsartan inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein] CTD PMID:29266779 valsartan multiple interactions EXP 6480464 Valsartan inhibits the reaction [Cyclophosphamide results in decreased expression of BCL2 protein] and Valsartan inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] CTD PMID:32197949 and PMID:34273911 vanadyl sulfate decreases expression ISO BCL2 (Homo sapiens) 6480464 vanadyl sulfate results in decreased expression of BCL2 protein CTD PMID:30407648 vancomycin multiple interactions EXP 6480464 JBP 485 inhibits the reaction [Vancomycin results in decreased expression of BCL2 protein] CTD PMID:29964132 vancomycin decreases expression EXP 6480464 Vancomycin results in decreased expression of BCL2 protein CTD PMID:29964132 vemurafenib multiple interactions ISO BCL2 (Homo sapiens) 6480464 [(+)-JQ1 compound co-treated with vemurafenib] results in decreased expression of BCL2 mRNA CTD PMID:27169980 venetoclax decreases activity ISO BCL2 (Homo sapiens) 6480464 venetoclax results in decreased activity of BCL2 protein CTD PMID:26214592 venetoclax multiple interactions ISO BCL2 (Homo sapiens) 6480464 [9H-purine-9-propanamine more ... CTD PMID:30647404 and PMID:37754227 venetoclax decreases expression ISO BCL2 (Homo sapiens) 6480464 venetoclax results in decreased expression of BCL2 protein CTD PMID:37754227 venlafaxine hydrochloride decreases expression EXP 6480464 Venlafaxine Hydrochloride results in decreased expression of BCL2 mRNA CTD PMID:25423262 venlafaxine hydrochloride multiple interactions EXP 6480464 Chloroquine inhibits the reaction [Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased expression of BCL2 protein]] more ... CTD PMID:29852128 and PMID:35104487 venom decreases expression ISO BCL2 (Homo sapiens) 6480464 Viper Venoms results in decreased expression of BCL2 mRNA and Viper Venoms results in decreased expression of BCL2 protein CTD PMID:25417048 and PMID:27613483 verapamil multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Temozolomide co-treated with Verapamil] results in decreased expression of BCL2 mRNA more ... CTD PMID:24373880 and PMID:30003979 verapamil decreases expression ISO BCL2 (Homo sapiens) 6480464 Verapamil results in decreased expression of BCL2 mRNA and Verapamil results in decreased expression of BCL2 protein CTD PMID:30003979 Vernodalin decreases expression ISO BCL2 (Homo sapiens) 6480464 vernodalin results in decreased expression of BCL2 protein CTD PMID:32726518 verteporfin multiple interactions EXP 6480464 Verteporfin inhibits the reaction [Melatonin inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]] CTD PMID:35093381 Vicanicin decreases expression ISO BCL2 (Homo sapiens) 6480464 vicanicin results in decreased expression of BCL2 protein CTD PMID:22063921 vildagliptin multiple interactions EXP 6480464 [dapagliflozin co-treated with Vildagliptin] inhibits the reaction [Dietary Fats results in decreased expression of BCL2 protein] and Vildagliptin inhibits the reaction [Dietary Fats results in decreased expression of BCL2 protein] CTD PMID:28807765 vinclozolin increases expression ISO BCL2 (Homo sapiens) 6480464 vinclozolin results in increased expression of BCL2 protein CTD PMID:36498866 vincristine decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to Vincristine CTD PMID:20162574 vincristine decreases expression EXP 6480464 Vincristine results in decreased expression of BCL2 mRNA CTD PMID:33038355 and PMID:36808657 vincristine multiple interactions EXP 6480464 Quercetin inhibits the reaction [Vincristine results in decreased expression of BCL2 mRNA] CTD PMID:33038355 vincristine multiple interactions ISO Bcl2 (Mus musculus) 6480464 KN 93 inhibits the reaction [Vincristine results in decreased expression of BCL2 mRNA] and KN 93 inhibits the reaction [Vincristine results in decreased expression of BCL2 protein] CTD PMID:34286406 vincristine decreases expression ISO Bcl2 (Mus musculus) 6480464 Vincristine results in decreased expression of BCL2 mRNA and Vincristine results in decreased expression of BCL2 protein CTD PMID:34286406 vincristine increases phosphorylation ISO BCL2 (Homo sapiens) 6480464 Vincristine results in increased phosphorylation of BCL2 protein CTD PMID:15907805 vincristine multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Doxorubicin co-treated with Dexamethasone co-treated with Vincristine co-treated with Cytarabine co-treated with Mercaptopurine co-treated with Methotrexate co-treated with Cyclophosphamide co-treated with Enzymes and Coenzymes] results in increased expression of BCL2 protein more ... CTD PMID:15907805 more ... vindesine multiple interactions ISO BCL2 (Homo sapiens) 6480464 Tamoxifen promotes the reaction [Vindesine results in increased expression of BCL2 mRNA] CTD PMID:19757172 vindesine increases expression ISO BCL2 (Homo sapiens) 6480464 Vindesine results in increased expression of BCL2 mRNA CTD PMID:19757172 vismodegib decreases expression ISO BCL2 (Homo sapiens) 6480464 HhAntag691 results in decreased expression of BCL2 protein CTD PMID:22087285 vismodegib multiple interactions ISO BCL2 (Homo sapiens) 6480464 [GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in decreased expression of BCL2 protein] CTD PMID:22087285 vitamin D decreases expression ISO BCL2 (Homo sapiens) 6480464 Vitamin D results in decreased expression of BCL2 mRNA CTD PMID:36442531 vitamin E multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Vitamin E co-treated with Curcumin] results in decreased expression of BCL2 protein and Vitamin E inhibits the reaction [cinnamaldehyde results in decreased expression of BCL2 protein] CTD PMID:15566391 and PMID:30935902 vitamin E increases expression EXP 6480464 Vitamin E results in increased expression of BCL2 mRNA CTD PMID:27353299 vitamin E multiple interactions EXP 6480464 [Vitamin E co-treated with Folic Acid] affects the expression of BCL2 protein more ... CTD PMID:16933212 more ... vitexin multiple interactions ISO Bcl2 (Mus musculus) 6480464 vitexin inhibits the reaction [APP protein modified form results in decreased expression of BCL2 protein] CTD PMID:29545167 vorinostat multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Bortezomib co-treated with vorinostat] results in increased cleavage of BCL2 protein more ... CTD PMID:15173093 more ... vorinostat multiple interactions ISO Bcl2 (Mus musculus) 6480464 ABT-737 inhibits the reaction [BCL2 protein results in decreased susceptibility to vorinostat] CTD PMID:19060243 vorinostat decreases response to substance ISO Bcl2 (Mus musculus) 6480464 BCL2 protein results in decreased susceptibility to vorinostat CTD PMID:19060243 vorinostat decreases expression EXP 6480464 vorinostat results in decreased expression of BCL2 protein CTD PMID:18310471 vorinostat multiple interactions EXP 6480464 [vorinostat co-treated with MYC protein] results in decreased expression of BCL2 mRNA more ... CTD PMID:17331788 and PMID:22711276 vorinostat decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to vorinostat and BCL2 results in decreased susceptibility to vorinostat CTD PMID:10597302 more ... vorinostat decreases expression ISO BCL2 (Homo sapiens) 6480464 vorinostat results in decreased expression of BCL2 mRNA and vorinostat results in decreased expression of BCL2 protein CTD PMID:15897598 more ... warfarin multiple interactions EXP 6480464 [Warfarin co-treated with Vitamin K 1] results in decreased expression of BCL2 protein and Vitamin K 2 inhibits the reaction [[Warfarin co-treated with Vitamin K 1] results in decreased expression of BCL2 protein] CTD PMID:27212383 water multiple interactions ISO Bcl2 (Mus musculus) 6480464 [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of BCL2 mRNA CTD PMID:29335169 WIN 55212-2 decreases expression ISO Bcl2 (Mus musculus) 6480464 (3R)-((2 more ... CTD PMID:26967640 withaferin A decreases expression ISO BCL2 (Homo sapiens) 6480464 withaferin A results in decreased expression of BCL2 protein CTD PMID:20438634 more ... withaferin A multiple interactions EXP 6480464 withaferin A inhibits the reaction [Cholesterol and Dietary results in decreased expression of BCL2 protein] CTD PMID:35734936 wogonin multiple interactions ISO BCL2 (Homo sapiens) 6480464 [wogonin co-treated with Fluorouracil] results in decreased expression of BCL2 protein CTD PMID:20570612 wogonin decreases expression ISO BCL2 (Homo sapiens) 6480464 wogonin results in decreased expression of BCL2 protein CTD PMID:20570612 wortmannin multiple interactions ISO BCL2 (Homo sapiens) 6480464 Wortmannin inhibits the reaction [[Hydrogen Peroxide co-treated with Arsenic Trioxide] results in decreased expression of BCL2 protein] more ... CTD PMID:15142122 more ... wortmannin multiple interactions EXP 6480464 Wortmannin inhibits the reaction [[1 more ... CTD PMID:19703415 and PMID:30542433 xanthohumol decreases expression ISO BCL2 (Homo sapiens) 6480464 xanthohumol results in decreased expression of BCL2 and xanthohumol results in decreased expression of BCL2 protein CTD PMID:15995977 more ... xanthohumol multiple interactions EXP 6480464 xanthohumol inhibits the reaction [Azoxymethane results in increased expression of BCL2 protein] CTD PMID:31714664 Xanthorrhizol decreases expression ISO BCL2 (Homo sapiens) 6480464 xanthorrhizol results in decreased expression of BCL2 protein CTD PMID:34664399 xenon atom increases expression EXP 6480464 Xenon results in increased expression of BCL2 protein CTD PMID:16034370 xenon(0) increases expression EXP 6480464 Xenon results in increased expression of BCL2 protein CTD PMID:16034370 Y-27632 multiple interactions ISO BCL2 (Homo sapiens) 6480464 Y 27632 inhibits the reaction [Cisplatin results in decreased expression of BCL2 mRNA] CTD PMID:20878077 Y-27632 increases expression ISO BCL2 (Homo sapiens) 6480464 Y 27632 results in increased expression of BCL2 mRNA CTD PMID:20878077 ytterbium decreases expression ISO BCL2 (Homo sapiens) 6480464 Ytterbium analog results in decreased expression of BCL2 protein CTD PMID:19632212 zearalenone decreases expression ISO Bcl2 (Mus musculus) 6480464 Zearalenone results in decreased expression of BCL2 mRNA and Zearalenone results in decreased expression of BCL2 protein CTD PMID:21767629 more ... zearalenone decreases expression EXP 6480464 Zearalenone results in decreased expression of BCL2 mRNA and Zearalenone results in decreased expression of BCL2 protein CTD PMID:30600648 more ... zearalenone increases expression ISO BCL2 (Homo sapiens) 6480464 Zearalenone results in increased expression of BCL2 mRNA CTD PMID:28965971 zebularine affects cleavage ISO BCL2 (Homo sapiens) 6480464 pyrimidin-2-one beta-ribofuranoside affects the cleavage of BCL2 protein CTD PMID:19459041 zebularine decreases expression ISO BCL2 (Homo sapiens) 6480464 pyrimidin-2-one beta-ribofuranoside results in decreased expression of BCL2 protein CTD PMID:23320119 zerumbone decreases expression ISO BCL2 (Homo sapiens) 6480464 zerumbone analog results in decreased expression of BCL2 protein and zerumbone results in decreased expression of BCL2 mRNA CTD PMID:16007145 and PMID:28987329 zerumbone multiple interactions EXP 6480464 zerumbone inhibits the reaction [[2-aminofluorene co-treated with Diethylnitrosamine] results in increased expression of BCL2 protein] CTD PMID:20452335 zidovudine affects response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein affects the susceptibility to Zidovudine CTD PMID:9850737 zidovudine increases expression EXP 6480464 Zidovudine results in increased expression of BCL2 mRNA CTD PMID:29594326 zidovudine decreases expression ISO BCL2 (Homo sapiens) 6480464 Zidovudine results in decreased expression of BCL2 mRNA CTD PMID:17696246 zidovudine multiple interactions ISO BCL2 (Homo sapiens) 6480464 Drugs and Chinese Herbal promotes the reaction [Zidovudine results in decreased expression of BCL2 mRNA] CTD PMID:17696246 zidovudine increases expression ISO BCL2 (Homo sapiens) 6480464 Zidovudine results in increased expression of BCL2 mRNA CTD PMID:9850737 zidovudine multiple interactions ISO Bcl2 (Mus musculus) 6480464 [Zidovudine co-treated with Lamivudine] results in decreased expression of BCL2 mRNA CTD PMID:18313992 zinc atom multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of BCL2 mRNA more ... CTD PMID:16979875 more ... zinc atom decreases expression ISO Bcl2 (Mus musculus) 6480464 Zinc deficiency results in decreased expression of BCL2 protein CTD PMID:20101602 zinc atom affects expression ISO BCL2 (Homo sapiens) 6480464 Zinc affects the expression of BCL2 mRNA CTD PMID:12107073 and PMID:16979875 zinc atom increases expression EXP 6480464 Zinc results in increased expression of BCL2 protein CTD PMID:16799065 zinc atom multiple interactions EXP 6480464 6-hydroxy-2 more ... CTD PMID:16799065 and PMID:31009641 zinc atom decreases expression ISO BCL2 (Homo sapiens) 6480464 Zinc deficiency results in decreased expression of BCL2 protein and Zinc results in decreased expression of BCL2 protein CTD PMID:16472982 and PMID:21600978 zinc dichloride multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Citric Acid co-treated with zinc chloride] results in decreased expression of BCL2 protein more ... CTD PMID:16624386 more ... zinc dichloride multiple interactions ISO Bcl2 (Mus musculus) 6480464 zinc chloride inhibits the reaction [Doxorubicin results in increased expression of BCL2 mRNA] CTD PMID:19714248 zinc molecular entity decreases expression ISO BCL2 (Homo sapiens) 6480464 Zinc Compounds results in decreased expression of BCL2 mRNA and Zinc Compounds results in decreased expression of BCL2 protein CTD PMID:24035972 zinc oxide decreases expression ISO Bcl2 (Mus musculus) 6480464 Zinc Oxide analog results in decreased expression of BCL2 mRNA more ... CTD PMID:24614525 more ... zinc oxide multiple interactions EXP 6480464 lead acetate promotes the reaction [Zinc Oxide results in decreased expression of BCL2 mRNA] and Zinc Oxide promotes the reaction [lead acetate results in decreased expression of BCL2 mRNA] CTD PMID:34553816 zinc oxide decreases expression EXP 6480464 Zinc Oxide results in decreased expression of BCL2 mRNA CTD PMID:34553816 zinc oxide increases expression ISO Bcl2 (Mus musculus) 6480464 Zinc Oxide results in increased expression of BCL2 mRNA CTD PMID:33236829 zinc oxide decreases expression ISO BCL2 (Homo sapiens) 6480464 Zinc Oxide analog results in decreased expression of BCL2 protein CTD PMID:27544635 zinc oxide multiple interactions ISO BCL2 (Homo sapiens) 6480464 Thioctic Acid inhibits the reaction [Zinc Oxide analog results in decreased expression of BCL2 protein] CTD PMID:27544635 zinc protoporphyrin multiple interactions ISO Bcl2 (Mus musculus) 6480464 zinc protoporphyrin inhibits the reaction [2-(3-benzoyl)-4-hydroxy-1 more ... CTD PMID:22763982 and PMID:27523796 zinc protoporphyrin multiple interactions EXP 6480464 zinc protoporphyrin inhibits the reaction [Tadalafil inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]] CTD PMID:32621855 zinc sulfate increases expression EXP 6480464 Zinc Sulfate results in increased expression of BCL2 protein CTD PMID:16799065 zinc sulfate multiple interactions ISO BCL2 (Homo sapiens) 6480464 Zinc Sulfate inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] CTD PMID:20096349 zinc sulfate multiple interactions EXP 6480464 6-hydroxy-2 more ... CTD PMID:16799065 zinc(0) multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of BCL2 mRNA more ... CTD PMID:16979875 more ... zinc(0) decreases expression ISO BCL2 (Homo sapiens) 6480464 Zinc deficiency results in decreased expression of BCL2 protein and Zinc results in decreased expression of BCL2 protein CTD PMID:16472982 and PMID:21600978 zinc(0) multiple interactions EXP 6480464 6-hydroxy-2 more ... CTD PMID:16799065 and PMID:31009641 zinc(0) increases expression EXP 6480464 Zinc results in increased expression of BCL2 protein CTD PMID:16799065 zinc(0) affects expression ISO BCL2 (Homo sapiens) 6480464 Zinc affects the expression of BCL2 mRNA CTD PMID:12107073 and PMID:16979875 zinc(0) decreases expression ISO Bcl2 (Mus musculus) 6480464 Zinc deficiency results in decreased expression of BCL2 protein CTD PMID:20101602 zingerone multiple interactions EXP 6480464 zingerone inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BCL2 mRNA] more ... CTD PMID:28442378 and PMID:36822304 zingerone increases expression EXP 6480464 zingerone results in increased expression of BCL2 mRNA CTD PMID:36822304 zingerone decreases expression ISO BCL2 (Homo sapiens) 6480464 zingerone results in decreased expression of BCL2 protein CTD PMID:31476248 ziram decreases expression EXP 6480464 Ziram results in decreased expression of BCL2 protein CTD PMID:28973382 zoledronic acid decreases response to substance ISO BCL2 (Homo sapiens) 6480464 BCL2 protein results in decreased susceptibility to zoledronic acid CTD PMID:11986784 zoledronic acid multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Tretinoin co-treated with zoledronic acid] results in decreased expression of BCL2 protein and [zoledronic acid co-treated with docetaxel] results in decreased expression of BCL2 protein CTD PMID:19103299 and PMID:20349282 zoledronic acid decreases expression ISO BCL2 (Homo sapiens) 6480464 zoledronic acid results in decreased expression of BCL2 mRNA CTD PMID:24714768 and PMID:28871336 zoledronic acid affects expression ISO BCL2 (Homo sapiens) 6480464 zoledronic acid affects the expression of BCL2 mRNA CTD PMID:19036117 zoledronic acid increases expression ISO BCL2 (Homo sapiens) 6480464 Zoledronic Acid results in increased expression of BCL2 mRNA CTD PMID:18225567 and PMID:35587103 zoledronic acid multiple interactions ISO Bcl2 (Mus musculus) 6480464 [zoledronic acid co-treated with Doxorubicin] results in decreased expression of BCL2 protein CTD PMID:19789217 zoledronic acid decreases expression ISO Bcl2 (Mus musculus) 6480464 zoledronic acid results in decreased expression of BCL2 mRNA CTD PMID:28871336 zolmitriptan multiple interactions EXP 6480464 zolmitriptan inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 mRNA] and zolmitriptan inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein] CTD PMID:31129132 zoxamide multiple interactions ISO BCL2 (Homo sapiens) 6480464 [Sulfur co-treated with zoxamide co-treated with metrafenone] results in decreased expression of BCL2 mRNA CTD PMID:35564597